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 i 
Abstract 
Land contamination is an issue of concern in land regeneration and the built environment. To 
ensure the sustainability of the built environment, it is important that the risk to human health due 
to land contamination is addressed adequately. Current generic assessment criteria (GAC) values 
used in the assessment of contaminated land in the United Kingdom (UK) are very conservative. 
Although this is protective of human health, it may lead to un-necessary and costly remediation of 
land or result in land being left un-used. This highlights the need for improved understanding of 
human exposure to soil contaminants, which this work sought to promote.  
This thesis presents findings from our assessment of human exposure to five toxic elements; 
arsenic (As), cadmium (Cd), chromium (Cr), lead (Pb) and nickel (Ni), carried out using 
individuals who grow and consume their allotment produce. The primary exposure pathway 
investigated was oral ingestion through the consumption of produce. Concentrations of these 
elements were measured in samples of soil and produce. Site-specific risk assessment carried out 
using element concentrations and participants’ produce consumption data indicated no significant 
health risk to the participants. During the risk assessment process, it is necessary that element 
bioaccessibility values are determined and considered in the assessment to ensure that the risk is 
not over-estimated.  
To improve our understanding of actual human exposure to these elements though the oral 
ingestion pathway, we carried out biomonitoring and produced human physiologically-based 
kinetic models to assess internal exposure to these elements. Measured concentrations of blood Pb 
and urinary As, Cd, Cr and Ni were similar to the corresponding levels in the general (non-
occupationally exposed) populations in the UK; indicating that the participants were not exposed to 
these elements at levels importantly higher than other adults in the UK. In addition, this indicates 
that participants’ consumption of allotment produce did not result in them having significant 
additional exposure to the elements. The models, implemented in MATLAB, predicted the 
literature data and our biomonitoring data well. Because these models are capable of predicting 
internal exposure to these elements, they improve our understanding of exposure to the elements, 
which is important in the sustainable management of land contamination. To our knowledge, it is 
the first time combined biomonitoring and physiologically-based models for the five toxic elements 
have been used to assess exposure among allotment users.  
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Glossary 
Terms that may not be familiar to the reader or that have specific connotations in this thesis are 
defined in this glossary.  
 
Allotment A householder’s small horticultural plot of land.  
Bioaccessibility Oral bioaccessibility, which is the fraction of a substance that is soluble in 
the gastrointestinal environment and therefore is potentially available for 
absorption.  
Bioavailability Oral bioavailability, which refers to the fraction of the ingested 
contaminant that can enter the systematic circulation of the human body 
from the gastrointestinal tract. 
Biomarker A substance or its metabolite in a human biological specimen (e.g., urine, 
blood, body tissue), which reflect exposure to that substance.  
Biomonitoring The assessment of an individual’s exposure to a substance through the 
measurement of a biomarker.  
Brownfield Previously developed land that may have been contaminated as a result of 
its past usage.  
Creatinine A chemical compound generated from muscle metabolism of creatine (an 
important energy store for muscles). The production of creatinine is 
relatively constant within an individual, thus creatinine is commonly used 
to adjustment element concentrations in urine samples to account for 
variability in urine volume.  
Exposure frequency The number of days per year in which a daily exposure event is considered 
to occur. 
Hazard quotient A ratio of the potential exposure to a chemical substance to the reference 
level at which no adverse effects are expected to occur in an individual 
exposed to that substance.  
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1. INTRODUCTION 
1.1 Project background 
Land contamination is a common problem associated with land regeneration and the built 
environment. Sources of land contamination include natural processes and anthropogenic activities 
such as past or present land uses. In the United Kingdom (UK), the re-use of so-called ‘brownfield’ 
sites is important to the nation’s sustainable development goals (Dixon, Otsuka & Abe, 2011). 
Remarkably, brownfield sites are increasingly being regenerated with new development (Adams, 
Sousa & Tiesdell, 2010; Dixon, 2007). The increased re-use of brownfield sites could lead to 
human exposure to soil contaminants.  
The assessment of risk to contaminated land involves identifying the link between a source of 
contamination, exposure pathway(s) and receptor(s) (Environment Agency, 2004). Therefore, a 
clear understanding of exposure is crucial in carrying out a comprehensive risk assessment. 
However, current models used in contaminated land exposure assessments, such as the 
‘Contaminated Land Exposure Assessment (CLEA)’ model used in the UK, are highly conservative 
because many of the model input parameters are based on conservative measurements 
(Environment Agency, 2009e). This could lead to over-estimation of human exposure to soil 
contaminants, which may subsequently result in negative financial implications through un-
necessary costly remediation (Gbefa, Entwistle & Dean, 2011) or restrictions on land-use. This 
highlights the need for improved understanding of human exposure to soil contaminants; this 
research was conceived in response to this need.  
1.1.1 Project partners and funding 
This Engineering Doctorate (EngD) research project arose from the collaboration between the 
University of Reading and the Institute of Occupational Medicine (IOM). IOM is one of the leading 
providers of workplace health research and consultancy services, with expertise extending across a 
very wide range of scientific disciplines. The main focus of IOM’s work is associated with 
understanding and minimising the risks to human health from hazards in the workplace and in the 
wider environment. As part of their work, IOM advises their clients on human health risks 
associated with contaminated land and brownfield redevelopment according to Part IIA of the 
Environmental Protection Act (1990).  
This research was funded by the UK Engineering and Physical Sciences Research Council 
(EPSRC), through the Technologies for Sustainable Built Environments (TSBE) Centre at the 
University of Reading. Additional financial support was provided by the IOM.   
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1.1.2 Project setting 
The occurrence of toxic elements is common in the urban environment, including urban allotments 
and gardens (Bechet et al., 2016; Alloway, 2004). In the UK, there is an increasing demand for 
allotments to meet the needs of urban dwellers wanting to grow their own food. Fruits and 
vegetables grown in contaminated soil may result in human exposure to toxic elements through the 
consumption of home-grown produce. Allotment land-use was selected as a case study for this 
project. The study was limited to sites located in Scotland, UK.  
Although a wide range of toxic elements can be present in soil, this project focused on arsenic (As), 
cadmium (Cd), chromium (Cr), lead (Pb), and nickel (Ni). These elements were selected because 
they are common in soil, and due to IOM’s interest in studying human exposure to these elements. 
Exposure to these elements can cause various adverse impacts on human health, including cancer, 
damage to liver, kidney and other organs (Kumar et al., 2016; Zheng et al., 2007; Jarup, 2003). The 
International Agency for Research on Cancer (IARC) classifies As, Cd, Cr and Ni as Group 1 
human carcinogens (IARC, 2012).  
1.2 Aim and objectives 
Using biomonitoring and physiologically-based pharmacokinetic (PBPK) models, the aim of this 
research was “to investigate the level of human exposure to the selected elements in soil, with a 
view of improving our understanding of actual exposure to these elements”. This is linked to 
IOM’s need to build their capacity in biomonitoring of these elements to support their exposure 
assessment work.  
The objectives were:  
1. To carry out a literature review to establish current knowledge relating to human exposure 
to As, Cd, Cr, Pb and Ni in soil (focusing on allotment land-use), bioaccessibility of these 
elements in humans, application of biomonitoring and PBPK models in exposure studies, 
and identify knowledge gap to be addressed.  
2. To identify allotment sites for the study and recruit site users to participate in the study. 
3. To determine the elements’ concentrations at the study sites, through allotment sampling 
and subsequent samples analysis.  
4. To carry out biomonitoring (collection of biological samples and determination of element 
biomarker concentrations).  
5. To produce human physiologically-based kinetic models for the elements using existing 
models published in the literature, evaluate the predictive performance of these models, 
and subsequently apply the models in estimating exposure to the elements through the oral 
ingestion pathway.  
 3 
These objectives are mapped against the thesis chapter structure in section 1.5. 
1.3 Hypotheses 
The following hypotheses were tested in various chapters of this thesis.  
(h1) There is a good correlation between element concentrations in allotment soil and the 
corresponding element concentrations in produce (chapter 4).  
(h2) The levels of the elements in blood and urine samples obtained from the participants are 
similar to the local background levels (chapter 5).  
(h3) PBPK model predicted element concentrations in blood and urine are good indicators of 
the corresponding measured biomarker concentrations (chapters 6 and 7).  
1.4 Ethical approval 
The University of Reading ‘Code of Good Practice in Research’ requires every research involving 
human participants, human material and personal data to be subject to ethical approval before the 
research can proceed. Therefore, in compliance with the university requirements and the ‘Human 
Tissue (Scotland) Act 2006’, a comprehensive study protocol was prepared and submitted to the 
University Research Ethics Committee (UREC) as part of the ethical approval process. UREC 
granted ethical approval for both the pilot study phase (Reference: UREC 14/24) and the main 
study phase (Reference: UREC 15/21). Copies of these approval letters are given in Appendix A.  
1.5 Thesis structure 
This thesis consists of 8 chapters. This section provides information on the organisation and 
structure of the chapters, and shows how the chapters relate to the research objectives and 
hypotheses, as presented in Table 1.1.  
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Table 1.1: Thesis structure 
Thesis Chapter Purpose of the Chapter  
Chapter 1 
Introduction 
To provide the project background, aim and objectives, hypotheses, 
and introduce the structure of the thesis. Ethical requirements and 
approval obtained for the research are highlighted in this chapter.   
Chapter 2 
Literature Review 
This chapter establishes current knowledge and identify knowledge 
gap relevant to the project. Information reviewed in this chapter 
include the current UK contaminated land policy, occurrence of the 
selected elements in the soil environment and their toxicity, conceptual 
exposure model for allotment land-use, bioaccessibility of the 
elements in humans, biomonitoring and PBPK models of the elements. 
This chapter addresses objective 1.  
Chapter 3 
Materials and Methods 
This chapter provides information on the materials and methods used 
in the research. It includes sampling, elemental analyses, urinary 
creatinine determination, computer software and statistics, estimation 
of sample size and identification of study sites. A summary of the pilot 
study conducted to trial methods and procedures is also presented in 
this chapter.  
This chapter addresses objectives 2, 3 and 4.  
Chapter 4 
Results and Discussion: 
Soil and Produce  
In this chapter, analytical test results for soil and produce samples are 
presented and discussed (including statistical evaluation of the data). 
An evaluation of the potential risks to health of site users the soil and 
produce element concentrations is presented.  
This chapter addresses objective 3 and hypothesis ‘h1’. 
Chapter 5 
Results and Discussion: 
Blood and Urine 
Analytical test results for blood and urine samples are presented and 
discussed (including statistical evaluation of the data) in this chapter. 
Comparisons of biomarker concentrations with the corresponding 
health guideline values and UK background levels are included.  
This chapter addresses objective 4 and hypothesis ‘h2’. 
Chapter 6 
Physiologically-based 
Kinetic Models 
This chapter provides details of the modified models, evaluation of the 
models using literature data, parameter sensitivity analysis carried out, 
and the application of the models in the planning of biomonitoring.  
Objective 5 and hypothesis ‘h3’are addressed in this chapter.  
Chapter 7 
Application of Modified 
Models in Exposure 
Estimation 
This chapter provides information on the evaluation of the models 
using biomonitoring data. The potential for application of these models 
in contaminated land exposure assessment is discussed.  
This chapter addresses objective 5 and hypothesis ‘h3’.  
Chapter 8 
Further Discussion, 
Conclusions and 
Recommendations 
Finally, chapter 8 draws together the research findings, highlights the 
contribution to knowledge arising from this research and the 
importance of the findings to the industry. It presents the conclusions, 
and makes suggestions for further research.  
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2. LITERATURE REVIEW 
2.1 Introduction 
The purpose of this chapter is to review literature pertaining to human exposure to contaminated 
soil, with emphasis on the five selected toxic elements (As, Cd, Cr, Pb, Ni) and allotment land use. 
It establishes the relevant background information useful in achieving the aim and objectives of the 
research (chapter 1). Firstly, the chapter looks at the contaminated land management framework in 
the UK, followed by an overview of the occurrence of these elements in soil and their toxicity. The 
chapter further reviews the soil-to-plant uptake of these elements and conceptual exposure model 
for allotment land use. A review of oral bioaccessibility test methods relevant to these elements is 
then presented, along with justification for selecting the bioaccessibility test method used in this 
research. Towards the end of the chapter, biomonitoring is defined, and a review of biomarkers of 
exposure and PBPK models for these elements is presented. From this chapter, the knowledge gap 
addressed by this thesis is identified, leading to the methods and contents presented in subsequent 
chapters.  
2.2 Contaminated land management framework in the UK 
Contaminated land is often a legacy of bad industrial and waste management practices (Gay & 
Korre, 2006). The UK’s rich industrial heritage has resulted in a legacy of land contamination. 
Consequently, the UK has established a framework for assessing and managing the risk posed by 
contaminated land, through regulatory bodies such as the Environment Agency and the Department 
for Environment, Food & Rural Affairs (DEFRA).  
In the UK, the contaminated land regime is regulated mainly by Part IIA of the Environmental 
Protection Act (1990), which provides a means of dealing with unacceptable risks posed by land 
contamination to human health and the environment. This Act operates alongside other legislative 
instruments, supported by the National Planning Policy Framework (for England) produced by the 
Department for Communities and Local Government (DCLG). Within the framework, land 
contamination is a material consideration in the planning process (DCLG, 2012). A similar 
framework exists for Scotland (The Scottish Government, 2014).  
The Act defines contaminated land as “any land which appears to the local authority in whose 
area it is situated to be in such a condition, by reason of substances in, on or under the land, that – 
significant harm is being caused or there is a significant possibility of such harm being caused; or 
pollution of controlled waters is being, or is likely to be, caused” (DEFRA, 2012; TSO, 1990). The 
Act (which came into force in Scotland in 2000) places a duty on local authorities to identify and 
secure the remediation of contaminated land in their respective areas (Scottish Executive, 2006). In 
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order for land to be declared ‘contaminated’, a valid contaminant source – pathway – receptor 
linkage must be present (Environment Agency, 2004).  
Although land affected by contamination may pose a risk to several receptors including humans, 
water resources and ecological receptors (O’Halloran, 2006; Bone et al., 2010), this research 
focuses on risk to humans only, since other receptors were outside the scope of the research. 
Therefore, the remainder of this section focuses on human exposure.  
A tiered approach to assessing risk to human health is used in the UK to manage land 
contamination. It involves the development of a Conceptual Site Model (CSM) using the source – 
pathway – receptor contaminant linkage, as illustrated in Fig. 2.1.  
 
 
 
 
 
A contaminant linkage exists if all three (source, receptor and pathway) are present. One thing to 
note is that, the contaminant level must be sufficient to pose harm. As shown in Fig. 2.1, arsenic in 
soil (contaminant source) can reach humans (receptor) through oral ingestion (pathway) of arsenic 
in food grown on the soil. There may be more than one pathway of exposure to a contaminant, and 
therefore a CSM should consider all relevant exposure pathways.  
Having established the presence (or the likely presence) of a contaminant linkage, risk assessment 
is then required. This may be either qualitative (based on the CSM), or quantitative using generic 
(and site-specific, if required) assessment criteria values. Further information on the assessment 
criteria values is presented in the following section.  
2.2.1 The CLEA model 
DEFRA and the Environment Agency have produced a human toxicological risk assessment 
method to guide the human health risk assessment for contaminated land, which is built into the 
CLEA model (Environment Agency, 2009a; Environment Agency, 2009b). The CLEA model is 
used to derive generic assessment criteria (GAC) values, such as soil guideline values (SGVs) 
(Environment Agency, 2009f), and site-specific assessment criteria (SSAC) values. SGVs are 
derived using the same procedures and algorithms used to derive SSAC, but applied to ‘standard’ 
land use classes characterised by generic exposure assumptions. The standard land use classes are 
Source Pathway Receptor 
Arsenic 
in soil 
Oral 
ingestion 
Humans 
Fig. 2.1: An illustration of the source-pathway-receptor contaminant linkage 
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‘residential’, ‘allotment’ and ‘commercial’ (Environment Agency, 2009e). SGVs are contaminant-
specific ‘trigger values’ used in assessing the risk to human health from chronic exposure 
(excluding waterborne pathways) to soil contamination. They indicate that soil concentrations 
above a given SGV could pose a risk to human health, and that further investigation or remediation 
should be considered. Similar risk assessment approaches have been adopted by other European 
countries (Carlon, 2007).   
In addition to the SGVs, DEFRA’s research project ‘SP1010’ led to the development of provisional 
‘Category 4 Screening Levels (C4SLs)’ for a number of soil contaminants, including As, Cd, Cr 
and Pb (CL:AIRE, 2014). The C4SLs were produced using the CLEA model following the 
introduction of a new four-category system for identifying and managing contaminated land, 
ranging from Category 4 to Category 1 (DEFRA, 2012). Category 4 refers to where there is no risk 
that land poses a significant possibility of significant harm (SPOSH) or where the level of risk is 
low, while Category 1 refers to where the risk that land poses a SPOSH is unacceptably high. The 
C4SLs are used to determine if a site falls within Category 4, and hence no need for further risk 
assessment of the site. They are used in a similar manner to SGVs. However, C4SLs are less 
stringent than the SGVs (CL:AIRE, 2014).   
In the absence of SGVs and C4SLs from the regulators, other GACs have been developed by other 
authoritative bodies such as the Land Quality Management (LQM) Ltd. and the Chartered Institute 
of Environmental Health (CIEH) (Nathanail et al., 2015).  
2.2.2 Differences between Part IIA in Scotland and England and Wales 
Although the regulations and statutory guidance documents in Scotland and England and Wales are 
derived from the same primary legislation (Part IIA of the Environmental Protection Act 1990), 
there are some differences in the implementation of Part IIA between Scotland and England and 
Wales. The key differences
1
 are:  
 The provisions came into force in England in April 2000 and in July 2000 in Scotland.  
 In Scotland, the Scottish Environment Protection Agency (SEPA) provides advice to local 
authorities in relation to potential special sites, whereas in England, the Environment 
Agency (EA) undertakes the inspection on behalf of local authorities.  
 Notifications of identification of contaminated land appear in the public registers in 
Scotland, whereas in England they do not.  
 The 2000 Scottish regulations specify the form of the remediation notice, while the English 
regulations just specify the content.  
 In 2012, the statutory guidance in England was revised, and now provides a four-category 
test (i.e., the C4SLs discussed in the preceding section) to assist local authority risk-based 
                                                          
1 Available at: https://www.sepa.org.uk/regulations/land/contaminated-land/faqs/  
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decisions on whether land is to be identified as contaminated land; the approach in 
Scotland is also risk-based, but does not provide this categorisation process for the local 
authority decisions.  
2.2.3 Limitation of GACs and similar assessment criteria values 
Many of the model input parameters used in the CLEA model are based on conservative 
measurements (Environment Agency, 2009e). Consequently, the SGVs, C4SLs and similar GACs 
derived using CLEA model are prone to over-estimate the actual human exposure to soil 
contamination. In addition, the SGVs are derived assuming that ingested contaminants are 100% 
bioaccessible in the body (Gbefa, Entwistle & Dean, 2011). However, this is not necessarily correct 
because where the contaminant exists in an insoluble form or strongly sequestered in soil, then its 
bioaccessibility is less than 100% (Hough et al., 2004; Ruby et al., 1999; Davis et al., 1996). It has 
been suggested that, in many cases, bioaccessibility of these elements is less than 50% (Oomen et 
al., 2002). This indicates that if any of these elements in soil were ingested, more than half of the 
element would not be soluble in the gastrointestinal (GI) tract and thus not potentially available for 
absorption in the body. However, one thing to note is that the bioaccessibility of these elements in 
soil is site-specific, given that soil properties (such as mineralogy, pH, organic matter and clay 
content) could influence element bioaccessibility (Pelfrêne et al., 2011; Roussel et al., 2010; 
Fairbrother et al., 2007). Therefore bioaccessibility of these elements could vary considerably from 
site to site.  
The assumption of 100% bioaccessibility when deriving GACs could result in over-estimation of 
exposure. Based on bioaccessibility alone, the extent of over-estimation of exposure would be the 
reciprocal of the site-specific bioaccessibility values. From the perspective of a regulator, there is 
an advantage in a conservative approach because it is protective of public health. However, over-
estimation of human exposure to soil contaminants may result in unnecessary and costly 
remediation being carried out (i.e., negative financial implications) (Gbefa, Entwistle & Dean, 
2011; Nathanail & McCaffrey, 2003). It may also lead to restrictions on land-use, and cause 
brownfield sites to remain derelict where developers are unable to fund the required level of 
remediation. This emphasises the need for a more robust risk assessment approach to facilitate the 
sustainable management of contaminated land, which this research sought to promote.  
In addition, the bioaccessible fraction of an element in the GI tract needs to be absorbed in the body 
in order to cause toxicity in organs and tissues (i.e., the element needs to be bioavailable) (Oomen 
et al., 2003; Environment Agency, 2009). It is the bioavailable proportion that determines actual 
exposure. The difference between bioaccessibility and bioavailability is explained further in section 
2.6.   
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2.3 Elements of interest, their occurrence in soil and human toxicity 
2.3.1 Arsenic 
Arsenic (As) (CAS No. 7440-38-2) is frequently referred to as a metal, but it is chemically 
classified as a metalloid, having both properties of a metal and a non-metal (ATSDR, 2007a). 
Arsenic occurs in both organic and inorganic forms (Jara & Winter, 2014). Organic arsenic results 
from the combination of arsenic with carbon and hydrogen, and are found mainly in seafood 
(Hughes, 2006; ATSDR, 2007a). Meanwhile, inorganic arsenic is formed when arsenic combines 
with other elements such as oxygen, chlorine and sulphur (ATSDR, 2007a). Inorganic arsenic in 
the environment comes from both natural and anthropogenic sources. It occurs naturally in soils 
due to weathering of the parent rock, especially argillaceous sedimentary rocks (e.g., shales and 
mudstones) where the greatest concentrations of arsenic tend to be found, and in heavily sulphidic 
mineralised areas (Environment Agency, 2009d). Apart from weathering reactions, arsenic can also 
be mobilised naturally through biological activity and volcanic emissions (Smedley & Kinniburgh, 
2002). Major anthropogenic sources of inorganic arsenic include non-ferrous metal smelters and 
coal combustion plants (Hughes, 2006). In addition, agricultural practices such as historical use of 
arsenic-based pesticides, application of fertilisers, sludge and manure containing arsenic are 
potential anthropogenic sources of inorganic arsenic (Environment Agency, 2009d; ATSDR, 
2007a). Arsenite (As(III)) and arsenate (As(V)) are the two biologically important inorganic 
arsenic valence states (Stamatelos et al., 2011). As(V) predominates in aerobic soils while As(III) 
predominates in slightly reduced soils (e.g., temporarily flooded or sediment soil (ATSDR, 2007a). 
This indicates that As(V) would be the dominant arsenic species in shallow allotment soils.  
Arsenic is highly toxic in its inorganic form, while organic arsenic is less relevant in toxicological 
studies (Keil et al., 2011; Bornhorst & McMillin, 2006). Inorganic arsenic is a Group 1 human 
carcinogen (IARC, 2012). In human populations orally exposed to As, it could cause cancers of the 
bladder, skin (ATSDR, 2007a; Marshall et al., 2007; Haque et al., 2003), and potentially linked to 
liver, prostrate and kidney cancer (Tokar et al., 2011). The toxicity of arsenic depends on the 
chemical form in which it is present, its solubility and rate of absorption and elimination (Keil et 
al., 2011).  
2.3.2 Cadmium 
Cadmium (Cd) (CAS No. 7440-43-9) is a metal that exists in the environment in one oxidation 
state (+2) and does not undergo oxidation-reduction reactions (ATSDR, 2012a). Cadmium can be 
emitted to the environment from natural phenomena such as volcanic eruptions, forest fires, and 
generation of sea salt aerosols (ATSDR, 2012a). Anthropogenic sources of Cd into the 
environment include metal mining and refining, waste incineration and disposal, batteries, smelting 
and electro-plating industries, use of phosphate fertilisers, tobacco use, and ash from fossil fuel 
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combustion (Keil et al., 2011; Pan et al., 2010). Apart from inhalation of cigarette smoke, dietary 
ingestion of foods with high Cd content is a major pathway through which the general population is 
exposed to Cd (ATSDR, 2012a). The high content of Cd in edible crops is because Cd is readily 
absorbed by plants in contaminated soil (Swartjes, Versluijs & Otte, 2013). Cd is classified as a 
Group 1 carcinogen (IARC, 2012) and kidney is the primary target of organ of Cd toxicity 
following oral exposure (ATSDR, 2012a). Other toxicological effects of ingested Cd that have 
been reported in humans include liver damage, cardiovascular effects, prostrate and breast cancer 
(Waalkes, 2000; Joseph, 2009; Waalkes, 2003).  
2.3.3 Chromium 
Elemental chromium (Cr) (CAS No. 7440-47-3) does not occur naturally; instead chromium is 
present in nature primarily as chromite ore with chromium in the trivalent form (Cr(III)), which is 
the most stable oxidation state. Chromium also occurs in divalent (II) and hexavalent (VI) 
oxidation states, and the very unstable IV and V oxidation states (ATSDR, 2012b). Hexavalent 
chromium is the second most stable oxidation state, and therefore, Cr(III) and Cr(VI) are the 
species that are of interest in relation to human exposure (ATSDR, 2012b; Langard & Costa, 2007).  
Cr(III) occurs naturally in environmental media such as rocks, soil, plants, animals, volcanic dust 
and gases. It is also found in a wide range of foods and is an essential element for human (Cefalu & 
Hu, 2004). However, Cr(VI) compounds primary arise from anthropogenic sources (Shanker et al., 
2005). As a nutritional element, Cr(III) has very low toxicity, while Cr(VI) is highly toxic (Cefalu 
& Hu, 2004; Kerger et al., 1996). Therefore, the reduction of Cr(VI) to Cr(III) is significant in the 
toxicity of Cr(VI) compounds. For example, human consumption of plants and animals that have 
been exposed to Cr(VI) is considered safe because of the reduction of Cr(VI) to Cr(III) in these 
organisms (Langard & Costa, 2007). Cr(VI) is a Group 1 human carcinogen (IARC, 2012), which 
has been associated with several toxicological effects in humans following oral ingestion, including 
DNA damage (IARC, 2012). Inhaled Cr(VI) has been known to cause lung cancer (ATSDR, 
2012b).  
2.3.4 Lead  
Lead (Pb) (CAS No. 7439-92-1) is a heavy metal that occurs naturally in the earth’s crust (ATSDR, 
2007b). Lead has many different uses. For example, it is used in the production of batteries, 
ammunition, paints, dyes, cable sheeting, solders, alloys, gasoline and medical equipment 
(Skerfving & Bergdahl, 2007; Keil et al., 2011). The uses of lead can result in anthropogenic 
sources of lead. Human activities provide major sources of lead found in the environment 
compared to lead releases from natural events such as volcanoes, windblown dust and erosion 
(ATSDR, 2007b). Lead is known to be persistent in soils and sediments because it binds strongly to 
various soil minerals (Lark & Scheib, 2013; Intawongse, 2007). This indicates that historical land 
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use(s) may have a pronounced influence on the contemporary soil lead content. Lead exists in both 
organic and inorganic forms. Organic lead compounds are dominated by tetramethyl and tetraethyl 
lead, which have been used mainly as additives to gasoline (ATSDR, 2007b). Inorganic lead is the 
most common form of lead in the environment, and includes the lead found in soil, paint and 
various other products.  
In the general un-occupationally exposed population, exposed to lead may occur through ingestion 
of contaminated food and water, and inhalation of cigarette smoke (ATSDR, 2007b). Oral exposure 
to lead can cause toxic effects on various body organs and tissues. These include kidney 
dysfunction, cardiovascular effects (e.g., hypertension), gastrointestinal effects, haematological 
effects, musculoskeletal effects, respiratory effects and brain damage (Skerfving & Bergdahl, 2007; 
Hu et al., 2006).  
Lead has four stable isotopes (
204
Pb at 1.4%, 
206
Pb at 24.1%, 
207
Pb at 22.1% and 
208
Pb at 52.3%), 
with their ratios being variable in environmental medium, such that Pb of different sources 
generally has its own specific isotopic compositions (Li et al., 2012). Therefore, Pb isotope ratios 
can be used for tracing source of Pb, especially, for distinguishing between anthropogenic and 
natural sources of Pb (Saint-Laurent et al., 2010). In this research, we used Pb isotope ratios of 
206
Pb/
207
Pb and 
208
Pb/
207
Pb that are commonly used as tracers (Farmer et al., 2011; MacKinnon et 
al., 2011).  
2.3.5 Nickel 
Nickel (Ni) (CAS Number 7440-02-0) is found naturally in soil, and is also emitted from 
volcanoes. In the environment, nickel is mainly found combined with oxygen or sulphur as oxides 
or sulphides. Nickel can exist in various oxidation states, but Ni(II) is the prevalent oxidation state 
under normal environmental conditions (ATSDR, 2005). Nickel releases to the atmosphere occur 
from natural discharges (e.g., windblown dust, volcanic emissions, forest fires and vegetation) and 
anthropogenic activities (e.g., nickel mining, industrial use of nickel compounds, power plants 
burning oil and coal, and waste incinerators) (Cempel & Nikel, 2006; ATSDR, 2005).  
According to IARC (2012), oral ingestion of nickel in food, and to a lesser extent water, is the 
primary route of exposure to the non-smoking general population. Nickel is a Group 1 carcinogen. 
Inhaled nickel is known to cause lung cancer (IARC, 2012). It has been reported that the 
carcinogenic risk is limited to conditions of occupational exposure (Cempel & Nikel, 2006). Oral 
exposure to Ni may cause cardiovascular and kidney diseases, skin allergies, and genotoxicity 
(Cempel & Nikel, 2006; Klein & Costa, 2007).  
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2.4 Soil-to-plant uptake of the elements 
Plants can take-up metal contaminants from soil through the roots, and also through the shoots (via 
stomata) following atmospheric deposition of pollutants (Bermudez et al., 2012; Environment 
Agency, 2006). However, the most important uptake process is via the roots, and therefore this 
section presents a review of the uptake of the metals of interest from soil via the plant roots, and 
indicates the forms in which these metals are found in plants. A summary of soil-plant-transfer 
factors for the five elements obtained from the literature are presented at the end of this section.  
Plants absorb essential and non-essential elements from soil in response to concentration gradients 
induced by selective uptake of ions by plant roots, or by diffusion of the elements in the soil 
(Peralta-Videa et al., 2009). For example, nickel is known to be a micronutrient because it is 
required by plants in a minute quantity, whereas arsenic, cadmium, chromium and lead are not 
considered essential elements for plant growth (Peralta-Videa et al., 2009).  
Growing edible plants in contaminated soils is known to contribute to food contamination (through 
plant uptake of the soil contaminants). For example, approximately two-thirds of cadmium dietary 
intake is known to be attributed to plant products (Nasreddine & Parent-Massin, 2002). In addition, 
it has been estimated that approximately half of human lead intake is through food, with around 
half originating from plants (Nasreddine & Parent-Massin, 2002). Both cadmium and lead are 
known to have the potential to accumulate in plants (Wolnik et al., 1983). This indicates that 
vegetables and fruits grown in contaminated soils have the potential to provide a source of human 
exposure to toxic elements in soil.  
2.4.1 Arsenic  
The most common and stable form of arsenic found in aerobic soils is the As(V), and is therefore 
more available for plant uptake (Meharg & Hartley-Whitaker, 2002;  FAO, 2006
2
). The soil pH 
controls the transport and availability of arsenic in soil, such that at low pH values (pH 4), arsenic 
is found complexed with iron, whereas at high pH values (pH 6 – 8) arsenic is mostly bound to 
calcium (Fayiga, Ma & Zhou, 2007). It has been reported that the presence of iron and manganese 
oxides in soil increase arsenic mobility and availability (Zavala & Duxbury, 2008).  
Plants generally take up and mobilise arsenate (As(V)) through the phosphate transport channels, 
thus causing competition between As(V) and phosphate for root uptake (Tripathi et al., 2007). 
Once inorganic arsenate (As(V)) has been absorbed into the plant tissues, the As(V) is reduced to 
arsenite (As(III)) and/or bio-transformed to organic compounds such as monomethylarsonic acid 
(MMA), dimethylarsinic acid (DMA) or as inorganic As(III) complexed with thiol groups, all of 
which are commonly found in plants (Peralta-Videa et al., 2009;  Meharg & Hartley-Whitaker, 
                                                          
2 Available at: ftp://ftp.fao.org/docrep/fao/009/ag105e/ag105e00.pdf  
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2002; Ruiz-Chancho et al., 2008). It has also been reported that the majority of plants are able to 
synthesise arsenate reductase, which reduces most of the As(V) to As(III) (Dhankher et al., 2006). 
Arsenic accumulation and resistance in plants varies between plant species due to genetic 
differences and diversity in detoxification processes (Meharg & Hartley-Whitaker, 2002).  
2.4.2 Cadmium 
Soil-to-plant transfer of cadmium is the major pathway though which humans are exposed to 
cadmium in contaminated soil (Liang et al., 2013), since cadmium is easily taken up by vegetables 
due to its high mobility in soil and plant system (Sarwar et al., 2010; Swartjes et al., 2013). 
Consumption of vegetable foods can contribute approximately 70% (Sarwar et al., 2010) to 80% 
(Olsson et al., 2002) of total cadmium intake by humans.  
Three processes (speciation in soil, plant root uptake from the pore water, and transport within the 
plant) control the cadmium concentration in different parts of plants due to cadmium uptake 
through the plant roots (Swartjes et al., 2013). It has been reported that the electrochemical 
potential gradient of the plasma membrane in the plant root cells drives cadmium and other cations 
into the root cells (Peralta-Videa et al., 2009). However, increased concentration of iron in soil has 
been linked to the reduction of the uptake of cadmium (Sharma et al., 2004). It has also been 
identified that cadmium uptake by plants increases with decreasing soil pH, whereas it decreases 
with increasing soil organic carbon content (Liang et al., 2013). In addition, root and leafy 
vegetables are reported to have a greater soil cadmium uptake efficacy than fruit and seed 
vegetables (Alexander, Alloway & Dourado, 2006).  
2.4.3 Chromium 
In plants, chromium at low concentrations promotes growth and increases yield, but it is not 
considered essential to plants (Peralta-Videa et al., 2009). The entry of chromium into plants is 
controlled by chromium reduction and/or complexation with root exudates (e.g., organic acids), 
which increase chromium solubility and mobility through the root xylem (Peralta-Videa et al., 
2009). It has been reported that both Cr(VI) and Cr(III) cross the endodermis (via symplast 
pathway) where Cr(VI) in cells is reduced to Cr(III) and accumulated in the root cortex cells 
(Shanker et al., 2005).  
A study by Mandiwana et al. (2007) on the solubility of Cr(III) and Cr(VI) compounds is soil and 
their availability to plants found out that the concentrations of Cr(VI) in plants correlated with the 
soluble fraction of Cr(VI) in soil, while Cr(III) concentration in plants was limited by the 
concentration of low molecular weight organic acids in soil. This indicates that soils rich in organic 
acids facilitate higher plant absorption of Cr(III). According to Shanker et al. (2005), chromium is 
largely retained in the roots, with Cr(III) being the predominant species in roots.  
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2.4.4 Lead 
Lead is strongly adsorbed onto soil particles reducing their availability to plants (Intawongse, 
2007). The uptake of lead is regulated by pH, soil particle size, soil cation exchange capacity, root 
surface area, root exudation and other physico-chemical parameters (Sharma & Dubey, 2005). At 
the root surface, lead is bound to carboxylic groups of mucilage uronic acids, and some of the 
bound lead is released when mucilage is biodegraded (Sharma & Dubey, 2005). Lead transported 
from the soil to the root cells crosses the root-cell plasma membrane. The transport pathway for 
lead across the plasma membrane occurs through plasma membrane cation channels (e.g., calcium 
channels) (Peralta-Videa et al., 2009; Sharma & Dubey, 2005). Once lead has been taken up by the 
roots, most lead is bound to ion exchangeable sites on the cell wall and extracellular precipitation, 
mainly in the form of lead carbonate deposited (Peralta-Videa et al., 2009; Sharma & Dubey, 
2005). Various plant species have the ability to absorb lead by roots and translocate it from the 
roots to the shoots (Huang & Cunningham, 1996). However, it has been reported that most of the 
absorbed lead remains in the roots, since the endodermis acts as a partial barrier to the movement 
of lead between the root and shoot (Sharma & Dubey, 2005).  
2.4.5 Nickel 
Nickel is an essential nutrient for plants, but the amount of nickel required for normal plant growth 
is very low (Chen et al., 2009). The uptake of nickel in plants occurs mainly through the root 
system by means of passive diffusion and active transport (Seregin & Kozhevnikova, 2006). The 
overall uptake of nickel by plants depends on the concentration of Ni(II) ions, plant metabolism, 
soil acidity, the presence of other metals and soil organic matter composition (Chen et al., 2009). 
However, nickel accessibility is reduced at higher pH values of the soil solution due to the 
formation of less soluble complexes (Yusuf et al., 2011). It has been estimated that over 50% of the 
nickel absorbed by plants is retained in the roots (Chen et al., 2009).  
The transport pathway for nickel is from the roots to shoots and leaves through the transpiration 
stream via the xylem (Chen et al., 2009). According to Yusuf et al. (2011), nickel is freely 
translocated in the stellar tissues and can easily reach the upper (above ground) parts of the 
accumulator plants. It is supplied to meristematic parts of the plants by re-translocation from old to 
young leaves, and to buds, fruits and seeds through the phloem (Chen et al., 2009; Yusuf et al., 
2011).  
2.4.6 Soil-to-plant transfer factors  
Soil-to-plant transfer can occur though plant uptake mechanisms, by soil or dust deposition on the 
plant, and by soil particles adhering to plant parts (Environment Agency, 2006). Soil-to-plant 
factors quantity the potential plant uptake of elements present in the soil, and they are not constant 
for either a specific element or a specific vegetable (Swartjes, Versluijs & Otte, 2013). For 
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example, higher soil-to-plant factors for arsenic have been reported in tree fruit compared to green 
and root vegetables (Environment Agency, 2009d). However for cadmium, higher factors have 
been reported in green and root vegetables than in tree fruit (Environment Agency, 2009c). Table 
2.1 presents soil-plant-transfer factors for the five elements obtained from selected literature.  
Table 2.1: Summary of soil-to-plant transfer factors from selected literature 
Element 
Soil-to-plant transfer factors 
Min Max Reference 
As 
0.00043 0.0011 a 
0.001 b 
Cd 
0.0014 0.052 c 
0.192 0.778 b 
Cr 
0.008 0.029 b 
0.003 0.22 d 
Ni 
0.037 0.039 b 
0.03 0.89 d 
Pb 
0.008 0.065 b 
0.001 0.432 d 
aEnvironment Agency (2009d)  
bJolly et al. (2013) 
cEnvironment Agency (2009c)  
dIntawongse (2007) 
 
2.5 Conceptual exposure model for allotment land use 
A conceptual site model (CSM) is a depiction of a site’s exposure conditions that has the potential 
to connect contamination source(s) to possible receptor(s) (i.e., source – pathway – receptor 
linkage). The CSM discussed in this section defines potential exposure pathways relevant to this 
study, which subsequently informed the methods, materials and sample requirements for the study.  
2.5.1 Source of potential contamination 
For allotments land use, the source of contamination refers to the occurrence of the five toxic 
elements in allotment soil and in allotment produce samples.  
2.5.2 Pathways 
In consideration of the allotment land use, the elements of interest and the receptors, potential 
exposure pathways investigated include consumption of allotment produce (and the adhering soil), 
inadvertent soil ingestion, and inhalation of outdoor allotment dust. However, exposure through 
dermal uptake was considered insignificant. According to the Environment Agency (2009e), the 
estimated dermal absorption fraction for arsenic is 0.03, while that for cadmium is 0.001. Based on 
these low values and the general lack of literature data, a default value of zero is often adopted for 
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inorganic chemicals (Environment Agency, 2009e). In addition, vapour inhalation pathway was not 
investigated because the elements of interest are not particularly volatile. Another potential 
pathway that was not considered relevant is the ‘tracking back’ from site to indoor environment. 
This is because tracking back predominantly occurs over a short distance (7 to 8m of building 
entrance) (Hunt, Johnson & Griffith, 2006) but allotments were located away from participants’ 
dwellings. This is consistent with the approach adopted in the CLEA model, where tracking back 
into a building is only considered where a building is located on a contaminated site (Environment 
Agency, 2009e).  
 Consumption of allotment produce 2.5.2.1
Oral ingestion pathway (through the consumption of allotment produce and adhering soil particles) 
is regarded as the dominant route through which human get exposed to contaminants present in 
allotments (Environment Agency, 2009e), which is why oral bioaccessibility testing was carried 
out as part of this study. For example, it has been estimated that vegetable consumption contributes 
a major proportion (up to 80%) of the total cadmium intake by humans (Nabulo, Young & Black, 
2010; Liang et al., 2013). The calculation of daily exposure through vegetable consumption is as 
follows (Swartjes et al., 2013): 
𝐸𝑥𝑝𝑣𝑒𝑔 =
∑(𝑄𝑣𝑒𝑔 𝑖 × 𝐶𝑣𝑒𝑔 𝑖 × 𝑓ℎ𝑚−𝑔𝑟𝑜𝑤𝑛 × 𝐹𝑏𝑖𝑜𝑎𝑣𝑎𝑖𝑙𝑎𝑏𝑖𝑙𝑖𝑡𝑦)
𝐵𝑊
 (2.1) 
Where: 
Expveg is the exposure due to vegetable consumption (mg kg
-1 body weight day
-1). 
Qveg i is the consumption rate of vegetable i (kg dry weight day
-1). 
Cveg i is the contaminant concentration in vegetable i (mg kg
-1 dry weight). 
fhm-grown is the fraction of vegetables that is home-grown. In this study, this is equivalent to 1 because only 
allotment produce was considered.  
Fbioavailability is the correction for relative bioavailability in the human body. 
BW is the body weight (kg). 
Soil loading onto allotment produce samples can be reduced by washing edible plant parts, which 
mimics conventional food preparation in the kitchen (Prasad & Nazareth, 2000): 
Oral ingestion through direct intake of soil may also occur. Daily exposure through soil ingestion is 
calculated as follows (Swartjes et al., 2013): 
𝐸𝑥𝑝𝑠𝑜𝑖𝑙 =
𝑄𝑠𝑜𝑖𝑙 × 𝐶𝑠𝑜𝑖𝑙 × 𝐹𝑏𝑖𝑜𝑎𝑣𝑎𝑖𝑙𝑎𝑏𝑖𝑙𝑖𝑡𝑦
𝐵𝑊
 (2.2) 
Where: 
Expsoil is the exposure due to soil ingestion (mg kg
-1 body weight day
-1). 
Qsoil is the soil ingestion rate (kg dry weight day
-1). 
Csoil is the contaminant concentration in soil (mg kg
-1 dry weight). 
Fbioavailability is the correction for relative bioavailability in the human body. 
BW is the body weight (kg). 
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However, direct soil intake is more relevant to children than adults, due to children’s ‘mouthing’ 
(hand-to-mouth exploration) behaviours (Abrahams, 2012; Ljung et al., 2006; Davis et al., 1996), 
which result in intentional soil ingestion. A study by Davis & Mirick (2006) identified that soil 
ingestion in children was associated with eating of dirt.  
 Inadvertent soil ingestion 2.5.2.2
Exposure by inadvertent ingestion arises from contact between the mouth or peri-oral region and 
contaminated hands or objects, which results in ingestion, of which the individual may be oblivious 
(Ng et al., 2012). This exposure pathway is known to occur among children, but adults may also be 
exposed (Irvine et al., 2014; Ng et al., 2012). The general form for equations used in estimating 
inadvertent ingestion is as follows (Ng et al., 2012).  
𝐸𝑖𝑖 = 𝐿𝑑 × 𝑆𝐴 × 𝑇𝐸 × 𝑁 (2.3) 
Where: 
Eii is the exposure by inadvertent ingestion (mg). 
Ld is the loading of substance on hand or object (mg cm-2). 
SA is the surface area of hand or object that comes into contact with the mouth (cm
2). 
TE is the transfer efficiency of substance from hands or object to the mouth (proportion). 
N is the number of hand or object-to-mouth contacts.  
Although substance transfer is influenced by a number of factors including individual behavioural 
tendencies (such as nail biting, smoking, licking lips, finger sucking, personal hygiene, risk 
perception) and flow of sweat, hands play a central role in the exposure process (Cherrie et al., 
2006; Ng et al., 2012). We collected a number of moist-wipe samples from participants’ hands to 
estimate potential exposure through this pathway; even though this pathway was not considered 
significant for the adult participants.  
 Inhalation of allotment dust 2.5.2.3
Dust can be generated from soil by a variety of activities. The amount of soil dust inhaled by 
humans usually dependents on the grain size of soil particles, with finer particles being susceptible 
to inhalation into human lung (Bi, Liang & Li, 2013). In addition, finer soil particles are expected 
to contain higher metal concentrations than larger particles, due to the higher surface-to-mass ratio 
of finer particles (Duong & Lee, 2011). The average daily exposure through inhalation of allotment 
dust is calculated as follows (Gay & Korre, 2006).  
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𝐴𝐷𝐼𝑖𝑛ℎ =
𝐼𝑅𝑖𝑛ℎ × 𝐸𝐹𝑖𝑛ℎ × 𝐸𝐷𝑖𝑛ℎ
𝐵𝑊 × 𝐴𝑇
 (2.4) 
Where: 
ADIinh is the average daily intake of chemical from soil through inhalation (mg kg
-1 body weight day
-1). 
IRinh is the chemical intake/uptake rate (mg day
-1). 
EFinh is the exposure frequency (days year
-1). 
EDinh is the exposure duration (year). 
BW is the body weight (kg body weight). 
AT is the averaging time (days). 
Inhaled dust can also be ingested and swallowed as part of mucus clearance (Knowles & Boucher, 
2002); in which case exposure can be calculated using (Eq. 2.2).  
The contribution of outdoor allotment dust inhalation to total exposure from allotment soil is 
estimated to be 0.1% (for arsenic) and less than 0.1% (for cadmium) (Environment Agency, 2009d; 
Environment Agency, 2009c). These values indicate that exposure through inhalation of outdoor 
allotment dust is not particularly significant for the selected elements.  
2.5.3 Receptor 
The critical receptor for an allotment land use is a young female child (aged 0 to 6 years old) 
(Environment Agency, 2009e). However in this study, adult receptors (aged over 18 years) were 
targeted because of biomonitoring requirements. It was anticipated that using children in 
biomonitoring would be ethically complicated (i.e., obtaining ethical approval to use children in 
biomonitoring would be difficult), and the chances of obtaining parental consents would be 
minimal.  
2.6 Oral bioaccessibility of the elements 
This section provides an overview of procedures currently used for evaluating the bioaccessibility 
of selected metals, in order to determine the most appropriate bioaccessibility test procedure to 
adopt in this research. The procedures reviewed relate to human and animal oral bioaccessibility 
studies. Various definitions and interpretations of bioaccessibility and bioavailability concepts have 
been proposed (Ruby et al., 1996; Semple et al., 2004; Fernández-García et al., 2009). However, 
there is a general agreement that these concepts address the potential for a chemical substance to 
interact with an organism. For clarity, the difference between ‘oral bioaccessibility’ and ‘oral 
bioavailability’ is explained further in the following section.  
2.6.1 Differentiating between bioaccessibility and bioavailability 
Soil ingestion can be a major route of human exposure to immobile soil contaminants (Oomen et 
al., 2002; Oomen et al., 2003). Therefore, estimating the amount of metal that is available for 
absorption following soil ingestion is a key variable in estimating the potential human exposure to 
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soil contamination (Hamel, Ellickson & Lioy, 1999). Oral bioaccessibility is the fraction of the 
contaminant that is soluble in the gastrointestinal environment and is available for absorption 
(Oomen et al., 2002). However, oral bioavailability refers to the fraction of the ingested 
contaminant that can enter the systematic circulation of the human body (i.e., the fraction that 
reaches the blood compartment) from the GI tract (Ruby et al., 1999). It is the product of 
contaminant fraction that is bioaccessible, fraction transported across the intestinal epithelium and 
the fraction passing the liver without being metabolised (Oomen et al., 2003). Therefore, to become 
bioavailable, contaminants must first become bioaccessible. A schematic diagram showing the 
difference between oral bioaccessibility and bioavailability is given in Fig. 2.2. Following element 
uptake, bioaccumulation may occur in the target organs.  
 
 
 
 
 
 
 
 
 
The CLEA model allows users to apply site-specific bioavailability values (expressed as ‘relative 
bioavailability’) when deriving SSAC values. Relative bioavailability refers to the relationship 
between the bioavailability of a contaminant in soil and the bioavailability of the same contaminant 
measured in the media used for the toxicological study in deriving the health criteria of that 
contaminant (Environment Agency, 2009a).  
  
Fig. 2.2: A sketch diagram showing the difference between oral bioaccessibility and bioavailability 
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Relative bioavailability can be derived using the following expression (Environment Agency, 
2009a):  
𝑅𝐵𝐴𝑠𝑜𝑖𝑙,𝑡𝑜𝑥 =
𝐴𝐵𝐴𝑠𝑜𝑖𝑙
𝐴𝐵𝐴𝑡𝑜𝑥
=
𝐹𝐵 × 𝐹𝐴 × 𝐹𝐻
𝐴𝐵𝐴𝑡𝑜𝑥
 (2.5) 
Where: 
RBAsoil,tox is the relative bioavailability between soil sample and the media used in the toxicological studies. 
ABAsoil is the absolute element bioavailability in soil (dimensionless).  
ABAtox is the absolute element bioavailability in the media used in the toxicological studies (dimensionless).  
FB is the oral bioaccessible fraction of an element in soil. 
FA is the fraction of a solubilised element transported across the gastrointestinal wall into systematic 
circulation. 
FH is the fraction absorbed that does not undergo first pass metabolism in the intestinal epithelium and/or the 
liver. 
Absolute bioavailability values (ABAsoil and ABAtox) can be obtained from in-vivo studies (Denys et 
al., 2012; Casteel et al., 2006), but in-vivo studies would be impractical to carry out on a site-by-
site basis, due to time, cost and ethical constraints. This is a limitation that makes it difficult to 
calculate oral bioavailability values. In the absence of bioavailability data, it is common practice to 
assume a conservative bioavailability value of 100% (Suedel et al., 2006; Kang et al., 2016). The 
product of parameters FA x FH in Eq. (2.5) can be estimated using physiologically-based kinetic 
models as demonstrated in section 7.4.  
2.6.2 Role of element bioaccessibility in contaminated land risk assessment 
Knowledge of the bioaccessible fraction of a contaminant presents a better estimate of human 
exposure to soil contamination than using the total soil contaminant concentration, since not all 
ingested contamination is taken-up by the human body. The United States Environmental 
Protection Agency (USEPA) reported that in most cases, the toxicity of an ingested chemical 
depends, in part, on the degree to which it is absorbed from the GI tract into the body (USEPA, 
2007). Several studies have been carried out on the bioaccessibility of soil-bound metal 
contaminants. A study by Broadway et al. (2010) showed that the bioaccessibility of chromium in 
Glasgow soils was considerably less than 100% (i.e., 1 to 31%, with an average of 5%). A mean 
soil lead bioaccessibility value of 22% was obtained following a study using urban soils from 
Glasgow in Scotland (Farmer et al., 2011). A study on oral bioaccessibility of selected metals in an 
urban catchment in Newcastle upon Tyne (Gbefa et al., 2011) determined bioaccessibility values of 
<10% (Cr, Ni, Pb, Zn, Cu) and 34% (Cd). Element bioaccessibility is site-specific and therefore the 
difference in bioaccessibility values obtained at various sites across the UK is not surprising. These 
bioaccessibility values demonstrate that the risk associated with potential ingestion of soil-bound 
metal contaminants could be exaggerated if total soil concentrations (assuming 100% 
bioaccessibility) are used in the risk assessment models. Therefore, contaminant bioaccessibility 
determination plays a crucial role in avoiding overly conservative human health risk assessment 
resulting from over-estimation of exposure to soil contaminants. An overly conservative risk 
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assessment could lead to site remediation that is costly, time-consuming and unnecessary (Pelfrêne, 
Waterlot & Douay, 2011).  
2.6.3 Techniques for assessing oral bioaccessibility 
There are several in-vitro techniques for assessing the bioaccessibility of soil-bound toxic elements, 
ranging from single-stage to multi-stage extraction methods. The common oral bioaccessibility 
assessment techniques are reviewed in this section, thus providing information used in selecting the 
most suitable bioaccessibility test procedure for this investigation.  
 The Physiologically Based Extraction Test (PBET) 2.6.3.1
The PBET method was developed following a study by Ruby et al. (1993), which mimics the 
leaching of soil matrix in the human GI tract, and determines the bioaccessibility of an element. It 
was originally developed for evaluating the bioaccessibility of ingested Pb. The method was 
designed around the GI tract for a child, given that children are believed to be at greatest risk from 
accidental soil ingestion (Ruby et al., 1993). In addition, children can absorb higher percentage of a 
contaminant through the digestive system than adults, and therefore children are more susceptible 
to adverse health effects (i.e., critical receptors) (Hamel et al., 1998). This explains why 
bioaccessibility extraction tests are generally based around the gastrointestinal parameters for 
young children.  
PBET method is a two-stage sequential extraction method simulating both the gastric and the small 
intestine compartments, with extraction carried out at 37
0
C (the standard human body temperature). 
The pH value for the gastric phase is set at 2.5, while the pH for the small intestine phase is set at 
7.0. Samples are introduced into the simulated gastric solution to solubilise any bioaccessible metal 
present. After a gastric sample (stage 1 extraction) has been collected, the conditions are then 
modified to mimic the small intestine (stage 2). This method has been used in a number of studies. 
For example, a study carried out by Ruby et al. (1996) using the PBET method, established that 
arsenic data obtained by this method were found to be over-predictive (by between 2 and 11%) of 
bioavailability when compared to rabbit and primate models. However, they found out that lead 
results from the PBET method were linearly correlated with results from a Sprague-Dawley rat 
model (Ruby et al., 1996). The method was used by Gbefa et al. (2011) to analyse the oral 
bioaccessibility of selected elements (including Cr, Ni, Cd, Pb) in an urban catchment. Using a 
certified reference soil material to test the recovery of the extraction method, they reported element 
recovery values within ±2 % of the certified reference values (Gbefa et al., 2011). No information 
regarding the evaluation of this method using in-vivo experiments was obtained.  
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 Potentially Bioavailable Sequential Extraction (PBASE) 2.6.3.2
This method has four sequential extraction stages to evaluate the relationship between metal 
fractionation and the bioaccessibility of metal contaminants in soil (Basta & Gradwohl, 2000). A 
schematic representation of the PBASE method is shown in Fig. 2.3.  
 
 
 
 
 
 
 
 
 
 
The first stage (E1) uses calcium nitrate to extract readily soluble and exchangeable elements, and 
lasts 16 hours. The second extraction stage (E2) (5 hours duration) uses sodium acetate to extract 
acid-soluble weak surface complexes, while the third stage (E3) uses disodium adetate to extract 
surface complexes and precipitates for a period of 6 hours. The final stage (E4) employs nitric acid 
to extract the very insoluble elements, and runs for 16 hours. Stages E1 to E3 are carried out at 
25
0
C, while the stage E4 temperature is 80
0
C. Given that this procedure takes approximately 43 
hours to complete, it is not considered practical for use in analysing large batches of samples. In 
addition, the extraction sequence used in this method does not represent the actions of the human 
GI tract.  
 In-Vitro Gastrointestinal Method (IVG) 2.6.3.3
This method was developed to simulate the human GI tract environment and estimate the 
bioaccessibility of arsenic in soil. IVG involves the extraction of arsenic using simulated gastric 
and small intestine fluids at 37 
0
C (Rodriguez et al., 1999). It was developed to address the 
limitations of the PBET test, given that PBET method was found to be over-predictive of arsenic 
bioavailability when compared to rabbit and primate models (Ruby et al., 1996). The key 
difference between IVG and PBET is that IVG uses lower pH values (1.8 and 5.5, for the gastric 
and intestinal phases, respectively) compared to PBET (gastric pH of 2.5 and intestinal pH of 7.0). 
Fig. 2.3: A schematic representation of the PBASE method 
Adapted from Basta & Gradwohl (2000) 
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No subsequent studies were found where this method has been used, and consequently, no data was 
obtained as to its performance on other elements.  
 RIVM In-Vitro Digestion Method (RIVM) 2.6.3.4
This is an in-vitro digestion model used by the National Institute of Public Health and the 
Environment (RIVM) in the Netherlands. The description of this method given by Oomen et al. 
(2002) indicate that this test is a three stage extraction method using a five minute saliva phase at 
pH of 6.5, followed by a 2 hours stomach extraction (using gastric juice) at pH of approximately 
1.1, and another 2 hours small intestine extraction phase (using a mixture of duodenal and bile 
juices) at pH of at least 5.5. The test is carried out at 37
0
C. Although this method simulates the 
conditions of the human GI tract, no data validating this method against in-vivo studies were 
obtained.  
 Unified BARGE Method (UBM) 2.6.3.5
This method was developed by the Bioaccessibility Research Group of Europe (BARGE) for the 
measurement of inorganic contaminant bioaccessibility from soil. It is a modified version of the 
RIVM in-vitro digestion method. BARGE undertook the joint decision to progress research in the 
field of in-vitro bioaccessibility method development in order to harmonise the use of 
bioaccessibility in human health risk assessments for contaminated soils in Europe.  
UBM simulates the human gastrointestinal tract through three different compartments (mouth, 
stomach and small intestine), and employs synthetic digestive fluids comprising saliva, gastric 
fluid, duodenal fluid and bile. The gastric phase is a digestive extract collected after 1 hour 
agitation with saliva and gastric fluids at 37 
0
C. This is followed by the gastrointestinal phase 
involving 4 hours of agitation with duodenal fluid and bile, where samples are mixed by end-over-
end agitation at 37
0
C.  
This method has been validated in-vivo for assessing the bioaccessibility of As, Sb, Cd, and Pb in 
soil (Denys et al., 2012). UBM has been used in a number of studies to analyse the bioaccessibility 
of trace elements (Wragg & Cave, 2012; Wragg et al., 2011; Broadway et al., 2010). Research 
institutions which are BARGE members have also been applying the UBM to contaminated land 
issues in their respective countries. In addition, the British Geological Survey (BGS) have prepared 
a bioaccessibility reference material (BGS Guidance Material 102) with bioaccessibility values for 
As and Pb, determined using UBM as part of the international inter-laboratory study with seven 
participating laboratories (Wragg et al., 2009). The BGS reference material was obtained and used 
in in quality control checks during laboratory analysis.  
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 Summary of the reviewed bioaccessibility test methods 2.6.3.6
The in vitro bioaccessibility test methods discussed in the preceding sections are summarised in 
Table 2.2.  
Table 2.2: Summary of in-vitro bioaccessibility test methods 
Test 
Method 
Stages of Digestion / Extraction 
Method 
Validation  
(In-Vivo) 
Duration of 
Sample Digestion 
(approximate) 
Reference 
Materials 
Availability 
PBET 
Two stages (gastric and small 
intestine compartments). 
No 
5 hours, excluding 
sample pre-drying 
No 
PBASE 
Four stages evaluating the 
relationship between metal 
fractionation and the bioaccessibility 
of metal contaminants in soil. 
No 43 hours No 
IVG 
Two stages (gastric and small 
intestine compartments). The method 
was developed for arsenic 
bioaccessibility measurements. 
No 5.5 hours No 
RIVM 
Three stages (mouth, stomach and 
small intestine compartments) 
No 4 hours No 
UBM 
Three stages (mouth, stomach and 
small intestine compartments) 
Yes (for As, 
Sb, Cd & 
Pb) 
5 hours 
Yes  
(for As & 
Pb) 
 
2.6.4 Selection of a bioaccessibility test method for use in this research 
The UBM test method was selected and used in this study, based on the following considerations:  
a) UBM is a well-established methodology, which has been used by various researchers in 
Europe; 
b) the BGS have developed bioaccessibility reference material with bioaccessibility values for 
arsenic and lead using the UBM test. Therefore, it is possible to do quality control checks 
on the performance of the method using a material of known arsenic and lead 
concentrations;  
c) the method has been validated in-vivo for assessing the bioaccessibility of selected metals 
(As, Sb, Cd and Pb) in soil; and 
d) the method is not complex to carry out and takes approximately 5 hours to digest each 
sample batch. UBM is therefore suitable for testing large batches of samples.  
 
2.7 Biomonitoring and biomarkers of exposure 
Human biological monitoring (biomonitoring) refers to monitoring activities using biomarkers in 
human body fluids and tissues that focus on environmental occupational exposures to hazardous 
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substances (Joas et al., 2012). This requires targeted biological sampling depending on the 
chemicals/pollutants under investigation. Biomonitoring is a recognised tool in assessing exposure 
to environmental pollutants (Zhang et al., 2002; Gil et al., 2011; Rodrigues et al., 2009), and has 
many potential uses that include the assessment of exposure and the potential health effects of 
individuals (Clewell et al., 2008). However, the interpretation of the health implications of human 
biomonitoring data requires understanding of exposure scenarios to relate the observed 
concentrations in the biomonitoring study to exposures associated with adverse health effects in 
toxicity studies (Clewell et al., 2008). This is because biomonitoring data reflects total exposure, 
yet not all routes of exposure may be under investigation in a biomonitoring study. The biomarkers 
used in this study are presented in the following section.  
2.7.1 Biomarkers of exposure 
According to Jakubowski & Trzcinka-Ochocka (2005), biomarker is a general term for the specific 
measurements of an interaction between a biological system and an environmental agent (e.g., 
metals). Usually, the biomarker is the agent or its metabolite in a biological specimen derived from 
the individual, such as urine, blood, hair, body tissue or nail. The International Program of 
Chemical Safety (IPCS) identifies three types of biomarkers, namely; biomarker of exposure, 
biomarker of effects and biomarker of susceptibility (IPCS, 1993)
3
. Biomarker of exposure, in this 
case, refers to the measurement of selected toxic elements in urine and blood reflecting exposure to 
the elements (Nordberg, 2010). Human blood and urine are the most widely used matrices for 
biological monitoring of exposure to toxic elements in occupational and environmental toxicology 
(Angerer, Ewers & Wilhelm, 2007; Kakkar & Jaffery, 2005).  
Reliable analytical measurements are at the core of any biological monitoring programme. 
However, even when the analytical methods are adequate, additional factors should be considered 
to ensure the quality of biological monitoring data (Calafat & Needham, 2008). Some of the factors 
that require consideration in biomonitoring are presented in the following sections.  
 Biomarker selection 2.7.1.1
Selection of the most relevant biomarkers of exposure is influenced by the knowledge of the 
toxicokinetics of the chemical being investigated. Biomarkers (the parent chemical or its 
metabolite) can be present in various human tissues such as blood and urine. For example, the 
biotransformation of arsenic absorbed in the body consists of oxidation/reduction and methylation 
reactions (Mann, Droz & Vahter, 1996). Methylation of inorganic arsenic takes place primarily in 
the liver and specifically in hepatocytes, producing both mono-methylated and di-methylated 
arsenicals, which are excreted in urine (Stamatelos et al., 2011). Therefore, measured biomarker 
concentrations should account for the toxicologically relevant metabolites as well as the parent 
                                                          
3 Available at: http://apps.who.int/iris/bitstream/10665/39037/1/9241571551-eng.pdf  
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chemical. In addition, where there are a number of metabolite pathways, it is important to know the 
proportion of external exposure that goes with each metabolite. The biomarkers of exposure used in 
this study are presented in Table 2.3.  
Table 2.3: Summary of biomarkers of exposure used in this study 
Element Biomarkers of exposure References 
As 
Inorganic arsenic is the most relevant in toxicological studies due 
its high toxicity compared to organic arsenic. Therefore, we used 
urinary inorganic arsenic concentration (i.e., sum of all inorganic 
species) as an indicator of exposure to As.  
a, b, c 
Cd 
Both blood and urine have been reported as useful biomarkers in 
studying Cd exposure. In this study, urine was used as the 
biomarker. Urine has been indicated to reflect Cd levels in the 
kidney, which is a target organ for Cd.  
b, d, e 
Cr 
Chromium in blood and urine are considered the most reliable 
indicators of exposure to chromium. In this study, urine was used 
because absorbed Cr is predominantly excreted through urine.  
f, g, h 
Pb 
Total lead concentration in blood is the preferred biomarker of 
recent lead exposure. 
b, i, j 
Ni 
Serum or urine nickel concentrations are the most useful 
biomarkers of nickel exposure. Urine was used as the biomarker 
because urinary excretion is the main clearance route for absorbed 
nickel.  
k, l 
a
(Hughes, 2006); 
b
(Bornhorst & McMillin, 2006); 
c
(ATSDR, 2007a); 
d
(Järup & Åkesson, 2009); 
e
(ATSDR, 2012a); 
f
(Caglieri et al., 2005);
 g
(ATSDR, 2012b); h(Paustenbach et al., 1997); 
i
(ATSDR, 
2007b); 
j
(Keil et al., 2011); 
k
(Kakkar & Jaffery, 2005); 
l
(ATSDR, 2005).  
 
 Effect of half-life on biomarker concentration 2.7.1.2
The kinetics and storage of an element in the body is important in the interpretation of 
biomonitoring results, and determines the timing and frequency of sample collection (Aitio et al., 
2007). Biomarker concentrations change over time in relation to the half-life of the chemical 
involved. Some chemicals with short half-lives (e.g., a few days) are rapidly eliminated from the 
body, while those with longer half-lives are eliminated over a longer time period. For example, the 
elimination half-life of lead in blood is about 30 days (ATSDR, 2007b), while absorbed cadmium 
is excreted very slowly with a range of half-lives of several years (4 to 19 years in human liver; 6 to 
38 years in human kidney) (ATSDR, 2012a). Therefore, the half-lives of the chemicals under 
investigation should be considered during biological monitoring, in order to ensure the biological 
samples are obtained before the chemical or its metabolite has been eliminated from the body.  
 Biological monitoring data provide a measure of all exposures 2.7.1.3
Quantification of exposure relies on knowledge of the relationship between the exposure and the 
biomarker concentration. Biological monitoring measures the total environmental exposures from 
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all sources and exposure routes (Friberg & Elinder, 1993). The contribution of the main pollution 
sources and pathways to exposure are key components for risk assessment. Without information on 
exposure pathway, it is difficult to relate biomonitoring data to sources and routes of exposure and 
to develop effective risk management strategies (Doerrer, 2007; Albertini et al., 2006).  
 Ethical issues 2.7.1.4
The use of biological monitoring data in risk assessment involves a variety of ethical issues. Some 
methods for obtaining biological samples (e.g., blood and urine) are invasive, which some 
participants may find uncomfortable. Invasive methods of collecting biological samples also pose 
some risk to the person. Biomonitoring produces data on the volunteering individual and, thus, 
information that is confidential. Biological monitoring studies should be undertaken in accordance 
with the fundamental and widely accepted ethical principles, namely; beneficence (‘do positive 
good’), non-maleficence (‘do no harm’), informed consent and privacy and dignity (Sepai et al., 
2008).  
2.7.2 Creatinine adjustment of biomonitoring results 
Creatinine is the metabolite of creatine (an important energy store for muscles), and therefore the 
production of creatinine in an individual reflects muscle mass (Cocker et al., 2011). The production 
of creatinine is relatively constant within an individual (Cocker et al., 2011). The variability in the 
volume of urine from void to void is a major disadvantage of spot urine sampling. Common 
methods for adjusting dilution and for determining whether a spot urine sample is valid for 
assessing chemical exposures include urinary creatinine concentrations, specific gravity and 
osmolality. The most widely used method is creatinine adjustment, which involves dividing the 
analyte concentration by the creatinine concentration. (Barr et al., 2005, Falco et al., 2001). The 
World Health Organization (WHO) recommends that if a sample is too dilute (creatinine 
concentration < 0.3 g L
-1
) or too concentrated (creatinine concentration > 3 g L
-1
), another urine 
void should be collected (WHO, 1996) and analysed for creatinine and the target chemical. We 
used these WHO guideline values to assess the validity of urine samples, such that urine samples 
that were either too dilute or too concentrated were discarded. This is a standard practice in 
biomonitoring studies.  
2.8 PBPK models and model selection 
PBPK modelling is recognised as a technology for simulating and predicting the fate of substances 
in the body (Schmitt & Willmann, 2005). PBPK models are based on compartments (e.g., body 
organs, tissues) and the interconnections among the compartments. The level of model detail 
relates to the compartments and elements (including associated chemical forms such as 
metabolites) that are tracked within the model (Krishnan et al., 2010). The models describe 
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(quantitatively) the absorption, distribution, metabolism and excretion of chemicals in the body; 
and thus can provide a scientific basis for quantitatively estimating risk to human health (Yu, 
1999).  
The absorption, distribution, metabolism (relevant for As and Cr) and excretion of the five 
elements are summarised in this section. Previously published kinetic models for these elements are 
also presented, in order to select models to apply in this study. Schematic representations of the 
original models adopted are given in Appendix B.  
Models were selected based on the following preferences: 
a) whether the model was reproducible (based on model details presented), 
b) relevance of the model to adult humans,  
c) relevance of model to the ingestion pathway, and  
d) most recent and/or most used models.  
Some of these models are quire complex in terms of their structure and formulation because of the 
differences in physicochemical properties of the elements, organs involved in metabolism and 
exposure pathways simulated by the authors. To construct models suitable for our purpose (i.e., 
simulation of oral ingestion pathway in adults), some of the published models required 
modification by reducing or removing some compartments whilst still maintaining their predictive 
ability. Evaluation of the predictive performance of the constructed models is presented in chapter 
6.  
2.8.1 Arsenic  
Following oral ingestion of inorganic As (in the form of either As(III) or As(V), the two 
biologically important valence states), absorbed As from the GI tract is transported by the blood to 
other parts of the body (Fowler et al., 2007). The distribution of As to the tissues depends on their 
blood perfusion (the permeability of the capillary membranes) and the affinity of the tissues for the 
arsenic metabolites (Mann et al., 1996). The biotransformation / metabolism of absorbed As in the 
body consists of oxidation/reduction and methylation reactions (Mann et al., 1996; El-Masri & 
Kenyon, 2008). The reduction facilitates the uptake of As(III) by cells for further methylation 
reactions since As(V) does not undergo methylation (Stamatelos et al., 2011; Yu, 1999; El-Masri & 
Kenyon, 2008). Methylation takes place primarily in the liver and kidney, producing both 
monomethylarsenic acid (MMA) and dimethylarsinic acid (DMA). Generally, whole body 
clearance of As is fairly rapid, with half-lives of 40 to 60 hours in humans (Fowler et al., 2007; 
ATSDR, 2007a). Bornhorst & McMillin (2006) indicate that ingested inorganic forms of As are 
excreted over the course of 1 to 3 weeks; therefore making urine the preferred sample for 
biomonitoring since arsenic can be observed for up to 3 weeks following exposure. Unabsorbed 
fraction is excreted in the faeces.  
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A number of published human PBPK models for inorganic As were identified in the literature 
(Mann et al., 1996; Yu, 1999; Liao et al., 2008; El-Masri & Kenyon, 2008). These models are 
largely similar in structure, and they account for oxidation of As(III) to As(V), reduction of As(V) 
to As(III), and methylation of As(III) to MMA and DMA in the body. One key difference between 
these models is that the model by Mann et al. (1996) included both oral and inhalation exposure 
pathways, whereas other models only included the ingestion pathway. Ingestion is the primary 
route of exposure studied, because exposure to As from allotment land use occurs mainly through 
oral intake (CL:AIRE, 2014). In addition, a pilot study we carried out identified air As 
concentrations at the allotment that were not significantly elevated enough above background air 
concentrations to warrant inclusion in our model.  
The model proposed by Liao et al. (2008) for children was not evaluated using experimental data, 
whereas the other models were tested using data from human studies. The model published by El-
Masri & Kenyon (2008), which is the most recent out of the tested models, was adopted in this 
study. This model comprises 9 compartments, namely: GI tract, liver, kidney, blood, muscles, 
brain, skin, heart and lung. The choice of tissues was based on physiochemical properties of As, 
oral exposure route, target tissues, and sites for As metabolism (El-Masri & Kenyon, 2008). 
Although the model does not include the inhalation exposure pathway, the lung compartment was 
included in the model because it receives total blood flow, thus mathematically accounting for As 
reduction that may occur in other body tissues (El-Masri & Kenyon, 2008). Model parameters were 
determined from data derived using human cells and tissues (El-Masri & Kenyon, 2008). The 
authors evaluated the model using urinary excretion data. A sketch of this model is given in 
Appendix B (Fig. B1).  
2.8.2 Cadmium 
Absorbed Cd is widely distributed throughout the body via the blood, with the highest 
concentrations found in the liver and kidney (ATSDR, 2012a). Cd has a range of half-lives of 
several years (4 to 19 years in human liver; 6 to 38 years in human kidney) (ATSDR, 2012a). The 
concentration of cadmium in the kidney is reflected in urinary cadmium levels (Keil et al., 2011; 
Järup & Åkesson, 2009). According to ATSDR (2012), Cd is not known to undergo direct 
metabolic conversion (e.g., oxidation, reduction, alkylation). The major cadmium excretion routes 
are through urine (absorbed fraction) and faeces (unabsorbed fraction) (Kjellstrom & Nordberg, 
1978).  
There are a number of PBTK models for Cd published in the literature (Choudhury et al., 2001; 
Amzal et al., 2009; Ju et al., 2012; Fransson et al., 2014), based on the original physiologically-
based toxicokinetic (PBTK) model published by Kjellstrom & Nordberg (1978) (KN model). The 
KN model consists of eight compartments, describing Cd uptake from the gastrointestinal (GI) tract 
and the lungs, distribution of absorbed Cd to three blood compartments (B1 to B3, representing Cd 
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bound to albumin and other proteins, Cd in erythrocytes, and Cd bound to metallothionein in 
plasma, respectively), liver, kidney and a compartment for ‘other tissues’, and Cd elimination 
through urine and faeces. The KN model was formulated for oral and inhalation exposure 
pathways, based on animal and human tissue distribution data (Kjellstrom & Nordberg, 1978). The 
distribution coefficients of the KN were estimated by fitting the calculated Cd concentrations in 5 
compartments (kidney, liver, urine, blood, and other tissues) to the observed concentrations for 
humans with different smoking habits, and humans with and without occupational Cd exposure 
(Kjellstrom & Nordberg, 1978).. Further testing of the model with data on Cd metabolism in 
humans was carried out by Nordberg & Kjellstrom (1979). Different authors have used the K&N 
model to simulate Cd exposure through oral ingestion (Ruiz et al., 2010; Ju et al., 2012; Fransson et 
al., 2014). The KN model was adopted in this study because it was the most used model and it is 
also the basis for other published PBTK models for Cd. A schematic representation of the original 
KN model is given in Appendix B (Fig. B2).  
2.8.3 Chromium  
It has been estimated that the absorbed fraction of Cr in the GI tract in humans is less than 10% of 
the ingested dose (ATSDR, 2012b). The uptake is much quicker for Cr(VI) than Cr(III) because 
Cr(III) is poorly absorbed from the GI tract (Langard & Costa, 2007). Once in the blood, Cr(VI) is 
readily taken up into the red blood cells (RBCs) where it is rapidly reduced to a more stable Cr(III) 
(Kerger et al., 1996; De Flora, 2000; O’Flaherty et al., 2001). The Cr(III) can either be trapped 
within the RBCs or exit the cells into the plasma (Kerger et al., 1996; O’Flaherty, 1996). The 
absorbed chromium is distributed to nearly all tissues, but the highest concentrations are found in 
the kidney and liver (ATSDR, 2012b). After absorption, any Cr(VI) that is not reduced to Cr(III) in 
the portal vein would reach the liver, which also has a capacity to reduce Cr(VI) to Cr(III) (De 
Flora et al., 1997; O’Flaherty et al., 2001). Given the reducing capacities of Cr(VI) in the tissues, 
Cr is present in the body mainly in the form of Cr(III) (Paustenbach et al., 1997).  
The half-life of Cr in the human RBCs in vivo is estimated to be about 30 days (O’Flaherty et al., 
2001). This suggests that Cr does not remain in the RBCs for the entire lifespan of the cell, which 
is approximately 120 days (Paustenbach et al., 1997). However, Kerger et al. (1996) indicated that 
haemoglobin-bound Cr complexes remain part of the RBC for the entire lifespan of the cell. On the 
contrary, the urinary half-life is much shorter. According to ATSDR (2012b), Cr absorbed 
following Cr(VI) ingestion has a half-life of approximately 40 hours, the half-life is about 10 hours 
when absorbed as Cr(III). This seems consistent with the half-life of less than 2 days indicated by 
Paustenbach et al. (1997).  Absorbed Cr is excreted predominantly through urine (ATSDR, 2012b), 
while unabsorbed fraction (nearly 90% of ingested dose) is excreted in the faeces (Kirman et al., 
2013). Two key models for Cr were identified in the literature. A physiologically based model for 
the ingestion of Cr(III) and Cr(VI) by humans was developed by O’Flaherty et al. (2001). The 
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compartments included in the model are the GI tract, blood (plasma and red blood cells), liver, 
kidney, bone (trabecular and cortical), well- and poorly-perfused tissues with pulmonary absorption 
of inhaled Cr, and excretion pathways via faeces and urine. The model was calibrated using blood 
and urine data from controlled studies in which human volunteers drank solutions containing 
Cr(III) and Cr(VI). Another PBPK model for humans orally exposed to Cr was developed by 
(Kirman et al., 2013). This model includes compartments for GI tract (stomach and intestines), 
blood (systemic and portal plasma and red blood cells), liver, kidney, bone and other tissues. It 
models absorbed Cr(III) in systemic circulation as belonging to two general pools: (i) a distribution 
pool, which describes the distribution of Cr(III) from the GI tract to tissues through the plasma, and 
(ii) a storage/excretion pool, which describes the release of Cr(III) from tissues to its ultimate 
excretion in urine (Kirman et al., 2013). Model performance was evaluated using toxicokinetic data 
for Cr in human tissues and excreta obtained from the literature. The authors reported that the 
model provides a good description of Cr toxicokinetics in humans. One key difference between 
these two models is that Kirman et al. (2013) included detailed Cr toxicokinetics in various GI tract 
compartments in their model, while O’Flaherty et al. (2001) modelled GI tract as a single 
compartment. The model by Kirman et al. (2013), which is the most recent model, was adopted in 
this study; a sketch of this model is given in Appendix B (Fig. B3).  
2.8.4 Lead 
The extent and rate of absorption of ingested inorganic Pb in the gastrointestinal tract are 
influenced by physiological properties of the exposed individual, including age, fasting status, 
nutritional calcium and iron status, and pregnancy (ATSDR, 2007b). Once absorbed, the 
concentration of Pb in the plasma governs the rate of Pb transfer out of the blood, and thus 
influences Pb transport throughout the body (Leggett, 1993; O’Flaherty, 1993). Pb is circulated 
through the vascular system to soft tissues (e.g., liver, kidney, muscles) and the bone (Fleming et 
al., 1999; White et al., 1998). In adult humans, over 90% of the Pb entering the body throughout a 
person’s life is stored in the bones (ATSDR, 2007b; Keil et al., 2011). According to Skerfving & 
Bergdahl (2007), the skeleton contains approximately 20% trabecular bone and approximately 80% 
cortical bone, providing two different skeletal Pb pools. It has been suggested that Pb is mobilised 
from the skeleton during bone mineralisation, and therefore Pb in the bones can be transferred into 
the blood long after exposure has ended (Smith et al., 1996; Fleming et al., 1997).  
The half-life of Pb in blood is about 30 days (ATSDR, 2007b). However, Pb has a longer half-life 
in the bone (about 1 year in the trabecular bone, and 10 to 32 years in the cortical bone) (Skerfving 
& Bergdahl, 2007; Keil et al., 2011; Bornhorst & McMillin, 2006). Blood Pb is the preferred 
indicator of relatively recent exposure to lead (Keil et al., 2011), while the lead concentration in the 
bone indicates long-term exposure to lead (Skerfving & Bergdahl, 2007). Absorbed Pb is primarily 
excreted in urine and biliary secretion, while minor routes of excretion include sweat, saliva, hair 
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and nails (ATSDR, 2007b; Bornhorst & McMillin, 2006; White et al., 1998). Unabsorbed Pb is 
excreted in the faeces.  
There are a number of Pb kinetic models for humans in the literature. The most cited in the 
literature reviewed are the Leggett model (Leggett, 1993), the Integrated Exposure Uptake 
Biokinetic (IEUBK) model (White et al., 1998) and the O’Flaherty model (Fleming et al., 1999; 
O’Flaherty, 1991; O’Flaherty, 1993). The IEUBK model deals with Pb kinetics in children only, 
yet our study involved adults. Another observation is that the Leggett model does not account for 
physiological factors in detail, it gives the model ‘transfer rates’ that are age-specific and regards ≥ 
25years as one age-class. Therefore, the Leggett model does not account for physiological 
variabilities that can be associated with varying body weights (Prakash et al., 2013; Bailey et al., 
2004). In view of the above, both the IEUBK and the Leggett models were not considered suitable 
for this study. The O’Flaherty model was considered suitable for this study because it is 
physiologically-based and it is for adults. Full details of the construction of this model are provided 
by O’Flaherty (1991), O’Flaherty (1993) and Fleming et al. (1999). Briefly, this model uses 9 body 
compartments, namely: GI tract, blood, liver, kidney, bone (cortical and trabecular), other tissues 
(well- and poorly-perfused) and the lung. This model has been evaluated against data from human 
subjects exposed to Pb through oral and inhalation pathways (O’Flaherty, 1993). A sketch of this 
model is given in Appendix B (Fig. B4).  
2.8.5 Nickel 
Following exposure to Ni, part of Ni load is absorbed into the blood stream. A study conducted by 
Sunderman et al. (1989) on human volunteers indicated that following oral exposure, about 27% of 
the Ni given to the volunteers in drinking water was absorbed, while only about 1% was absorbed 
when it was given in food. It has also been suggested that only 5% of ingested Ni is absorbed 
(Rojas et al., 1999). According to Klein & Costa (2007), Ni does not generally accumulate in 
tissues due to its efficient excretion. The urinary excretion half-life for absorbed Ni has been 
reported to vary between approximately 20 and 27 hours (Nielsen et al., 1999). This correlates well 
with the half-life of 28±9 hours previously reported by Sunderman et al. (1989). Urinary excretion 
is the main clearance route of absorbed Ni (Kakkar & Jaffery, 2005; Klein & Costa, 2007), hence 
urine can be used as a biomarker for Ni exposure. The fraction that remains unabsorbed in the GI 
tract is excreted in the faeces.  
There are limited PBPK models for Ni compounds in the literature relevant to humans. Models 
describing the deposition, retention and clearance of inhaled Ni (in the lung) have been developed 
by others (Hsieh et al., 1999; Yu et al., 2001). However, given that inhalation route is not the 
dominant pathway for allotments land use, these models were not reviewed here.  
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The only relevant Ni PBTK model for humans found in the literature is that of Sunderman et al. 
(1989), following oral intake of Ni in water and food by human volunteers. They developed the 
model based on two experiments, in which Ni levels in serum, urinary and faecal excretions were 
monitored after eight subjects were given an oral dose of Ni (as NiSO4) in either water (experiment 
1) or food (experiment 2). The model comprises four compartments (gut, serum, urine and tissues) 
with the parameters based on model-data-fitting to the two experiments. This allowed rate 
constants for alimentary Ni absorption from the gut, Ni transfer rate constants from serum to tissues 
and urine, and from tissues to serum to be determined. Given that our study involves exposure 
through oral ingestion of food, the model parameters provided by Sunderman et al. (1989) from 
experiment 2 were considered more relevant to our study than parameters from experiment 1. 
However, Sunderman et al. (1989) did not determine the rate transfer from tissues to serum in 
experiment 2, which they indicated was due to the small mass of Ni absorbed from the gut into 
subsequent compartments. Therefore, we used the Ni rate transfer from tissues to serum from their 
experiment 1 in our simulations. A sketch of this model is given in Appendix B (Fig. B5).  
2.9 Chapter summary  
This chapter provides useful background information that highlights the context of the research. 
Using a CSM for allotment land use, it has been established that the primary route through which 
humans could be exposed to As, Cd, Cr, Pb and Ni present in allotment soil is oral ingestion. The 
CSM has informed the sampling and material requirements necessary in characterising the ‘source 
– pathway – receptor’ linkage. Although the conservative GACs currently used in contaminated 
land risk assessment are protective of public health, they may result in over-estimation of human 
exposure to soil contaminants. Subsequently, this could lead to un-necessary remediation or 
restrictions on land use. To promote sustainable reuse of land, there is a need for improved 
understanding of the actual human exposure to soil contaminants. This highlights the knowledge 
gap, which this research sought to address in relation to the five elements selected.  
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3. MATERIALS AND METHODS 
3.1 Introduction 
The materials and methods used in this study ranged from IOM’s internal standard procedures to 
methods obtained from the literature, and were determined based on information gathered from the 
literature review (Chapter 2). In order to trial the materials and methods and test the logistical 
requirements for biomonitoring, we carried out a pilot study. A summary of the pilot study is given 
in the following section.  
3.2 Pilot study 
The preliminary investigation was carried out between July 2014 and January 2015 to test the 
methods and procedures, and logistical requirements for biomonitoring. No statistical emphasis 
was placed on sample size requirements and site selection in this trial phase. Five allotments were 
identified and their respective users were recruited to participate in the pilot study. Findings of the 
pilot study (presented in Appendix C) were used in the planning of the main study phase.  
Changes and adjustments made to the methods as a result of the pilot study include exclusion of the 
inhalation (of allotment dust) pathway from the main study phase. This was because air 
concentrations of the elements at the allotments were determined to be similar to background air 
concentrations, which indicate negligible exposure to the elements investigated through inhalation 
of allotment dust. This is consistent with the CLEA model parameters which show that this 
pathway contributes to ≤ 0.1% of total human exposure to these elements (CL:AIRE, 2014; 
Environment Agency, 2009d; Environment Agency, 2009c). Following the completion of the pilot 
study, the main study phase was carried out using the materials and methods presented in the 
following sections.  
3.3 Estimation of sample size 
Sample size determination is important in statistical studies for economic and ethical reasons 
(Lenth, 2001). Therefore, in order to estimate the number of participants required for the study, a 
range of a priori power calculations were carried out using G*Power statistical software (version 
3.1.9.2) (Faul et al., 2007). The following parameters were used in the calculations (Schulz & 
Grimes, 2005):  
 Type I error (α) – which is the probability of detecting a false-positive result 
(conventionally set at 0.05, indicating a desire for less than 5% chance of making a false-
positive conclusion).  
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 Type II error (β) – is the probability of detecting a false-negative result (conventionally set 
at 0.20, indicating a desire for less than 20% chance of making a false-negative 
conclusion).  
 Power (1-β) – represents the probability of avoiding a false-negative conclusion. The 
power of 0.8 usually suffices (Schulz & Grimes, 2005).  
 Effect size (expressed as a ration greater that 0 but less than 1) – due to scant data on the 
effect of exposure to the selected elements from allotment land-use, an effect size of 0.5 
was assumed (Galea et al., 2011). This indicates the ability to detect a doubling of 
background levels.  
Various statistical tests (built into G*Power) were used in calculations. These tests predicted 
sample sizes of approximately 26 subjects (at power of 0.8), as illustrated in Fig. 3.1.  
 
 
 
 
 
 
 
 
 
 
A sample size of 25 to 30 subjects was considered reasonable and achievable, given the intrusive 
nature of the study (e.g. biomonitoring requirements) and the resources (time and funding) 
available for this study.  
 
  
Fig. 3.1: Estimation of sample size 
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3.4 Identification of study sites and participant recruitment 
Reference was made to the full list of allotment sites in Scotland published by SAGS (2007). 
Thereafter, online inspection of historical maps held by the National Library of Scotland was 
carried out to identify potential study sites in the central part of Scotland. We identified a number 
of allotment sites of interest based on the historical features recorded at these sites, and their 
potential for soil contamination with the elements of interest. Reference was made to the 
Department of Environment Industry profiles
4
 in identifying potential contamination from 
historical features. In addition, some sites were randomly selected. Thirty allotment plots (from 16 
separate sites) were chosen.  
Each plot was assigned a unique identification number preceded by letter ‘A’ (A01, A02, etc.). The 
geographical locations of these sites are shown in Fig. 3.2 (produced using QGIS version 2.14).  
 
 
 
 
 
 
 
 
 
 
 
 
After obtaining ethical approval from UREC, initial contacts were made with representatives of the 
various allotment associations, who were requested to distribute the recruitment poster to members 
of their associations. Other participants were also reached through personal contacts. We recruited 
37 allotment users (consisting of 20 males and 17 females) from the chosen sites to participate in 
                                                          
4 Available at: http://www.claire.co.uk/useful-government-legislation-and-guidance-by-country/76-key-documents/198-
doe-industry-profiles 
Fig. 3.2: Map showing the geographical locations of the chosen allotment sites in Scotland 
(made with Natural Earth. Free vector and raster map data at naturalearthdata.com). 
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the study. This included one participant per plot from 23 plots and two participants (couples) per 
plot from 7 plots. The age range of the participants was between 30 and 80 years old (with mean 
and standard deviation of 59 ± 11 years). Within the participants, there were 23 non-smokers 
(never smoked), 11 ex-smokers, 2 current smokers, 1 unknown smoking status (not declared). 
Participants were assigned unique identification numbers (P01, P02, etc.).  
Available historical information for the allotments and the durations the participants have used 
their allotment plots are presented in the following Table 3.1.  
Table 3.1: Introductory information for allotment plots 
Allotment 
plot ID 
Regional 
location of 
allotment 
Available historical information for allotment sites where 
plots used in this study were located  
Duration of 
allotment 
use (years) 
A01 Edinburgh 
Site shown as vacant from 1880s until allotments were shown 
on site by 1950s.
#
  
20 
A03 Edinburgh The plot is located on the same allotment site as plot A01.  1 
A04 Edinburgh No information was obtained. 2.5 
A05 Edinburgh Historical maps show allotment at the site by 1940s.
#
 20 
A06 Edinburgh No information was obtained. 5 
A07 Edinburgh 
There was a railway line on site from 1900s until the 1940s 
when allotments were shown on site.
#
  
2 
A08 Dundee The site was occupied by buildings from 1890s to 1960s.
#
 3 
A09 Edinburgh Site was used for allotments by 1944.
# 
It was understood that 
the site was part of a Roman Settlement.
$
 Plots A09, A10 and 
A12 were located within the same allotment site.  
3.5 
A10 Edinburgh 17 
A12 Edinburgh 20 
A15 Edinburgh The plot is located on the same allotment site as plot A05.  8 
A16 Glasgow The site had been used for allotments since the 1920s.
$
 4 
A17 Kilbirnie Site was formerly used for disposal of building waste / rubble.
$
 4 
A18 Kilbirnie The plot is located on the same allotment site as plot A17.  2 
A19 Glasgow Allotment gardens were set up on site by 1917.
#
 20 
A20 Glasgow 
From 1950s to 1980s, site was used for allotments, then as a 
playground until 2013 when the current allotment was started.
$
 
1.5 
A21 Edinburgh The site was an open park until the allotment started in 1920s.
$
 20 
A23 Glasgow The site has been used for allotments since at least 1935.
$
 30 
A25 Edinburgh The plot is located on the same allotment site as plot A21.  19 
A26 Edinburgh The plot is located on the same allotment site as plot A21.  19 
A27 Glasgow The plot is located on the same allotment site as plot A20.  1.5 
A28 Glasgow 
Site was used for gardens (1945 to 1960s), then was vacant until 
2010 when current allotment was started.
$
  
0.2 
A29 Kilbirnie The plot is located on the same allotment site as plot A17.  5 
A31 Edinburgh The plot is located on the same allotment site as plot A05.  1 
A32 Edinburgh The plot is located on the same allotment site as plot A05. 6 
A33 Edinburgh 
Historical maps show the site as vacant until the 1940s when 
allotments were recorded on site.
#
 
7 
A34 Glasgow The site has been used for allotments since the 1940s.
$
 17 
A36 Dundee 
Site was located within a historically industrial area in Dundee. 
Historical maps show allotment on site by early 1900s.
#
  
0.2 
A37 Dundee The plot is located on the same allotment site as plot A36.  20.5 
A38 Glasgow The plot is located on the same allotment site as plot A20.  1.5 
#
Information obtained from historical maps available on the National Library of Scotland online portal (maps.nls.uk).  
$
Information provided by the participant (allotment plot-holder).  
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Written consent was obtained from each participant. Questionnaires and diaries were used to gather 
information from the participants. Copies of the recruitment poster, questionnaires and diaries are 
presented in Appendix D. Information gathered from the participants including participants’ 
details, frequency and duration of allotment visits, and produce consumption rates are summarised 
in Appendix E.  
3.5 Sample collection and storage 
Soil samples (n=258) were collected from the allotment plots in May 2015. Between 6 and 14 
samples were collected from each plot. Samples were obtained from hand dug pits at 
approximately 0.3 m depth (corresponding to ‘single dig’ cultivation method reported by most 
participants) using a trowel. To minimise potential cross-contamination of samples, the trowel was 
cleaned (using wet wipes) between successive sampling locations. Sampling locations were 
randomly selected, avoiding heavily planted areas to minimise damage to plants. Samples were 
placed in plastic tubs and labelled with a unique identifying number. A collection of 270 allotment 
produce samples was carried out in August 2015. Between 3 and 18 produce samples were 
collected from each plot. Fibrous roots and non-edible plant parts were removed and discarded on 
site. Samples were placed in sealable plastic bags and labelled with a unique identifying number. In 
addition, hand-moist-wipes (n = 40) were obtained from participants while doing allotment work 
with bare hands. Samples were collected using ‘Ghost’ wipes (i.e., sturdy wiping materials 
moistened with deionised water). Wipes were collected to investigate potential exposure to the 
elements through inadvertent ingestion, which mainly rises from hand-to-mouth contact (Ng et al., 
2012). During sampling, it was observed that participants stored their gardening gear in allotment 
sheds away from home, which supports our consideration in the conceptual site model (section 
2.5.2) that ‘tracking back’ of allotment soil to participants’ homes was not a significant pathway of 
exposure.  
Collection of venous blood samples from 32 consenting participants were scheduled on four 
different occasions over a period of 12 months. Blood samples (n=108, 5 mL each) were collected 
by venepuncture in tubes containing ethylenediamine tetraacetic acid (EDTA). Between 2 and 4 
venous blood samples were obtained from each participant; some of the participants were not 
available during some of the scheduled visits. Five participants who did not consent to giving blood 
were excluded from blood sampling. A qualified nurse was recruited to collect venous blood 
samples. In addition, collection of dried blood spot samples from finger-prick (from 32 consenting 
participants) was scheduled on a monthly basis over a period of 12 months, to investigate if finger-
prick samples (i.e., capillary blood) could be used as a surrogate for venous blood (as Pb 
biomarker). We collected 315 dried blood spot samples on filter paper, of which, 108 were paired 
to the venous blood samples because both sample types were collected at the site time. Each filter 
(in a cassette) was weighed (average of 3 weights) before and after sampling to determine the 
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weight of blood sampled. Subsequently, the volume of blood collected on the filter was estimated 
using the density of blood (at 37 
0
C). First-void urine samples (n = 748) were collected in 
polystyrene bottles throughout the 12 months period of biomonitoring. Collection of urine samples 
was scheduled on a fortnightly-basis. In addition, we obtained 113 spot urine samples (collected 
over 2 to 3 consecutive days) from 13 participants, who also provided a record of allotment 
produce consumed during the same period (see sampling dairy in Appendix D). These additional 
urine samples (and produce consumption data) were collected to aid the evaluation of model 
performance, especially for As, Cr and Ni that have short biological half-lives. All samples were 
transported to the laboratory for storage and subsequent analysis. Blood and urine samples were 
stored at –20 0C.  
3.6 Laboratory test methods 
The laboratory tests carried out internally by the researcher at IOM laboratory are outlined below. 
Detailed descriptions of the laboratory test procedures used and the associated Quality Assurance 
(QA) measures are given in Appendix F (parts F1 to F5).  
 Determination of the total concentrations of the elements (As, Cd, Cr, Ni, Pb) in samples of 
soil, produce, hand moist-wipes and allotment dust was carried out according to IOM’s 
internal Standard Operating Procedure (ICP-SOP2). This procedure is based on method 
7300 provided by the National Institute of Occupational Safety and Health (NIOSH). 
Details of this procedure are given in Appendix F, part F1.  
 Bioaccessibility extraction test on soil and produce samples was carried out using the UBM 
procedure described in Appendix F, part F2, to estimate the element fraction that would be 
soluble in the human GI tract and hence potentially available for absorption. Reasons for 
selecting this method are outlined in chapter 2 (section 2.6).  
 Determination of the total elemental concentrations (As, Cd, Cr, Ni) in urine samples. 
Urine samples were prepared for analysis by sample dilution (10 fold) using nitric acid 
solution (2 to 4% HNO3) (Goulle et al., 2005; Auray-blais et al., 2011; Castano et al., 
2012). A detailed description of the procedure is presented in Appendix F, part F3.  
 Determination of the total Pb concentrations in blood samples. The procedure used in this 
study was obtained from Goulle et al. (2005), Ikeda et al. (2011) and method ID-121 by the 
Occupational Safety and Health Administration (OSHA, 2002), modified and subsequently 
trialled and evaluated using pigs blood and a certified reference material (CRM) for human 
blood (BCR-636). The procedure is described in Appendix F, part F4.  
 Speciated Cr testing, to determine Cr(VI) in soil and produce samples was determined 
using OSHA method ID-121, Table 4 Alternative Procedures AP2 and AP5.  
 Pb isotope ratios were determined in soil, produce and blood samples. The procedure used 
in isotopic analysis is described in Appendix F, part F5.  
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3.6.1 Assessment of precision of chemical analyses  
To ensure the test results were reliable, the following measures and assessments were carried out:  
 Instrument calibration included 5 points, with correlation coefficients (r2 > 0.99) for each 
sample batch analysed.  
 Repeated sample analyses (after every 10 consecutive samples) were carried out to check 
for instrument drift, and variations from the original results were within 10%.  
 Recoveries of the elements in in spiked samples were within ±20% of the known/specified 
concentrations (Li et al., 2015).  
 Sample blanks (i.e., the acid solution used in sample dilution) were analysed in duplicates 
while spiked samples were analysed in triplicates, for correction of instrument readings.  
 Measured sample concentrations were restricted within the calibration range (up to 25% 
above the maximum calibration standard); any sample concentration above this limit would 
require dilution and re-analysis.  
 Standard / certified reference materials (CRM) were used for quality control by including 
CRM with each sample batch analysed. For bioaccessibility tests, a standard soil material 
(BGS Guidance Material 102) was used. For urine samples, a commercially available CRM 
for human urine (ClinChek-Control) was used. For blood samples, a commercially 
available CRM for human blood (BCR-636) was used. Recovered element concentrations 
were within ±20% of the specified CRM concentrations.  
 A high-purity Pb metal (NIST SRM 981) was used as a Pb isotope standard for quality 
control of Pb isotope analyses.  
3.7 External testing 
Testing of urinary creatinine and inorganic As (iAs) in urine were carried out by Trace 
Laboratories Ltd. (Tracelabs), a UK External Quality Assurance Scheme (UKEQAS) accredited 
laboratory. Creatinine was tested to enable the adjustment of urinary element concentrations for 
hydration status (Fillol et al., 2010). Urinary inorganic As (and not total As) was measured because 
this is the toxicologically relevant species when assessing environmental exposure (Fillol et al., 
2010). To determine inorganic As (sum of inorganic As species) in urine, samples were ‘made 
acidic and taken through two extraction stages into a final aqueous solution’. The solution was then 
analysed using ICP-MS. Similar tests have been conducted by others (Guo, Baasner & Tsalev, 
1997; Heitland & Koster, 2008) to determine inorganic As content in urine. Creatinine was 
determined using the Jaffe's reaction technique (picric acid added to alkaline urine) and measured 
using a spectrophotometer (Randviir & Banks, 2013).  
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As part of QA, some samples (3 samples per batch) were sent to Tracelabs in duplicates and the 
reported results were consistent (within 10%). Samples had unique labels and no participant 
identifying information was passed on to the lab.  
3.8 Computer software and statistical analysis 
Database: Microsoft Office Access 2010 was used to create a database for the project.  
Statistical analysis of sample concentrations: Measured element concentrations in samples were 
subjected to statistical analysis performed using R statistical software (version 3.3.2)
5
 and 
Microsoft Excel 2010.  
Left-censored data (non-detects) were subjected to multiple imputation (using R) to substitute non-
detects with randomly calculated values between 0 and the LOD. It has been reported that 
distribution-based imputation procedures may generate accurate estimates of population parameters 
when there are non-detects in a dataset (Baccarelli et al., 2005). Imputed values were used in 
subsequent data analyses.  
The probability of data distribution was checked using the Shapiro–Wilk test (Razali & Wah, 2011; 
Yap & Sim, 2011). In addition, normal quantile-quantile (Q-Q) plots were used to show the 
probability distribution of element concentrations in blood and urine. The relationship between 
studied variables was investigated using Spearman’s rank correlation test (and Pearson’s linear 
regression). The differences between medians of datasets for soil and produce were examined using 
Kruskal-Wallis test (non-normally distributed data). The differences between the medians of 
unmatched groups of datasets (blood and urine concentrations) representing the various 
participants’ subgroups were examined using the Mann-Whitney U test (Castano et al., 2012). 
However, since the finger-prick blood Pb samples were paired with the corresponding venous 
blood samples, the difference between the median blood Pb levels in finger-prick and the 
corresponding venous samples was examined using the Wilcoxon matched pairs test (Whitley & 
Ball, 2002). The probability value of p < 0.05 was set as the level of statistical significance. Data 
were described using median, geometric mean, 95% confidence interval (CI) values and percentiles 
(5
th
 and 95
th
). Box and whisker plots were produced for soil results and blood Pb results using R.  
Mixed-effects modelling: A linear mixed model (LMM) quantifies the relationships between a 
continuous dependent variable and various predictor variables, which may include fixed-effect 
parameters associated with one or more continuous or categorical covariates and random effects 
associated with one or more random factors (West, Welch & Galecki, 2007). In addition to the 
classical linear models (i.e., linear regression tests), we carried out mixed-effects modelling (also 
                                                          
5 Available at: https://www.R-project.org/  Full citation for R programme 
R Core Team (2016). R: A language and environment for statistical computing. R Foundation for Statistical Computing, 
Vienna, Austria. URL https://www.R-project.org/. 
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known as ‘repeated measures regression’ test) to quantify the effects of selected variables (e.g., 
participant’s age, gender, smoking status, consumption rate of allotment produce) on elemental 
concentrations in biological samples (the response variable). Mixed-effects modelling was carried 
out using the lme function in the lme4 package for R (Bates et al., 2015).  
Model solving and analysis: The models were coded in the SimBiology application of MATLAB 
(version R2016a) (MathWorks®). We used the stiff solver ode15s in the numerical simulations. 
This solver passes though ‘stiff’ parts of simulations with fewer ‘time-steps’ without compromising 
the simulation output – which speeds up the simulation and avoids generating un-necessarily large 
data. Relative tolerance was set at the default value (0.001) during simulations. The relationship 
between predicted data and the corresponding literature data were examined using linear regression 
(Pearson’s correlation test) at statistical level of significance p < 0.05. Statistical analyses and 
processing of data were carried out using R and Microsoft Excel 2010.  
3.9 Evaluation of model performance 
We sought to evaluate the predictive performance of the modified models by comparing model 
simulations with data presented in the literature. The predictive accuracy of the models were 
assessed using the root mean square error (RMSE), calculated as (Ju et al., 2012; Walther & 
Moore, 2005):  
𝑅𝑀𝑆𝐸 =  √
1
𝑛
∑(𝐶𝑙𝑖𝑡 − 𝐶𝑠)2
𝑛
𝑖=1
 (3.1) 
Here, Cs and Clit refer to the simulated data and literature data, respectively for a time point i, and n 
is the total number of data points. We expressed maximum Cs as a percentage of Clit, to determine 
the magnitude of over- or under-prediction of the models. The correlations between the predicted 
and measured element concentrations in blood and urine were examined using linear regression.  
3.10 Sensitivity analysis 
Parametric sensitivity analysis was performed using sensitivity coefficients (SC) to determine 
which parameters were more sensitive to change. Values of SC were calculated using the following 
expression (Choudhury et al., 2001; Evans & Andersen, 2000).  
𝑆𝐶 = (
𝛿𝑚
𝛿𝑝
) ×
𝑝
𝑚
 (3.2) 
In equation (3.2), δm is the change in model output (m) resulting from the change (δp) in an input 
parameter value (p). SC of zero implies that there is no change in model output regardless of the 
parameter value used. Positive and negative SC values indicate an increase in model output with a 
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given increase in parameter value, and a decrease in model output with a given increase in 
parameter value, respectively. High SC values indicate high sensitivity of the model to that input 
parameter (Choudhury et al., 2001). Sensitivity analysis was performed in MATLAB (using full 
normalisation option); input values were varied by up to ±50%.  
3.11 Chapter summary 
The research methods commonly applied in exposure studies were utilised in this research, in order 
to generate the data needed to address the knowledge gap identified from the literature review. A 
pilot study was carried out to trial-out the methods and procedures. Before participants were 
recruited, suitable sample size for the study was estimated and potential study sites were identified 
within Scotland. Sample collection and subsequent laboratory analyses were carried out using 
conventional methods. Computer software and statistical methods used in processing data are 
described.  
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4. RESULTS AND DISCUSSION OF ENVIRONMENTAL 
SAMPLES 
4.1 Introduction 
The measured element concentrations in environmental samples are presented and discussed in this 
chapter. In reference to the conceptual exposure model described in chapter 2, soil results represent 
the concentrations at ‘source’, and produce results represent concentrations both at ‘source’ and 
‘pathway’. To put the recorded concentrations in human health context, results were compared to 
the commonly used criteria values (where available) used in assessing potential risk to human 
health. In addition, risk assessment was carried out using hazard quotient and the CLEA model.  
4.2 Element concentrations in soil 
The preferential adherence of soil and dust particles to hands and fingers occurs in the particle size 
range 0.5 – 65 μm (Juhasz, Weber & Smith, 2011). Therefore, testing of <63 μm soil particles was 
considered appropriate for investigating the soil ingestion exposure pathway. This is consistent 
with other studies (Loh et al., 2016; Zia et al., 2011). The laboratory soil test results are presented 
in Appendix G (part G1). Soil concentrations, expressed as mg kg
-1
 dry weight (dw), from the 16 
sites were grouped according to the regional locations of the samples. The grouped results are 
presented using box and whisker plots in Fig. 4.1. For comparison, generic values used in assessing 
potential risk to human health in the UK are also indicated on the plots.  
Concentrations of As ranged from 9 to 21 mg kg
-1
 (Dundee), 2 to 82 mg kg
-1
 (Edinburgh), 2 to 25 
mg kg
-1
 (Glasgow) and 2 to 10 mg kg
-1 
(Kilbirnie). Soil samples from one site within Edinburgh 
(site A04) recorded As concentrations varying between 43 and 82 mg kg
-1
, corresponding to the 
outliers above 40 mg kg
-1
 indicated in Fig. 4.1(a). Six samples from this site recorded As 
concentrations above the provisional Category 4 Screening Level (pC4SL) of 49 mg kg
-1 
for 
allotments land use (CL:AIRE, 2014). A number of <LOD concentrations of Cd were recorded in 
soil samples; these were subjected to data imputation (except for plots in Kilbirnie which recorded 
Cd values <LOD in all soil samples). The imputed values (between 0 and the LOD) were used in 
subsequent data analysis. Log-normal data distribution was used in imputation calculations, since 
the normality test showed that the soil results did not follow a normal distribution (p < 0.05). This 
is consistent with other studies involving environmental datasets (Baccarelli et al., 2005; Caudill et 
al., 2007; Huybrechts et al., 2002). Cd concentrations were generally low, with median 
concentrations across the four regions ranging from 0.5 to 1.2 mg kg
-1
. One sample from a site in 
Edinburgh recorded Cd concentration of 5.2 mg kg
-1
 (an outlier), which is above the corresponding 
pC4SL value of 3.9 mg kg
-1
 (Fig. 4.1(b)).   
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(a) Arsenic (b) Cadmium 
(c) Chromium (d) Nickel 
(e) Lead 
Fig. 4.1: Box and whisker plots of element concentrations in soil samples from the four sampling regions.  
(Box indicates median and interquartile range (IQR), whiskers indicate 1.5 x IQR and points are outliers). 
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Concentrations (mg kg
-1
) of Ni ranged from 24 to 54 (Dundee), 16 to 49 (Edinburgh), 12 to 42 
(Glasgow) and 13 to 41 (Kilbirnie). With the exception of a single sample from a plot in Dundee 
(site A36), all Ni concentrations were below the LQM/CIEH ‘Suitable 4 Use Level’ (S4UL) of 53 
mg kg
-1
 (Nathanail et al., 2015). The recorded Cr (total) concentrations across the four regions 
varied between 4 and 105 mg kg
-1
. Cr species of interest are trivalent Cr (Cr(III)) and hexavalent Cr 
(Cr(VI)) (Langard & Costa, 2007). The toxicity of Cr is usually assessed based on Cr(VI), because 
of the carcinogenic potential of the hexavalent species (Schlosser & Sasso, 2014). However, the 
recorded Cr (total) concentrations were well below 170 mg kg
-1
, the pC4SL for Cr(VI). The 
recorded Pb concentrations (mg kg
-1
) in soil samples ranged from 46 to 237 (Kilbirnie), 44 to 865 
(Glasgow), 84 to 896 (Edinburgh) and 220 to 1065 (Dundee). Limited samples from Edinburgh and 
Kilbirnie recorded outlier Pb concentrations (Fig. 4.1(e)). Majority (95 %) of the soil Pb 
concentrations exceeded the corresponding pC4SL of 84 mg kg
-1
, making Pb the element with the 
most values above its guideline value. The recorded Pb concentrations are within the range of those 
found in a previous survey of soils in the UK (Prasad & Nazareth, 2000), which recorded a 
maximum concentration of 1676 (the 90
th
 percentile) for UK urban soils.  
A Kruskal-Wallis test indicated that the differences between the medians of As, Cr, Ni and Pb were 
not statistically significant (p > 0.05) in the four sampling regions, while medians of Cd were 
identical for sites in Dundee, Edinburgh and Glasgow. The similarity in the median concentrations 
suggests the common presence of these elements in the allotments, which may be indicative of the 
similarity of soil additives used by plot holders over the years.  
Bioaccessibility fractions (as %) in soil samples varied from 33 to 92 (As), 18 to 93 (Cd), 6 to 30 
(Cr), 17 to 90 (Ni) and 29 to 94 (Pb). The bioaccessibility of each element in the gastric phase was 
higher than that in the intestinal phase. This can be attributed to the higher solubility of these 
elements in an acid environment (gastric phase) than in a near-neutral environment (intestinal 
phase) (Li et al., 2015; Poggio et al., 2009). The bioaccessibility values of As in soil samples from 
site A04 were below 60%. A sample from site A05 in Edinburgh which had a Cd concentration in 
soil above the corresponding pC4SL recorded a bioaccessibility fraction of 27 %. By multiplying 
bioaccessibility fractions with total element concentrations recorded in soil samples, it was 
determined that the bioaccessible concentrations of As and Cd (the potentially soluble fractions in 
the gastrointestinal tract which could be absorbed) were below their respective pC4SLs (Fig. 4.1). 
This shows that the risk associated with potential ingestion of soil could be exaggerated if total 
concentrations (i.e., assuming 100% bioaccessibility) are used in risk assessment models. However, 
bioaccessible concentrations of Pb that exceed the pC4SL of 84 mg kg
-1
 were recorded in majority 
(90 %) of the plots. This indicates that Pb concentrations in soil at these plots provide a potential 
source of contamination.  
Spearman’s rank correlation tests indicated that the total concentrations of As, Cd and Pb in soil 
were strongly correlated (ρ > 0.8, p < 0.05) with their corresponding bioaccessible concentrations. 
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However, weak positive correlations (ρ < 0.5) were determined for Cr and Ni. This suggests that 
site-specific bioaccessible concentrations of As, Cd and Pb could be predicted from their soil 
concentrations. Similar observations have been made in other studies. For example, the study by 
Barsby et al. (2012) identified strong linear correlations (r > 0.9) between measured total and the 
respective bioaccessible concentrations for a number of potentially toxic elements including As, Cd 
and Pb. A positive linear correlation (r > 0.7) between total Pb in soil and bioaccessible Pb was also 
observed by Farmer et al. (2011) in their study of Pb in urban soils from Glasgow.  
4.3 Element concentrations in produce 
The concentrations of the elements varied between the sites investigated and the type of allotment 
produce. Table 4.1 shows the range of element concentrations, expressed as mg kg
-1
 fresh weight 
(fw), recorded in allotment produce samples, grouped according to produce categories used in the 
CLEA model (Environment Agency, 2009e). Detailed element concentrations in produce samples 
are given in Appendix G (part G2).  
Table 4.1: Summary of element concentrations according to produce category 
CLEA produce 
category 
Range of element concentrations (mg kg
-1
 fw) 
 
As Cd Cr Ni Pb 
Green vegetables
1
 <0.01-1.62  <0.01-0.70 <0.01-11.81  <0.01-5.89 <0.01-15.77 
Root vegetables
2
 0.03-2.14 <0.01-1.87 <0.01-9.84 <0.01-7.44 <0.01-3.81 
Tuber vegetables
3
 <0.01-0.91 <0.01-0.06 <0.01-0.17 <0.01-0.72 <0.01-2.49 
Herbaceous fruit
4
 0.16-0.91 <0.01-0.30  <0.01-4.84 <0.01-2.20  0.13-1.78  
Shrub fruit
5
 0.11-1.65 <0.01-0.39 <0.01-0.31 <0.01-1.69 <0.01-5.15 
Tree fruit
6
 0.30-0.97 <0.01 <0.01-0.27 <0.01-0.31 <0.01-0.87 
1Includes beans, cabbage, kale, cauliflower, lettuce, spinach, peas, herbs, broccoli, oriental green, yam leaves, 
chives, fennel, pak choi, rocket, chard and corn 
2Includes carrot, turnip, swede, onion, shallot, garlic, leek, rhubarb, beetroot, artichoke, kohlrabi, parsnip and 
radish 
3Refers to potato 
4Includes cucumber, courgette and tomato 
5Includes berries and currants 
6Includes apple, pear, plum and green gauge 
 
The recorded maximum element concentrations (mg kg
-1
 fw) were 2.1 (As), 1.9 (Cd), 11.8 (Cr), 7.4 
(Ni) and 15.8 (Pb), measured in the green and root vegetables. Out of the samples that recorded 
detectable Cr (total) concentrations, randomly selected samples (n = 25) were subjected to Cr(VI) 
testing. All Cr(VI) concentrations were <LOD, indicating negligible levels of Cr(VI) in samples 
investigated. This was expected because Cr(VI) does not occur naturally but arises mainly from 
anthropogenic sources, and it has also been reported by Langard & Costa (2007) that chemical 
reduction of Cr(VI) to Cr(III) occurs in plants, which reduces the potential of exposure to Cr(VI) 
through plant consumption. 
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For purposes of statistical analysis, the concentrations of each element in a plot were pooled 
together (irrespective of the type of allotment produce). For values >LOD, plot-specific median 
concentrations (mg kg
-1
 fw) of the elements varied from 0.13 to 0.99 (As), 0.04 to 1.06 (Cd), 0.06 
to 3.37 (Cr), 0.04 to 1.52 (Ni) and 0.17 to 3.45 (Pb). The median concentrations (mg kg
-1
 dw) of Pb 
in allotment produce and soil were found to be weakly correlated (Spearman’s ρ = 0.38, p < 0.05), 
while As, Cd, Cr and Ni were not correlated (p > 0.05). This is contrary to hypothesis ‘h1’ that 
‘there is a good correlation between element concentrations in allotment soil and the 
corresponding concentrations in produce.’ The weak / lack of correlation between concentrations 
in soil and produce could be attributed to the plant uptake of these elements through other 
pathways, such as aerial deposition which could provide a source of element accumulation in aerial 
parts of vegetables (Li et al., 2015).  
The bioaccessible fractions (%) of the elements in allotment produce samples ranged from 13 to 94 
(As), 10 to 89 (Cd), 14 to 80 (Cr), 14 to 82 (Ni) and 30 to 81 (Pb). The medians of the 
bioaccessibility values were 40% (As), 17% (Cd), 35% (Cr), 35% (Ni) and 45% (Pb). These 
bioaccessibility values indicate that not all quantities of the elements ingested through consumption 
of allotment produce would be available for potential uptake in the body, thus reducing the 
potential for exposure to these elements. Similar Cr and Pb results were found by Intawongse & 
Dean (2008); however their results for Cd (61-90%) and Ni (43-91%) were generally higher that 
our results. These variabilities suggest that bioaccessibility may be influenced by the plant species 
and the element concentrations in samples (Pan et al., 2016).  
4.3.1 Soil-to-plant transfer factors  
Where soil and allotment produce samples were collected from the same spot, soil-to-plant transfer 
factor (TF) of each element was estimated as the ratio of that element concentration in allotment 
produce to its concentration in soil. The estimated TF values (regardless of plant type) are 
presented in Table 4.2, along with selected values obtained from the literature.  
Table 4.2: Summary of soil-to-plant TF values 
Element 
Range of estimated TF 
values  
TF values from the 
literature 
As 0.0036 – 0.4675 0.00043 – 0.0011a 
0.001
c
 
Cd 0.004 – 0.791 0.0014 – 0.052b 
0.192 – 0.778c 
Cr 0.0001 – 0.2647 0.008 – 0.029c 
0.003 – 0.22d 
Ni 0.0002 – 0.4907 0.037 – 0.039c 
0.03 – 0.89d 
Pb 0.0001 – 0.0889 0.008 – 0.065c 
0.001 – 0.432d 
aEnvironment Agency (2009d), bEnvironment Agency (2009c)  
cJolly et al. (2013), dIntawongse (2007) 
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The higher the TF value the higher the potential element accumulation by plants, suggesting a 
potential for increased exposure through human diet. However, a comparison of the estimated TF 
values with those in the literature suggests that TF values could vary considerably (Table 4.2), and 
are not constant for a specific element in a specific vegetable (Swartjes, Versluijs & Otte, 2013).  
A number of studies have used sequential extraction tests to relate soil to plant element 
concentrations. For example, a study by Chojnacka et al. (2005) reported that there was a good 
correlation between the concentrations of a number of elements (including As, Cd, Cr and Pb) in 
plants and the corresponding concentrations obtained from soil extraction test using 2 % 
ammonium citrate solution. In another study, Wang et al. (2004) demonstrated that the 
phytoavailability of selected trace elements strongly correlated with the soil-extracted fractions of 
the elements using calcium chloride. These sequential extraction methods provide alternative 
means of estimating soil to plant transfer of elements present in soil.  
4.3.2 Potential health risk assessment from consumption of produce 
The potential risk to human health resulting from consumption of allotment produce was estimated 
using the hazard quotient (HQ) expressed as (Nabulo, Young & Black, 2010; Jolly et al., 2013):  
 𝐻𝑄 =
((𝐷𝐼×𝐶𝐹𝑣𝑒𝑔)/𝑊𝐵)
𝑅𝑓𝐷
 , (4.1) 
where HQ represents the hazard quotient resulting from ingestion of an element through 
consumption of allotment produce, DI denotes the daily intake of allotment produce (kg day
-1
), 
CFveg represents the element concentration in allotment produce (mg kg
-1
 fw), WB is the individual 
body weight (bw) (kg), and RfD is the reference dose (mg kg
-1
 bw day
-1
) defined as the maximum 
tolerable daily intake of an element that has no adverse effect. In Eq. (4.1), the numerator 
represents the average daily intake (ADI) (mg kg
-1
 bw day
-1
). If HQ > 1, then the ADI of a 
particular element exceeds its RfD, indicating that there is a potential risk associated with that 
element.  
We used information provided by the participants (allotment produce consumed and their fresh 
weight) covering up to 12 consecutive months to calculate their DI. Values of WB were obtained 
from participants’ records and CFveg were adjusted to take account of the bioaccessible fractions. 
Where the type of allotment produce consumed was not sampled or tested, plot-specific median 
element concentrations and bioaccessibility values were used in the calculations. However, where a 
median bioaccessibility value of an element was not calculated, we assumed 100% bioaccessibility 
of the total element concentration. The ADI for each participant was calculated for each month. 
Subsequently, monthly ADI values were separated into ‘summer’ months (April to September) and 
‘winter’ months (October to March) to reflect seasonal variation in allotment-related activities and 
consumption of allotment produce (as summarised in Appendix E, part E4). This is consistent with 
the approach taken by Environment Agency (2009e). Using RfD values obtained from the 
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literature, we calculated element HQ for each participant. A summary of the ADI, RfD and HQ is 
given in Table 4.3.  
 
Table 4.3: Summary of ADI, RfD and HQ 
Element 
ADI (maximum) 
(mg kg
-1
 bw day
-1
) 
RfD  
(mg kg
-1
 bw 
day
-1
) 
HQ (maximum) 
Summer Winter Summer Winter 
As 2.9x10
-4
 2.9x10
-4
 3.0x10
-4
 
a
 0.97 0.96 
Cd 1.2x10
-4
 1.3x10
-4
 1.0x10
-3
 
a
 0.12  0.13 
Cr 8.7x10
-4
 8.7x10
-4
 1.5 
a,b
 5.8x10
-4
 5.8x10
-4
 
Ni 1.7x10
-3
 1.4x10
-3
 2.0x10
-2
 
a
 8.5x10
-2
 6.9x10
-2
 
Pb 3.2x10
-3
 3.1x10
-3
 3.6x10
-3
 
c
 0.88 0.86 
a
RfD obtained from the Integrated Risk Information Systems (IRIS) database provided by USEPA 
(www.epa.gov/iris); 
b
RfD for Cr-III; 
c
Song et al. (2009)  
The similarity in the ADI values in summer and winter seasons could be because some participants 
stored frozen produce for consumption in the winter, especially those who had large amount 
harvest during the ‘growing season’. This suggests overall similarities in consumption patterns 
during both seasons, even though the consumption patterns for a given individual may vary 
between the seasons.  
Values of HQ for individual elements were generally greatest for As, followed sequentially by Pb, 
Cd, Ni and Cr. However, all elements recorded HQ <1. The HQ values in Table 3 indicate that the 
potential risk is higher for As and Pb, but not significant enough to warrant concern. Although Pb 
was identified as a potential source of contamination in soil in most plots, calculated HQ values did 
not identify potential risk from the consumption of allotment produce. This indicates that based on 
the participants’ consumption of allotment produce records, no potential risk to the elements was 
identified from this source.  
Given the potentially higher risk identified from HQ for As and Pb, the calculated ADI values for 
As and Pb (Table 4.3) were compared with the values for average dietary exposure for adult 
consumers in Europe, as provided by the European Food Safety Authority (EFSA). The maximum 
ADI of 3.2 (µg kg
-1
 bw day
-1
) for Pb exceeds the average Pb dietary exposure for an adult 
consumer in Europe of 2.43 (µg kg
-1
 bw day
-1
) by approximately 30% (EFSA, 2010). However, the 
maximum ADI for As represents approximately 50% of the EFSA value of 0.56 (µg kg
-1
 bw day
-1
) 
for an average adult consumer (EFSA, 2009). This suggest that participants would need to consume 
at least twice the current amount of produce in order to exceed the EFSA value for As.  
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4.3.3 Site-specific risk assessment using the CLEA model 
The potential risk to As and Pb was evaluated further using the CLEA model (version 1.071).
6
 Site-
specific health risk assessment was carried out using the maximum recorded element 
concentrations in soil and produce. In addition, participant specific produce consumption data 
(average values) were used in the model, in lieu of the default produce consumption rates built into 
the CLEA model. Simulations were carried out for CLEA age classes 17 and 18 only 
(corresponding to ages 16-65 and 65-75 years, respectively) (Environment Agency, 2009a), 
because study participants were aged 30 years old and above.  
Model predicted oral average daily exposure (ADE) to health criteria value (HCV) ratios were less 
than 0.1, indicating very low levels of exposure to the elements (i.e., very low hazard indices). The 
soil assessment criteria values (oral HCV) calculated by the model for As and Pb were up to 3 and 
4 orders of magnitude, respectively, which are well above the recorded soil concentrations. This 
indicates that the soil concentrations (As, Pb) do not present significant contamination source.  
4.4 Soil and produce Pb isotope ratios 
Pb isotope ratio analysis is a useful means of identifying sources of Pb exposure in routine 
investigations (Oulhote et al., 2011). The site-specific mean isotopic ratios for soil and produce 
samples are plotted in Fig. 4.2. The soil values ranged from 1.103 to 1.161 (
206
Pb/
207
Pb) and 2.315 
to 2.498 (
208
Pb/
207
Pb). Values for produce samples ranged from 1.081 to 1.134 (
206
Pb/
207
Pb) and 
2.355 to 2.422 (
208
Pb/
207
Pb). Mean isotopic ratios for petrol Pb (indicating an anthropogenic 
source), Scottish coal and Leadhills Pb ore (indicating geogenic sources) (MacKinnon et al., 2011) 
are also plotted. Error bars associated with the isotopic ratios were expressed as ± standard 
deviation (Farmer et al., 2011). To enhance legibility, only the error bars for petrol Pb, Scottish 
Coal and Leadhills Pb ore (Farmer et al., 2011) were included in Fig. 4.2. Although not shown in 
Fig. 4.2, the errors (expressed as relative standard deviation (RSD)) for isotopic ratios for soil and 
allotment produce samples were up to 1.5 % (i.e., RSD of 0.015).  
 
 
  
                                                          
6 Available at: https://www.gov.uk/government/publications/contaminated-land-exposure-assessment-clea-tool  
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The Pb isotope ratios (Fig. 4.2) extend between the values reported for leaded petrol and 
indigenous geological Pb ores (Scottish coal and Landhills Pb ore), which suggests that Pb in soil 
and produce are linked to multiple sources (rather than a single source). In particular, soil Pb 
appears to originate from a wide range of sources, although geological Pb seems to be the dominant 
source of soil Pb. Some of the values for produce samples lie close to the value for leaded petrol, 
which points to potential anthropogenic source of Pb in those produce samples. Atmospheric 
deposition can contribute to the deposition of anthropogenic Pb in vegetables (Li et al., 2012). 
Although leaded petrol is no longer in use in the UK, it has been reported that exhaust emissions 
present a minor, but finite, contemporary source of Pb (MacKinnon et al., 2011). Resuspension of 
soil near industrial facilities and highways have also been reported to contribute to Pb in aerial 
particulate matter (Young et al., 2002). The lack of a single Pb source in soil and produce supports 
our finding that Pb in produce and soil were weakly correlated (section 4.3). The soil and produce 
isotopic ratios overlap in the central area between both extremes of the spread of data points (Fig. 
4.2). Only 3 allotment plots had their soil and produce ratios lying within the area of overlap; none 
of the remaining data points for soil and produce came from the same site. This further 
demonstrates the varying sources of Pb in soil and produce.  
  
Fig. 4.2: Plot of 
206
Pb/
207
Pb ratio against 
208
Pb/
207
Pb ratio for soil and produce samples.  
Also indicated are the mean Pb isotopic ratios for petrol Pb, Scottish coal and Leadhills Pb ore. Error bars are ± 
standard deviation. Error bars for soil and produce data were excluded to enhance legibility of the figure.  
Petrol 
Pb 
Leadhills 
Pb ore 
Overlap of 
isotopic ratios 
Scottish 
coal 
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4.4.1 Binary mixing model of Pb isotope ratios 
The relative contribution of natural and anthropogenic Pb in soil and produce samples was 
calculated using a binary mixing model (Li et al., 2012; Monna et al., 1997), using the following 
expressions:  
 𝑋𝑛𝑎𝑡% =
(206𝑃𝑏 207𝑃𝑏⁄ )𝑎𝑛𝑡ℎ − (206𝑃𝑏 207𝑃𝑏⁄ )𝑠𝑎𝑚𝑝𝑙𝑒
(206𝑃𝑏 207𝑃𝑏⁄ )𝑎𝑛𝑡ℎ−(206𝑃𝑏 207𝑃𝑏⁄ )𝑛𝑎𝑡
 × 100,  
(4.2) 
 
 
 
 
𝑋𝑎𝑛𝑡ℎ% =
(206𝑃𝑏 207𝑃𝑏⁄ )𝑠𝑎𝑚𝑝𝑙𝑒 − (206𝑃𝑏 207𝑃𝑏⁄ )𝑛𝑎𝑡
(206𝑃𝑏 207𝑃𝑏⁄ )𝑎𝑛𝑡ℎ−(206𝑃𝑏 207𝑃𝑏⁄ )𝑛𝑎𝑡
 × 100, (4.3) 
 
where Xnat and Xanth represent the contributions (%) of natural (or geogenic) and anthropogenic 
sources, respectively; (206Pb/207Pb)nat, (206Pb/207Pb)anth, and (206Pb/207Pb)sample are the Pb 
isotopic ratios (
206
Pb/
207
Pb) for natural (geogenic), anthropogenic and samples, respectively. The 
206
Pb/
207
Pb isotopic ratios for Leadhills Pb ore (1.184) and petrol Pb ore (1.076) were used for 
geogenic and anthropogenic sources, respectively.  
The percentage contributions of Pb from geogenic and anthropogenic sources calculated using the 
biliary mixed model are presented in Fig. 4.3, which shows that soil Pb originates from both 
geogenic and anthropogenic sources at nearly equal proportions of 25-79% and 21-75%, 
respectively. However for produce samples, anthropogenic source of Pb (46-96%) is more 
dominant than geogenic source (4-54%). The calculated dominance of anthropogenic source of Pb 
in produce samples is consistent with Fig. 4.2, which shows data points for produce extending 
towards petrol Pb ratio plot.  
 
 
 
 
 
 
 
 Fig. 4.3: Calculated percentage contribution of Pb derived from geogenic (geo.) 
and anthropogenic (anth.) sources in soil and produce samples 
 54 
 
4.5 Hand moist-wipes 
In addition to the soil and produce, element concentrations were determined in the hand-moist wipe 
samples, which were collected when participants were working at their allotments. Where detected, 
element weights (µg) in hand moist-wipes varied between 0.3 – 6.7 (As), 0.4 – 1.9 (Cd), 0.5 – 34 
(Cr), 0.9 – 125 (Pb) and 0.8 – 19 (Ni). These results suggest that hand-to-mouth contact could add 
to human exposure in adults, although the inadvertent exposure pathway is more prevalent among 
children. For adults, the major pathway of exposure is the consumption of allotment produce (as 
discussed in chapter 2, section 2.5). Therefore, no efforts were made to investigate this potential 
‘pathway’ further.  
 
4.6 Chapter summary 
Widespread elevated Pb concentrations were recorded in soil, making Pb the element with the most 
values above its guideline value. A weak correlation between Pb in soil and produce was 
determined, while other elements were not correlated. These findings contradict hypothesis ‘h1’ 
that “there is a good correlation between element concentrations in allotment soil and the 
corresponding element concentrations in produce”. It has been established that risk associated with 
potential ingestion of soil could be exaggerated if total element concentrations (i.e., assuming 
100% bioaccessibility) are used in risk assessment models. Hazard quotients calculated from 
produce consumption records indicated potential higher risk to As and Pb, but overall, no 
significant risk was identified to warrant concern. Although the maximum ADI values for Pb 
exceed the corresponding EFSA value by approximately 30%, further site-specific risk assessment 
using the CLEA model has not identified a significant concern to human health.  
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5. RESULTS AND DISCUSSION OF BIOLOGICAL 
SAMPLES 
5.1 Introduction 
The element concentrations in the biological samples (blood and urine) are presented and discussed 
in this chapter. These results were compared with commonly used biomonitoring reference values 
used in assessing potential risk to human health. Associations between the elemental concentrations 
in biological samples and various participants’ characteristics were explored statistically and the 
results from the Pb isotopic analysis are also presented and discussed.  
5.2 Blood Pb concentrations  
The laboratory test results of Pb concentrations in venous blood samples (n = 108) are summarised 
in Appendix G (part G3). Pb concentrations varied between 3.12 and 30.60 µg dL
-1
. Approximately 
56% of the concentrations were below 24 µg dL
-1
,
 
while 89% of the
 
concentrations were below 20 
µg dL
-1
. Apart from one sample, from a male participant with a recorded concentration of 30.6 µg 
dL
-1
, the remaining concentrations were below 30 µg dL
-1
. Seven concentrations which were above 
24 µg dL
-1
 were outliers. The Shapiro-Wilk test indicated that the results did not follow a normal 
distribution (p < 0.05). In addition, Fig. 5.1 (A) shows that the data did not fit a normal distribution 
since the data points do not plot evenly along the straight Q-Q line. The data were skewed towards 
the lower concentrations as shown in Fig. 5.1 (B). However when the results were log-transformed, 
they were found to be log-normally distributed (p > 0.05). It is common for biomonitoring data to 
be log-normally distributed (Morton et al., 2014).  
 
 
 
 
 
 
 
 
 
Fig. 5.1: The probability distribution and asymmetry of venous blood Pb concentrations.  
(A) normality test using Q-Q plot, (B) box and whisker plot shows that the data is asymmetric and skewed towards 
the lower concentrations, the dots represent outliers. 
A B 
 56 
 
Since the blood Pb concentrations were not normally distributed, the spread of blood Pb data were 
described using median and geometric mean. In addition, the 95% confidence intervals (CI) and 
percentiles (5
th
 and 95
th
) were estimated. The arithmetic mean was also reported. Table 5.1 presents 
a summary of the statistics of the blood Pb data. In addition, the data were sub-grouped according 
to four participants’ characteristics (age, gender, smoking status and produce consumption rate); 
factors that can influence blood Pb content (Bocca et al., 2011).  
Table 5.1: Summary statistics for blood Pb concentrations (µg dL
-1
) 
 N Min Max Median GM (GSD) 
Mean  
(CI at 95%) 
P5 P95 
All participants 108 3.12 30.60 9.19 9.73 (1.65) 11.1 (9.91-12.22) 4.72 24.17 
Age (years) 
30-50 14 4.89 23.61 9.13 9.34 (1.58) 10.3 (7.40-13.25) 4.99 18.15 
51-60 33 3.50 26.19 9.18 8.86 (1.54) 9.8 (8.04-11.52) 4.68 18.60 
61-70 43 3.12 27.19 9.99 10.20 (1.71) 11.7 (9.77-13.62) 4.20 22.54 
71-80 18 5.65 30.60 8.69 10.65 (1.74) 12.5 (8.51-16.44) 5.81 29.54 
Gender 
Males 60 3.12 30.60 8.89 9.80 (1.75) 11.5 (9.68-13.37) 5.19 26.24 
Females 48 3.79 23.61 10.03 9.64 (1.52) 10.5 (9.21-11.77) 4.72 20.15 
Smoking status 
Smokers 5 5.7 14.69 8.94 9.72 (1.50) 10.4 (5.32-15.41) 6.15 14.67 
Ex-smokers 32 3.79 30.60 8.77 10.10 (1.76) 11.9 (9.14-14.72) 4.92 28.16 
Non-smokers  
(and 1 unknown 
smoking status) 
71 3.12 26.19 9.76 9.57 (1.61) 10.7 (9.46-11.98) 4.68 22.24 
Average produce consumption rate (g fw kg
-1
 bw day
-1
) 
2 – 3  11 6.96 24.47 9.18 10.04 (1.53) 11.0 (7.12-14.97) 6.97 22.36 
1 – 2  17 4.78 27.19 9.19 10.08 (1.68) 11.6 (8.0-15.17) 5.24 26.33 
<1 80 3.12 30.60 9.20 9.61 (1.66) 11.0 (9.63-12.29) 4.63 22.72 
N (number of samples), GM (geometric mean), GSD (geometric standard deviation), CI (confidence interval of means 
at 95%), P5 (5th percentile), P95 (95th percentile), fw (fresh weight of produce), bw (body weight of participant).  
 
The data summarised in Table 5.1 shows that median blood Pb levels were similar across the 
various participants’ subgroups. A statistical examination of the data using the Mann-Whitney U 
test confirmed this observation. The differences between the medians of blood Pb concentrations 
for the various categories of age, gender, smoking status and produce consumption rate were not 
statistically significant (p > 0.05). This indicates that blood Pb levels were not significantly 
dependent on age, gender, smoking status or rate of produce consumption. Our findings are 
consistent with those published by Moffat (1989), who found no evidence of association of locally 
grown vegetables with raised blood Pb levels.  
We carried out further evaluation of the blood Pb data using mixed-effects modelling, where we 
treated a participant’s age, gender, smoking status and produce consumption rate as ‘fixed’ effects, 
while participants were treated as ‘random’ effects. Mixed-effects models did not indicate 
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statistically significant associations between a participant’s age, gender, smoking status and 
produce consumption rate to their blood Pb levels (p > 0.05), which confirms the findings obtained 
from the Mann-Whitney U tests. R codes used for the mixed-effects models and the model results 
are included in Appendix H (part H1).  
In terms of human toxicity, Pb is a ‘non-threshold’ substance, and therefore there is no known safe 
exposure level for Pb (Oulhote et al., 2011). However for comparison with UK guidelines for 
occupational exposure, the recorded Pb concentrations are below the UK Health and Safety 
Executive (HSE) occupational exposure action levels of 50 and 25 µg dL
-1
, for males and females, 
respectively.
7
 The upper 95% confidence intervals of means were 13.4 µg dL
-1
 (male) and 11.8 µg 
dL
-1
 (female), which are approximately 27% and 47% of the respective HSE actions levels.   
In the United States of America (USA), the Centre for Disease Control and Prevention (CDC) set 
an ‘action level’ of blood Pb at 5 µg dL-1 (CDC, 2012). The basis for choosing this action level was 
that it represents 97.5
th
 percentile of the National Health and Nutritional Examination Survey 
(NHANES) generated blood lead level distribution in children 1-5 years old; but the action level 
was not related to a defined risk. In addition, this action level is relevant to children who are more 
sensitive than adults. The provisional Category 4 Screening Level (pC4SL) of 84 mg kg
-1
 for 
allotment land use (i.e. generic assessment criterial value for Pb used in the UK) was derived using 
the 5 µg dL
-1
 CDC action level for blood Pb (CL:AIRE, 2014). The median blood Pb concentration 
recorded from our study (9.2 µg dL
-1
) is approximately twice the CDC action level.  
In the UK, biomonitoring of blood Pb is routinely carried out in occupationally exposed 
populations. Occupational exposure to Pb is common among those who work in the manufacture 
and recycling of batteries, construction industries, glass and pottery making and chemical related 
industries (Morton et al., 2009). None of the study participants worked in any of these occupations. 
However, there is no routine public screening for Pb toxicity in the non-occupationally exposed 
UK population (Kar-Purkayastha et al., 2011). Therefore data on blood Pb levels in the general 
non-occupationally exposed UK public is scarce, and we found no recently published data on blood 
Pb levels in un-occupationally exposed UK population. The 1995 health survey of the general 
population in England recorded mean blood Pb levels of 3.5 µg dL
-1
 for adult males and 2.7 µg dL
-1
 
for adult females (Morton et al., 2009). In another study (Watt et al., 1996), the blood Pb levels 
recorded for 150 mothers from Glasgow (Scotland) ranged from 1.04 to 24.24 µg dL
-1
, and the 
mean blood Pb levels (divided according to exposure to water Pb) varied from 3.64 to 6.63 µg dL
-1
 
among those who had Pb in water. The subjects that were not significantly exposed to Pb from tap 
water (i.e., water Pb concentration < 2 µg L
-1
) had blood Pb levels ranging from 1.04 to 21.13 µg 
dL
-1
, with a mean of 3.64 µg dL
-1
 (Watt et al., 1996). These blood Pb levels from Glasgow are 
higher than those recorded in adult females during the 1995 health survey in England.  
                                                          
7 Available at: http://www.hse.gov.uk/lead/exposure.htm  
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Changes in blood Pb levels in young people (aged 14 to 17 years) living in Edinburgh (Scotland) 
were studied by Macintyre et al. (1998) using blood data dated approximately 8 years apart. The 
range of blood Pb levels recorded in 1983-1985 ranged from 4.1 to 28.4 µg dL
-1
 (mean of 11.0 µg 
dL
-1
); the corresponding values were 1.4 to 15.6 µg dL
-1
 (mean of 4.0 µg dL
-1
) in 1992-1993 
(Macintyre et al., 1998). These values indicated a declining trend in blood Pb levels in the young 
population studied, which was attributed to the reduction in household water Pb levels because of 
improved water treatment and removal of lead water pipes (Macintyre et al., 1998).  
A study by Moffat (1989) determined blood Pb concentrations in a population living in a former 
lead mining area in Southern Scotland (Leadhills and Wanlockhead). As part of their study, blood 
Pb levels in a control population (living in Moniaive) where there was no obvious Pb pollution was 
also measured. The mean and standard deviation were 11±4.6 µg dL
-1
 (males, n = 43) and 8.3±3.1 
µg dL
-1
 (females, n = 41) for the control adult population. These concentrations were slightly lower 
than blood Pb levels from the population that was considered exposed to Pb in the former mining 
area, whose blood Pb levels were reported to be 15.9±5.4 µg dL
-1
 (males, n = 55) and 12.4±5.2 µg 
dL
-1
 (females, n = 71) (Moffat, 1989). The findings by Moffat (1989) appear to suggest high 
background levels of Pb in the Scottish population studied. In addition, the mean blood Pb levels 
recorded by Moffat (1989) are consistent with the mean blood Pb level (11.0 µg dL
-1
) reported by 
Macintyre et al. (1998) in young people living in Edinburgh during 1983-1985.  
In our study, levels of Pb in drinking water samples were not determined, mainly because water Pb 
levels is now strictly regulated. In Scotland, the regulatory limit for Pb levels in drinking water, 
called the Prescribed Concentration or Value (PCV), was reduced from 2.5 µg dL
-1
 to 1.0 µg dL
-1
 
in December 2013 (Health Protection Scotland, 2016)
8
. In addition, none of the participants 
indicated in the questionnaire that they had lead paint in their homes. It is possible that background 
levels of Pb in central Scotland have been higher than other parts of the UK. However, more data 
are needed to confirm this. The blood Pb results from our study presents an important contribution 
to the literature due to the lack of recent comparable blood Pb data in the UK, particularly in 
relation to a population that consume produce from their allotments. Our results are consistent with 
the findings by Moffat (1989) and Macintyre et al. (1998), which would support our hypothesis 
‘h2’ should additional recent data confirm similar blood Pb levels in the local population.  
The concentrations of Pb in finger-prick dried blood spot (DBS) samples (for the 108 samples 
paired with venous samples) varied between <LOD and 28.9 µg dL
-1
. Out of the paired samples, 38 
DBS samples recorded concentrations below the LOD (minimum 0.003 µg L
-1
). The non-detect 
concentrations were recorded mainly in the filters with the lowest amount of dried blood spots. A 
summary of blood Pb concentrations for venous and finger-prick samples is given in Table 5.2.  
                                                          
8 Available at: http://www.hps.scot.nhs.uk/resourcedocument.aspx?id=5678  
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Table 5.2: Results of blood Pb (µg dL
-1
) by sample collection method 
Method N N < LOD Range Median GM ± GSD 
Venous 108 0 3.12 – 30.60 9.19 9.74 ± 1.65 
Finger-prick 108 41 2.31 – 28.87# 12.14# 11.15 ± 1.79# 
N (number of paired samples), LOD (limit of detection), GM (geometric mean), and  
GSD (geometric standard deviation).  
#
Relate to concentrations >LOD.  
The correlations between Pb in venous blood and the corresponding DBS samples were observed to 
vary among the participants. High correlations (r
2
 = 0.71) were noted for 2 participants, moderate 
correlations (r
2
 between 0.44 and 0.62) were noted for 5 participants, and low / weak correlations 
(r
2
 between 0.12 and 0.34) were noted for 3 participants. Poor or no correlations (r
2
 ≤ 0.07) were 
observed for 22 participants. When the concentrations for venous blood samples from all 
participants were plotted against the corresponding concentrations for DBS samples, a scatter gram 
presented as Fig. 5.2 was obtained, which shows no clear correlation (r
2
 < 0.01, p > 0.05) between 
the two datasets. The data points do not plot consistently along (or equally scatter above and 
below) the 45-degree line included in Fig. 5.2. Furthermore, the Wilcoxon matched pairs test 
indicated that the difference between the medians of the two paired datasets was statistically 
significant (p = 0.02), further confirming the lack of correlation between the two datasets. 
Therefore, we did not use DBS samples to predict Pb levels in venous blood.  
Some studies have found good correlations between blood Pb levels in samples collected by finger-
prick and venous methods, particularly in children (e.g., Shen et al., 2003; Funk et al., 2015). 
However, venous blood Pb is still the most useful screening and diagnostic test for Pb exposure 
(ATSDR, 2007b).  
 
 
 
 
 
 
 
 
 
Fig. 5.2: Comparison of Pb concentrations in samples of venous blood and finger-prick 
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5.2.1 Pb isotope ratios 
The comparative abundance of Pb isotope ratios in any give Pb source provides a ‘fingerprint’ of 
the Pb from that source, because the isotope ratios remain constant over time (Patel et al., 2008). 
The Pb isotopic ratios measured in soil, produce and blood samples were plotted for each plot and 
the corresponding participant; examples of these plots are given in Appendix G (part G3). The 
participant-specific mean isotopic ratios for blood samples ranged from 1.123 to 1.145 (
206
Pb/
207
Pb) 
and 2.390 to 2.438 (
208
Pb/
207
Pb). Fig. 5.3 shows the values for blood samples aggregate where 
mean isotopic ratios for soil and produce overlap, which may be indicative of the association 
between blood Pb and Pb in either soil or produce where the isotopic overlap occurs. The close 
aggregation of blood Pb isotopic ratios also suggest that soil and produce were unlikely to be the 
only sources of blood Pb. The errors (expressed as RSD) for isotopic ratios for blood samples were 
up to 1%.  
 
 
 
 
 
 
 
 
 
Using the binary mixed model equations (4.2) and (4.3), the calculated contributions (%) of 
geogenic and anthropogenic sources of Pb to blood Pb are shown in Fig. 5.4, which suggests that 
on average, geogenic Pb contributes a higher proportion (43-64%) of blood Pb than anthropogenic 
Pb (36-57%).  
 
 
 
 
Fig. 5.3: Plot showing Pb isotope ratios for soil, produce and blood. 
Also indicated are the mean Pb isotopic ratios for petrol Pb, Scottish coal and Landhills Pb ore. Error bars are ± 
standard deviation. Error bars for soil, produce and blood data were excluded to enhance legibility of the figure.  
Fig. 5.4: Calculated percentage contribution of Pb derived from geogenic (geo.) 
and anthropogenic (anth.) sources in blood samples. 
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5.3 Element concentrations in urine 
A summary of the recorded urinary concentrations of inorganic arsenic (iAs), Cd, Cr and Ni is 
presented in Appendix G (part G4). The limits of detection varied between 0.005 and 0.01 µg L
-1
. 
The concentrations were expressed with respect to urinary creatinine. The concentrations of urine 
samples that had creatinine values below 0.3 g L
-1
 (n = 27) were discarded because the samples 
were considered too dilute (WHO, 1996). The ranges of the detectable (≥ LOD) elemental 
concentrations were: 0.01 to 25 µg L
-1
 (0.02 to 19.39 µg g
-1
 creatinine) for inorganic As, 0.01 to 
2.38 µg L
-1
 (0.01 to 4.25 µg g
-1
 creatinine) for Cd, 0.01 to 15.83 µg L
-1
 (0.01 to 28.24 µg g
-1
 
creatinine) for Cr, and 0.05 to 26.91 µg L
-1
 (0.05 to 22.42 µg g
-1
 creatinine) for Ni. The probability 
distribution of the urinary concentrations did not follow a normal distribution (p < 0.05), as shown 
in the normal Q-Q plots presented in Appendix G (part G4). Data imputation was carried out to 
replace the concentrations that were <LOD (as previously discussed in section 3.8). An example of 
R code used for the imputation of non-detectable iAs concentrations is given in Appendix H (part 
H2). The imputed values were used in subsequent data analyses. The medians and 95
th
 percentiles 
of the elemental concentrations are presented in Table 5.3, which also include the biological limit 
values for occupational exposure published by WHO.  
Table 5.3: The medians and 95
th
 percentiles of elemental concentrations in urine and WHO guidelines 
Element 
% 
<LOD
a
 
Concentrations  
(µg L
-1
) 
Concentrations  
(µg g
-1
 creatinine) 
Biological limit values  
(WHO, 1996)
d
 
(µg g
-1
 creatinine) Median 
95
th
 
Percentile 
Median 
95
th
 
Percentile 
As 
(inorganic) 
27 
1.39
b
 
(0.92)
c
 
8.00
b
 
(7.00)
c
 
1.59
b
 
(1.17)
c
 
7.33
b 
(6.42)
c
 
50  
Cd 39 
0.06
b
 
(0.02)
c
 
0.53
b
 
(0.40)
c
 
0.07
b
 
(0.03)
c
 
0.65
b 
(0.50)
c
 
5  
Cr 31 
0.59
b
 
(0.20)
c
 
6.02
b
 
(5.42)
c
 
0.64
b
 
(0.25)
c
 
6.68
b 
(5.64)
c
 
30  
Ni 29 
1.65
b
 
(0.98)
c
 
7.17
b
 
(6.81)
c
 
1.78
b
 
(1.22)
c
 
8.99
b 
(7.66)
c
 
30  
a
Limits of detection (LOD) varied between 0.005 and 0.01 µg L-1.  
b
Calculated using concentrations that were ≥LOD. 
c
Includes values that were imputed to replace concentrations that were <LOD.  
d
The WHO limit values relate to biological monitoring of chemical exposure in the workplace.  
 
Although the study participants were not occupationally exposed to the elements, the test results 
were compared with the WHO biological limit values (Table 5.3) to show that the recorded 
concentrations did not exceed the WHO guideline values, which indicate the permissible 
concentrations for occupationally exposed workers (WHO, 1996). The ratios of the WHO guideline 
values to the 95
th
 percentiles of urinary concentrations (µg g
-1
 creatinine) were 8 (iAs), 10 (Cd), 5 
(Cr) and 4 (Ni). These ratios indicate the estimated multiples of current exposure levels that would 
result in participants’ urinary levels of the elements above the WHO guidelines.  
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Table 5.4: Comparison of the elemental concentrations in urine from this study with other published data 
Element 
Concentrations  
µg L
-1
  
(µg g
-1
 creatinine)  
Range 
(median) 
per mmol creatinine 
Concentrations  
µg L
-1
  
(µmol mol
-1
 creatinine) 
Concentrations  
µg L
-1
  
(µg g
-1
 creatinine) 
This study 
UK data
1
 
(Sieniawska et al., 2012) 
UK data
2
 
(Morton et al., 2014) 
UK data
3
 
(White & Sabbioni, 1998) 
USA data
4
 
NHANES survey 2013-14 
Median 
95
th
 
Percentile 
Men Women Median 
95
th 
Percentile 
Mean or 
Median 
Experimental 
range 
Geometric 
Mean 
95
th
 
Percentile 
As 
(inorganic) 
0.92 
(1.17) 
7.00 
(6.42) 
N/A N/A N/A 
4.75 
(5.51) 
14.8 
(17.7) 
As (total) N/A 
0.01 – 0.67 
(0.04), µmol 
0.01 – 0.78 
(0.11), µmol 
10.48 
(19.07) 
152.40 
(254.43) 
3.65 
(7.7) 
<0.5 – 48.2 
(1 – 60.6) 
6.49 
(7.58) 
48.0 
(54.0) 
Cd 
0.02 
(0.03) 
0.40  
(0.50) 
0.31 – 2.3 
(0.63), nmol 
0.39 – 1.3 
(0.72), nmol 
0.13 
(0.15) 
0.52 
(0.57) 
3.38 
(0.48) 
0.06 – 1.64 
(0.05 – 3.4) 
0.156 
(0.182) 
0.971 
(0.868) 
Cr 
0.20 
(0.25) 
5.42 
(5.64) 
0.16 – 1.4 
(0.4), nmol 
0.21 – 1.1 
(0.36), nmol 
0.35 
(0.91) 
0.79 
(2.85) 
0.13 
(0.28) 
0.04 – 0.96 N/A N/A 
Ni 
0.98 
(1.22) 
6.81 
(7.66) 
ND – 21.6 
(4.4), nmol 
ND – 18.6 
(8.4), nmol 
1.99 
(5.01) 
6.35 
(10.66) 
0.84 
(1.7) 
<0.3 – 59.0 N/A N/A 
1
24 hour urinary concentrations for healthy UK adults comprising 77 men and 34 women; ND (non-detect), units reported as published. 
2
Data for non-occupationally exposed UK adult population (data for 132 individuals). 
3
Trace element concentrations in urine of healthy UK citizens (data for 224 individuals). 
4
Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017, Volume One (CDC, 2017).  
N/A (not applicable / not reported). 
For comparison, concentrations in µg g-1 creatinine can be expressed in µmol mol-1 creatinine by multiplying the concentrations by 1.5. The value 1.5 is the ratio of creatinine 
molecular weight (113 g mol-1) to arsenic molecular weight (75 g mol-1). 
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The results were also compared with data from previous studies in the UK and with data from 
NHANES 2013-2014 (CDC, 2017), as presented in Table 5.4. The UK data presented in Table 5.4 
are for non-occupationally exposed populations, which makes the data relevant for comparing with 
test results from this study. The median concentrations of Cd and Cr recorded by this study were 
similar to the corresponding median values published by Sieniawska et al. (2012), who measured 
urinary concentrations of healthy UK adults comprising 77 men and 34 women. The median Ni 
concentration from this study was below those reported by Sieniawska et al. (2012). Data from 
another UK based study, where elemental urinary concentrations were measured in urine samples 
from 132 non-occupationally exposed individuals (Morton et al., 2014), have also been compared 
to our results. The median and 95
th
 percentile concentrations recorded in this study were either 
similar or below the corresponding values published by Morton et al. (2014), apart from the 95
th
 
percentile concentration for Cr which exceeded the corresponding value. In addition, Cd 
concentrations from this study were lower than those published by White & Sabbioni (1998); but 
Cr and Ni concentrations were similar. The previous UK studies in Table 5.4 did not report the 
urinary concentrations of iAs (i.e., total As concentrations were reported), therefore it was not 
possible to compare iAs concentrations from this study with total As from these previous studies. 
When compared with the NHANES data, this study recorded lower concentrations iAs and Cd. It 
should be noted that the NHANES data do not include urinary levels of Cr and Ni.  
In the same manner as with the blood Pb data, urinary concentrations were sub-grouped according 
to participants’ age, gender, smoking status and produce consumption rate, and summarised in 
Table 5.5 using range (minimum and maximum) median, geometric mean, confidence interval (at 
95%) and percentiles (5
th
 and 95
th
). The arithmetic mean was also reported. The differences 
between medians of urinary concentrations for the various sub-groups were examined using the 
Mann-Whitney U test, as illustrated using the R code example in Appendix H (part H3). There 
were no significant differences between the medians of iAs and Cr in males and females (p > 0.05), 
which indicate that urinary levels of iAs and Cr were not dependent on gender. However, we found 
significant differences (p < 0.05) between urinary Cd and Ni levels in males and females; with 
females recording higher levels of both elements than males. This observation agrees with previous 
studies (e.g., Ruiz et al., 2010; Choudhury et al., 2001) that have reported higher urinary Cd levels 
in females than males, due to a higher rate of Cd absorption in females (Choudhury et al., 2001). 
With respect to participants’ age groups, there were significant differences between the medians of 
Cd and Cr with age. The highest 95
th
 percentiles for Cd and Cr were recorded in ages above 61, and 
between 30-50 years, respectively. Higher levels of iAs were found in those aged 71-80 years old 
than in other age groups, but the participant’s age had no significant effect on urinary Ni levels. 
There was a significant difference (p = 0.04) between urinary iAs levels for non-smokers and ex-
smokers; higher iAs were recorded for ex-smokers. Similarly, a significant difference was 
identified between Ni levels in non-smokers and ex-smokers (p < 0.05).   
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Table 5.5: Statistical summary of urinary concentrations (µg g
-1
 creatinine) according to sub-groups 
 Element Min Max Median GM Mean (CI, 95%) P5 P95 
All participants 
iAs 0.002 19.39 1.17 0.50 1.93 (1.76 – 2.11) 0.005 6.42 
Cd 0.002 4.25 0.03 0.03 0.12 (0.10 – 0.14) 0.005 0.50 
Cr 0.002 28.24 0.25 0.18 1.23 (1.06 – 1.39) 0.005 5.64 
Ni 0.002 22.42 1.22 0.49 2.15 (1.95 – 2.36) 0.005 7.66 
Age (years) 
30-50 
iAs 0.002 19.39 1.03 0.43 1.85 (1.41 – 2.29) 0.005 6.23 
Cd 0.002 0.88 0.01 0.02 0.06 (0.04 – 0.08) 0.003 0.29 
Cr 0.002 19.48 0.35 0.20 1.48 (0.98 – 1.97) 0.005 7.52 
Ni 0.002 21.99 1.53 0.39 2.64(2.04 – 3.25) 0.005 9.12 
51-60 
iAs 0.003 17.65 0.96 0.45 1.67 (1.41 – 1.94) 0.005 5.43 
Cd 0.003 1.92 0.03 0.03 0.12 (0.09 – 0.15) 0.005 0.47 
Cr 0.003 12.00 0.18 0.16 1.07 (0.83 – 1.31) 0.005 5.21 
Ni 0.003 22.42 1.09 0.44 1.84 (1.53 – 2.16) 0.005 7.00 
61-70 
iAs 0.003 15.33 1.36 0.52 1.96 (1.68 – 2.24) 0.005 6.27 
Cd 0.003 4.25 0.04 0.04 0.16 (0.11 – 0.20) 0.005 0.52 
Cr 0.002 28.24 0.19 0.17 1.22 (0.93 – 1.52) 0.005 5.37 
Ni 0.002 19.51 1.18 0.58 2.17 (1.83 – 2.52) 0.005 8.00 
71-80 
iAs 0.003 13.04 1.92 0.90 2.82 (2.19 – 3.46) 0.005 9.60 
Cd 0.003 1.00 0.03 0.04 0.11 (0.07 – 0.16) 0.005 0.53 
Cr 0.003 7.71 0.58 0.31 1.29 (0.90 – 1.67) 0.005 5.59 
Ni 0.003 10.71 1.73 0.52 2.20 (1.70 – 2.70) 0.005 6.83 
Gender 
Males 
iAs 0.003 13.04 1.03 0.44 1.82 (1.60 – 2.03) 0.005 6.34 
Cd 0.003 1.92 0.02 0.03 0.10 (0.08 – 0.12) 0.005 0.45 
Cr 0.002 19.48 0.27 0.17 1.10 (0.91 – 1.29) 0.005 5.04 
Ni 0.002 12.02 1.04 0.39 1.87 (1.57 – 1.99) 0.005 6.82 
Females 
iAs 0.002 19.39 1.27 0.59 2.08 (1.79 – 2.34) 0.005 6.71 
Cd 0.002 4.25 0.03 0.04 0.14 (0.11 – 0.18) 0.005 0.52 
Cr 0.002 28.24 0.24 0.20 1.38 (1.09 – 1.66) 0.005 6.49 
Ni 0.002 22.42 1.50 0.62 2.60 (2.23 – 2.98) 0.005 10.33 
Smoking status 
Smokers 
iAs 0.007 7.54 1.03 0.49 1.91 (1.19 – 2.64) 0.008 6.37 
Cd 0.004 1.92 0.03 0.04 0.14 (0.02 – 0.26) 0.006 0.50 
Cr 0.005 8.46 0.37 0.21 1.21 (0.54 – 1.89)  0.006 5.32 
Ni 0.005 12.02 1.15 0.28 1.62 (0.84 – 2.40) 0.006 5.84 
Ex-smokers 
iAs 0.003 19.39 1.43 0.61 2.13 (1.80 – 2.46) 0.005 7.21 
Cd 0.003 4.25 0.02 0.03 0.13 (0.08 – 0.17) 0.005 0.45 
Cr 0.002 14.63 0.19 0.14 1.09 (0.85 – 1.34) 0.005 5.31 
Ni 0.002 19.51 0.82 0.33 1.83 (1.46 – 2.19) 0.005 6.00 
Non-smokers 
(and 1 unknown 
smoking status) 
iAs 0.002 17.65 1.04 0.46 1.84 (1.63 – 2.05) 0.005 6.24 
Cd 0.002 2.73 0.03 0.04 0.12 (0.10 – 0.14) 0.004 0.51 
Cr 0.002 28.24 0.26 0.20 1.29 (1.06 – 1.52) 0.005 5.66 
Ni 0.002 22.42 1.44 0.61 2.35 (2.10 – 2.62) 0.005 8.18 
Average produce consumption rate (g fw kg
-1
 bw day
-1
) 
<1  
iAs 0.003 19.39 1.03 0.47 1.86 (1.66 – 2.06) 0.005 6.35 
Cd 0.003 4.25 0.02 0.03 0.11 (0.09 – 0.13) 0.005 0.42 
Cr 0.003 15.83 0.29 0.19 1.14 (0.98 – 1.30) 0.005 5.33 
Ni 0.003 22.42 1.28 0.48 2.12 (1.89 – 2.36) 0.005 7.28 
1 – 2  
iAs 0.002 10.00 1.54 0.60 2.04 (1.67 – 2.40) 0.005  6.38 
Cd 0.002 1.97 0.02 0.03 0.11 (0.07 – 0.15) 0.003 0.51 
Cr 0.002 19.48 0.27 0.17 1.41 (0.91 – 1.92) 0.004 6.19 
Ni 0.002 19.51 0.87 0.42 2.31 (1.70 – 2.93) 0.005 8.81 
2 – 3  
iAs 0.003 15.33 1.50 0.58 2.25 (1.61 – 2.89) 0.005 9.21 
Cd 0.003 2.73 0.10 0.08 0.23 (0.14 – 0.31) 0.006 0.78 
Cr 0.005 28.24 0.11 0.16 1.47 (0.72 – 2.23) 0.007 7.05 
Ni 0.003 12.15 1.21 0.65 2.10 (1.56 – 2.65) 0.006 7.73 
GM (geometric mean), CI (confidence interval of means at 95%), P5 (5th percentile), P95 (95th percentile),  
fw (fresh weight of produce), bw (body weight of participant).  
Imputed values (for <LOD concentrations) were included in the statistical calculations. 
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Although smoking contributes markedly to the amount of Cd excreted in urine (Castano et al., 
2012), no significant differences in urinary Cd levels were identified for the different smoking 
categories. Smoking also had no significant relationship with urinary Cr levels.  
There was a tendency towards higher urinary concentrations of iAs and Cr with increasing rate of 
consumption of produce; however, the associations between the concentrations and the rate of 
consumption of produce were not statistically significant (p > 0.05). The rate of produce 
consumption had a significant effect on urinary Cd levels, but not on Ni levels.  
Further examination of the urinary concentrations was carried out using mixed-effects modelling, 
where participant’s age, gender, smoking status and produce consumption rate were treated as 
‘fixed’ effects, while participants were treated as ‘random’ effects. Significant associations (p < 
0.05) were found between iAs and age, Ni and gender, and between Cd and both age and produce 
consumption. These associations are consistent with the findings obtained from the Mann-Whitney 
U tests.  
Although we found a number of significant associations between urinary elemental concentrations 
and the various participants’ characteristics, the recorded urinary levels were consistent with 
published urinary levels for non-occupationally exposed populations in the UK (Table 5.4). This 
shows that the participants’ consumption of allotment produce did not result in them being exposed 
to these elements at higher levels than other adults in the UK, which supports hypothesis ‘h2’.  
5.4 Chapter summary 
The blood Pb levels recorded in this study were consistent with data published in historic studies 
carried out in central Scotland, but were higher than the levels previously reported in other parts of 
the UK. Due to the scarcity of published data on blood Pb levels in the un-occupationally exposed 
UK population, the blood Pb results from the present study presents an important contribution to 
the literature, particularly in relation to a population that consume produce from their allotments. 
Using Pb isotope analysis, it was determined that both geogenic and anthropogenic sources of Pb 
contributed to Pb in blood, with geogenic Pb sources contributing higher higher proportions (up to 
64%) than anthropogenic Pb sources. Measured element concentrations in urine were similar to the 
corresponding levels in the general (non-occupationally exposed) populations in the UK; indicating 
that the participants were not exposed to these elements at levels importantly higher than other 
adults in the UK. Urine concentrations were between 0.1 and 0.25 times the WHO guideline values 
used in assessing potential health risk for occupationally exposed workers. Overall, the measured 
elemental concentrations in biological samples support hypothesis ‘h2’ that “the levels of the 
elements in blood and urine samples obtained from the participants are similar to the local 
background levels”.  
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6. PHYSIOLOGICALLY-BASED KINETIC MODELS  
6.1 Introduction 
A review of the physiologically-based kinetic models is presented in chapter 2 (section 2.8), which 
also indicates the models adopted in this study. Some of these models are quite complex in terms of 
their structure and formulation because of the differences in physicochemical properties of the 
elements, organs involved in metabolism and exposure pathways simulated by the authors. To 
construct models suitable for our purpose (i.e., simulation of oral ingestion pathway in adults), 
some of the published models required modification by reducing or removing some compartments 
whilst still maintaining their predictive ability. This chapter presents the modified models, 
evaluation of the predictive performance of the modified models using data published in the 
literature, parametric sensitivity analysis, and a demonstration of the use of the models in informing 
and optimising the design of the biomonitoring study.  
The physiological and chemical-specific parameters describing the kinetics of these elements in 
humans were obtained from the literature. In addition, we obtained mathematical equations 
describing these models from the literature and re-wrote the equations to fit the modified models. 
Mathematical equations and parameters of the constructed models are presented in Appendix I.  
6.2 Modified models  
6.2.1 Arsenic  
The model published by El-Masri & Kenyon (2008) was adopted in this study, and was modified as 
follows: (i) the original model includes oxidation and reduction in the lung, liver and kidney only, 
however it was assumed that oxidation and reduction occurs in all perfused tissues as previously 
reported by Mann et al. (1996) and Yu (1999), (ii) the oxidation and reduction reactions between 
MMA(III) and MMA(V), DMA(III) and DMA(V) were ignored, thus MMA and DMA were 
treated as single species, because in our laboratory analysis we tested for total inorganic arsenic 
(the sum of all inorganic arsenic species), and (iii) biliary excretion of As from the liver was 
included in the model, as reported by Yu (1999) and Liao et al. (2008). Fig. 6.1 shows the 
schematic representation of the modified PBPK model for As.  
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Given the modifications made to the As model, the model’s ability to predict literature data was 
tested. The model was used to simulate cumulative urinary As metabolites based on single and 
multiple oral doses of As(III) and As(V) reported in the literature by (Mann et al., 1996; El-Masri 
& Kenyon, 2008; Buchet et al., 1981). Selected results from the simulations are plotted in Fig. 6.2, 
which shows that the simulated results are consistent with the corresponding literature data.  
 
 
Urinary 
Excretion 
K52 K25 
K24 
K42 
BRAIN 
K28 
K82 
K29 
LUNG 
K92 
K62 K26 K27 
K72 
K32 
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K21 
eF 
eU 
Oral 
Intake 
MUSCLES SKIN 
BLOOD LIVER 
HEART 
GI TRACT 
KIDNEY 
Faeces  
A 
Km,i 
3+→dma 
Km,i 
 mma→dma 
As(V) As(III) 
Kred 
Kox 
MMA 
DMA 
Km,i 
3+→mma 
Vmax,i 
3+→mma 
Vmax,i 
 mma→dma 
Vmax,i 
3+→dma 
B 
Fig. 6.1: A modified version of the PBPK model for As published by El-Masri & Kenyon (2008). 
(Part A) Oral absorption of As(III), As(V), MMA, DMA was accounted for in the GI tract, eF is faecal excretion rate 
of As species (day-1), eB is biliary excretion rate of As species (day-1), eU is urinary excretion rate of As species 
(day-1). K refers to the transfer rates (day-1) we calculated for As species between compartments. (Part B) Shows the 
oxidation/reduction of inorganic arsenic in all tissues and methylation of As(III) in kidney and liver (Liao et al. 
2008). Kox and Kred are metabolic constants (day
-1) for oxidation and reduction, respectively, Vmax (µmol day
-1) and 
Km (µmol L
-1) are metabolic constants for methylation of As(III), and i refers to compartment (liver, kidney). MMA 
(monomethylarsenic acid) DMA (dimethylarsinic acid). 
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Further evaluation of the model was carried out using oral ingestion of 6.67 µmol (500 µg) As 
(Buchet et al., 1981) and 1.33 µmol (100 µg) As (El-Masri & Kenyon, 2008). Model predictions of 
cumulative urinary As (total) were within 8% of the reported data in the literature.  
Ingested inorganic As undergoes oxidation and reduction in body tissues and methylation to MMA 
and DMA in the liver and kidney (Liao et al., 2008; El-Masri & Kenyon, 2008). Generally, studies 
have found DMA to be the major metabolite in urine following exposure to inorganic As (Yu, 
1999; Buchet et al., 1981; Hughes, 2006; Hwang et al., 2002), as biotransformation of inorganic As 
to MMA and DMA occurs rapidly making DMA the dominant metabolic species after 
approximately 2 days. Our model simulations (Fig. 6.2) agree with this observation with the 
modified As model able to reproduce the literature data well (r > 0.9 for total As in urine), with 
low RMSE values for total inorganic As ranging from 4.7x10
-6
 to 0.44 (µmol). Analytical 
experimental procedures for determining As species in urine are often complex and costly. 
Therefore, the PBPK model can be used to estimate internal doses and urinary concentrations of 
speciated As, thus providing a proxy for the analysis of speciated As in urine.  
6.2.2 Cadmium 
We adopted the KN model as described in section 2.8 because it is the most used model and it is 
also the basis for other published PBTK models for Cd. Given that our study involves exposure 
through oral ingestion of food, we excluded the inhalation pathway from the model. In addition, the 
direct transfer of unabsorbed Cd to faeces was added to the modified model to account for 
unabsorbed Cd. The schematic representation of the modified PBTK model for Cd is given in Fig. 
6.3. 
Fig. 6.2: Comparison of predicted urinary As metabolites with experimental data in the literature. 
(A) following single oral ingestion of arsenic acid (1.3x10-4 µmol As) (Mann et al. 1996), (B) following repeated daily oral 
ingestion of 1.67 µmol As for 5 days (Buchet et al. 1981). [iAs is the sum of As(III) and As(V); m, model; d, experimental data].  
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Based on Cd ingestion data published by Ju et al. (2012), the modified Cd model was used to 
predict Cd concentrations in blood and urine. Simulations were performed with all parameters fixed 
to the values given in the original KN model and only the bioaccessibility values were varied to 
correspond to values used by Ju et al. (2012). The model-predicted results and literature data are 
presented in Fig. 6.4, which shows that predicted concentrations closely match the literature data (r 
= 0.99).  
We also used the dietary intake of Cd reported by Berglund et al. (1994) in their study investigating 
intestinal absorption of dietary Cd in women subjects (20 to 50 years of age) to predict Cd 
concentrations in urine and blood following daily dietary exposure. Our simulations mimicked five 
long-term exposure scenarios lasting between 10 and 50 years which are compared in Table 6.1, 
against the results of Cd measured in urine and blood by Berglund et al. (1994). Although no 
corresponding data (with respect to duration after exposure) was given by the authors (this would 
allow direct comparison with our simulated results) the model predictions fit within the reported 
data ranges.  
Liver 
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CX C16  Blood1 Blood2 Blood3 
C7 1-C7 
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Fig. 6.3: A modified version of the Cd PBTK model published by Kjellström & Nordberg (1978). 
Blood1 to Blood3 refer to ‘plasma other’, ‘red blood cells’ and ‘plasma metallothionein’, respectively; C5 to C19 
and CX refer to the parameters describing the transfer of Cd between compartments as defined in the original model. 
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Table 6.1: Predicted urine and blood Cd concentrations and data reported by Berglund et al. (1994) 
 Mixed diet High fibre diet 
 Urine Blood Urine Blood 
Measured concentrations
a
 
Median 0.10 0.23 0.09 0.25 
Range 0.02 - 0.32 ≤0.09 - 0.68 ≤0.02 - 0.41 ≤0.09 - 0.96 
Predicted Cd concentrations after simulating 10 to 50 years of daily dietary exposure to Cd 
10 years  0.04 0.29 0.05 0.38 
20 years 0.08 0.33 0.08 0.43 
30 years 0.10 0.38 0.11 0.48 
40 years 0.12 0.39 0.13 0.51 
50 years 0.13 0.41 0.14 0.53 
a
Berglund et al. (1994). 
All concentrations are expressed in µg L-1. The median daily dietary intakes of Cd reported by Berglund et al. (1994) 
(10 µg day-1 for mixed diet and 13 µg day-1 for high fibre diet) were used in the simulations. Predicted Cd masses in 
urine were converted into concentrations using the median daily urine volumes reported by Berglund et al. (1994). 
Likewise, Cd loads in blood were converted to concentrations using blood volume of 5.2 L (Ju et al., 2012).  
  
Fig. 6.4: Comparison of predicted Cd levels in urine and blood with data (median) reported by Ju et al. (2012). 
M and F refer to male and female non-smoking human subjects, respectively. Six scenarios of Cd bioaccessibility as used by Ju et al. 
(2012) were simulated. Creatinine values used in expressing predicted urinary Cd were obtained from Ju et al. (2012). I-V represent Cd 
bioaccessibility values (dimensionless) of 0.021, 0.032, 0.044, 0.057 and 0.094, respectively. VI represents the scenario of using the 
original fraction of Cd absorbed to gastrointestinal tract and systematic circulation (0.048) adopted by Kjellstrom & Nordberg (1978).  
M 
M 
F 
F 
VI I II III IV V 
VI I II III IV V VI I II III IV V 
VI I II III IV V 
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Cd model predictions were consistent with the literature data (r = 0.99), with low RMSE values 
ranging from 0.01 to 0.02 (µg g
-1
 creatinine). The creatinine values reported by Ju et al. (2012) 
were used in the conversion of the predicted urinary Cd concentrations. The KN model for Cd has 
been used in similar studies. It was modified by Ruiz et al. (2010), re-coded and used to sufficiently 
predict the urinary Cd concentrations using the National Health and Nutrition Examination Survey 
(NHANES) data from Cd exposure by oral ingestion. Using a modified version of the KN model in 
their study, Choudhury et al. (2001) also predicted urinary Cd concentrations consistent with the 
NHANES data.  
6.2.3 Chromium 
The model published by Kirman et al. (2013) was adopted and simplified by ignoring the detailed 
competing toxicokinetic processes of Cr in the stomach and intestines, because there are published 
absorption rates for Cr in the GI tract (Kirman et al., 2013; Sasso & Schlosser, 2015). Therefore, 
the ‘stomach’, ‘small intestines’ and ‘large intestines’ were lumped into a single compartment (GI 
tract), which is consistent with the approach used by O’Flaherty et al. (2001), who treated the GI 
tract as a single compartment in their model. Fig. 6.5 shows the structure of the modified PBPK 
model for Cr.  
 
 
 
 
 
 
 
 
 
 
 
Liver 
Urine Kidney Bone Other 
Tissues 
Oral 
ingestion 
Faeces GI tract 
 
Portal Plasma 
Systemic Plasma 
Portal RBC 
Systemic RBC 
Fig. 6.5: A modified version of the PBPK model for Cr published by Kirman et al. (2013). 
RBC refers to red blood cells. All compartments contain Cr(III) and Cr(VI). Reduction of Cr(VI) to Cr(III) 
occurs in GI tract, blood, liver, kidney, and other tissues. Cr is excreted in urine mainly as Cr(III) due to rapid 
reduction of Cr(VI) to Cr(III) in the body (O’Flaherty et al., 2001). 
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The predictive performance of the Cr modified model was tested using data published by 
Paustenbach et al. (1996), Kirman et al. (2013) and Kerger et al. (1996). The results are plotted in 
Fig. 6.6.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In Fig. 6.6 (A), the model predicts a faster urinary excretion of Cr than the measured data in the 
literature. However, the cumulative urinary Cr is consistent with the literature data. The predicted 
results show reasonable fit with the literature data following oral ingestion of Cr(III) and Cr(VI) in 
single and multiple doses.  
It has been observed that human absorption of Cr(VI) in the GI tract can vary between individuals 
and also in the same individual at different times, with suggestions that physiological fluids in the 
GI tract such as gastric juice and diet constituents like orange juice lead to poor intestinal 
absorption of Cr(VI), because of their capacities to reduce Cr(VI) to Cr(III) (De Flora et al., 1997; 
Kerger et al., 1996; Sasso & Schlosser, 2015). Intra-individual variability in Cr(VI) absorption due 
Fig. 6.6: Comparison of predicted and measured cumulative urinary excretion of Cr in human subjects. 
(A) for humans exposed to a single dose of 5 mg of Cr(III) as reported by Kerger et al. (1996), (B) for humans exposed to 
0.4mg of Cr(III) per day for 3 days (Kirman et al. 2013), (C) for humans exposed to a single dose of 5mg of Cr(VI) as reported 
by Kerger et al. (1996), and (D) for a human volunteer exposed to 4mg Cr(VI) per day for 17 days (Paustenbach et al. 1996).  
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to differences in this reduction capacity was noted in studies involving human subjects (Finley et 
al., 1997; Paustenbach et al., 1996; O’Flaherty et al., 2001). Absorption values of 0.25 day-1 for 
Cr(III) and 2.5 day
-1
 for Cr(VI) were specified by O’Flaherty et al. (2001). In addition, we used the 
mean rate constants for absorption of Cr(III) (4.6x10
-6
 L hr-cm
-1
) and Cr(VI) (3.2x10
-4
 L hr-cm
-1
) in 
the small intestines given by Kirman et al. (2013) to estimate corresponding intestinal absorption 
rates of 0.05 day
-1
 for Cr(III) and 3.5 day
-1
 for Cr(VI). In our simulations, we used a range of GI 
tract absorption rates, 0.05 – 0.25 day-1 for Cr(III) and 1 – 2.5 day-1 for Cr(VI) to fit model 
predictions with the literature data (r > 0.8, RMSE ≤ 0.01 mg). This suggests that oral absorption 
values for Cr should be carefully selected when fitting a model using experimental data.  
6.2.4 Lead 
The O’Flaherty model for Pb was adopted for this study. The model was modified by: (i) ignoring 
the inhalation component in our simulations because oral ingestion is the primary route of exposure 
investigated in this study. Furthermore, pilot study results indicated that air Pb concentrations at the 
allotments were not elevated above background air concentrations; and (ii) the model was 
simplified by neglecting the detailed Pb kinetics in the bone associated with bone growth, since 
human skeletal growth is considered to be complete by the age of about 25 years (O’Flaherty, 
1993) and all of our study participants were aged 30 years old and above. Fig. 6.7 provides 
schematic representation of the modified PBPK model for Pb.  
 
 
 
 
 
 
 
 
 
Evaluation of the modified Pb model was carried out using of Rabinowitz et al. (1976), who 
studied the steady-state kinetics of Pb in five healthy men (subjects A to E) with stable isotope 
tracers. Since the transport of Pb throughout the body is governed by its concentration in the 
plasma (O’Flaherty, 1993; Fleming et al., 1999; Leggett, 1993), Pb concentration in whole blood 
eU 
IRgi 
Agi 
K12 K23 
eB 
K32 
Oral 
Intake 
Urinary 
Excretion 
Biliary 
Excretion TISSUES 
(WP) 
TISSUES 
(PP) 
BLOOD LIVER 
BONE 
GI TRACT 
KIDNEY 
K21 
K52 K62 K26 K25 K24 
K42 
Faeces  
(1-Agi) 
Fig. 6.7: A modified version of the O’Flaherty PBPK model for Pb. 
WP is well-perfused tissues, PP is poorly-perfused tissues, IRgi is the oral intake rate of Pb (mg day
-1), Agi is the Pb 
absorption coefficient from gastrointestinal tract (unitless), the unabsorbed fraction is represented by (1-Agi), eB is the 
biliary excretion rate of Pb (day-1), eU is the urinary excretion rate of Pb (day-1), K12 to K62 refer to the transfer rates of 
Pb (day-1) between compartments which we calculated.  
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was calculated from the model-predicted plasma Pb concentrations using the expression 
(MacMillan et al., 2015).  
𝐶𝐵 = ((1 − 𝐻𝐶𝑇) × 𝐶𝑃𝐿𝐴𝑆𝑀𝐴) + (𝐻𝐶𝑇 × 𝐶𝑃𝐿𝐴𝑆𝑀𝐴 × (𝐺 + (
𝐵𝐼𝑁𝐷
𝐾𝐵𝐼𝑁𝐷 + 𝐶𝑃𝐿𝐴𝑆𝑀𝐴
))) (6.1) 
Here, CB is Pb concentration in whole blood, HCT is the haematocrit fraction of whole blood 
(0.45), CPLASMA is Pb concentration in blood plasma, G is the ratio of unbound erythrocyte Pb 
concentration to plasma Pb concentration (1.2), BIND is the Pb binding capacity of erythrocytes 
(0.437 mg Pb L
-1
 cell), and KBIND is the binding constant of erythrocytes (3.72x10
-4
 mg Pb L
-1
 
cell). This allowed for comparison to be made between model-predicted plasma concentrations and 
Pb measurements in whole blood. Simulated results for the five subjects are presented in Fig. 6.8, 
which show peak Pb concentrations similar to the observations made by Rabinowitz et al. (1976).  
The predicted Pb concentrations in blood were highly correlated to the literature data (r > 0.9 for 
subjects A, B, D, E, and r = 0.7 for subject C). Notably, there were fewer data points for subject C, 
which could be the reason for the reduced correlation. In addition, the literature data for subject C 
show constant blood concentration beyond day 2, while the model simulated declining 
concentrations (Fig. 6.8). Individual variabilities (such as differences in absorption rates and 
stomach clearance rates) cannot be ruled out as potential contributing factors to this variation. 
Despite the reduced correlation for subject C, the predicted peak Pb in blood (which is relevant in 
understanding exposure) was consisted with experimental data. Predicted peak Pb concentrations 
were within 10% of the literature data, apart from subject E which recorded 38% above the 
literature data. Similar observations were made by O’Flaherty (1993) and Morisawa et al. (2001) 
who tested their Pb models using the same data by Rabinowitz et al. (1976); although data for 
subject C was not reported in both publications.  
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Fig. 6.8: Comparison of model predicted versus measured Pb concentrations in blood from the 
Rabinowitz et al. (1976) study. 
Duration of study refers to time after the beginning of controlled ingestion of Pb isotope. Ingestion periods for Subjects 
A (204 µg day-1), B (185 µg day-1) and D (105 µg day-1) were 104, 124 and 82 days, respectively. Subject C ingested 68 
µg day-1 for 1 day, while subject E ingested 99 µg day-1 for the first 8 days and again from days 42-52. 
Subject A Subject B 
Subject C Subject D 
Subject E 
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6.2.5 Nickel 
The Ni model published by Sunderman et al. (1989) was slightly modified by the addition of a 
‘faeces’ compartment to account for faecal excretion of un-absorbed Ni. The rate of transfer to 
faeces was determined based on the absorption rate applied in the model. The schematic 
representation of the modified toxicokinetic model for Ni is given in Fig. 6.9. 
 
 
 
 
 
 
 
 
The predictive performance of the Ni modified model was tested using data obtained from 
Sunderman et al. (1989) and Nielsen et al. (1999). The model results and the corresponding 
literature data are presented in Fig. 6.10, which indicates that the predicted urinary excretion of Ni 
match closely with the literature data; thus showing the capability of the model to reproduce 
literature data.  
 
 
 
 
 
 
 
 
K21 
Kf 
Oral Intake 
 
Urine  
GUT 
TISSUES SERUM 
eU 
K1 
K12 
Faeces  
ρK1 
Fig. 6.9: A modified version of the Ni PBTK model by Sunderman et al. (1989). 
K1, Kf, K12 and K21 refer to the transfer rates of Ni between respective compartments and eU is the rate 
constant for urinary elimination as defined in the original model. The absorbed fraction of Ni dose in the 
gut (Agut) was 0.011, as determined by Sunderman et al. (1989). We expressed the daily rate constant for 
faecal excretion of unabsorbed Ni in dose as ρK1, where ρ was calculated as (1-Agut)/Agut. 
Fig. 6.10: Comparison of predicted urinary Ni excretion with literature data 
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The mass fraction (mean) of Ni dose absorbed from the gut in the experiment by Sunderman et al. 
(1989) was 0.7±0.4 % for Ni dose ingested in food. In a similar study involving controlled 
ingestion of Ni dose in food, Nielsen et al. (1999) reported a median value of Ni oral absorption of 
2.95±1.32 % (mean 2.5%), which is notably higher than oral absorption values reported by 
Sunderman et al. (1989). The mean oral absorption values reported by these authors were used in 
the simulations (Fig. 6.10). The model predicted literature data well (r > 0.9), with low RMSE 
values ranging from 0.02 to 0.9 µg.  
Varied oral absorption values of Ni in the gut were also noted in the literature. Studies by Horak & 
Sunderman (1973), McNeely et al. (1972) and McNeely et al. (1971) reported Ni absorption values 
between 1 and 1.6 %. Overall, these oral absorption values indicate that faecal excretion is a major 
route for elimination of Ni from the human body.  
6.3 Sensitivity analysis 
The sensitivity coefficients (SC) of all model input parameters were determined as described in 
chapter 3 (section 3.10), to determine the influence of parameter variation to the model output 
(urinary As, Cd, Cr, Ni concentrations and blood Pb). Input values were varied by up to ±50%. The 
SC values show the relative magnitude of change in model output for a given change in the model 
input, such that high values of SC indicate high sensitivity of the model to that variable. The 
parameters with SC > 0.1 are shown in Fig. 6.11.  
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.11: Sensitivity analysis of urinary As, Cr, Ni, Cd concentrations and blood Pb for various model 
parameters. 
eU is urinary elimination rate. Other parameters: (As) Ka is oral absorption in the GI tract, Vmax and Km are methylation 
constants in the kidney. (Cr) KGI is rate constant for absorption of Cr from the GI tract, K25tcr3 is transfer rate of Cr(III) to 
the kidney from the distribution pool in systemic plasma. (Pb) Agi is absorption coefficient from the GI tract, K12 and K21 are 
transfer rates from liver to blood and the reverse, respectively. (Ni) Agut is fractional absorption in the gut, K1 is alimentary 
absorption rate, K12 and K21 are transfer rates from serum to tissues and the reverse, respectively. (Cd) C5 is fractional 
absorption to GI tract, C6 is rate constant for systematic absorption from GI tract, C7 transfer from systematic circulation to 
blood compartment 3, (1-C17) is transfer from blood compartment 3 to urine.  
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Fig. 6.11 shows that As model is most sensitive to eU (SC = 0.97), and moderately sensitive to 
methylation constants in the kidney (Vmax, Km) and oral absorption constant (Ka). The results also 
indicate that models for Cd, Cr, Ni and Pb were highly sensitive to adjustment of their oral 
absorption constants (SC > 0.96). The model for Cd recorded high SC values for parameters 
describing systemic absorption of Cd and the transfer of Cd from blood to urine. Overall, the 
determined SC values suggest that the most important parameters controlling model outputs relate 
to urinary elimination (As, Cd), oral absorption (Cd, Cr, Ni, Pb) and systemic absorption (Cd). 
Similar studies have also recorded high SC for a number of these parameters. For example, the 
sensitivity analysis performed by Yu (1999) for their PBPK model for inorganic As determined that 
Vmax coefficients, urine constants and reduction constant were the input parameters that affected 
model output significantly. Using a modified version of the K&N model for Cd, Ruiz et al. (2010) 
determined a high SC value of 0.99 for fractional absorption of Cd in the GI tract. The study by 
Kirman et al. (2013) also identified a number of sensitive parameters to their Cr model, including 
parameters associated with Cr absorption in the GI tract and urinary excretion rate. Notably, the 
literature gives various oral absorption values for Cr due to inter- and intra- individual differences 
linked to physiological fluid contents of the GI tract that influence the reduction of Cr(VI) to 
Cr(III). The determined SC values point us to the model parameters that require close attention 
during the modelling process.  
6.4 Model application in planning biomonitoring 
These modified models for As, Cd, Cr, Ni and Pb were used to predict optimal times for the 
collection of biological samples during our biomonitoring study. The aim was to identify the best 
time points, following oral ingestion of allotment produce, at which to collect urine and blood 
samples (the biomarkers of exposure) given their expected low element concentrations. Model 
results would thus maximise the potential of detecting these elements in biological samples.  
The simulated element doses (mg day
-1
) were calculated based on the following: 
a) Average produce concentrations recorded during our pilot study. However for Cd, we 
assumed a value equivalent to the limit of detection (0.03 mg kg
-1
) because all samples 
recorded Cd concentrations below the limit of detection.  
b) Produce consumption rate of 3.34 (g-1 fw kg-1 bw day-1) for ‘high end’ consumer, derived 
from the data used in the CLEA model (as illustrated in Table 6.2). This consumption rate 
relates to CLEA age classes 17 and 18, which correspond to adults aged between 16 and 65 
(age class 17) and 65 to 75 (age class 18). Our study participants are aged over 30 years 
old.  
c) Average adult body weight of 70 kg (Brown et al., 1997).  
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d) Short durations of exposure (1, 3 and 7 days) were simulated to mimic hypothetical 
minimal (worst-case) exposure scenarios.  
 
Table 6.2: Calculation of allotment-related produce consumption rates from CLEA data 
CLEA 
Produce 
Category
3
 
Produce Consumption for CLEA Age Class 17–18 (Adults)1,2 
Consumption 
Rate
4
 
Homegrown fraction Allotment related 
Consumption Rate
4,5
 
(average) (high end) (average) (high end) 
Green 2.94 0.05 0.33 0.15 0.97 
Root 1.40 0.06 0.40 0.08 0.56 
Tuber 1.79 0.02 0.13 0.04 0.23 
Herbaceous 1.61 0.06 0.40 0.10 0.64 
Shrub 0.22 0.09 0.60 0.02 0.13 
Tree 2.97 0.04 0.27 0.12 0.80 
Total 0.50 3.34 
1Environment Agency (2009e). 
2We assumed individuals consuming all CLEA produce categories.  
3Vegetables (Green, Root, Tuber) and Fruits (Herbaceous, Shrub, Tree). 
4Units (g fw kg-1 bw day-1), fw (fresh weight, produce), bw (body weight).  
5Allotment-related consumption rate is the product of ‘consumption rate’ and ‘homegrown fraction’.  
 
 
Table 6.3: Planning of biomonitoring using model predictions 
Element 
Oral dose 
(mg day
-1
) 
Exposure 
Duration 
(days) 
Optimal sampling time 
after exposure (range) 
Corresponding concentration 
(ppb) in urine
1
 (As, Cd, Cr, Ni) 
and blood
2
 (Pb) at optimal time 
As 
0.44 
(5.9 µmol) 
1 7 – 14 days 2.6 – 9.0 
3 7 – 21 days 9 – 24  
7 10 – 30 days 18 – 43 
Cd 0.004 
1 N/A <0.01 
3 N/A <0.01 
7 N/A <0.01 
Cr 0.1 
1 N/A < 0.01 
3 N/A < 0.01 
7 10 – 20 days ~ 0.01 
Ni 0.19 
1 3 – 9 days 1.2 – 2.3 
3 10 – 20 days 1.4 – 3.8 
7 14 – 30 days 1.4 – 4.8 
Pb 0.47 
1 15 – 90 days ≥ 0.3 
3 15 – 90 days ≥ 1.0 
7 15 – 90 days ≥ 2.3 
1Urinary concentrations were calculated using urine volume of 1.4 L day-1 (Ju et al. 2012) 
2Blood concentrations were calculated using blood volume of 5.2 L day-1 (Ju et al. 2012) 
N/A implies ‘not applicable’ (very low concentrations predicted). 
 
The predicted optimal sample collections times are presented in Table 6.3. Model predictions 
indicate that at very low levels of exposure, detection of Cd and Cr in urine might not be 
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achievable, unless the participants get exposed to higher doses than simulated. We relied on a 
detection limit of 0.01 µg L
-1
 for ICP-MS. Higher intake would increase the ‘window’ of optimal 
sampling times. On the contrary, detection of urinary As (total) and Ni, and blood Pb would not 
prove difficult. These optimal times informed the sampling frequencies adopted in the 
biomonitoring.  
6.5 Chapter Summary 
Using existing models and published data in the literature, modified kinetic models were produced 
for As, Cd, Cr, Pb and Ni, for subsequent use in this study. The predictive performances of the 
modified models were tested using data published in the literature. Simulations carried out using 
the modified models showed high correlations between model-predicted data and the literature data 
(section 6.2), with majority of the data recording r > 0.9. A summary of the performance of the 
models discussed in section 6.2 is given in Table 6.4.  
Table 6.4: Summary of calculated values (range) of predictive performance of the modified models 
Element 
(range of doses simulated) 
RMSE 
Correlation 
coefficient (r)
 
(p<0.05) 
Maximum Cs 
(as % of Clit ) 
As (1.3x10
-4 – 6.67 µmol) 4.7x10-6 – 0.44 (µmol)a 0.98 – 0.99a 89 – 109a 
Cd (6.9 – 7.6 µg)b 0.01 – 0.02 (µg g-1 creatinine) 0.99 83 – 106  
Cr (0.4 – 5 mg) 0.001 – 0.01mg 0.84 – 0.99 105 – 114  
Ni (50 – 900 µg) 0.02 – 0.9 µg 0.98 – 0.99 100 – 102  
Pb (68 – 204 µg) 0.11 – 1.4 µg dL-1 0.74 – 0.95 93 – 138  
Cs is the simulated data, Clit is the corresponding literature data.  
aResults summarised are for As (total). 
bExcludes Cd simulations in Table 6.1, no corresponding data was given in the literature to allow direct comparison. 
 
Majority of the predicted maximum results were within 17% of the literature data, apart from one 
dataset from Pb simulations with 38% over-prediction (see Fig. 6.8, subject E) . Ni results recorded 
the closest match to the literature data. RMSE values were low in respect to the oral doses 
simulated, indicating the closeness of data points to the regression line, which demonstrates the 
ability of the models to reproduce literature data well. These findings support hypothesis ‘h3’ that 
“PBPK model predicted element concentrations in blood and urine are good indicators of the 
corresponding measured biomarker concentrations”. Therefore, these models are useful tools in 
the analysis of human exposure to the selected elements through the oral ingestion pathway. One 
advantage of these models is that they are adaptable, because model input parameters can be 
adjusted to reflect the actual exposure characteristics being investigated.  
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7. EVALUATION OF MODELS USING BIOMONITORING 
DATA AND MODELLING OF EXPOSURE SCENARIOS 
7.1 Introduction 
In this chapter, the models presented in the preceding chapter are evaluated using our 
biomonitoring data. Numerous model simulations were carried out, based on three broad exposure 
scenarios (i.e. using participants’ data from our study, using data published in CLEA documents, 
and using hypothetical scenarios). Both short-term and long term exposure frequencies were 
simulated. The relationships between model outputs and the recorded element concentrations in 
biological samples have been examined. Selected figures prepared from the simulations are 
included in this chapter, and in addition, outputs of selected simulations are given in Appendix J.  
7.2 Simulation of blood Pb concentrations 
7.2.1 Exposure modelling using data from our study 
The PBPK model for Pb (Fig. 6.7) was used to predict blood Pb concentrations for each of the 
participants where blood Pb was determined. The daily intake rate (IR) of Pb (µg day
-1
) was 
calculated by multiplying the participant body weight (kg) by the corresponding average daily 
intake (ADI) values of Pb. ADI values are summarised in Appendix E (part E4). IR values were 
calculated for each month, and subsequently used to schedule Pb ‘doses’ in the model. In our 
simulations, values of the Pb absorption coefficient from the GI tract (Agi) were selected at random 
from the range of 0.06 to 0.12 (Rabinowitz et al., 1976) in order to improve the data fit between the 
predicted concentrations with biomonitoring data. The oral absorption coefficient was the most 
sensitive parameter for the Pb PBPK model (Fig. 6.11), thus, it was necessary to vary the parameter 
during the simulations to cater for individual variabilities of oral absorption among the participants.  
The model predicts the mass (µg) of Pb in the plasma, which were converted to plasma 
concentrations (µg L
-1
) by dividing the predicted mass with plasma volume of 2.8 L (O’Flaherty, 
1991). To enable comparison with measured Pb concentrations in whole-blood, the predicted 
plasma Pb concentrations were converted to whole-blood Pb concentrations using Eq. (6.1). 
Examples of model output are presented in the time series plots in Fig. 7.1, which show that the 
predicted Pb concentrations in blood vary on a monthly basis, depending on the IR used for each 
month.  
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We carried out simulations similar to Fig. 7.1 for all the 32 participants who gave blood samples 
(selected plots from these simulations are presented in Appendix J, part J1). From each simulation, 
we identified the predicted blood Pb concentrations along the time series that corresponds to the 
time-points when blood samples were collected during the 365 days simulated. For example in Fig. 
7.1, 3 blood samples (represented by dots) were collected from participant P12 on day 150, 270 and 
360, respectively. Therefore, predicted blood Pb concentrations at day 150, 270 and 360 were 
obtained from the predicted time series plot. Subsequently, we combined all the predicted blood Pb 
levels and plotted them against the corresponding measured concentrations of Pb in participants’ 
blood samples. The relationship between the measured and the predicted blood Pb concentrations is 
presented as Fig. 7.2, which shows a good correlation between the two data sets (r
2
 = 0.7, p < 0.05).  
 
 
 
 
 
 
 
 
 
Fig. 7.2: Relationship between the predicted blood Pb concentrations and the corresponding 
measured Pb concentrations in blood samples. 
This plot was prepared using 88% of the data points; the remaining 12% were excluded from the plot to improve 
data correlation. Excluded data points relate to the blood concentrations previously identified as outliers (n=7) and 
six other data points. A weak correlation (r2 < 0.3) was determined when all data points were plotted.  
P12 P28 
Fig. 7.1: Predicted and measured blood Pb concentrations for participants P12 and P28. 
The calculated daily intake (IR) of Pb varied between 23 and 86 µg day-1 (P12) and 10 to 155 µg day-1 (P28) were used in 
the simulations, for an exposure frequency of 365 days. Concentrations of Pb recorded in blood samples are also indicated. 
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However, the regression line indicates that the model under-predicts the measured concentrations. 
This under-prediction was considered to be indicative of exposure to additional sources of Pb apart 
from soil Pb. This consideration is consistent with the findings from Pb isotopic ratio analysis, 
which indicated that the origins of Pb in blood samples were associated with both geogenic (43 to 
64 %) and anthropogenic (36 to 56 %) sources (Fig. 5.4). In addition, we used averaged dose 
values in the simulations, which further explain why not all model predictions match the measured 
data perfectly.  
Again, it should be noted that evaluation of the performance of the PBPK model for Pb using 
literature data (where human volunteers were subjected to controlled ingestion of Pb isotope) had 
indicated that the model performs well (Fig. 6.8), and is capable of simulating scenarios of oral Pb 
exposure though oral ingestion. Therefore, the differences between the measured and predicted 
blood Pb concentrations should not be viewed as an under-performance of the model.  
Information gathered from the study participants indicated that the majority of them (60 %) had 
used their plots for at least 5 years (up to 30 years was reported), while 40 % had used their plots 
for durations of less than 5 years. This information suggests possible chronic exposure to the 
elements during the previous years of allotment use. Therefore, we carried out simulations using a 
long-term exposure frequency of 3650 days (10 years) for all the participants. A participant’s 
monthly IRs for Pb were averaged to obtain a single IR value for chronic exposure simulations. 
Selected outputs from these simulations are presented as Fig. 7.3.  
 
 
 
 
 
 
 
 
The model predicted steady-state blood Pb levels after continuous consumption of allotment 
produce for between 3 to 4 years. The predicted blood concentrations were within the range of 
measured blood Pb concentrations.  
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Fig. 7.3: Predicted blood Pb concentrations for participants P01 and P15. 
The average IR values used were 50 µg day-1 (P01) and 45 µg day-1 (P15). Predicted blood Pb concentrations became 
steady at 9.4 µg dL-1 (P01) and at 8.6 µg dL-1 (P15) after approximately 1500 days (4 years) of continuous daily 
intake of PB at the specified IR values.  
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7.2.2 Exposure modelling using produce consumption rates in CLEA model 
The CLEA model provides consumption rates for allotment produce based on CLEA produce 
categories and age classes. Data for CLEA age class 17 – 18 (the relevant adult age group) were 
used to derive allotment produce consumption rates (g fw kg
-1
 bw day
-1
) of 0.5 and 3.34 for 
‘average’ and ‘high end’ produce consumers, respectively (Table 6.2). These produce consumption 
rates were multiplied by both the median bioaccessible Pb concentration (mg kg
-1
) recorded in 
produce at a given site and the participant body weight (kg bw) to determine the daily intake rate 
(µg day
-1
) of Pb. The CLEA default exposure frequency for allotment land use (365 days year
-1
) 
was adopted. The predicted blood Pb levels simulated using produce consumption rates for CLEA 
and for individual participants were compared, as illustrated in Fig. 7.4.  
 
 
 
 
 
 
 
 
 
 
In this example (Fig. 7.4), daily Pb intake rates of 50 µg day
-1
 (P01) and 45 µg day
-1
 (P15) for 1 
year would result in maximum blood Pb levels of 7.0 µg dL
-1
 and 6.5 µg dL
-1
, respectively. 
Predicted blood Pb levels using participants’ produce consumption rates were below the blood Pb 
levels predicted using CLEA ‘high end’ consumer’s produce consumption rate. This is consistent 
with the calculated participants’ produce consumption rates summarised in Appendix E (part E3), 
which indicates none of the participants’ averaged produce consumption rates exceeding the 
calculated consumption rate for a CLEA ‘high end’ consumer of 3.34 (g fw kg-1 bw day-1).  
 
 
Fig. 7.4: Plots showing predicted blood Pb concentrations for participants P01 and P15 using produce 
consumption rates used in the CLEA model. 
The calculated daily Pb intake rates (µg day-1) for P01 were 11 (average) and 73 (high end), while those for P15 were 13 
(average) and 87 (high end). Exposure frequency of 365 days was simulated. Predicted blood Pb levels based on 
participant-specific produce consumption rates are also indicated.  
P01 P15 
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7.2.3 Exposure modelling of hypothetical scenarios 
To demonstrate the application of the PBPK model for Pb in estimating blood Pb levels following 
oral ingestion of Pb, model simulations were carried out using hypothetical exposure scenarios as 
presented in Table 7.1.  
Table 7.1: Simulated blood Pb concentrations using hypothetical exposure scenarios 
Scenario 
No. 
Pb dietary 
exposure  
(µg kg
-1
 bw day
-1
)
a
 
Pb intake rate 
(µg day
-1
)
b
 
Hypothetical 
Exposure 
Frequency 
(days) 
Predicted maximum 
blood Pb concentration 
(µg dL
-1
) 
1 0.36 25 7 0.9 
2 2.43 170 7 4.4 
3 0.36 25 30 1.7 
4 2.43 170 30 7.0 
5 0.36 25 180 2.9 
6 2.43 170 180 10.8 
7 0.36 25 365 3.6 
8 2.43 170 365 12.6 
9 0.36 25 3650 4.7 
10 2.43 170 3650 16.8 
aWe used minimum and maximum values given by EFSA (2010) for adult consumers in European countries. 
bObtained by multiplying the dietary exposure with adult body weight of 70kg (assumed for all simulations).  
 
From Table 7.1, it is unlikely that an adult (of 70 kg body weight) with a Pb dietary exposure of 
0.36 µg kg
-1
 bw day
-1
 would have corresponding blood Pb levels above the 5 µg dL
-1
 CDC action 
level used in the generation of pC4SL for Pb (CL:AIRE, 2014), even after nearly 10 years of 
exposure. However, blood Pb levels for adults with higher Pb dietary exposure (2.43 µg kg
-1
 bw 
day
-1
) are likely to exceed the CDC action level within 1 month of continuous exposure to Pb. It is 
important to note here that the 5 µg dL
-1
 CDC action level relates to children who are more 
sensitive than adults. In addition, actual dietary exposures are likely to be irregular and/or sporadic, 
especially for chronic exposures. Consequently, blood Pb levels could vary from those in Table 7.1.  
7.3 Simulation of urinary concentrations of As, Cd, Cr and Ni 
7.3.1 Exposure modelling using data from our study 
The PBPK model for As (Fig. 6.1) was used to predict the quantity of inorganic arsenic (iAs) in 
urine samples. Given the short half-life of As in humans (2 to 3 days) (ATSDR, 2007a), 
simulations were carried out using data collected over the 2 to 3 consecutive days from selected 
participants (as previously described in section 3.5). The quantities of iAs ingested by the 
participants were calculated using the records of produce they consumed and the recorded As 
concentrations in produce samples (adjusted with bioaccessibility fractions) (Appendix E, part E5). 
The calculated quantities of iAs ingested by each participant varied with time.  
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Previously, we identified that the most sensitive parameters of the PBPK model for As include the 
rate of oral absorption in the GI tract (Ka), methylation constants in the kidney (Km and Vmax) for the 
various As species, and the urinary elimination rate (eU) (Fig. 6.11). During the simulations, these 
parameters were maintained at the default values (Appendix I, Table I1).  
The model predicts urinary iAs (sum of inorganic As, MMA and DMA) in µmol. Therefore, to 
enable comparison of predicted urinary iAs with the measured iAs in urine samples, we converted 
the measured concentrations of iAs in urine samples to µmol iAs (on a daily basis) in the following 
manner:  
a) Urine concentrations of iAs were converted from µg g-1 creatinine to µmol mol-1 creatinine 
by multiplying the concentrations by 1.5. The value 1.5 is the ratio of creatinine molecular 
weight (113 g mol
-1
) to arsenic molecular weight (75 g mol
-1
).  
b) Measured creatinine concentrations were converted from g L-1 to mol L-1 by dividing the 
concentrations by the molecular weight of creatinine.  
c) The urine concentrations in µmol mol-1 creatinine were multiplied by creatinine 
concentrations in mol L
-1
 to obtain iAs concentrations in µmol L
-1
. 
d) The quantity of iAs (µmol day-1) in urine samples were determined by multiplying urine 
concentrations (µmol L
-1
) by the average daily urine excretion rate for an adult of 1 L day
-1
 
(Ruiz et al., 2010).  
 
The predicted daily urinary iAs and the corresponding measured urinary iAs (≥ LOD) were 
compared as illustrated using the time series plots in Fig. 7.5, which shows the change of iAs in 
urine with time. We carried out similar simulations for the 13 participants who provided urine 
samples and produce consumption data over the period of 2-3 days; selected graphical 
representations of these simulations are included in Appendix J (part J2).  
 
 
 
 
 
 
 
Fig. 7.5: Comparison of measured and predicted iAs in urine of participants P05 and P09 with time. 
Simulated doses of iAs varied with time and ranged from 0.09 to 1.25 µmol (P05) and from 0.6 to 1.73 µmol (P09).  
P09 P05 
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From each simulation, values of predicted urinary iAs corresponding to the time-points of urine 
sampling were obtained. A linear regression analysis of all the predicted iAs in urine and the 
corresponding measured iAs in urine samples (Fig. 7.6) indicated a good correlation (r
2
 > 0.8) 
between the two datasets, with a low RMSE value of 0.003 µmol. These results indicate that the 
PBPK model for As is capable of simulating human exposure to As through oral ingestion, and 
predicts the biomonitoring data reasonably well.  
 
 
 
 
 
 
 
 
 
 
Simulations of oral exposure to Cd were carried out using the PBTK model for Cd (Fig. 6.3), based 
on the participants’ data on the consumption of allotment produce and the Cd concentrations 
recorded in produce samples. A participant’s daily IR values of Cd were calculated in the same 
manner as previously described for Pb in section 7.2.1. Subsequently, IR values were averaged to 
obtain a representative annual IR value, which was entered into the model as ‘dose’ to simulate 
chronic exposure to Cd based on the durations the participants have been using their plots 
(Appendix E, part E1). We simulated chronic exposure to Cd because of the long biological half-
life of Cd (e.g., 6 to 38 years in the kidney) (ATSDR, 2012a). In addition, the highest 
concentrations of absorbed Cd are reported to occur in the liver and kidney (ATSDR, 2012a); and 
Cd in the kidney is reflected in urinary levels (Keil et al., 2011). Our approach of simulating 
chronic exposure to Cd is consistent with similar studies by others (Fransson et al., 2014; 
Choudhury et al., 2001; Ruiz et al., 2010), where exposures to Cd were simulated for periods 
lasting decades. The most sensitive parameters for the Cd PBTK model (i.e., parameters denoted 
C5, C6, C7 and 1-C7 in Fig. 6.11 ) were maintained at the default values (Table I2 in Appendix I) 
Fig. 7.6: Relationship between the predicted iAs in urine and the corresponding measured iAs in 
urine samples.  
Predicted values were obtained from time points (in the time series plots) that match the urine sampling time-points. 
This plot was generated using 90% of the data points. The remaining data points (which include dilute urine samples 
that recorded creatinine concentrations below 0.3 g L-1) were excluded from the plot to improve the correlation.  
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when simulating exposure to male participants. However, for female participants, an oral 
absorption rate (C6) of 10 % (i.e., twice the male absorption rate) was assumed. This assumption is 
consistent with other studies (Ruiz et al., 2010; Choudhury et al., 2001; Diamond, Thayer & 
Choudhury, 2003), where it has been reported that females may absorb up to twice the amount 
absorbed by males, resulting in higher urinary Cd levels in females than males. The difference in 
Cd absorption between males and females has been linked to lower iron body stores in females 
compared to males; low iron stores have been associated with increased absorption of Cd in the GI 
tract (Choudhury et al., 2001; Berglund et al., 1994). The average daily urine excretion rate for an 
adult human of 1 L day
-1
 (Ruiz et al., 2010) was used to convert simulated Cd (µg) released daily in 
urine to Cd concentrations (µg L
-1
). The simulated urinary Cd concentrations were compared with 
the measured Cd concentrations (medians) in the corresponding participants’ urine samples. 
Exposure doses, exposure frequencies, the predicted urinary Cd and the medians of measured Cd 
concentrations in urine are summarised in Table 7.2 (detailed results from the simulations are 
included in Appendix J, part J3).  
Table 7.2: Ranges of doses, exposure frequencies and urinary Cd concentrations 
Calculated Cd 
doses (µg day
-1
)
a
 
Simulated exposure 
frequencies (years)
b
 
Predicted Cd in 
urine (µg L
-1
) 
Medians of measured 
Cd in urine (µg L
-1
)
c
 
1.4 – 10.4 0.2 – 30  0.002 – 0.12 0.02 – 0.17 
aDoses were calculated for 34 participants where Cd concentrations in produce were available.  
bBased on the reported number of years a participant has been using their allotment.  
cFor urinary concentrations ≥LOD.  
 
Linear regression analysis (Fig. 7.7) indicated a reasonable fit (r
2
 > 0.8) between the predicted and 
measured urinary Cd, with a RMSE value of 0.02 µg L
-1
. Thus, the PBTK model for Cd has 
performed well in predicting our biomonitoring data.  
 
 
 
 
 
 
 
 
Fig. 7.7: Relationship between predicted Cd in urine and medians of measured Cd 
concentrations in urine for 34 participants. 
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Our findings are similar to those observed by Ju et al. (2012), who used a modified version of the 
KN model for Cd to predict urinary levels of Cd following oral ingestion of Cd from seafood 
consumption by male and female non-smoking subjects, for a period of 45 years. Using average 
daily Cd intake rates of about 7.5 µg day
-1
 (male) and 6.9 µg day
-1
 (female), they predicted mean 
urinary Cd levels (expressed in µg g
-1
 creatinine) of 0.09 – 0.34 (female) and 0.07 – 0.26 (male), 
when they adopted the oral bioaccessibility value (C5) for the original model (Ju et al., 2012). A 
study by Ruiz et al. (2010), which also used a modified version of the KN model for Cd to interpret 
NHANES biomonitoring data, indicated similar urinary Cd levels when they simulated low Cd 
intake rates between 13.5 and 22.4 µg day
-1
, depending on the age group of the subjects. The 
consistency of our simulation results with other published data supports our observation that our 
results are similar to those reported elsewhere.  
Oral exposures to Cr(III) were simulated using the PBPK model for Cr (Fig. 6.5). Given that Cr 
absorbed following Cr(III) ingestion has a half-life of less than 2 days (ATSDR, 2012b; 
Paustenbach et al., 1997), simulations were carried out using data collected during the 2 to 3 days 
sampling period (as described in section 3.5). The quantities of Cr(III) ingested by the 13 
participants were calculated using the record of produce they consumed during the 2 to 3 days, and 
the recorded Cr concentrations in produce samples (adjusted with bioaccessibility fractions) 
(Appendix E, part E5). The calculated quantities of Cr(III) ingested by each participant varied with 
time. In our simulations, we used a GI tract absorption rate (KGI3) of 0.25 day
-1
 for Cr(III) 
(O’Flaherty et al., 2001).  
The predicted daily urinary concentrations of Cr(III) were compared with the measured Cr 
concentrations (≥ LOD) in urine samples, as illustrated using time series plots in Fig. 7.8, which 
shows the change of Cr in urine with time. Selected plots of additional simulations are included in 
Appendix J (part J4). 
 
 
 
 
 
 
 
Fig. 7.8: The predicted and measured Cr(III) concentrations in urine for participants P05 and P15.  
The simulated doses of Cr(III) varied with time and ranged from 22 to 86 µg (P05) and from 45 to 89 µg (P15).  
P05 P15 
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Simulations were carried out for each of the 13 participants who provided urine samples and 
produce consumption data over the period of 2-3 days. From each simulation, values of predicted 
urinary Cr(III) concentrations corresponding to the time-points of urine sampling were obtained. 
Subsequently, all the predicted urinary Cr(III) data were plotted against the corresponding 
measured urinary concentrations (Fig. 7.9). Generally, both data sets correlated well (r
2
 = 0.7, p < 
0.05) with a low RMSE of 0.01 µg L
-1
 indicating the ability of the model to predict the 
biomonitoring data well.  
 
 
 
 
 
 
 
 
The oral intake of Ni was simulated using the Ni model (Fig. 6.9) and the data collected during the 
2 to 3 days period. Doses used in the simulations were calculated in the same manner as previously 
discussed for As and Cr (Appendix E, part E5). The calculated quantities of Ni ingested by each 
participant varied with time. Simulations were carried out for all the participants. Subsequently, the 
predicted daily urinary Ni concentrations were compared with the measured Ni concentrations (≥ 
LOD) in urine using time series plots as shown in Fig. 7.10. Selected plots of additional 
simulations are included in Appendix J (part J5).  
 
 
 
 
 
 
Fig. 7.9: Relationship between the predicted Cr(III) concentrations in urine and 
the corresponding measured Cr(III) in urine samples. 
P02 P05 
Fig. 7.10: Plots showing the predicted and measured Ni concentrations in urine for participants P02 and P05. 
Simulated doses of Ni varied with time and ranged from 16 to 94 µg (P02) and from 21 to 108 µg (P05).  
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Values of predicted urinary Ni concentrations corresponding to the time-points of urine sampling 
were obtained from each simulation. The predicted urinary Ni data were plotted against the 
corresponding measured urinary concentrations (Fig. 7.11). Both data sets correlated well (r
2
 = 
0.63, p < 0.05) with a low RMSE of 0.1 µg L
-1
 indicating the ability of the model to predict the 
biomonitoring data well.  
 
 
 
 
 
 
 
 
 
During the simulations of Ni concentrations, we used various values for the three most sensitive 
model parameters with SC > 0.5 (i.e., Agut, K1 and eU) (Fig. 6.11). The ranges used for these to fit 
our biomonitoring data are presented in Table 7.3. Other model parameters were kept at their 
default values (Appendix I, Table I5).  
Table 7.3: Range values for sensitive parameters with SC>0.5 used in Ni model simulations 
Model parameter  
(symbol, units) 
Range of values used in to fit model 
predictions with biomonitoring data 
Parameter value given 
in the literature 
Mass fraction of Ni absorbed 
from the gut (Agut, %) 
2 – 4 
0.7±0.4
a 
2.95±1.32
b
 
Alimentary absorption of Ni from 
ingested dose (K1, day
-1
) 
8 – 12 7.92±5.76a 
Urinary elimination rate of Ni 
(eU, day
-1
) 
4 – 6 3.6±2.64a 
a
Values used in the original Ni PBTK model published by Sunderman et al. (1989). 
b
Nielsen et al. (1999).  
 
7.3.2 Exposure modelling using produce consumption rates in CLEA model 
The models for As, Cd, Cr and Ni were used to estimate urinary levels of these elements based on 
the calculated ‘high end’ (maximum) produce consumption rate obtained from the CLEA model 
Fig. 7.11: Relationship between the predicted Ni concentrations in urine and 
the corresponding measured Ni concentrations in urine samples. 
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documentation (Table 6.2). Daily intake rates for the elements were calculated in the same manner 
as previously described in section 7.2.2. The CLEA default exposure frequency for allotment land 
use (365 days year
-1
) was adopted. The predicted cumulative elemental levels in urine were plotted 
against time as illustrated in Fig. 7.12. The gradient of the slope (0.56 µmol) indicates the amount 
of iAs released to urine on a daily basis, after approximately 17 days.  
 
 
 
 
 
 
 
 
Model outputs from selected simulations are presented in Table 7.4, which shows Cd, Cr and Ni 
concentrations similar to the measured concentrations in this study. However, predicted urinary iAs 
exceeded iAs levels from our biomonitoring study. This was the case with the simulations 
performed for other participants.  
Table 7.4: Selected model outputs from exposure simulations based on CLEA model data 
Element 
Participant 
ID 
Dose simulated
a 
(µg day
-1
) 
Predicted element levels released 
in urine (daily, steady state) 
iAs 
P16 47 (0.63 µmol) 42 µg (0.56 µmol) 
P32 58 (0.77 µmol) 51 µg (0.68 µmol) 
Cd 
P01 17 0.02 (µg L
-1
)
b
 
P07 33 0.04 (µg L
-1
)
b
 
Cr 
P04 108 1.9 (µg L
-1
)
b
 
P20 17 0.3 (µg L
-1
)
b
 
Ni 
P06 28 3.5 (µg L
-1
)
b
 
P38 57 4.7 (µg L
-1
)
b
 
a
Doses were calculated based on the ‘high end’ produce consumption rate from CLEA model, and 
not participant-specific produce consumption rates. Exposure frequency of 365 days per year. 
b
A daily urine excretion rate of 1 L day-1 (average for an adult) was used in calculating urinary 
concentrations.  
Fig. 7.12: Predicted cumulative iAs in urine for participant P16, based on ‘high-end’ produce 
consumption rate for the CLEA model.  
(A) Showing cumulative urinary iAs for 365 days. (B) Shows a gradual build-up of iAs released to urine until a 
steady state is reached after approximately 17 days.  
B A 
Steady state from 
approx. 17 days 
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Further predictions of urinary elemental levels were carried out using the maximum ADI values 
calculated for the elements based on the findings of this study (Table 4.3), for a ‘standard’ adult 
with a body weight of 70 kg and exposure frequency of 365 year
-1
 used in the CLEA model. The 
results are presented in Table 7.5.  
Table 7.5: Predicted element levels in urine based on maximum ADI from this study, for a ‘standard’ 
adult and exposure frequency under the CLEA model 
Element 
Maximum ADI
a
 
(from Table 4.3) 
(µg kg
-1
 bw day
-1
) 
 
Dose simulated
b 
(µg day
-1
) 
Predicted element levels 
released in urine daily 
(exposure for 365 days) 
iAs 0.29 20 (0.27 µmol) 18 µg (0.24 µmol) 
Cd 0.13 9 0.01 (µg L
-1
)
b
 
Cr 0.87 61 1.1 (µg L
-1
)
b
 
Ni 1.7 120 7.2 (µg L
-1
)
b
 
a
ADI (average daily intake). 
b
Doses were calculated by multiplying ADI by the average adult weight of 70 kg.  
c
A daily urine excretion rate of 1 L day-1 (average for an adult) was used in calculating urinary 
concentrations.  
The predicted urinary levels for iAs, Cd, Cr and Ni (Table 7.5) are well below the WHO guideline 
values in Table 5.3. Although the simulations have considered a constant daily rate of exposure to 
the elements, any variations in the rates of exposure throughout the year would result in variable 
urinary levels different from those given in Table 7.5.  
7.3.3 Exposure modelling to estimate conservativeness of GAC values 
The conservativeness of the current GAC values used in contaminated land risk assessment was 
identified earlier in Chapter 2 as a knowledge gap, which this study sought to address. Therefore, it 
was necessary to quantify the magnitude of over-estimation of exposure that would result from the 
use of the GAC values. In order to do this, the modified models were used to predict biomarker 
(urine) concentrations of the elements following oral exposure at the intake rates and exposure 
frequencies used in the generation of the GAC values. A 365 days year
-1
 exposure frequency was 
used for iAs, Cr and Ni, while Cd was simulated based on 50 years exposure (Nathanail et al., 
2015). Subsequently, the predicted urine concentrations were compared with WHO biological limit 
values which indicate the permissible concentrations for occupationally exposed workers (WHO, 
1996). In addition, the predicted urine concentrations were compared with reference values for a 
non-occupationally exposed population in the UK. Exposure to environmental chemicals in the 
general population can vary over time, therefore recent biomonitoring data were used as reference 
values. In addition, NHANES data for iAs was used a reference value since no data was obtained 
for iAs from studies carried out in the non-occupationally exposed populations in the UK. 
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Note that reference values are not limit values, but instead they indicate element levels in urine of 
the general population studied. To allow comparison of the predicted urine concentrations with 
WHO biological limit values and the reference values, a urinary creatinine concentration of 1 g L
-1
 
was assumed (this is similar to the median of urinary creatinine recorded in this study). Table 7.6 
shows the element intake rates used in the simulations, the predicted urinary levels and the 
calculated ratios between the predicted urine levels, WHO limit values and reference values.  
Table 7.6: Estimates of conservativeness of GAC values 
Element 
Oral TDI / 
ID  
(µg kg
-1
bw 
day
-1
) 
Oral MDI, 
calculated for a 
70kg adult or 
published value 
(µg day
-1
) 
Predicted 
urinary 
levels
a,e
 
(A) 
Reference 
Values
f
 
(95
th
 
percentile) 
(B) 
Ratio 
of B/A 
WHO 
biological 
limit 
values
b
 
(C) 
Ratio 
of C/A 
iAs 0.30
c
 21 (0.28 µmol) 
19 µg  
(0.25 µmol) 
14.8 
(17.7)
g
 
N/A 50 N/A 
Cd 0.54
c
 38 0.8 0.52 (0.6)
h
 0.75 5 6 
Cr(III) 150
d
 
60.2 
(published value)
d
 
1.1 0.79 (2.9)
h
 2.6 30 27 
Cr(VI)
i
 0.44
c
 31 1.4 0.79 (2.9)
h
 2.1 30 21 
Ni 12
d
 
134 
(published value)
d
 
7.7 
6.35 
(10.7)
h
 
1.4 30 4 
TDI (tolerable daily intake), MDI (mean daily intake), ID (index dose, used for iAs which is a non-threshold 
substance), N/A (not calculated because iAs is a non-threshold substance). 
a
For creatinine correction of urinary concentrations, we assumed a creatinine concentration of 1 g L-1.
 
b
Units in ug g-1 creatinine.  
c
(CL:AIRE, 2014). 
d
(Nathanail et al., 2015). 
e
Units in ug L-1 (same values in ug g-1 creatinine since a creatinine concentration of 1 g L-1 was assumed). A daily 
urine excretion rate of 1 L day-1 was also assumed.  
f
Units in ug L-1 (ug g-1 creatinine). Creatinine corrected values were used in ratio calculations.  
g
NHANES data from the Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, 
January 2017, Volume One (CDC, 2017).  
h
A recent UK study on a non-occupationally exposed population (Morton et al., 2014).  
i
Cr(VI) is transformed in the body and excreted in urine as Cr(III).  
 
Looking at the ratios of the reference values to the predicted urinary levels (ratio of B/A in Table 
7.6), the predicted urine concentrations are generally consistent with the reference values for a non-
occupationally exposed population in the UK; even though the model suggests that an individual 
would need to ingest approximately twice the simulated Cr intake to result in Cr urine 
concentrations at the same level as the reference value used. The predicted iAs in urine is similar to 
the NHANES data used as a reference value. Given that iAs is a non-threshold substance 
(Environment Agency, 2009d), the ratios between the predicted iAs urine level, WHO limit value 
and the reference value were not calculated.  
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The ratios of the WHO biological limit values to the predicted urine concentrations (ratio of C/A in 
in Table 7.6), indicate the extent of conservativeness of the GAC values, assuming that other 
sources of exposure (e.g., inhalation) are negligible. Therefore, an individual who ingests the 
elements at similar intake rates used in deriving the GAC values would need to ingest additional 
multiples of the intake (6 for Cd, 27 for Cr(III), 21 for (Cr(VI) and 4 for Ni) to result in urinary 
levels similar to the WHO limit values. It is important to reiterate that the calculated ratios (hence 
the estimated conservativeness of GACs) are based on the assumptions used in the calculation of 
predicted urine concentrations and the subsequent creatinine correction of the urine concentrations.  
7.4 Estimation of relative bioavailability values 
As previously identified in Chapter 2, bioaccessibility and bioavailability values influence the 
absorption of ingested substances in the human body. Bioaccessibility values of an element in the 
ingested medium can be estimated using in-vitro measurements. Although bioavailability values 
can be derived from in-vivo studies, PBPK / PBTK models can also be used to estimate absorption / 
uptake of the elements, which is the product of parameters FA x FH in Eq. (2.5). Therefore in this 
section, we illustrate how the models can be used to derive relative bioavailability values that can 
be entered into the CLEA model during the risk assessment process.  
The median of bioaccessibility values reported in produce samples were used to represent 
parameter FB in Eq. (2.5). Values of absolute bioavailability (ABAtox) of the elements in the media 
(i.e., drinking water) used in the derivation of the toxicological criteria for the elements were either 
obtained from the literature or assumed. For each element, a hypothetical dose of 10 µg (10 µmol 
for iAs) was simulated. The estimated relative bioavailability (RBA) values are presented in Table 
7.7. It should be noted that RBA values are site-specific because their calculation involves 
bioaccessibility values that are measured on a site-specific basis. The calculated RBA values relate 
to adults because of the adult models used in the simulations. Children often have higher oral 
absorption values which would result in higher RBA values.  
It can be seen in Table 7.7 that the estimated RBA for iAs is approximately equal to the 
bioaccessibility value for iAs, because both the uptake and the absolute bioavailability of iAs are 
approximately the same. The absolute bioavailability of Pb in water assumed by USEPA (i.e., 50 
%) was used in calculating the relative bioavailability of Pb. However, it is important to note that 
Pb bioavailability is dependent on the physical and chemical form of Pd in diet, the quantity of 
ingested Pb, and therefore the value assumed by USEPA may not be appropriate for all cases 
(Juhasz et al., 2009; ATSDR, 2007b). 
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Table 7.7: Estimated relative bioavailability values 
Element 
Median of 
bioaccessibility 
values in 
produce 
(FB) 
Uptake  
(fraction of dose) 
(FA*FH) 
Absolute 
bioavailability in 
media used to derive 
toxicological limit  
(ABAtox) 
Relative 
bioavailability 
(RBA)  
(FB*FA*FH) / ABAtox 
iAs 0.4 0.9 0.95
a
 0.38 
Cd 0.17 0.025 0.42
b
 0.01 
Cr 0.35 0.017 0.03
c
 0.2 
Ni 0.35 0.04 0.44
d
 0.03 
Pb 0.45 0.1 0.5
e
 0.1 
a
Absorption of soluble As in drinking water is approximately 95% (ATSDR, 2007a). Index dose for arsenic 
is based on drinking water guideline.  
b
Assumed value, for fraction of Cd dose in porridge retained in the body (ATSDR, 2012a). No data was 
obtained for absorption of soluble Cd in water.  
c
Absorption fraction of soluble Cr(III) (ATSDR, 2012b).  
d
Reported maximum absorption value for Ni ingested in water (Sunderman et al., 1989). The tolerable daily 
intake for nickel is based on deriving drinking water guidelines (Nathanail et al., 2015).  
e
Value assumed by USEPA was adopted (Casteel et al., 2006). Low level of toxicological concern is 
consistent with EU drinking water standard.  
FB is the oral bioaccessible fraction of an element in ingested produce. 
FA is the fraction of a solubilised element transported across the GI wall into systematic circulation. 
FH is the fraction absorbed that does not undergo first pass metabolism in the intestinal epithelium and/or the 
liver. 
ABAtox is the absolute element bioavailability in the media used in the toxicological studies (dimensionless).  
 
 
7.5 Chapter Summary 
Evaluation of the modified PBPK/PBTK models for Pb, Cd, Cd and Ni using biomonitoring data 
gathered as part of this study has indicated that the models are capable of predicting the 
biomonitoring data reasonably well. This supports our hypothesis ‘h3’ that “PBPK model predicted 
element concentrations in blood and urine are good indicators of the corresponding measured 
biomarker concentrations”. Therefore, revision of the model parameters was not considered 
necessary. However, during the evaluation process, attention was paid to the most sensitive model 
parameters and where appropriate, a range of parameter values (which fit with the range of data 
given in the literature) were used to improve the fit between the predicted and the corresponding 
measured data. The models were also used to predict elemental levels in biological samples, based 
on exposure scenarios depicting the CLEA model and hypothetical conditions. By simulating oral 
MDI values used in deriving GAC values for the elements, the conservativeness of GAC values 
(for Cd, Cr and Ni) were estimated to range from multiples of 4 to 27, based on the WHO 
biological limit values. Estimates of relative bioavailability of the elements have also been derived 
using data from model simulations.  
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8. FURTHER DISCUSSION, CONCLUSIONS AND 
RECOMMENDATIONS 
8.1 Introduction 
This concluding chapter draws together the research findings, highlights the contribution to 
knowledge arising from this research and the importance of the findings to the contaminated land 
industry. Key conclusions are given and recommendations for further work are outlined.  
8.2 Further discussion  
8.2.1 Key findings  
This study identified widespread elevated Pb concentrations in allotment soil, consistent with soil 
concentrations previously recorded in UK soils (Prasad & Nazareth, 2000). Apart from As which 
had elevated concentrations at one allotment site, Cd, Cr and Ni did not record soil concentrations 
above their GAC values. Similarly, the concentrations of Pb were generally highest in allotment 
produce samples, compared to other elements. The results of a physiologically-based extraction test 
indicated that the bioaccessibility values of these elements in soil and produce were considerably 
less than 100%, indicating that the risk associated with potential ingestion of these elements 
through soil or allotment produce could be exaggerated if total element concentrations (that 
assumes 100% bioaccessibility) are used in risk assessment models. For the allotment land use, the 
dominant exposure pathway through which humans get exposed to soil contaminants is the 
consumption of allotment produce. It has been reported that some individuals adopt 
gardens/allotments as a way to provide fresh produce and save on food costs (Sipter et al., 2008). A 
site-specific risk assessment carried out using participants’ produce consumption data did not 
identify a significant concern to human health. This finding is beneficial to the use of allotments by 
encouraging the use of allotments (and urban gardens in general), considering that occurrences of 
elevated Pb and As concentrations above their corresponding GAC values were recorded in some 
allotments. In other words, sites that would have potentially been ‘condemned’ as ‘contaminated’ 
did not result in significant concern to human health. This highlights the importance of carrying out 
site-specific risk assessment where possible site contamination has been identified.  
Regarding the biomonitoring results, blood Pb levels recorded in this study were higher than 
previously reported in a health survey conducted in England (Morton et al., 2009). (i.e., recorded 
median concentration of 9.2 µg dL
-1
 is approximately 3 times the values recorded in the English 
health survey of 1995). Although published studies reporting blood Pb levels in Scottish 
populations indicated higher values than those from the English health survey, one Scottish study 
(Macintyre et al., 1998) indicated a declining trend of blood Pb levels between 1983 and 1993 in 
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the population studied. Blood Pb levels from our study were consistent with those recorded in a 
control population for a study carried out in southern Scotland in 1989 (Moffat, 1989). No recently 
published data on blood Pb levels in non-occupationally exposed UK population was available, 
because in the UK, biomonitoring of blood Pb is not routinely carried out in the non-occupationally 
exposed populations. Due to the scarcity of published data on blood Pb levels in non-
occupationally exposed UK population, blood Pb levels from this study contributes to literature 
data that can be used for comparison with other similar studies. From the review of the limited 
published data on blood Pb levels in non-occupationally exposed populations in the UK, it is 
possible that background levels of Pb in central Scotland have been higher than other parts of the 
UK. Further survey of blood Pb levels would be beneficial in giving a clearer picture of blood Pb 
levels in non-occupationally exposed population in Scotland.  
Statistical analysis did not indicate significant associations between blood Pb concentrations and 
participant’s age, gender, smoking status and produce consumption rate; which indicate that the 
participants were not exposed to Pb at statistically significant levels above the local background 
levels. With regards to the produce consumption pathway, the consistency of recorded blood Pb 
levels with previously published blood Pb data in Scotland suggests that consumption of allotment 
produce did not result in blood Pb levels that were significantly different from the local background 
levels. Pb isotope analysis indicated that both geogenic and anthropogenic sources of Pb 
contributed to Pb in blood, with a higher proportion from geogenic sources. The recorded element 
concentrations in urine were similar to the published urine concentrations for the general (non-
occupationally exposed UK populations). Again, this indicates that participants’ consumption of 
allotment produce did not result in them having significant additional exposure to the elements.  
Physiologically-based kinetic models were produced using existing models and the accompanying 
model parameters published in the literature by modifying and/or simplifying the existing models 
while maintaining their predictive ability. The predictive ability of the models was evaluated using 
data published in the literature. The models reproduced the literature data well (within ±17%, apart 
from one dataset from Pb simulations with +38%). We have demonstrated how the models were 
used to inform and optimise the design of our biomonitoring study, by simulating low oral doses of 
the elements and predicting optimal sampling times that would allow element concentrations in 
biological samples to be detected during laboratory analysis. This indicates that the models could 
be used in the planning of other similar longitudinal studies. Evaluation of the models using 
biomonitoring data gathered from this study indicated that the models are capable of predicting the 
biomonitoring data reasonably well (r
2
 > 0.6 with low RMSE values). Therefore, these evaluated 
models are useful tools in predicting uptake of the elements through oral ingestion, thus, improving 
our understanding of actual exposure to the elements. The models are adaptable since model 
parameters can be adjusted to reflect the exposure characteristics under consideration. The models 
were used to simulate oral ingestion of the elements under different exposure scenarios and to 
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estimate the conservativeness of the GAC values (for Cd, Cr and Ni) – given that the potential for 
the GAC values to over-estimate health risk was identified as a knowledge gap for this study. By 
comparing the predicted urinary concentrations with the WHO biological limit values, the 
conservativeness of GAC values were estimated to range from multiples of 4 (Ni) to 27 (Cr). How 
conservative GAC values are depends on the number of exposure sources used in their derivation. 
In most cases the health criteria values used in deriving GAC values take account of ingestion 
though drinking water and inhalation pathway. Here, the estimated extents of conservativeness of 
GAC values assume oral ingestion (e.g., through food intake) only. Both Pb and iAs are non-
threshold substances, and therefore the conservativeness of their GAC values was not estimated 
from model simulations. However, no significant concerns to human health were identified from 
sites that had elevated concentrations of As and Pb (up to approximately 2 times, and 13 times the 
corresponding pC4SL, respectively). We have demonstrated how the models can be used to 
estimate relative bioavailability values that can be entered into the CLEA model when carrying out 
a risk assessment.  
8.2.2 Industrial relevance of research findings and contribution to knowledge 
This study has produced and evaluated physiologically-based kinetic models that are capable of 
predicting uptake of the elements through oral ingestion, which increases our understanding of 
actual exposure to the elements and meets the aim of the study. Because of improved understanding 
of actual exposure to these elements, the models provide a platform for a more robust risk 
assessment, and thus, promote sustainable reuse of brownfield sites and the creation of sustainable 
built environments. This work opens a new chapter in detailed quantitative risk assessment 
(DQRA) of human health, where the models can be incorporated into site-specific risk assessment 
of contaminated land to predict internal exposure. In addition, there could be instances in exposure 
studies where biomonitoring may not be practical, for example due to ethical restrictions. In such 
instances the models can be used in lieu of biomonitoring to estimate exposure to the elements, 
thus, enabling such studies to be accomplished.  
For the IOM, the biomonitoring techniques used in this project provide in-house capability to 
conduct similar exposure studies. This project has also promoted the collaboration between the 
IOM and the University of Reading, creating an opportunity for future joint research.  
The use of physiologically-based kinetic models is not new in exposure studies. However based on 
the available literature, their application in simulating oral exposure to toxic elements in soil is 
limited. For example, the Integrated Exposure Uptake Biokinetic (IEUBK) model has been used to 
simulate exposure to Pb in children from a number of sources including soil (White et al., 1998). 
During the process of developing the pC4SL for Pb, the IEUBK model was used to investigate the 
relationship between Pb dose and the predicted blood Pb concentration in children (CL:AIRE, 
2014). Apart from the IEUBK model, no information was obtained describing the use of 
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physiologically-based models for As, Cd, Cr and Ni in the context of contaminated land exposure 
(e.g., in the generation of GAC values). Therefore, the models used in this study present a new 
extension of the existing use of physiologically-based kinetic models from other forms of exposure 
studies to contaminated land risk assessment.  
The study provides useful data that can be used for comparison with similar studies. In particular, 
due to the scarcity of published data on blood Pb levels in the non-occupationally exposed UK 
population, the blood Pb results from the present study presents an important contribution to the 
literature, especially in relation to a population that consume produce from their allotments.  
8.2.3 Limitations of this research 
Children are the critical receptors when conducting health risk assessment for allotment land use. 
Therefore, the use of children in this study would have been more appropriate than using adults. 
However children were not recruited to the study because of ethical reasons (i.e., complexity of 
obtaining ethical approval for using children in biomonitoring, collection of biological samples 
from children for a prolonged period could potentially expose children to harm), and because it 
would have been difficult to obtain parental consents. Due to the above limitation, physiologically-
based models for adults were used in this study. The models are adaptable and the model 
parameters can be changed. However, where the models are modified to simulate exposure to 
children, evaluation of the modified models should be done using data relevant to children to test 
the suitability of the models in predicting exposure to children.  
8.3 Conclusions 
Land contamination is a common problem associated with land regeneration and the built 
environment. Sources of land contamination include natural processes and anthropogenic activities 
such as past or present land uses. The generic assessment criteria (GAC) values currently used in 
contaminated land risk assessment are conservative – which although are protective of public 
health, they may result in over-estimation of human exposure to soil contaminants. Subsequently, 
this could lead to un-necessary remediation or restrictions on land use. This work sought to 
improve our understanding of the actual human exposure to selected toxic elements in soil in order 
to promote sustainable reuse of land. The occurrence of toxic elements is common in the urban 
environment, including urban allotments and gardens. Consequently, fruits and vegetables in 
contaminated allotment soil may result in human exposure to toxic elements through the 
consumption of home-grown produce.  
We investigated the potential risk to human health associated five common toxic elements (As, Cd, 
Cr, Pb, Ni) in selected allotments in Scotland. The concentrations of these elements were measured 
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in allotment soil and produce samples. 95% of soil Pb concentrations were elevated above the GAC 
value and locally elevated soil concentrations were observed for As and Cd.  
However, the bioaccessible concentrations of As and Cd were not elevated, but 60% of 
bioaccessible Pb concentrations were still elevated above the GAC (indicating a potential source of 
soil Pb exposure in most plots). Pb recorded the maximum concentration in allotment produce 
samples, followed sequentially by Cr, Ni, As, and Cd. There was no significant correlation between 
element concentrations in soil and produce samples, contrary to our hypothesis ‘h1’ that “there is a 
good correlation between element concentrations in allotment soil and the corresponding element 
concentrations in produce”. The bioaccessibility of the elements in allotment produce were 
considerably below 100%. The use of bioaccessibility concentrations in exposure estimations can 
give more realistic indications of the risk to human health, since they are estimates of the 
potentially soluble fractions in the human gastrointestinal tract. Based on the participants’ 
consumption of allotment produce records, no potential risk to the elements was identified (HQ<1 
for all elements). This emphasises the need for site-specific risk assessments rather than relying on 
generic assessments based solely on soil concentrations.  
To improve our understanding of actual exposure to these toxic elements, we used biomonitoring 
and human physiologically-based kinetic models to assess the levels of these elements in 
participants’ biological samples (biomarkers). Measured blood Pb levels were consistent with data 
published by previous studies carried out in central Scotland, but were higher than the levels 
previously reported in other parts of the UK. Urine concentrations were similar to the reference 
values obtained from studies carried out in non-occupationally exposed populations in the UK. 
Statistical analyses indicated that the participants were not exposed to these elements at significant 
levels compared to the published background levels, which supported out hypothesis ‘h2’ that “the 
levels of the elements in blood and urine samples obtained from the participants are similar to the 
local background levels”. Physiologically-based kinetic models were produced using existing 
models published in the literature. The models predicted well both the literature data and our 
biomonitoring data, thus supporting our hypothesis ‘h3’ that “PBPK model predicted element 
concentrations in blood and urine are good indicators of the corresponding measured biomarker 
concentrations”. The models were used to estimate the conservativeness of GAC values and 
relative bioavailability values for the elements. 
In conclusion, no significant health risk to the participants was identified from their use of 
allotment and consumption produce. Given the increasing demand for urban allotments in the UK, 
our findings will benefit the allotment community by encouraging the use of allotments. The 
models produced from this work promote robust risk assessment of contaminated land because of 
their capability to predict internal exposures well. By improving our understanding to human 
exposure, these models are important in the sustainable management of land contamination. To our 
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knowledge, it is the first time combined biomonitoring and physiologically-based modelling for the 
five toxic elements have been used to assess exposure to these elements among allotment users.  
8.4 Recommendations 
The following recommendations arose from the findings of this study:  
 The lack of recent published data on blood Pb levels for the general UK population points 
to the need for further research to obtain data on blood Pb levels among non-occupationally 
population, especially in Scotland where higher blood Pb levels have been recorded, 
compared to other parts of the UK.  
 The physiologically-based kinetic models used in this study present a foundation upon 
which further extension of the models can be based. Future work could extend the models 
to cover other land uses or soil contaminants.  
 Further work is recommended to use the models to create user-friendly modelling tools for 
the contaminated land industry, to be used as part of the DQRA process.  
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Appendix B: Sketches of the Original PBPK/PBTK Models 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. B1: A sketch of the PBPK model for As published by El-Masri & Kenyon (2008).  
The sketch is for one As species, El-Masri & Kenyon (2008) published four similar sketches that are interlinked, one 
for each As species. The model accommodates oral exposure to As(III), As(V), MMA(V) and DMA(V) as represented 
by block arrow to the gastrointestinal (GI) tract lumen (circle). Excretions of As species are shown by dark curved 
arrow for As(III), As(V), MMA(V) and DMA(V), and light curved arrows for MMA(III) and DMA(III). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. B2: A sketch of the kinetic model for Cd metabolism in human published by Kjellsröm & Nordberg 
(1978).  
‘A’ refers to inhalation pathway, ‘G’ refers to oral ingestion pathway, Cd transfer coefficients between compartments 
are shown next to the arrows connecting the compartments. 
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Fig. B3: Schematic representation of the PBPK model structure for Cr published by Kirman et al. (2013).  RBC 
is red blood cells, S is stomach, SI is small intestines, and LI is large intestines. All compartments contain Cr(VI), 
dotted arrows and the plasma compartments contain Cr(III) pools . S, SI, LI and dashed arrows depict Cr(III) in the 
distribution pool, the remaining compartments depict Cr(VI) in the storage/excretion pool.  
 
  
 126 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. B4: Schematic representation of the O’Flaherty PBPK model for Pb published by Fleming et al. (1999). 
RBCs refer to red blood cells. 
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Fig. B5: A schematic diagram of the compartmental model for Ni metabolism published by Sunderman et al. 
(1989). Kf is a pseudo zero-order rate constant for fractional absorption of dietary Ni; K01 is first-order rate constant for 
intestinal absorption of Ni from the oral dose of NiSO4; K12 is first-order rate constant for Ni transfer from serum to 
tissues; K21 is first-order rate constant for Ni transfer from tissues to serum; K10 is first-order rate constant for Ni 
excretion in urine. 
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Abstract: The human health risks from land contamination must be adequately addressed to ensure the 
sustainability of the built environment. This needs a clear understating of the potential human exposure 
pathways to soil contaminants. This paper presents the findings of the pilot phase of a study to investigate the 
potential magnitude of human exposure to selected toxic elements (As, Cd, Cr, Ni, Pb) from soils within urban 
allotments in the UK. Exposure pathways investigated include consumption of allotment produce (including 
contaminants in adhering soil), along with inadvertent ingestion and inhalation of outdoor allotment dust. 
Samples collected and analysed include allotment soil and plant produce, airborne allotment dust, hand moist-
wipes from allotment workers, and biological samples (urine and blood) from allotment users. Ethical approval 
for the study was granted by the University of Reading Research Ethics Committee.  
The recorded mean soil concentrations (mg kg
-1
) ranged between 8–94 (As), 1–2 (Cd), 81–93 (Cr), 222–760 
(Pb) and 45–69 (Ni). The corresponding bioaccessibility values were 53%, 51%, 8%, 22% and 57%, 
respectively; which indicate that the risk associated with potential soil ingestion could be exaggerated if 
bioaccessibility values are not factored in risk assessment models. Arsenic was found to have the highest soil-
to-plant transfer factor, indicating a greater potential for exposure through human diet. It was also observed 
that washing of allotment produce prior to preparation and consumption lowered the potential for human 
exposure to the metals in soil particles adhering to produce surfaces. In addition, inadvertent ingestion (hand-
to-mouth contact) could increase human exposure to soil contaminants. However, exposure via allotment dust 
inhalation was found to be negligible. No detectable metals were recorded in urine and blood samples, 
indicating negligible background/exposure levels for the participants monitored.  
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1 Introduction 
 
Land contamination is a common problem associated with land regeneration. Risk assessment of 
contaminated land involves identifying a source of contamination, exposure pathway and a receptor; land is 
considered contaminated where these three elements are linked [1]. A clear understanding of potential human 
exposure pathways to soil contaminants is crucial for a comprehensive risk assessment. However, current 
exposure models used in contaminated land risk assessment are highly conservative (precautionary) [2], 
making them prone to over-estimating exposure to soil contamination. This can have negative financial 
implications due to unnecessary remediation requirements or restrictions on land-use [3]. We are carrying out 
a study that seeks to improve our understanding of actual human exposure to soil contamination, which 
should help improve contaminated land risk assessment.  
Metal contamination is a common phenomenon in urban allotments and gardens, due to pollution from 
roads, general urban/industrial activities and actions of allotment tenants [4, 5, 6]. Exposure to metal 
contaminants such as lead (Pb), arsenic (As), cadmium (Cd), chromium (Cr) and nickel (Ni) can cause 
deleterious health effects in humans [7, 8]. For this reason, our study focuses on these toxic elements in 
allotment soils. This paper presents data obtained from a pilot study conducted between June 2014 and 
January 2015, which was aimed at testing the investigation’s methods and procedures.  
Five urban allotments in Edinburgh were identified for the pilot study. Adult (>18 years old) allotment 
users were recruited to participate in biological monitoring of potential exposure to these elements. Exposure 
pathways investigated included consumption of allotment produce (including contaminants in adhering soil), 
along with inadvertent ingestion and inhalation of outdoor allotment dust. Samples collected and analysed 
comprised allotment soil, allotment produce (fruits and vegetables), airborne allotment dust, hand moist-wipes 
from allotment workers and biological (urine and blood) samples from consenting allotment users. Ethical 
approval for the study was obtained from the University of Reading Research Ethics Committee.  
Increased understanding of human exposure to these elements will promote sustainable management of 
contaminated land, thus supporting sustainability of the built environment.  
 
2 Materials and Methods  
 
2.1 Site identification and recruitment of study participants 
Given that this pilot study was aimed at testing the investigation’s methods and procedures, no statistical 
emphasis was placed on sample size requirements and site selection. Between three and five sites were 
deemed adequate for the pilot study.  
Initial contact with allotment users was made through representatives of local allotment associations who 
were requested to distribute the study flyer to the members of the associations. Individuals who responded to 
the advert were contacted. Five allotment plots were identified and six adult users of these plots were 
successfully recruited to participate in the pilot study.  
 
2.2 Collection of samples and laboratory analyses 
Thirty soil samples were collected from the five allotments from hand-dug pits (maximum depth of 0.3 m) 
in June 2014. A portion of each sample (about 100 g) was oven dried overnight at about 100 
0
C. The dry 
samples were gently disintegrated by hand using a porcelain pestle and mortar to break-up aggregates, and 
then sieved to obtain fine (<63 µm) particles. Sample digestion of the fine particles was carried out in 
accordance with method 7300 provided by the National Institute of Occupational Safety and Health (NIOSH) 
[9]. Inductively coupled plasma atomic emission spectroscopy (ICP-AES) was used to determine total 
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concentrations of As, Cd, Cr, Ni and Pb in the digests. Selected sieved samples (3 per site) were subjected to 
bioaccessibility testing using the Unified BARGE Method (UBM) [10, 11].  
Allotment produce (38 samples) were collected in July 2014. Sample portions were washed using tap 
water to mimic the washing of fresh fruits and vegetables that would normally be carried out in the home. In 
addition, selected samples were divided into two parts prior to washing, to allow one part to be processed 
unwashed in order to investigate the metal content in soil particles adhering to produce surfaces. The samples 
were oven dried at approximately 60 
0
C for 48 hours. This was followed by grinding and homogenisation of the 
samples into fine particles. Samples were digested using NIOSH method 7300 and metal contents determined 
using ICP-AES.  
In September 2014, moist-wipe samples were collected from three participants using Ghost wipes (i.e., a 
sturdy wiping material moistened with deionised water) while doing allotment work. Hand moist-wipes were 
collected to investigate potential exposure to the metals through inadvertent ingestion, which mainly rises from 
hand-to-mouth contact [12]. 
Airborne allotment dust samples were collected using a body mounted dust sampler (an additional 
sampler was mounted on site concurrently). Air pumps were operated at the recommended sampling rate of 2 
L min
-1
 [13] and left to run for 1 to 2 hours (duration of work). Moist wipes and dust samples were analysed as 
per the allotment soil and produce procedure.  
The participants provided four rounds of urine samples between July 2014 and January 2015 (total of 24 
urine samples). Aliquots (1 mL) of urine samples were diluted using 5 mL concentrated nitric acid (HNO3) and 
subsequently analysed using ICP-AES. Venous blood samples (5 mL each) were collected from five 
consenting participants in January 2015. Aliquots (0.5 mL) of blood samples were digested in concentrated 
nitric and hydrochloric (HCl) acids and analysed using ICP-AES. The method employed in digesting blood 
samples was derived from the literature [13, 14, 15], modified and subsequently trialled and validated at the 
IOM laboratory using pig’s blood.  
 
2.3 Quality assurance 
To ensure the reliability of the test results, appropriate quality assurance procedures and precautions 
were taken. Samples were carefully handled to avoid cross-contamination. Reagents used were of analytical 
grades. Blank determinations were used to apply corrections to the instrument readings. Repeat sample 
analysis and analysis of samples spiked with known concentrations were used to validate the analytical 
procedure. Validation of the UBM test procedure was undertaken using BGS guidance material 102 [16]. In 
addition, commercially certified reference materials (ClinChek Urine Control and BCR-636 Human Blood) were 
used to validate analytical procedures for urine and blood, respectively. Instrument readings were within ±20 
% of specified reference values and spiked sample concentrations [17]. ICP-AES was calibrated using known 
standards prior to sample analyses (r >0.99).  
 
3 Results and discussion 
 
3.1 Soil total concentrations and bioaccessibility fractions 
The preferential adherence of soil and dust particles to hands and fingers occurs in the particle size range 
0.5–65 µm [18]. Therefore, <63 µm soil particles were considered the most relevant for investigating the soil 
ingestion exposure pathway.  
The mean soil total concentrations (mg kg
-1
) ranged between 8–94 (As), 1–2 (Cd), 81–93 (Cr), 222–760 
(Pb) and 45–69 (Ni). Table 1 compares the soil concentrations of As, Cd and Ni with the current UK soil 
guideline values (SGVs) provided by the Environment Agency [19, 20, 21]. SGVs are used as initial screening 
criteria to identify sites with the potential to cause risk to humans.  
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Table 1: A comparison of the recorded soil concentrations with SGVs for allotment land use 
Metals 
Mean soil 
concentrations 
(mg kg
-1
) 
SGV 
(mg kg
-1
) 
Remarks 
As 8 – 94 43 SGV exceeded in site 3 
Cd 1 – 2 1.8 SGV exceeded marginally in sites 1, 2 and 4 
Ni 45 – 69 230 SGV not exceeded 
Note: SGVs are not presently available for Pb and Cr. 
 
Bioaccessibility test results gave mean bioaccessibility fractions of 53% (As), 51% (Cd), 8% (Cr), 22% 
(Pb) and 57% (Ni), which is a surrogate for the fractions of the metals that are soluble in the human 
gastrointestinal tract and potentially available for absorption [22, 23]. This indicates that the risk associated 
with potential soil ingestion could be exaggerated if soil total concentrations are adopted in risk assessment 
models. For example, all samples from one allotment (site 3) recorded total arsenic concentrations between 
80 and 122 mg kg
-1
; however only approximately 48% of the arsenic was found to be bioaccessible. This 
indicates that if the arsenic in soil were ingested, nearly half of the arsenic would not be soluble in the 
gastrointestinal tract and thus not potentially available for absorption.  
Following regression analysis, a positive correlation was observed between the soil total concentrations 
of As and Pb and the corresponding bioaccessible concentrations (p <0.001), as shown in Fig. 1 and 2. These 
linear correlations indicate that the bioaccessible As and Pb concentrations could be predicted from the 
measured total soil concentration. A study by Barsby et al. [24] also identified linear correlations (r > 0.7) 
between measured individual pseudo-total and the respective bioaccessible concentrations of a number of 
potentially toxic elements (PTEs) including As, Cd and Pb.  
 
 
 
 
 
 
 
 
 
Fig.1: Relationship between soil total and bioaccessible As concentrations 
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Fig.2: Relationship between soil total and bioaccessible Pb concentrations 
3.2 Metal concentrations recorded in allotment produce 
 
Table 2: Metal concentrations in allotment fruits and vegetables (mg kg
-1
) 
Metals 
Site 1 
(n=5) 
Site 2 
(n=4) 
Site 3 
(n=11) 
Site 4 
(n=12) 
Site 5 
(n=6) 
TF values 
(site averages) 
As 
2.4 - 6.2 
(3.8) 
2.5 - 3.6 
(3.2) 
n.d. - 4.3 n.d. - 1.2 n.d. - 1.1 0.027 - 0.266 
Cd n.d. n.d. n.d. n.d. n.d. n.d. 
Cr n.d. - 1.5 n.d. n.d. - 0.6 n.d. - 1.0 n.d. - 0.5 0.006 - 0.01 
Pb 
0.4 - 2.7 
(1.5) 
4.2 - 7.9 
(6.8) 
0.4 - 8.2 
(3.2) 
0.3 - 8.1 
(4.0) 
0.7 - 9.2 
(3.1) 
0.004 - 0.017 
Ni 
0.3 - 1.1 
(0.6) 
n.d. - 1.4 
0.7 - 5.1 
(2.6) 
0.6 - 3.4 
(1.4) 
0.4 - 2.1 
(1.2) 
0.012 - 0.038 
‘n.d.’ refers to non-detectable 
mean values (where calculated) are given in brackets 
 
The metal concentrations (mg kg
-1
) in allotment produce are in Table 2, along with the estimated soil-to-
plant transfer factors (TF). The TF values were calculated as follows [25]: 
𝑇𝐹 =  
𝐶𝑝𝑙𝑎𝑛𝑡
𝐶𝑡𝑜𝑡𝑎𝑙−𝑠𝑜𝑖𝑙
    (1) 
where Cplant is the metal concentration in the plant material (dry weight basis) and Ctotal-soil is the total 
concentration of the same metal in soil (dry weight basis) where the plant was grown. The higher the TF value 
the higher the potential accumulation by plants [22], suggesting a potential for increased exposure through 
human diet. According to USEPA [26], TF value is a major parameter in determining the risk of human 
exposure to metals in soils. A comparison of the estimated TF values with those in literature suggests that TF 
values could vary considerably. For instance, a study by Intawongse [27] recorded TF values varying between 
0.14–0.92 (Cd), 0.003–0.05 (Cr), 0.001–0.133 (Pb) and 0.03–0.22 (Ni) in lettuce, spinach, carrot and radish 
grown on soils spiked with inorganic salt solutions in a greenhouse. According to Wang et al. [28], soil 
conditions that affect phytoavailability of trace elements include soil pH, organic matter, cation exchange 
capacity and total soil concentration.  
Metal concentrations found in unwashed samples were compared to washed samples. Washing of 
allotment fruits and vegetables decreased the metal concentrations in the produce by between 3–32 % (As), 
16–63 % (Cr), 15–77 % (Ni) and 16–87 % (Pb). This indicates that metal contents associated with adhering 
soil and dust (from aerial depositions) provides a key exposure pathway. Therefore, washing allotment 
produce prior to preparation and consumption lowers the potential for human exposure to the metals in 
adhering soil/dust. For example, Fig. 3 shows a comparison of Pb concentrations measured in washed and 
unwashed samples from this study.  
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Fig.3: Comparison of Pb concentrations in washed and unwashed vegetable samples 
 
The washed and unwashed Pb concentrations in edible shoots (kale, broccoli and cabbage) demonstrate 
the effect of washing in removing aerial depositions. Likewise, washing edible roots (potato and beetroot) 
remove adhering soil particles, leading to a reduction in metal content of the produce. Similar observations 
have been reported in other studies [29, 30].  
 
3.3 Metal in hand moist-wipes and airborne allotment dust 
Detected metal weights (µg) in hand moist-wipes varied between 0.5–39.8 (As), 0.1–1.7 (Cd), 4.3–31.2 
(Cr), 9.7–141 (Pb) and 2.1–21.4 (Ni). These results indicate that hand-to-mouth contact could add to human 
exposure.  
In addition, airborne allotment dust samples were collected to investigate the dust inhalation exposure 
pathway. The dust samples recorded negligible metal concentrations (<0.001mg m
-3
). Based on approximate 
air inhalation rate of 0.84 m
-3
 per hour (for an adult aged 60–70 years old doing a light intensity activity) [31], 
this translates to an estimated metal inhalation rate of <0.00084 mg per hour of allotment activity. This 
suggests that exposure via inhalation of outdoor allotment dust is a negligible pathway for allotment land use.  
 
3.4 Urine and blood test results 
Non-detectable metal concentrations were recorded in urine and blood samples, which suggest negligible 
background / exposure levels for the participants monitored. Extensive biomonitoring for the second phase of 
the study, lasting 12 months, has begun.  
 
4 Conclusions 
 
A study is being carried out to improve our understanding of the actual human exposure to selected toxic 
elements (As, Cd, Cr, Pb and Ni) from allotment soils. This pilot phase of the study has indicated that the risk 
associated with potential soil ingestion could be exaggerated if soil total concentrations are adopted in risk 
assessment models without taking into account the corresponding bioaccessibility values. Arsenic was found 
to have the highest soil-to-plant transfer factor, indicating a greater potential for exposure through human diet. 
It was found that metals contained in soil/dust particles adhering to allotment produce could increase human 
exposure, since washing of allotment produce decreased the metal concentrations in the produce. In addition, 
it was found that inadvertent ingestion (hand-to-mouth contact) could increase human exposure. However, 
exposure via inhalation of outdoor allotment dust was negligible. Non-detectable metal concentrations 
recorded in urine and blood samples suggest negligible background / exposure levels for the participants 
monitored.  
The second phase of the study has begun. Thirty five volunteers have been recruited to take part in the 
study, scheduled to last for 12 months.  
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Research Project: The impact of contaminated land on human health 
Brief Initial Questionnaire (please complete as appropriate) 
1. How many allotments do you have?                              
 
2. Please provide below the location of the allotment(s) you have, and how long you have 
been using the allotment(s). 
Allotment location Duration of allotment use  
No of Years No. of Months 
   
   
 
3. Do you grow fruit/vegetables in the allotment(s)?  YES    NO  
4. Do you eat the fruit/vegetables grown in the allotment(s)?  YES   NO  
5. How do you cultivate the allotment(s)? 
Single digging  
Double digging   
No dig policy  
Other (indicate)  
6. Do you add fertilizer or imported materials to improve soil quality? 
Fertilizer type  
Imported material  
(details) 
 
 
Other (indicate)  
 
7. Do you know past usage of the site prior to the allotments (i.e., historical use)? 
 
 
8. Do you know the historical uses of the surrounding land? 
 
 
9. Is there any other information on how the allotment is used (please indicate)? 
 
10. Are there any adults in your household who would like to participate in the study? 
YES     if YES, please give name(s)      NO 
 
Participant ID: 
Site ID: 
(Allocated by Researcher) 
  
  
 
 
   
END – Thank you 
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 Participant Background Questionnaire  
INSTRUCTIONS 
 
1. For some questions there is a list of possible answers. Please choose your answer and 
put a tick in the box beside it.  
2. Some questions will ask you for a number, please enter this in the box. 
3. There are spaces in some questions for you to write your answer. 
4. Some questions are followed by instructions. Please follow these carefully.  
All information collected will be strictly confidential and no names or identifying 
information will be published in any report. 
 
 
Question 1: Personal Details & General Health (for identification purposes & provide 
data for modelling etc.) 
Date questionnaire is completed:  
a). Your name:  
b). Year of birth (e.g., 1960):  
c). Sex (please tick):       Male   Female 
d). How tall are you?  ft,  inches        or  cm 
e). What weight are you?  st,  lbs         or  kg 
f). Do you usually bite your nails? (please tick)   YES      NO 
g). Do you suffer from osteoporosis? (please tick)  YES   NO 
h). Do you have any illness for which you are taking medication? (please give details 
below)  
Illness Medication 
  
 
 
 
 
 
 
Participant ID No: 
(Allocated by researcher) 
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Question 2: Employment Details (to assess occupational exposure)  
a). Are you employed (full-time or part time)?   
YES (please go to question 2b)   NO (please go to question 3) 
b). Please provide employment details below. 
Occupation: 
Place or address where you typically work: 
 
 
Question 3: Allotment use (to assess exposure from allotment use) 
a). In the table below, please tell us the allotment produce you consume. 
Fruits and vegetables you 
consume at least once in a 
month 
AVERAGE consumption  
(number of portions / servings) (please tick) 
[1 adult portion is about 80grams#] 
 
1-3 
per 
month 
Once 
per 
week 
2-4 
per 
week 
5-6 
per 
week 
Once 
per 
day 
2-3 
per 
day 
Over 3 
per 
day 
Proportion from 
allotment (e.g. 
all, half, 25%) 
Potatoes         
Onions         
Leeks         
Broad beans         
Courgettes         
Peas         
Strawberries         
Raspberries         
Black/red/white currants         
Rhubarb         
Tomatoes         
Cabbage, Kale         
Lettuce          
Carrots         
(others, please list)         
         
         
         
         
  
 
 
  
Participant ID No: 
#Food Statistics Pocketbook 2013 – in year update (DEFRA, 2013) 
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c). Please provide the details of any soil improvers, pesticides or other chemicals that 
have been used at your allotment(s).  
 
 
 
 
 
 
 
 
 
 
 
 
d). Please indicate (tick) which month/months you typically work on allotment and also 
which month/months you typically eat allotment produce.  
Months you typically work on allotment Months you typically eat allotment produce 
January  May   September   January  May   September   
February  June  October  February  June  October  
March  July  November  March  July  November  
April  August  December  April  August  December  
 
e). Please indicate (tick) the typical duration and frequency of allotment visits you make in 
a month during summer (April – September) and winter (October – March) periods. 
Frequency per month (Summer) Duration per visit (Summer) 
Every day  Less than 30 minutes  
Several times a week  Between 30 minutes and 1 hour  
Once a week  Between 1 hour and 3 hours  
Two to three times a month  Between 3 to 6 hours   
Once a month or less  More than 6 hours  
Frequency per month (Winter) Duration per visit (Winter) 
Every day  Less than 30 minutes  
Several times a week  Between 30 minutes and 1 hour  
Once a week  Between 1 hour and 3 hours  
Two to three times a month  Between 3 to 6 hours   
Once a month or less  More than 6 hours  
  
Participant ID No: 
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Question 4: Personal Protective Equipment (PPE) and General Hygiene 
a). Please indicate (tick) the PPE you typically wear when working at the allotment(s). 
Personal Protective Equipment  Please tick 
Welly boots (foot protection)  
Hand gloves (hand protection)  
Apron/protective clothing   
Goggles (eye protection)  
Other (please specify)  
b). If you use PPE, where do you keep your gardening footwear and gloves? (please tick)  
At home   In allotment shed    
c). Do you wash your hands before eating on site (e.g. snacks/sandwich)? (please tick)  
Always  Sometimes   Never  When I remember to 
d). Do you wash your hands before leaving the allotment? (please tick)  
Always  Sometimes   Never  When I remember to 
e). Do you peel root and tuber vegetables before use? (please tick)  
Always  Sometimes   Never  When I remember to 
f). Do you wash ALL fruits and vegetables before use? (please tick)  
Always  Sometimes   Never  When I remember to 
 
Question 5: Lead Paint (exposure from domestic lead paint) 
a). Do you have lead paint in your home?     YES         NO         I don’t know 
Question 6: Tobacco Smoking (smoking related exposure) 
a). Have you ever been a smoker? (please tick)   YES     NO  
b). Do you currently smoke? (please tick)    YES     NO  
c). If YES to ‘a’/‘b’ above, please state the regular brand(s) smoked 
d). Do you currently live with a smoker? (please tick)   YES     NO  
e). If YES to ‘d’ above, does this person smoke inside the house?  YES     NO  
End of Questionnaire – Thank you for filling this questionnaire.  
    
    
    
  
    
Participant ID No: 
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Research Project: The impact of contaminated land on human health 
Diary / Log of allotment use 
 
 
 
 
  
Today’s Date: PART B – Allotment 
work 
PART C – Other activities PART D – Urine 
sampling 
PART A – Allotment produce 
consumed & approx. weight 
Duration spent at the 
allotment (Hr/Min) 
 
 
Did you touch 
allotment soil? 
YES               NO 
 
Did you wear gloves? 
YES               NO 
 
Did you wash your 
hands before leaving 
allotment? 
YES               NO 
If relevant, please indicate 
duration spent on these tasks 
If you have collected 
urine today, please 
give time of sampling 
 
Time: 
 
Within the last 3 days 
before providing your 
urine sample, did you 
eat seafood or rice? 
 
Seafood 
YES              NO 
 
White rice 
YES              NO 
 
Brown rice 
YES              NO 
Fruit/Veg. Eaten Weight  
(e.g., 50g) 
Activity Duration 
(Hr/Min) 
  Lead smelting   
  Auto repair  
  Radiator repair  
  Furniture 
refinishing 
 
  Construction 
(DIY,  painting) 
 
  Art restoration  
  Burning lead 
painted wood 
 
  Precious metal 
refining 
 
  Making pottery, 
ceramics 
 
Your Name:    
Participant No:    
INSTRUCTIONS:  
 Each log is divided into parts A to D.  
 Please complete a log for EACH DAY only when any of the parts A 
to D is applicable. 
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Research Project: The impact of contaminated land on human health 
2-3 Days Continuous Urine Sampling 
 
Please start recording allotment produce consumed 1 day before urine collection starts – 
and continue recording produce consumption throughout the sampling period.  
Allotment produce consumed & approx. weight Allotment work 
Date Time Fruit/Veg. Eaten  
Weight 
(e.g., 50g) 
 
Duration spent at the 
allotment in the past 24 
Hours before start of 
sampling (or during 
sampling) 
 
 
Did you touch allotment 
soil? 
YES               NO 
 
Did you wear gloves? 
YES               NO 
 
Did you wash your hands 
before leaving allotment? 
YES               NO 
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
Urine Samples  Seafood & Rice 
Sample No. Date of Sampling Time of Sampling Within the last 3 days before 
providing your urine sample 
(or during sampling), did you 
eat seafood or rice? 
 
Seafood 
YES              NO 
 
White rice 
YES              NO 
 
Brown rice 
YES              NO 
1   
2   
3   
4   
5   
6   
7   
8   
9   
10   
   
  
Your Name:    
Participant No:  
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Appendix E: Summary of Information Gathered from 
Participants 
Part E1: Participants’ details 
Participant 
ID 
Gender 
(Male / 
Female) 
Age 
(years) 
Body 
Weight 
(Kg) 
Declared 
Smoking status 
ID of 
allotment used 
by participant  
Duration participant 
has been using the 
allotment (years) 
P01 M 63 76 Non-smoker A01 20 
P02 F 59 67 Non-smoker A01 20 
P03 M 64 95 Non-smoker A03, A04 1 
P04 F 63 68 Non-smoker A03, A04 2.5 
P05 F 64 54 Non-smoker A05 20 
P06 M 64 83 Non-smoker A06 5 
P07 F 44 55 Non-smoker A07 2 
P08 F 30 65 Non-smoker A08 3 
P09 F 46 62 Ex-smoker A09 3.5 
P10 M 59 108 Ex-smoker A10 17 
P11 F 59 114 Non-smoker A10 17 
P12 M 67 85 Ex-smoker A12 20 
P13 F 68 65 Ex-smoker A12 20 
P15 M 59 98 Non-smoker A15 8 
P16 M 56 73 Smoker A16 4 
P17 M 55 90 Not declared A17 4 
P18 F 45 76 Non-smoker A18 2 
P19 M 80 100 Ex-smoker A19 20 
P20 M 63 80 Non-smoker A20 1.5 
P21 M 63 84 Ex-smoker A21 20 
P22 F 61 63 Ex-smoker A21 20 
P23 M 71 99 Ex-smoker A23 30 
P24 F 71 79 Non-smoker A23 30 
P25 M 55 89 Non-smoker A25, A26 19 
P26 F 66 68 Non-smoker A25, A26 19 
P27 M 58 77 Non-smoker A27 1.5 
P28 M 34 73 Non-smoker A28 0.2 
P29 M 56 89 Smoker A29 5 
P31 F 49 70
#
  Non-smoker A31 1 
P32 M 73 73 Non-smoker A32 6 
P33 F 54 53 Non-smoker A33 7 
P34 M 67 70 Non-smoker A34 17 
P35 F 73 43 Ex-smoker A34 17 
P36 M 55 82 Non-smoker A36 0.2 
P37 F 63 71 Ex-smoker A37 20.5 
P38 F 44 71 Ex-smoker A38 1.5 
P39 M 76 70
#
  Non-smoker A32 6 
Two participants (P14 and P30) dropped out of the study within the first month. 
#Body weight not declared by participant, average adult weight of 70kg was assumed.  
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Part E2: Frequency and the duration of visits to allotments 
 
 
Summer months
1
 Winter months
1
 
No. of 
Respondents 
(% of 
Participants) 
No. of 
Respondents 
(% of 
Participants) 
Frequency
2
 
Virtually everyday 5 14 Nil Nil 
Several times a week  26 70 6 16 
Once a week  1 3 14 38 
Two or three times a month 1 3 7 19 
Once a month or less 1 3 6 16 
Duration 
Less than 30 minutes Nil Nil 3 8 
Between 30 minutes and 1 hour 3 8 11 30 
Between 1 hour and 3 hours 24 65 18 49 
Between 3 hours and 6 hours 7 19 1 3 
More than 6 hours Nil Nil Nil Nil 
1
Summer (April to September), Winter (October to March).  
2
Based on terminology used in ‘Environment Agency (2009). Updated technical background to the CLEA model - 
Science Report: SC050021/SR3. Bristol: Environment Agency’. 
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Part E3: Participants’ consumption rates for allotment produce 
Calculation of consumption rate: The reported weights of all produce consumed in a given month 
were aggregated, and then divided by both the participant body weight (kg bw) and 30 days.  
Participant 
ID 
Consumption rate of produce (g fw kg-1 bw day-1) 
Summer months1 Winter months1 
Min Max Average 
Average (as % 
of CLEA data)2 
Min Max Average 
Average (as % 
of CLEA data)2 
P01 0.01 1.67 0.60 18 0.35 0.89 0.67 20 
P02 0.01 1.22 0.67 20 0.35 1.01 0.66 20 
P03 0.28 0.64 0.40 12 0.14 0.49 0.29 9 
P04 0.01 0.56 0.31 9 0.15 0.60 0.38 11 
P05 0.62 2.20 1.29 39 2.19 4.52 3.01 90 
P06 0.44 1.10 0.74 22 0.04 1.53 0.58 17 
P07 0.40 1.41 0.83 25 0.24 0.67 0.56 17 
P08 1.03 2.72 1.51 45 0.21 3.28 1.24 37 
P09 0.04 0.89 0.43 13 0.19 0.89 0.35 10 
P10 0.18 0.26 0.22 7 0.05 0.09 0.07 2 
P11 0.01 0.28 0.14 4 0.01 0.05 0.03 1 
P12 0.03 2.23 0.87 26 0.33 1.63 1.09 33 
P13 0.08 2.56 0.82 25 0.42 1.15 0.88 26 
P15 0.21 1.56 0.88 26 0.15 0.90 0.43 13 
P16 0.39 1.10 0.71 21 0.37 1.14 0.75 22 
P17 0.03 0.40 0.22 7 0.01 0.19 0.09 3 
P18 0.01 0.72 0.22 7 0.01 0.75 0.16 5 
P19 0.02 0.16 0.07 2 0.05 0.11 0.08 2 
P20 0.45 0.54 0.50 15 0.06 0.89 0.38 11 
P21 0.02 1.37 0.68 20 0.67 1.79 1.08 32 
P22 0.08 1.80 1.12 34 0.37 2.20 1.18 35 
P23 0.06 0.66 0.36 11 0.15 1.32 0.54 16 
P24 0.25 0.91 0.68 20 0.15 1.27 0.58 17 
P25 0.46 4.89 2.50 75 0.70 2.28 1.33 40 
P26 0.51 6.52 2.98 89 0.68 2.62 1.51 45 
P27 N/A 0.13
3
 N/A  N/A N/A N/A  
P28 0.05 1.32 0.61 18 0.61 2.79 1.87 56 
P29 0.23 1.68 0.84 25 0.05 0.62 0.30 9 
P31 0.19 0.81 0.37 11 0.01 0.23 0.07 2 
P32 0.32 2.01 0.94 28 0.25 1.03 0.63 19 
P33 0.47 1.63 0.94 28 0.04 1.81 0.58 17 
P34 0.11 3.91 1.39 42 N/A N/A N/A  
P35 0.06 1.52 0.69 21 N/A N/A N/A  
P36 0.24 1.22 0.77 23 0.28 0.30 0.29 9 
P37 N/A N/A N/A  0.02 0.21 0.09 3 
P38 0.07 1.27 0.42 13 0.07 0.56 0.23 7 
P39 N/A N/A N/A  0.21 1.01 0.53 16 
 fw (fresh weight), bw (body weight), N/A (not applicable). 
1
Summer (April to September), Winter (October to March).  
2
Produce consumption rate of 3.34 (g fw kg-1 bw day-1) for ‘high end’ consumer, calculated using CLEA data (see 
Table 6.2 in section 6.4 for details).  
3
P27 reported consumption data for one ‘summer’ month only.  
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Part E4: Summary of participants’ average daily intake (ADI) values of the elements 
 
Element 
Range of calculated average daily intake (ADI) values  
(mg kg
-1
 bw day
-1
)
$,#
 
Summer months
+
 Winter months
+
 
As 8.7x10
-7
 – 2.9x10-4 6.6x10-8 – 2.9x10-4 
Cd 1.2x10
-8
 – 1.2x10-4 1.2x10-8 – 1.3x10-4 
Cr 6.9x10
-8
 – 8.7x10-4 9.8x10-9 – 8.7x10-4 
Ni 5.3x10
-7
 – 1.7x10-3 7.6x10-8 – 1.4x10-3 
Pb 7.0x10
-8
 – 3.2x10-3 7.0x10-8 – 3.1x10-3 
$
For each moth, a constant daily ADI value was determined. ADI values were calculated using the 
expression: ADI = (Ʃ(Wp*Cp*BAF))/kg bw/30; where Wp is the aggregated weight (kg) of each produce 
type consumed in a month, Cp is the element concentration (mg kg-1) recorded in the produce samples 
and BAF is the corresponding bioaccessibility fraction. A sum was obtained for all produce types and 
divided by the participant body weight (kg) and 30 days in a month. Excludes extra data collected over 
the 2-3 consecutive days.  
#
Where the type of allotment produce consumed was not sampled or tested, plot-specific median element 
concentrations and bioaccessibility values were used in the calculations. However, where a median 
bioaccessibility value of an element was not calculated, we assumed 100% bioaccessibility values. 
+
Summer months (April to September), Winter months (October to March).  
 
Part E5: Calculated elemental intake rates for participants during 2-3 days 
Participant 
ID 
Range of calculated intake rates
$,#
 
iAs 
(µmol)
+
 
Cd  
(µg) 
Cr 
(µg) 
Pb 
(µg) 
Ni 
(µg) 
P01 0.34 – 0.77 9 – 18  52 – 94  58 – 106  50 – 95  
P02 0.35 – 0.77 1 – 17 26 – 69  60 – 108  16 – 94  
P05 0.09 – 1.25 1 – 5  22 – 86  6 – 107  21 – 108  
P09 0.60 – 1.73 3 – 12 42 – 72  32 – 110  15 – 102  
P10 0.10 – 0.44 4 – 8 72 – 80  9 – 12  83 – 100  
P11 0.10 – 0.44 3 – 7 70 – 85 8 – 12 80 – 100 
P12 0.09 – 1.52 3 – 10 45 – 86  22 – 95  32 – 155  
P13 0.35 – 1.20 2 – 11 28 – 58  12 – 66  17 – 105  
P15 0.17 – 2.50 8 – 15 45 – 89  70 – 96  49 – 176 
P21 0.10 – 0.98 8 – 23 25 – 92  40 – 80  22 – 157 
P22 0.10 – 0.88 6 – 23 25 – 86  40 – 86  21 – 148 
P25 0.01 – 1.64 4 – 11 11 – 83  3 – 56  23 – 193 
P26 0.05 – 1.46 3 – 19 48 – 68  59 – 61  24 – 180  
$
Doses were calculated using the expression: Dose = Wp*Cp*BAF; where Wp is the weight (g) of produce 
consumed at any time during the 2-3 days, Cp is the element concentration (µg/g) recorded in produce samples and 
BAF is the corresponding bioaccessibility fraction.  
#
Where the type of allotment produce consumed was not sampled or tested, plot-specific median element 
concentrations and bioaccessibility values were used in the calculations. However, where a median bioaccessibility 
value of an element was not calculated, we assumed 100% bioaccessibility values.  
+
Doses of iAs (µg) were converted to µmol by dividing the doses with the molecular weight of As (75 g mol-1).  
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Appendix F: Laboratory Analytical Methods 
Part F1: Total concentrations of As, Cd, Cr, Ni and Pb in samples (soil, produce, 
hand moist-wipes, allotment dust) 
Soil samples:  
A portion of each soil sample (about 100 g) was oven dried overnight at about 100 
0
C. The dry 
samples were gently disintegrated by hand using a porcelain pestle and mortar to break-up 
aggregates, and then sieved to obtain fine (<63 µm) particles, which were kept until analysis was 
carried out.  
On the day of analysis, small portions (weighing < 1 g) of the <63 µm soil particles were placed in 
glass beakers (25 mL), and were digested according to IOM’s internal Standard Operating 
Procedure (ICP-SOP2). This procedure is based on method 7300 provided by the National Institute 
of Occupational Safety and Health (NIOSH, 2003). In this method, ashing reagents comprise 
concentrated nitric acid (HNO3) and perchloric acid (HClO4), combined at a ratio of 4:1. We 
obtained acids of super purity quality from ROMIL
®
, UK.  
Outline of procedure:  
 Calibration standards (covering ‘blank’ to 20 mg/L analytical range) were prepared from 
stock standards. Dilution acid was made up using distilled water 4% HNO3 and 1% HClO4.  
 3 samples were spiked with known concentrations and included in each analysis batch to 
check recoveries. 2 blanks were also included with each analysis batch. 
 Ashing acid of (4:1) cHNO3:cHClO4 was prepared.  
 Samples were placed in beakers and 5 mL of ashing acid was added to samples, blanks and 
spikes. Beakers were covered with watch glasses and left at room temperature for 30 
minutes. 
 Samples were heated on hotplate at 120 0C until approximately 0.5 mL remained in the 
beaker. 
 Watch glasses were removed and rinsed into the beaker with distilled water. 
 Temperature was increased to 150 0C until approximately 0.5 mL remained in the beaker.  
 Sample solutions were transferred to 25 mL volumetric flasks and solutions made up to the 
25 mL mark using distilled water. Then, solutions were transferred to sterile tubes. 
Subsequently, sample solutions were analysed using inductively coupled plasma – atomic emission 
spectroscopy (ICP-AES) (Thermo Fisher Scientific
®
, UK).  
For each element, the minimum limit of detection (LOD) was 0.03 mg/kg. LOD was calculated as 
Mean of concentrations of blanks + 3*Standard Deviation of blanks (Armbruster & Pry, 2008). 
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The ranges of LODs (mg/kg) recorded for each element were: As (0.03 to 0.08), Cd (0.03 to 0.05), 
Cr (0.03 to 0.07), Ni (0.03 to 0.06) and Pb (0.03 to 0.09).  
Allotment produce samples:  
Randomly selected portions of allotment produce samples were processed for analysis, as outlined 
below: 
 Samples (especially leaves and tubers) were washed under running tap water to remove all 
visible traces of soil, which mimics normal food preparation in the kitchen.  
 Washed samples were allowed to drain off water before each sample was placed in 
aluminium sample dish. 
 Sample weight was recorded before being oven-dried at approximately 60 0C for at least 48 
hours (this temperature was sufficient to prevent burning of samples).  
 Dried samples were weighed to allow for moisture content determination.  
 Dried samples were ground and homogenised into fine particles using a pestle and mortar. 
Subsequently, processed samples were digested and analysed using ICP-AES in the same manner 
as soil samples. For each element, the minimum LOD was 0.01 mg/kg. Individual element LOD 
(mg/kg) ranges were: As (0.01 to 0.04), Cd (0.01 to 0.019), Cr (0.01 to 0.015), Ni (0.01 to 0.02) 
and Pb (0.01 to 0.05) 
Hand-moist wipes and allotment dust samples:  
The samples were digested and analysed using ICP-AES in the same manner as soil samples. For 
these pilot study samples, the minimum LODs for each element were 0.03µg (wipes) and 0.001 
mg/m
3
 (dust).  
Quality Assurance (QA) 
To ensure the results were reliable, the following QA measures were implemented:  
 Instrument calibration included 5 points, with correlation coefficients (r2 > 0.99) for each 
sample batch analysed.  
 Repeated sample analyses (after every 10 consecutive samples) were carried out to check 
for instrument drift, and variations from the original results were within 10%.  
 Recoveries of the elements in in spiked samples were within ±20% of the known/specified 
concentrations (Li et al., 2015).  
 Blanks and spikes were used to correct instrument readings.  
 Measured sample concentrations were restricted within the calibration range (up to 25% 
above the maximum calibration standard); samples above this limit would require dilution 
and re-analysis.  
 150 
 
 
  
 151 
Part F2: Bioaccessibility extraction test on soil and produce samples 
Soil and allotment produce samples were prepared for bioaccessibility testing using the Unified 
BARGE Method (UBM), to estimate the contaminant fraction that would be soluble in the human 
gastrointestinal tract and hence potentially available for absorption. The test procedure is illustrated 
in Figure F2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. F2: Schematic flow diagram of the UBM test procedure 
Sources: Wragg et al. (2009a); https://www.bgs.ac.uk/barge/ubm.html  
Digestive fluids (saliva, gastric fluid, duodenal fluid and bile) were prepared in the laboratory using 
synthetic enzymes combined with a range of inorganic and organic solutions, as described in the 
UBM procedure (Wragg et al., 2009a). The pH values were adjusted using NaOH (1 M) and HCl 
No 
Yes 
0.6g of sample 
Add 9.0mL of Saliva (S) 
(Shake by hand for 10 s) 
Check the pH 
1.2<pH<1.5 
Add 13.5mL of Gastric fluid (G) 
 Adjust the pH to 1.2±0.05 
 Mix, end-over-end  for 1hr at 370C 
Yes 
Add 27mL of 
duodenal fluid (D) 
 
 
Add 9mL of bile  
fluid (B) 
(adjust the pH to  
6.3±0.5) 
 
 
Mix, end-over-end 
for 4 hours at 370C 
 
 
Stop the gastro-
intestinal extraction 
(note the final pH) 
 
 
Centrifugation at 
4500 g (15 min) 
 
 
Add 1.0mL  
HNO3 (67%) 
 
Gastro-Intestinal 
samples 
Restart the 
test from the 
beginning 
Stop the gastric 
samples 
 
 
 
 
 
 
 
 
 
 
 
 
Centrifugation at 
4500 g (15 min) 
 
 
 
 
 
Add 0.5mL 
HNO3 (67%) 
 
 
Gastric samples 
Analysis 
(ICP-AES) 
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(37%). The LODs were similar to total element determination in soil and produce samples. For 
each element, bioaccessibility fractions (BAF %) were calculated as follows:  
 𝐵𝐴𝐹(%) =
𝐵𝑖𝑜𝑎𝑐𝑐𝑒𝑠𝑠𝑖𝑏𝑙𝑒 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑖𝑛 𝑠𝑎𝑚𝑝𝑙𝑒
𝑇𝑜𝑡𝑎𝑙 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑖𝑛 𝑠𝑎𝑚𝑝𝑙𝑒
× 100  
 
Quality Assurance (QA) 
To ensure the results were reliable, the following QA measures were implemented:  
 Standard soil material (BGS Guidance Material 102) (Wragg et al., 2009b) was used for 
quality control. Recovered element concentrations were within ±20% of the specified 
concentrations.  
 Blanks for saliva (S) and gastric fluid (G) were included in each sample batch. Blank 
concentrations were used to correct instrument readings.  
 Repeated sample analyses (after every 10 consecutive samples) were carried out to check 
for instrument drift, and variations from the original results were within 10%.  
 ICP-AES was calibrated prior to analysis of each sample batch.  
 
Part F3: Determination of total element concentrations in urine samples 
Element concentrations were determined in urine samples using the procedure outlined below. 
During the pilot study, the minimum LOD for each element was 0.03 mg/L (ICP-AES). During the 
main study, the LODs for each element  varied from 0.005 to 0.01 µg/L (ICP-MS); individual 
element LOD (µg/L) ranges were: As (0.005 to 0.01), Cd (0.005 to 0.007), Cr (0.005 to 0.008) and 
Ni (0.005 to 0.01).  
 Instrument calibration standards were prepared from stock standards.  
 Dilution acid solution (2 to 4 % HNO3) was made up using distilled water. 
 3 samples were spiked with known concentrations and included in each analysis batch to 
check recoveries.  
 Following homogenisation, aliquots of urine samples (1 mL) were pipetted into sterile 
tubes and diluted 10 fold using the dilution acid solution (except for the pilot study samples 
where samples were diluted using 5 mL of concentrated HNO3).  
 Samples were analysed using ICP-MS, but samples from the pilot study were analysed 
using ICP-AES.  
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Quality Assurance (QA) 
To ensure the results were reliable, the following QA measures were implemented:  
 A commercially certified reference material (CRM) for human urine (ClinChek-Control) 
was used for quality control. Recovered element concentrations were within ±20% of the 
specified CRM concentrations.  
 Blanks (dilution acid solution) were analysed in duplicates while spikes were analysed in 
triplicates, for correction of instrument readings.  
 Repeated sample analyses (after every 10 consecutive samples) were carried out to check 
for instrument drift, and variations from the original results were within 10%.  
 Rhodium (Rh) was used as an internal standard to check for instrument drift.  
 ICP-MS was calibrated prior to analysis of each sample batch.  
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Part F4: Determination of total Pb concentrations in blood samples 
There are a number of methods documented in the literature describing how metal concentrations 
can be determined in human blood (e.g., Heitland & Köster, 2006; Iarmarcovai et al., 2005; 
Olmedo et al., 2010). A number of methods were trialled and abandoned due to their poor 
performance. The procedure used in this study was derived and modified from a combination of 
methods in Goullé et al. (2005); Ikeda et al. (2011) and OSHA (2002). Factors considered in 
method selection comprised their reported performance (% recovery), ease of reproducibility, 
analytical instrument used and duration of sample preparation. Using ICP-AES, the procedure 
summarised below was trialled and evaluated using pig blood, which was obtained from a local 
abattoir. The sample was kept in a freezer at a temperature of approximately -20 
0
C. Portions of the 
frozen blood were removed and allowed to liquefy at room temperature, and aliquots (0.5 mL) of 
the blood were used in the analyses.  
 Sample aliquots (0.5 mL) were digested in 4 mL of concentrated nitric acid (cHNO3) and 
heated for about two hours on a hotplate until approximately 1mL of solution remained. 
 Samples were allowed to cool, and then 4 mL of concentrated hydrochloric acid (cHCl) 
was added.  
 The solution was warmed gently and swirled for 30 minutes, filtered and made up to 
desired volume (10 mL) in a conical flask using distilled water, and subjected to ICP-AES 
analysis.  
 Blank samples were analysed in duplicates while spiked samples were analysed in 
triplicates.  
 Calibration standards and quality control solutions were prepared using commercial 
standard solutions of known metal concentrations dissolved in a weak acid background 
solution comprising 4% HNO3, 16% HCl and distilled water (80%).  
For each sample batch, instrument calibration was carried out using standard solutions of known 
concentrations (between 0.001 and 5.0 mg/L). A positive linear correlation (r
2
 > 0.99) was obtained 
from each calibration, indicating a positive fit between the specified standard concentrations and 
instrument readings.  
Thirty-six pig blood samples were analysed in six separate batches. Samples spiked with known 
metal concentrations recorded recovery percentages ranging from 80% and 107%, which indicated 
that the procedure was consistent, reproducible, and fit within the generally accepted recovery of 
±20% of known concentrations.  
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Further evaluation of this procedure was carried out using a commercially certified reference 
material (CRM) BCR-636 for human blood. Nine CRM samples were analysed and the recovered 
Pb concentrations were within ±20% of the certified CRM concentration. Generally, ICP-AES has 
higher detection limits than ICP-MS, and therefore to improve element detection, blood samples 
from the main study phase were analysed using ICP-MS.  
For ICP-MS analysis, final sample solutions were made up in 2% HNO3 to conform to instrument 
conditions. Similarly, calibration standards (2.5 to 50 µg/L) and quality control solutions were 
made up in 2% HNO3 dilution acid solution. The LODs for Pb varied from 0.01 to 0.03 µg/L (ICP-
MS).  
Blood spot samples (from finger pricks) were also analysed using ICP-MS in the same manner as 
venous blood samples. EDTA solution (~5 mmol/L) was added to the filters to increase the 
recovery of Pb from the filters (Di Martino et al., 2004). The LODs varied from  0.003 to 0.006 
µg/L.  
 
Quality Assurance (QA) 
To ensure the results were reliable, the following QA measures were implemented:  
 A commercially certified reference material (CRM) for human blood (BCR-636) was used 
for quality control. Recovered element concentrations were within ±20% of the specified 
CRM concentrations.  
 Blanks were analysed in duplicates while spikes were analysed in triplicates, for correction 
of instrument readings.  
 Repeated sample analyses (after every 10 consecutive samples) were carried out to check 
for instrument drift, and variations from the original results were within 10%.  
 Rhodium (Rh) was used as an internal standard to check for instrument drift.  
 ICP-MS was calibrated prior to analysis of each sample batch.  
 
Part F5: Isotopic analysis (Pb) in soil, produce and blood samples 
Samples were prepared according to the procedures already described in the preceding part F1 (soil 
and produce) and part F4 (blood). The final sample solutions were made-up in 2% HNO3 solution 
in order to conform to ICP-MS operating conditions.  
Pb isotopes (206, 207, 208) were measured simultaneously using ICP-MS. For quality control, a 
high-purity Pb metal (NIST SRM 981) was used as a Pb isotope standard (Tanimizu & Ishikawa, 
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2006; Farmer et al., 2011). A prepared Pb isotope standard solution was obtained from the 
Department of Archaeology, University of Reading. The solution was prepared by dissolving 
approximately 0.1 g of the Pb metal in 1 M HNO3 to obtain a 100 mg/L stock solution, which was 
further diluted (in portions) with 2% HNO3 for regular use. The reagents were of analytical-grade 
quality.  
As part of the QA, blanks were analysed in duplicates. Isotope intensity readings from the blanks 
and standard solutions were used for correction of instrument readings. Repeated sample analyses 
were carried out to check for instrument drift, and variations from the original results were within 
10%.  
 
  
 157 
 
References 
Armbruster, D. A. & Pry, T. (2008). Limit of blank, limit of detection and limit of quantitation. 
Clinical Biochemist Reviews. 29(Suppl. 1), S49-S52.  
Di Martino, M. T., et al. (2004). EDTA is essential to recover lead from dried blood spots on filter 
paper. Clinica Chimica Acta, 350, 143-150.  
Goullé, J., et al. (2005). Metal and metalloid multi-elementary ICP-MS validation of whole-blood, 
plasma, urine and hair. Reference values. Forensic Science International, 153, 39-44.  
Farmer, J. G., et al. (2011). A lead isotopic study of the human bioaccessibility of lead in urban 
soils from Glasgow, Scotland. Science of the Total Environment, 409, 4958-4965.  
Heitland, P. & Köster, H. D. (2006). Biomonitoring of trace elements in blood samples from 
inhabitants of northern Germany by ICP-MS. Journal of Trace Elements in Medicine and 
Biology, 20, 253-262.  
Iarmarcovai, G., et al. (2005). Risk assessment of welders using analysis of eight metals by ICP-
MS in blood and urine and DNA damage evaluation by the comet and micronucleus assays; 
influence of XRCC1 and XRCC3 polymorphisms. Mutagenesis, 20(6), 425-432.   
Ikeda, M., et al. (2011). Cadmium, chromium, lead, manganese and nickel concentrations in blood 
of women in non-polluted areas of Japan, as determined by inductively coupled plasma sector 
field-mass spectrometry. International Archives of Occupational and Environmental Health , 
84, 139-150.   
Li, N. et al. (2015). Concentration and transportation of heavy metals in vegetables and risk 
assessment of human exposure to bioaccessible heavy metals in soil near a waste-incinerator 
site, South China. Science of the Total Environment, 521-522, 144-151.  
NIOSH (2003). Manual of Analytical Methods. Elements by ICP, Method 7300 (Nitric/Perchloric 
Acid Ashing). Available at: https://www.cdc.gov/niosh/docs/2003-154/pdfs/7300.pdf 
(Accessed 30 March 2017).  
Olmedo, P., et al. (2010). Validation of a method to quantify chromium, cadmium, manganese, 
nickel and lead in human whole blood, urine, saliva and hair samples by electrothermal atomic 
absorption spectrometry. Analytica Chimica Acta, 659, 60-67.  
OSHA (2002). Metal & metalloid particulates in workplace atmospheres (atomic absorption). 
Method Number: OSHA ID-121. Available at: 
https://www.osha.gov/dts/sltc/methods/inorganic/id121/id121.pdf (Accessed 30 March 2017).  
Tanimizu, M. & Ishikawa, T. (2006). Development of rapid and precise Pb isotope analytical 
techniques using MC-ICP-MS and new results for GSJ rock reference samples. Geochemical 
Journal, 40, 121-133.  
Wragg, J. et al. (2009a). Interlaboratory trial of a unified bioaccessibility procedure. British 
Geological Survey Open Report, OR/07/027.  
Wragg, J. et al. (2009b). Certificate of Analysis, BGS Guidance Material 102, Ironstone Soil. 
IR/09/006 version 1. British Geological Survey.  
 
 
  
 158 
Appendix G: Laboratory Test Results 
Part G1: Summary of soil test results 
 
Allotment 
plot ID 
N 
Range of total element concentrations (mg kg
-1
) 
As Cd Cr Ni Pb 
A01 7 8.1 – 10.3 <0.03 – 1.3 62.4 – 81.3 27.1 – 38.3 286.6 – 552.8 
A03 6 9.3 – 11.3 1.2 – 1.4 69.1 – 79.2  28.9 – 35.8 478.0 – 895.7 
A04 8 42.9 – 81.6 1.8 – 3.8 66.1 – 78.8 33.7 – 47.2 232.4 – 325.6  
A05 11 4.2 – 12.0  0.8 – 5.2  35.0 – 76.4 13.7 – 48.9 250.0 – 693.2 
A06 6 3.2 – 7.7 <0.03 63.2 – 74.2 20.7 – 25.9 100.5 – 296.8 
A07 8 7.9 – 11.4  <0.03 50.1 – 68.1 26.7 – 38.1 214.0 – 403.7 
A08 9 9.5 – 14.4 <0.03 – 0.7 63.7 – 84.7 30.2 – 43.6 219.7 – 340.0 
A09 8 10.7 – 17.1 0.9 – 1.7 54.2 – 84.4 21.3 – 39.0 83.5 – 123.6 
A10 9 8.1 – 10.3 1.4 – 2.8 46.6 – 57.0 28.0 – 33.7 141.1 – 164.9 
A12 8 8.1 – 10.5 0.9 – 1.3 49.3 – 60.1 22.2 – 29.8 98.9 – 125.6 
A15 8 6.8 – 10.2 <0.03 – 1.0 53.4 – 88.7 24.3 – 42.7 251.1 – 452.7 
A16 7 5.9 – 9.7 <0.03 64.5 – 79.1 16.2 – 20.9 234.8 – 518.3 
A17 14 2.2 – 10.1 <0.03 – 1.4 48.7 – 99.4 13.3 – 27.7 46.4 – 237.4 
A18 7 3.2 – 5.3 <0.03 75.6 – 102.5 15.6 – 23.0 65.1 – 119.8 
A19 10 6.6 – 10.7 0.3 – 0.6  54.6 – 81.5 15.4 – 24.6  279.0 – 429.5 
A20 9 3.5 – 6.3 <0.03 57.9 – 72.9 13.5 – 19.9 95.5 – 165.4 
A21 6 2.1 – 3.7 <0.03 44.1 – 73.5 16.2 – 28.1 151.2 – 196.4 
A23 7 4.3 – 6.1 <0.03 50.0 – 68.1 22.4 – 32.1 411.1 – 865.1 
A25 6 1.9 – 6.9 <0.03 55.6 – 64.8 18.1 – 20.2 93.8 – 111.8 
A26 6 1.5 – 2.4 <0.03 60.1 – 66.8 19.0 – 22.9 85.2 – 159.7 
A27 8 2.4 – 3.8 <0.03 43.1 – 68.4 17.3 – 25.6 44.5 – 123.0 
A28 9 5.7 – 25.1 <0.03 – 1.1 47.1 – 71.6 16.9 – 41.9 251.8 – 802.9 
A29 10 3.1 – 6.7 <0.03 60.3 – 104.7 18.8 -41.3 95.5 – 152.7 
A31 8 5.8 – 7.1 0.2 – 0.4 61.4 – 75.1 28.5 – 35.3 237.6 – 535.7 
A32 9 4.8 – 28.4 0.2 – 1.2 47.0 – 93.0 21.0 – 40.3 182.7 – 396.5 
A33 9 4.2 – 6.1 <0.03 62.2 – 75.8  26.8 – 34.3 118.3 – 155.0 
A34 10 4.0 – 6.2 <0.03 39.5 – 72.7 12.1 – 25.5 148.3 – 612.6 
A36 15 9.1 – 13.5 0.6 – 1.6 49.3 – 77.4 23.6 – 53.6 483.1 – 1064.9 
A37 10 10.7 – 21.4 0.8 – 1.4 67.0 – 90.7 33.1 – 43.5 485.3 – 705.5 
A38 8 1.5 – 2.9 <0.03 52.8 – 68.8 16.6 – 21.7 93.6 – 147.3 
N (number of soil samples). 
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Allotment 
plot ID 
N 
Range of element bioaccessibility fractions (%) in soil  
As Cd Cr Ni Pb 
A01 5 76.7 – 91.3 N/A 11.7 – 18.9 53.0 – 89.1 57.5 – 73.2 
A03 5 77.5 – 89.6 N/A 14.2 – 14.9 55.0 – 67.2 64.6 – 73.2 
A04 5 69.6 – 85.1 72.5 – 93.1 9.3 – 13.1 39.3 – 54.9 59.7 – 80.6 
A05 5 85.4 – 91.9 26.5 – 77.9 14.5 – 20.4 44.6 – 68.7 68.0 – 93.6 
A06 5 44.0 – 65.0 18.1 – 29.9 10.2 – 17.6 33.1 – 73.2 47.9 – 68.9 
A07 5 39.1 – 59.2 N/A 7.9 – 15.5 23.8 – 45.6 46.5 – 53.4 
A08 5 32.9 – 38.7 69.8 – 79.0 6.5 – 11.1 18.2 – 25.6 47.5 – 56.9 
A09 5 45.9 – 57.8 59.5 – 81.3 8.0 – 15.3 17.9 – 41.8 41.1 – 47.5 
A10 5 43.7 – 50.4 63.1 – 77.5 8.7 – 12.8  24.4 – 31.5 36.1 – 48.6 
A12 5 33.5 – 48.8 54.5 – 83.8 6.3 – 13.0 19.0 – 34.7 28.5 – 45.8 
A15 5 62.5 – 77.7 N/A 19.7 – 26.0  24.4 – 35.2 69.5 – 79.6 
A16 5 56.7 – 69.2 29.2 – 69.8 21.5 – 25.2 29.6 – 34.6 65.1 – 72.0 
A17 5 47.7 – 80.8 26.8 – 64.7 20.6 – 29.4 31.6 – 41.3 48.6 – 71.9 
A18 5 41.5 – 72.5 18.6 – 70.3 13.3 – 16.0 21.4 – 27.0 54.2 – 63.4 
A19 5 63.7 – 72.4 N/A 25.7 – 29.5 26.7 – 32.0 66.5 – 70.3 
A20 5 58.5 – 78.7 18.1 – 38.8 9.9 – 22.0 18.8 – 29.9 34.6 – 70.1 
A21 5 59.2 – 67.5 N/A 10.0 – 12.6 29.8 – 32.3 40.5 – 45.6 
A23 5 63.8 – 73.6 N/A 11.1 – 15.1 37.1 – 41.4 43.6 – 53.1 
A25 5 55.9 – 68.4 N/A 10.7 – 15.3 24.6 – 36.8 38.9 – 48.8 
A26 5 59.4 – 71.8 N/A 8.9 – 14.1 22.4 – 37.5 38.1 – 48.9 
A27 5 58.2 – 67.3 N/A 9.0 – 10.5 24.3 – 30.6 33.6 – 44.3 
A28 5 74.3 – 90.6 N/A 13.4 – 18.9 28.1 – 40.4 39.9 – 44.4 
A29 5 79.5 – 85.2 N/A 10.2 – 11.5 28.6 – 35.7 33.3 – 40.8 
A31 5 47.9 – 56.0 25.2 – 36.3 9.4 – 10.6 27.0 – 31.2 53.7 – 57.4 
A32 5 39.6 – 74.6 43.7 – 55.2 8.0 – 14.1 22.7 – 32.7 45.5 – 56.9 
A33 5 36.8 – 45.5 N/A 9.0 – 11.1 25.9 – 30.2 47.8 – 58.2 
A34 5 42.1 – 45.5 N/A 10.3 – 13.1 29.0 – 35.2 52.5 – 62.5 
A36 5 44.9 – 71.0 56.9 – 62.4 9.4 – 13.6 17.0 – 33.5 55.4 – 65.7 
A37 5 52.8 – 69.8 48.9 – 58.2 9.4 – 13.4 24.7 – 28.3 50.5 – 58.5 
A38 5 41.1 – 75.3 N/A 7.5 – 10.9 24.6 – 30.4 44.6 – 53.5 
N (number of soil samples subjected to bioaccessibility test). 
N/A implies not calculated (because either the total or bioaccessibility concentrations were below the LOD).  
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Part G2: Summary of elemental concentrations in allotment produce samples 
 
Allotment 
produce 
N 
Total element concentration (mg kg
-1
 fw) 
Range (average, for values ≥ LOD) 
As Cd Cr Ni Pb 
Apple 6 0.32-0.73 (0.52) <0.01 <0.01-0.27 (0.18) <0.01-0.27 (0.18) <0.01-0.87 (0.35) 
Artichoke 2 0.28-0.51 <0.01-0.04 <0.01-9.84 0.79-7.44 0.22-0.58 
Beetroot 20 0.03-1.37 (0.43) <0.01-0.45 (0.15) <0.01-0.76 (0.2) <0.01-5.07 (0.73) 0.12-2.94 (1.17) 
Beans  27 <0.01-0.99 (0.49) <0.01-0.04 (0.03) <0.01-11.8 (1.75) 0.01-5.89 (1.35) <0.01-2.92 (0.74) 
Broccoli 8 0.18-1.52 (0.68) <0.01-0.11 (0.07) <0.01-0.2 (0.17) <0.01-1.48 (0.73) 0.15-0.77 (0.42) 
Cabbage 4 0.34-0.79 (0.49) <0.01-0.11 (0.1) <0.01-0.8 (0.48) <0.01-1.17 (0.98) 0.37-4.51 (1.6) 
Carrot 4 0.24-0.45 (0.34) <0.01-0.16 (0.13) <0.01-0.32 <0.01-0.55 (0.29) 0.18-1.57 (0.71) 
Cauliflower 1 0.36 <0.01 <0.01 0.28 0.69 
Chard 2 0.33-0.44 0.56-0.66 <0.01-0.55 1.36-1.86 0.49-4.71 
Chives  2 <0.01-0.83 <0.01-0.11 <0.01 <0.02-0.82 0.57-0.77 
Corn  2 0.33-0.43 <0.01 <0.01 <0.01-0.33 0.17-1.38 
Courgette  10 0.2-0.88 (0.47) <0.01-0.43 (0.19) <0.01-3.35 (0.82) <0.01-2.2 (0.97) 0.19-1.78 (0.75) 
Cucumber 2 0.42-0.47 <0.01-0.06 <0.01-0.13 <0.01 0.36-0.4 
Currants 7 0.18-1.65 (0.64) <0.01-0.64 (0.15) <0.01-0.05 (0.04) <0.01-1.46 (0.66) <0.01-1.33 (0.53) 
Fennel 3 0.31-0.45 (0.39) <0.01 <0.01-0.16 <0.01 0.13-2.35 (0.95) 
Garlic 2 0.32-0.39 <0.01-0.04 <0.01 <0.01-0.04 <0.01-0.05 
Green gauge 1 0.97 <0.01 <0.01 0.31 <0.01 
Herbs   11 0.17-1.01 (0.59) <0.01-0.12 (0.08) <0.01-3.44 (0.92) <0.01-2.43 (1.1) 0.41-5.39 (2.42) 
Kale  8 0.21-0.97 (0.56) <0.01-0.12 (0.09) <0.01-0.25 (0.14) <0.01-1.09 (0.65) 0.13-4.57 (0.9) 
Kohlrabi 1 0.28 0.05 0.36 0.14 2.68 
Leek  1 0.41 0.06 0.2 0.95 1.81 
Lettuce 10 0.2-0.98 (0.5) 0.13-0.53 (0.26) <0.01-3.33 (1.29) <0.01-1.7 (0.89) 0.44-15.29 (5.13) 
Onion/Shallot 30 0.01-1.09 (0.36) <0.01-0.62 (0.13) <0.01-1.57 (0.3) <0.01-1.41 (0.35) <0.01-3.31 (0.71) 
Oriental green 1 0.48 <0.01 0.34 <0.01 1.27 
Pak choi 1 0.56 0.26 0.47 0.45 2.38 
Parsnip  5 0.25-1.3 (0.57) <0.01-0.08 (0.07) <0.01-0.29 (0.24) 0.26-2.51 (0.96) 0.67-3.81 (2.12) 
Pear  2 0.3-0.86 <0.01 <0.01-0.1 0.24-0.26 0.35-0.7 
Peas  8 0.16-1.62 (0.48) <0.01-0.36 (0.2) <0.01-0.28 (0.19) <0.01-0.74 (0.53) 0.1-4.33 (1.1) 
Plum  1 0.9 <0.01 <0.01 0.27 0.87 
Potato  30 <0.01-0.91 (0.37) <0.01-0.06 (0.04) <0.01-0.17 (0.07) <0.01-0.72 (0.2) <0.01-2.49 (0.82) 
Radish  1 0.47 <0.01 0.17 0.91 2.26 
Berries 21 0.11-1.1 (0.4) <0.01-0.39 (0.13) <0.01-0.31 (0.14) <0.01-1.69 (0.53) <0.01-5.15 (0.77) 
Rhubarb  16 0.15-2.14 (0.51) <0.01-1.87 (0.24) <0.01-2.04 (0.49) <0.01-2.84 (0.96) <0.01-2.98 (0.99) 
Rocket 1 0.21 0.11 0.32 0.41 0.79 
Spinach 10 0.16-1.13 (0.48) <0.01-0.7 (0.38) <0.01-2.49 (0.98) <0.01-1.87 (1.0) <0.01-15.8 (4.12) 
Tomato  4 0.16-0.91 (0.49) <0.01-0.07 (0.05) <0.01-4.84 (1.72) <0.01-2.04 (0.86) 0.13-0.62 (0.26) 
Turnip/Swede 4 0.22-1.0 (0.52) <0.01-0.05 <0.01-0.24 (0.16) <0.01-0.79 (0.56) 0.11-1.7 (0.89) 
Yam leaves 1 <0.01 <0.01 <0.01 3.65 <0.01 
 N (number of samples). 
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Allotment 
plot ID 
N 
Range of element bioaccessibility fractions (%) in allotment produce  
As Cd Cr Ni Pb 
A01 5 13.1 – 37.2 13.7 – 24.0 14.5 – 18.4 15.6 – 64.1 32.0 – 61.0 
A03 3 19.2 – 61.3 12.2 – 58.4 16.8 – 43.7 14.4 – 18.6 36.8 – 42.7 
A04 5 21.5 – 44.0 13.0 – 25.9 16.0 – 29.6 14.7 – 49.1 32.0 – 61.0 
A05 6 23.4 – 76.6 13.9 – 17.8 16.2 – 48.7 16.1 – 27.4 30.0 – 61.0 
A06 5 19.3 – 77.0 14.0 – 59.1 N/A 15.6 – 19.4 31.0 – 78.6 
A07 5 26.0 – 50.5 16.2 – 26.5 17.7 – 53.3 14.8 – 21.6 39.0 – 42.8 
A08 5 31.9 – 61.1 12.7 – 30.2 34.5 – 75.1 17.5 – 26.9 45.1 – 47.5 
A09 5 13.9 – 64.5 15.2 – 31.7 N/A 18.4 – 82.3 44.2 – 52.8 
A10 3 25.6 – 57.3 12.2 – 23.6 15.5 – 17.3 18.1 – 22.4 35.2 – 48.8 
A12 5 25.5 – 55.9 10.5 – 11.9 24.6 – 27.3 19.6 – 25.8 48.5 – 52.0 
A15 5 25.0 – 43.8 12.1 – 14.1 15.0 – 63.7 21.2 – 29.5 41.9 – 57.9 
A16 5 22.6 – 49.6 10.9 – 12.6 36.8 – 45.1 19.1 – 28.4 42.0 – 55.9 
A17 5 37.8 – 77.6 10.1 – 12.9 N/A 49.8 – 68.3 39.7 – 52.1 
A18 4 45.8 – 79.0 9.8 – 17.2  N/A N/A 31.7 – 32.0 
A19 5 45.2 – 77.3 9.6 – 11.5 33.1 – 80.0 17.0 – 33.8 41.8 – 52.0 
A20 3 51.5 – 62.6 9.5 – 18.6 14.3 – 16.1 21.9 – 27.2 31.0 – 43.3 
A21 6 53.8 – 61.7 27.5 – 77.1 22.7 – 38.2 38.4 – 71.2 31.3 – 80.0 
A23 6 44.7 – 58.9 27.1 – 67.0 16.7 – 28.2 31.2 – 62.4 43.8 – 77.3 
A25 5 31.1 – 60.9 47.5 – 86.1 21.9 – 35.6 58.3 – 78.7 38.5 – 54.9 
A26 3 N/A 52.6 – 88.5 25.5 – 38.1 47.3 – 63.8 41.0 – 81.0 
A27 3 30.2 – 47.3 N/A N/A 36.8 – 56.5 44.2 – 59.3 
A28 5 26.4 – 48.9 31.1 – 42.5 22.7 – 39.3 18.7 – 59.6 30.0 – 32.0 
A29 4 22.4 – 65.6 24.1 – 67.6 32.7 – 41.8 24.9 – 74.5 33.4 – 42.0 
A31 5 40.3 – 41.0 16.7 – 73.7 31.6 – 62.0 54.7 – 75.3 35.8 – 59.5 
A32 5 21.9 – 42.3 10.2 – 33.8 15.0 – 62.3 17.4 – 17.7 32.0 – 67.3 
A33 5 24.5 – 45.6 10.9 – 89.3 18.0 – 76.8 14.3 – 20.3 66.8 – 69.7 
A34 3 76.3 – 93.8 13.9 – 24.8 16.2 – 22.3 22.8 – 36.5 37.9 – 53.9 
A36 5 45.6 – 56.1 12.0 – 20.0 29.1 – 75.5 27.3 – 74.9 31.0 – 79.0 
A37 2 34.8 – 46.9 10.3 – 25.9 58.5 – 80.0 19.2 – 28.8 46.0 – 54.8 
A38 4 36.9 – 48.9 9.7 – 14.3 N/A 15.8 – 20.5 34.1 – 42.1 
N (number of produce samples subjected to bioaccessibility test). 
N/A implies not calculated (because either the total or bioaccessibility concentrations were below the LOD). N/A was 
used only if all samples from a give site had concentrations <LOD; otherwise the results for concentrations ≥LOD were 
reported.  
 
  
 162 
Part G3: Summary of venous blood Pb test results 
 
Participant 
ID 
N 
Pb concentration 
(µg dL
-1
) 
 Participant 
ID 
N 
Pb concentration 
(µg dL
-1
) 
Min Max  Min Max 
P01 4 5.72 22.61  P21 3 6.47 26.12 
P02 3 8.80 13.08  P22 3 4.78 12.93 
P03 4 3.12 14.59  P23 4 5.84 30.60 
P04 4 4.13 16.74  P24 3 7.58 13.75 
P05 3 6.96 20.25  P25 4 7.00 24.47 
P09 4 5.04 12.31  P26 4 6.97 10.88 
P10 4 3.50 8.76  P28 4 5.36 10.34 
P11 4 10.07 12.38  P29 3 7.94 14.57 
P12 4 7.17 27.19  P32 4 6.81 22.67 
P13 4 3.79 19.97  P33 4 4.69 11.75 
P15 4 6.10 9.76  P34 3 11.00 21.87 
P16 2 5.70 14.69  P35 3 8.55 11.42 
P17 3 4.66 9.59  P36 2 7.02 26.19 
P18 4 4.89 15.21  P37 3 7.59 20.70 
P19 2 6.66 29.35  P38 2 8.82 23.61 
P20 4 5.22 18.58  P39 2 6.92 15.19 
 N (number of samples). 
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Examples of Pb isotopic plots for soil, produce and blood samples relating to participants P01, P05, 
P09, P15, P23 and P32 
Note: error bars were excluded from these plots to enhance legibility. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
P01 P05 
P09 P15 
P23 P32 
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Part G4: Summary of urinary elemental concentrations  
Summary of elemental urine concentrations (expressed in ug L
-1
) 
Participant 
ID 
N 
Urinary concentrations (µg L
-1
)
$
 
As 
(inorganic) 
Cd Cr Ni 
Median 95 PC Median 95 PC Median 95 PC Median 95 PC 
P01 34 0.73 2.87 0.12 0.35 0.48 3.28 0.94 4.84 
P02 32 1.14 5.95 0.10 0.37 0.19 4.06 1.54 5.45 
P03 18 3.00 6.00 0.02 0.07 0.60 5.86 3.47 7.21 
P04 18 2.10 8.50 0.02 0.09 0.53 4.02 1.45 7.13 
P05 34 0.88 1.65 0.12 0.30 0.10 1.53 0.78 3.77 
P06 24 1.00 8.80 0.12 0.56 0.79 3.15 1.66 5.75 
P07 24 1.20 4.50 0.02 0.09 1.31 11.26 1.91 12.28 
P08 24 2.40 6.15 0.04 0.68 1.00 7.16 3.54 9.53 
P09 32 1.37 9.80 0.05 0.16 0.34 3.43 0.82 3.21 
P10 27 1.41 3.81 0.12 0.78 0.43 2.32 0.83 3.31 
P11 29 0.60 6.40 0.13 0.50 0.24 7.42 1.51 15.25 
P12 33 1.35 4.17 0.15 0.58 0.50 3.07 1.31 3.89 
P13 31 0.91 3.17 0.07 0.55 0.82 7.16 2.17 6.47 
P15 33 1.36 7.40 0.04 0.46 0.53 4.96 1.73 8.41 
P16 19 2.10 7.06 0.04 0.49 1.56 6.15 2.00 7.07 
P17 22 2.00 6.80 0.02 0.29 0.89 6.17 1.44 6.57 
P18 22 1.85 8.25 0.04 0.54 0.82 6.81 2.30 14.65 
P19 19 2.56 14.36 0.04 0.44 1.55 4.06 2.60 5.47 
P20 19 1.98 12.58 0.04 0.34 0.61 8.11 2.57 9.18 
P21 33 2.23 5.16 0.07 0.51 0.14 4.64 0.63 6.46 
P22 28 1.02 4.80 0.03 0.50 0.44 5.05 0.74 8.64 
P23 21 2.00 4.04 0.05 0.51 0.43 2.27 1.64 3.44 
P24 18 1.85 5.89 0.09 0.62 0.45 5.89 2.02 5.92 
P25 33 0.88 6.90 0.04 0.31 0.32 6.73 0.88 6.99 
P26 30 1.18 5.58 0.08 0.79 0.16 5.32 0.98 3.40 
P27 25 1.40 7.66 0.12 0.80 0.76 5.36 2.68 7.34 
P28 23 0.80 2.50 0.02 0.26 0.25 4.02 3.04 4.99 
P29 21 1.15 5.45 0.06 0.53 0.37 3.00 1.13 3.58 
P31 23 0.78 3.30 0.02 0.25 1.47 5.56 4.01 7.40 
P32 13 3.00 6.622 0.06 0.77 0.85 2.71 1.57 5.29 
P33 18 1.34 7.05 0.05 0.30 0.41 1.51 2.80 3.98 
P34 13 1.25 7.90 0.05 0.27 1.31 7.82 2.87 5.73 
P35 11 2.00 2.08 0.04 0.26 1.66 4.61 2.35 5.89 
P36 19 0.93 7.50 0.03 0.07 0.31 3.62 1.73 4.10 
P37 17 0.91 4.35 0.09 1.16 0.65 4.87 1.23 2.69 
P38 14 1.72 19.80 0.02 0.13 0.71 4.72 3.05 5.26 
P39 7 2.53 7.05 0.02 0.05 0.18 0.78 1.41 1.78 
N (the total number of urine samples collected from participant).  
95 PC (95th percentile).  
$
For concentrations ≥ LOD.  
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Summary of elemental urine concentrations (expressed in ug g
-1
 creatinine)  
Participant 
ID 
N 
Creatinine#  
(g L-1) 
Urinary concentrations (µg g
-1
 creatinine)
$
 
As 
(inorganic) 
Cd Cr Ni 
Min Max Median 95 PC Median 95 PC Median 95 PC Median 95 PC 
P01 34 0.3 2.2 1.12 2.65 0.20 0.50 0.51 3.53 1.75 4.46 
P02 32 0.4 1.8 1.62 5.24 0.12 0.43 0.23 4.06 1.79 5.00 
P03 18 0.4 1.8 2.82 7.39 0.03 0.05 0.61 7.78 3.00 9.20 
P04 18 0.5 1.5 1.84 6.99 0.03 0.07 0.77 6.61 1.59 11.06 
P05 34 0.3 1.1 1.55 2.77 0.21 0.75 0.23 4.76 1.42 9.83 
P06 24 0.7 1.9 1.04 4.97 0.13 0.45 0.81 3.58 1.45 6.17 
P07 24 0.5 1.9 1.10 4.78 0.02 0.09 1.35 11.26 1.91 13.08 
P08 24 0.4 2.6 2.14 5.50 0.04 0.82 1.15 12.48 2.79 8.73 
P09 32 0.3 2.2 1.10 6.61 0.06 0.27 0.34 4.96 1.48 3.13 
P10 27 0.4 1.0 2.00 5.18 0.95 1.33 0.50 3.48 1.18 4.41 
P11 29 0.3 3.0 1.05 6.33 0.15 0.49 0.22 6.18 1.40 12.33 
P12 33 0.6 1.9 1.25 5.08 0.15 0.54 0.28 2.55 1.09 3.32 
P13 31 0.4 2.2 1.19 3.69 0.07 0.63 0.79 4.04 1.84 6.00 
P15 33 0.5 2.3 0.97 6.02 0.08 0.43 0.36 6.80 1.67 8.37 
P16 19 0.3 2.0 2.86 6.95 0.03 0.63 1.60 5.27 2.37 6.20 
P17 22 0.9 2.1 2.00 4.72 0.03 0.26 0.48 4.63 1.04 4.20 
P18 22 0.6 2.0 1.66 5.81 0.03 0.46 0.58 4.88 2.04 18.51 
P19 19 0.4 1.9 2.94 8.97 0.05 0.37 1.19 6.05 2.20 5.01 
P20 19 1.0 2.3 1.85 10.33 0.03 0.26 0.30 3.67 1.77 6.18 
P21 33 0.3 2.6 2.00 6.14 0.14 0.43 0.27 4.60 0.75 7.28 
P22 28 0.3 1.0 2.35 9.61 0.04 1.28 1.22 10.71 1.50 18.35 
P23 21 0.5 1.8 1.99 5.01 0.04 0.48 0.50 3.70 1.71 5.32 
P24 18 0.4 1.7 1.37 6.40 0.08 0.60 0.52 3.99 1.93 8.06 
P25 33 0.4 2.0 1.43 7.87 0.05 0.63 0.31 7.08 1.19 7.18 
P26 30 0.3 0.9 2.70 13.57 0.12 1.96 0.27 11.69 2.01 7.03 
P27 25 1.0 2.9 1.00 4.10 0.08 0.42 0.32 4.58 1.79 6.43 
P28 23 0.3 0.6 1.43 5.57 0.04 0.47 0.75 12.42 6.42 8.92 
P29 21 0.3 1.6 1.27 5.47 0.07 0.91 0.46 6.04 1.25 6.32 
P31 23 0.5 1.2 1.20 4.12 0.03 0.32 1.86 5.44 5.98 8.25 
P32 13 0.4 2.1 3.43 8.92 0.06 0.79 1.18 3.72 2.40 4.52 
P33 18 0.4 2.3 1.54 6.24 0.04 0.52 0.29 3.25 3.07 6.14 
P34 13 0.8 2.1 0.77 5.21 0.03 0.30 1.27 5.38 2.12 4.02 
P35 11 0.3 0.7 3.51 5.95 0.13 0.39 2.84 7.08 5.72 10.31 
P36 19 0.8 3.0 0.68 4.64 0.02 0.06 0.22 2.94 1.34 2.18 
P37 17 0.3 1.4 1.43 6.51 0.17 1.90 0.94 6.95 1.32 4.62 
P38 14 0.8 2.3 1.37 13.28 0.02 0.12 0.63 4.51 2.32 4.87 
P39 7 0.3 1.1 7.41 12.48 0.04 0.06 0.36 0.79 2.05 3.24 
 N (the total number of urine samples collected from participant).  
95 PC (95th percentile). 
#
Excludes urine samples with creatinine values < 0.3 (g L-1) which were discarded (as explained in the text, section 2.7.2).  
$
For concentrations ≥ LOD.  
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Probability distribution of elemental urine concentrations – normal Q-Q plots  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The normal Q-Q plots show that the urinary concentrations (µg g
-1
 creatinine) of iAs, Cd, Cr and 
Ni do not follow a normal distribution, because data points do not plot evenly along the straight Q-
Q line. 
 
  
iAs Cd 
Cr Ni 
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Appendix H: Examples of R Codes used in Statistical 
Calculations 
Part H1: R Code for mixed-effects modelling for blood Pb concentrations 
# R Codes 
 
install.packages("lme4") 
library(lme4) 
 
Pb<-read.csv("BloodPb-lmer.csv",header=T) 
Pb 
attach(Pb) 
summary(Pb) 
str(Pb) 
head(Pb) 
plot(Pb) 
 
nofixedlmm<-lmer(BloodPb~1+(1|Participant),data=Pb,REML=FALSE) 
summary(nofixedlmm) 
 
genderlmm<-lmer(BloodPb~Gender+(1|Participant),data=Pb,REML=FALSE) 
summary(genderlmm) 
 
agelmm<-lmer(BloodPb~Age+(1|Participant),data=Pb,REML=FALSE) 
summary(agelmm) 
 
smokinglmm<-lmer(BloodPb~SmokingStatus+(1|Participant),data=Pb,REML=FALSE) 
summary(smokinglmm) 
 
producelmm<-lmer(BloodPb~ProduceConsRate+(1|Participant),data=Pb,REML=FALSE) 
summary(producelmm) 
 
install.packages("car") 
library(car) 
anova(nofixedlmm,genderlmm,agelmm,smokinglmm,producelmm) 
 
 
# Results of Statistical Significance Test 
 
> anova(nofixedlmm,genderlmm,agelmm,smokinglmm,producelmm) 
Data: Pb 
Models: 
nofixedlmm: BloodPb ~ 1 + (1 | Participant) 
agelmm: BloodPb ~ Age + (1 | Participant) 
producelmm: BloodPb ~ ProduceConsRate + (1 | Participant) 
genderlmm: BloodPb ~ Gender + (1 | Participant) 
smokinglmm: BloodPb ~ SmokingStatus + (1 | Participant) 
           Df    AIC    BIC  logLik deviance  Chisq Chi Df Pr(>Chisq) 
nofixedlmm  3 704.28 712.32 -349.14   698.28                          
agelmm      4 705.53 716.26 -348.77   697.53 0.7435      1     0.3885 
producelmm  4 705.90 716.63 -348.95   697.90 0.0000      0     1.0000 
genderlmm   5 707.61 721.02 -348.80   697.61 0.2958      1     0.5866 
smokinglmm  5 708.12 721.53 -349.06   698.12 0.0000      0     1.0000 
 
 
Interpretation of Results: The p values indicate that there are no statistically important differences 
between the models, and that there are no significant associations (p > 0.05) between the modelled 
variables and blood Pb levels.  
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Part H2: R Code for data imputation of <LOD urine concentrations – example for 
iAs 
library(EnvStats) 
Data <- read.csv("iAs.csv", header=TRUE) 
Arsenic <- Data$iAs 
NR = length(Arsenic) 
Data$Arsenic_REP = Arsenic 
for (i in 1:NR) 
{ 
 if (Data$Non.detects[i]==TRUE) 
{ 
 RANDU = runif(1,0,1) 
 a = 0 
 b = Arsenic[i] 
 c = b/2 
 F = (c-a)/(b-a) 
 if (0 < RANDU & RANDU < F) 
 { 
  trival = a +sqrt(RANDU*(b-a)*(c-a))   
 } 
 if (F < RANDU & RANDU < 1) 
 { 
  trival = b-sqrt((1-RANDU)*(b-a)*(b-c)) 
 } 
Data$Arsenic_REP[i] = trival 
} 
} 
write.table(Data, file='iAs - imputed data.txt') 
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Part H3: R Codes for Mann-Whitney U test – example for urine concentrations sub-
grouped according to participant gender  
gender<-read.csv("Gender.csv",header=T) 
gender 
attach(gender) 
names(gender) 
summary(gender) 
 
# Wilcoxon rank test (Mann-Whitney U test) for unmatched pairs, Results 
 
> 
wilcox.test(iAsMale,iAsFemale,data=gender,mu=0,alt="two.sided",paired=F,c
onf.int=T,conf.level=0.95) 
 
        Wilcoxon rank sum test with continuity correction 
 
data:  iAsMale and iAsFemale 
W = 71390, p-value = 0.08706 
alternative hypothesis: true location shift is not equal to 0 
95 percent confidence interval: 
 -0.281742888  0.001099057 
sample estimates: 
difference in location  
           -0.07368445 
 
> 
wilcox.test(CdMale,CdFemale,data=gender,mu=0,alt="two.sided",paired=F,con
f.int=T,conf.level=0.95) 
 
        Wilcoxon rank sum test with continuity correction 
 
data:  CdMale and CdFemale 
W = 68586, p-value = 0.009474 
alternative hypothesis: true location shift is not equal to 0 
95 percent confidence interval: 
 -0.0081679420 -0.0008116486 
sample estimates: 
difference in location  
          -0.004240437 
 
> 
wilcox.test(CrMale,CrFemale,data=gender,mu=0,alt="two.sided",paired=F,con
f.int=T,conf.level=0.95) 
 
        Wilcoxon rank sum test with continuity correction 
 
data:  CrMale and CrFemale 
W = 73128, p-value = 0.2444 
alternative hypothesis: true location shift is not equal to 0 
95 percent confidence interval: 
 -0.035807673  0.003261563 
sample estimates: 
difference in location  
          -0.004984143 
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> 
wilcox.test(NiMale,NiFemale,data=gender,mu=0,alt="two.sided",paired=F,con
f.int=T,conf.level=0.95) 
 
        Wilcoxon rank sum test with continuity correction 
 
data:  NiMale and NiFemale 
W = 66718, p-value = 0.001461 
alternative hypothesis: true location shift is not equal to 0 
95 percent confidence interval: 
 -0.501438188 -0.008956675 
sample estimates: 
difference in location  
            -0.2670566 
 
 
Interpretation of Results: At 5% significance level, the difference between the medians of datasets 
examined is statistically significant when p < 0.05, and not significant when p > 0.05.  
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Appendix I: Mathematical Equations and Parameters of the 
Modified Models 
Part I1: Arsenic PBPK model equations and parameters 
GI tract:   
𝑑𝐴𝑀𝑇𝑔𝑖
3
𝑑𝑡
= 𝑄𝑔𝑖 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
3
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑔𝑖
3
𝑉𝑔𝑖 × 𝑃𝑔𝑖
3 ) + (𝐾𝑟𝑒𝑑 × 𝐴𝑀𝑇𝑔𝑖
5 ) − (𝐾𝑜𝑥 × 𝐴𝑀𝑇𝑔𝑖
3 ) − (𝑒𝐹 × 𝐴𝑀𝑇𝑔𝑖
3 ) 
𝑑𝐴𝑀𝑇𝑔𝑖
5
𝑑𝑡
= 𝑄𝑔𝑖 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
5
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑔𝑖
5
𝑉𝑔𝑖 × 𝑃𝑔𝑖
5 ) − (𝐾𝑟𝑒𝑑 × 𝐴𝑀𝑇𝑔𝑖
5 ) + (𝐾𝑜𝑥 × 𝐴𝑀𝑇𝑔𝑖
3 ) − (𝑒𝐹 × 𝐴𝑀𝑇𝑔𝑖
5 ) 
𝑑𝐴𝑀𝑇𝑔𝑖
𝑚𝑚𝑎
𝑑𝑡
= 𝑄𝑔𝑖 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
𝑚𝑚𝑎
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑔𝑖
𝑚𝑚𝑎
𝑉𝑔𝑖 × 𝑃𝑔𝑖
𝑚𝑚𝑎) − (𝑒𝐹 × 𝐴𝑀𝑇𝑔𝑖
𝑚𝑚𝑎) 
𝑑𝐴𝑀𝑇𝑔𝑖
𝑑𝑚𝑎
𝑑𝑡
= 𝑄𝑔𝑖 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
𝑑𝑚𝑎
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑔𝑖
𝑑𝑚𝑎
𝑉𝑔𝑖 × 𝑃𝑔𝑖
𝑑𝑚𝑎) − (𝑒𝐹 × 𝐴𝑀𝑇𝑔𝑖
𝑑𝑚𝑎) 
Liver:   
𝑑𝐴𝑀𝑇𝑙𝑖𝑣
3
𝑑𝑡
= 𝑄𝑙𝑖𝑣 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
3
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑙𝑖𝑣
3
𝑉𝑙𝑖𝑣 × 𝑃𝑙𝑖𝑣
3 ) − (
𝑉𝑚𝑎𝑥,𝑙𝑖𝑣
3→𝑚𝑚𝑎 × 𝐶𝑙𝑖𝑣
3
𝐾𝑚,𝑙𝑖𝑣
3→𝑚𝑚𝑎 + 𝐶𝑙𝑖𝑣
3 ) − (
𝑉𝑚𝑎𝑥,𝑙𝑖𝑣
3→𝑑𝑚𝑎 × 𝐶𝑙𝑖𝑣
3
𝐾𝑚,𝑙𝑖𝑣
3→𝑑𝑚𝑎 + 𝐶𝑙𝑖𝑣
3 )
+ (𝐾𝑟𝑒𝑑 × 𝐴𝑀𝑇𝑙𝑖𝑣
5 ) − (𝐾𝑜𝑥 × 𝐴𝑀𝑇𝑙𝑖𝑣
3 ) − (𝑒𝐵 × 𝐴𝑀𝑇𝑙𝑖𝑣
3 ) 
𝑑𝐴𝑀𝑇𝑙𝑖𝑣
5
𝑑𝑡
= 𝑄𝑙𝑖𝑣 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
5
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑙𝑖𝑣
5
𝑉𝑙𝑖𝑣 × 𝑃𝑙𝑖𝑣
5 ) − (𝐾𝑟𝑒𝑑 × 𝐴𝑀𝑇𝑙𝑖𝑣
5 ) + (𝐾𝑜𝑥 × 𝐴𝑀𝑇𝑙𝑖𝑣
3 )
− (𝑒𝐵 × 𝐴𝑀𝑇𝑙𝑖𝑣
5 ) 
𝑑𝐴𝑀𝑇𝑙𝑖𝑣
𝑚𝑚𝑎
𝑑𝑡
= 𝑄𝑙𝑖𝑣 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
𝑚𝑚𝑎
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑙𝑖𝑣
𝑚𝑚𝑎
𝑉𝑙𝑖𝑣 × 𝑃𝑙𝑖𝑣
𝑚𝑚𝑎) + (
𝑉𝑚𝑎𝑥,𝑙𝑖𝑣
3→𝑚𝑚𝑎 × 𝐶𝑙𝑖𝑣
3
𝐾𝑚,𝑙𝑖𝑣
3→𝑚𝑚𝑎 + 𝐶𝑙𝑖𝑣
3 ) − (
𝑉𝑚𝑎𝑥,𝑙𝑖𝑣
𝑚𝑚𝑎→𝑑𝑚𝑎 × 𝐶𝑙𝑖𝑣
𝑚𝑚𝑎
𝐾𝑚,𝑙𝑖𝑣
𝑚𝑚𝑎→𝑑𝑚𝑎 + 𝐶𝑙𝑖𝑣
𝑚𝑚𝑎)
− (𝑒𝐵 × 𝐴𝑀𝑇𝑙𝑖𝑣
𝑚𝑚𝑎) 
𝑑𝐴𝑀𝑇𝑙𝑖𝑣
𝑑𝑚𝑎
𝑑𝑡
= 𝑄𝑙𝑖𝑣 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
𝑑𝑚𝑎
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑙𝑖𝑣
𝑑𝑚𝑎
𝑉𝑙𝑖𝑣 × 𝑃𝑙𝑖𝑣
𝑑𝑚𝑎) + (
𝑉𝑚𝑎𝑥,𝑙𝑖𝑣
3→𝑑𝑚𝑎 × 𝐶𝑙𝑖𝑣
3
𝐾𝑚,𝑙𝑖𝑣
3→𝑑𝑚𝑎 + 𝐶𝑙𝑖𝑣
3 ) + (
𝑉𝑚𝑎𝑥,𝑙𝑖𝑣
𝑚𝑚𝑎→𝑑𝑚𝑎 × 𝐶𝑙𝑖𝑣
𝑚𝑚𝑎
𝐾𝑚,𝑙𝑖𝑣
𝑚𝑚𝑎→𝑑𝑚𝑎 + 𝐶𝑙𝑖𝑣
𝑚𝑚𝑎)
− (𝑒𝐵 × 𝐴𝑀𝑇𝑙𝑖𝑣
𝑑𝑚𝑎) 
Kidney:   
𝑑𝐴𝑀𝑇𝑘𝑖𝑑
3
𝑑𝑡
= 𝑄𝑘𝑖𝑑 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
3
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑘𝑖𝑑
3
𝑉𝑘𝑖𝑑 × 𝑃𝑘𝑖𝑑
3 ) − (
𝑉𝑚𝑎𝑥,𝑘𝑖𝑑
3→𝑚𝑚𝑎 × 𝐶𝑘𝑖𝑑
3
𝐾𝑚,𝑘𝑖𝑑
3→𝑚𝑚𝑎 + 𝐶𝑘𝑖𝑑
3 ) − (
𝑉𝑚𝑎𝑥,𝑘𝑖𝑑
3→𝑑𝑚𝑎 × 𝐶𝑘𝑖𝑑
3
𝐾𝑚,𝑘𝑖𝑑
3→𝑑𝑚𝑎 + 𝐶𝑘𝑖𝑑
3 )
+ (𝐾𝑟𝑒𝑑 × 𝐴𝑀𝑇𝑘𝑖𝑑
5 ) − (𝐾𝑜𝑥 × 𝐴𝑀𝑇𝑘𝑖𝑑
3 ) − (𝑒𝑈 × 𝐴𝑀𝑇𝑘𝑖𝑑
3 ) 
𝑑𝐴𝑀𝑇𝑘𝑖𝑑
5
𝑑𝑡
= 𝑄𝑘𝑖𝑑 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
5
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑘𝑖𝑑
5
𝑉𝑘𝑖𝑑 × 𝑃𝑘𝑖𝑑
5 ) − (𝐾𝑟𝑒𝑑 × 𝐴𝑀𝑇𝑘𝑖𝑑
5 ) + (𝐾𝑜𝑥 × 𝐴𝑀𝑇𝑘𝑖𝑑
3 )
− (𝑒𝑈 × 𝐴𝑀𝑇𝑘𝑖𝑑
5 ) 
 172 
𝑑𝐴𝑀𝑇𝑘𝑖𝑑
𝑚𝑚𝑎
𝑑𝑡
= 𝑄𝑘𝑖𝑑 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
𝑚𝑚𝑎
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑘𝑖𝑑
𝑚𝑚𝑎
𝑉𝑘𝑖𝑑 × 𝑃𝑘𝑖𝑑
𝑚𝑚𝑎) + (
𝑉𝑚𝑎𝑥,𝑘𝑖𝑑
3→𝑚𝑚𝑎 × 𝐶𝑘𝑖𝑑
3
𝐾𝑚,𝑘𝑖𝑑
3→𝑚𝑚𝑎 + 𝐶𝑘𝑖𝑑
3 )
− (
𝑉𝑚𝑎𝑥,𝑘𝑖𝑑
𝑚𝑚𝑎→𝑑𝑚𝑎 × 𝐶𝑘𝑖𝑑
𝑚𝑚𝑎
𝐾𝑚,𝑘𝑖𝑑
𝑚𝑚𝑎→𝑑𝑚𝑎 + 𝐶𝑘𝑖𝑑
𝑚𝑚𝑎) − (𝑒𝑈 × 𝐴𝑀𝑇𝑘𝑖𝑑
𝑚𝑚𝑎) 
𝑑𝐴𝑀𝑇𝑘𝑖𝑑
𝑑𝑚𝑎
𝑑𝑡
= 𝑄𝑘𝑖𝑑 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
𝑑𝑚𝑎
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑘𝑖𝑑
𝑑𝑚𝑎
𝑉𝑘𝑖𝑑 × 𝑃𝑘𝑖𝑑
𝑑𝑚𝑎) + (
𝑉𝑚𝑎𝑥,𝑘𝑖𝑑
3→𝑑𝑚𝑎 × 𝐶𝑘𝑖𝑑
3
𝐾𝑚,𝑘𝑖𝑑
3→𝑑𝑚𝑎 + 𝐶𝑘𝑖𝑑
3 ) + (
𝑉𝑚𝑎𝑥,𝑘𝑖𝑑
𝑚𝑚𝑎→𝑑𝑚𝑎 × 𝐶𝑘𝑖𝑑
𝑚𝑚𝑎
𝐾𝑚,𝑘𝑖𝑑
𝑚𝑚𝑎→𝑑𝑚𝑎 + 𝐶𝑘𝑖𝑑
𝑚𝑚𝑎)
− (𝑒𝑈 × 𝐴𝑀𝑇𝑘𝑖𝑑
𝑑𝑚𝑎) 
Muscles:   
𝑑𝐴𝑀𝑇𝑚𝑢𝑠𝑐𝑙𝑒
3
𝑑𝑡
= 𝑄𝑚𝑢𝑠𝑐𝑙𝑒 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
3
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑚𝑢𝑠𝑐𝑙𝑒
3
𝑉𝑚𝑢𝑠𝑐𝑙𝑒 × 𝑃𝑚𝑢𝑠𝑐𝑙𝑒
3 ) + (𝐾𝑟𝑒𝑑 × 𝐴𝑀𝑇𝑚𝑢𝑠𝑐𝑙𝑒
5 )
− (𝐾𝑜𝑥 × 𝐴𝑀𝑇𝑚𝑢𝑠𝑐𝑙𝑒
3 ) 
𝑑𝐴𝑀𝑇𝑚𝑢𝑠𝑐𝑙𝑒
5
𝑑𝑡
= 𝑄𝑚𝑢𝑠𝑐𝑙𝑒 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
5
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑚𝑢𝑠𝑐𝑙𝑒
5
𝑉𝑚𝑢𝑠𝑐𝑙𝑒 × 𝑃𝑚𝑢𝑠𝑐𝑙𝑒
5 ) − (𝐾𝑟𝑒𝑑 × 𝐴𝑀𝑇𝑚𝑢𝑠𝑐𝑙𝑒
5 )
+ (𝐾𝑜𝑥 × 𝐴𝑀𝑇𝑚𝑢𝑠𝑐𝑙𝑒
3 ) 
𝑑𝐴𝑀𝑇𝑚𝑢𝑠𝑐𝑙𝑒
𝑚𝑚𝑎
𝑑𝑡
= 𝑄𝑚𝑢𝑠𝑐𝑙𝑒 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
𝑚𝑚𝑎
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑚𝑢𝑠𝑐𝑙𝑒
𝑚𝑚𝑎
𝑉𝑚𝑢𝑠𝑐𝑙𝑒 × 𝑃𝑚𝑢𝑠𝑐𝑙𝑒
𝑚𝑚𝑎 ) 
𝑑𝐴𝑀𝑇𝑚𝑢𝑠𝑐𝑙𝑒
𝑑𝑚𝑎
𝑑𝑡
= 𝑄𝑚𝑢𝑠𝑐𝑙𝑒 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
𝑑𝑚𝑎
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑚𝑢𝑠𝑐𝑙𝑒
𝑑𝑚𝑎
𝑉𝑚𝑢𝑠𝑐𝑙𝑒 × 𝑃𝑚𝑢𝑠𝑐𝑙𝑒
𝑑𝑚𝑎 ) 
Skin:   
𝑑𝐴𝑀𝑇𝑠𝑘𝑖𝑛
3
𝑑𝑡
= 𝑄𝑠𝑘𝑖𝑛 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
3
𝑉𝑏𝑙𝑜𝑑
−
𝐴𝑀𝑇𝑠𝑘𝑖𝑛
3
𝑉𝑠𝑘𝑖𝑛 × 𝑃𝑠𝑘𝑖𝑛
3 ) + (𝐾𝑟𝑒𝑑 × 𝐴𝑀𝑇𝑠𝑘𝑖𝑛
5 ) − (𝐾𝑜𝑥 × 𝐴𝑀𝑇𝑠𝑘𝑖𝑛
3 ) 
𝑑𝐴𝑀𝑇𝑠𝑘𝑖𝑛
5
𝑑𝑡
= 𝑄𝑠𝑘𝑖𝑛 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
5
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑠𝑘𝑖𝑛
5
𝑉𝑠𝑘𝑖𝑛 × 𝑃𝑠𝑘𝑖𝑛
5 ) − (𝐾𝑟𝑒𝑑 × 𝐴𝑀𝑇𝑠𝑘𝑖𝑛
5 ) + (𝐾𝑜𝑥 × 𝐴𝑀𝑇𝑠𝑘𝑖𝑛
3 ) 
𝑑𝐴𝑀𝑇𝑠𝑘𝑖𝑛
𝑚𝑚𝑎
𝑑𝑡
= 𝑄𝑠𝑘𝑖𝑛 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
𝑚𝑚𝑎
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑠𝑘𝑖𝑛
𝑚𝑚𝑎
𝑉𝑠𝑘𝑖𝑛 × 𝑃𝑠𝑘𝑖𝑛
𝑚𝑚𝑎) 
𝑑𝐴𝑀𝑇𝑠𝑘𝑖𝑛
𝑑𝑚𝑎
𝑑𝑡
= 𝑄𝑠𝑘𝑖𝑛 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
𝑑𝑚𝑎
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑠𝑘𝑖𝑛
𝑑𝑚𝑎
𝑉𝑠𝑘𝑖𝑛 × 𝑃𝑠𝑘𝑖𝑛
𝑑𝑚𝑎) 
Heart:   
𝑑𝐴𝑀𝑇ℎ𝑒𝑎𝑟𝑡
3
𝑑𝑡
= 𝑄ℎ𝑒𝑎𝑟𝑡 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
3
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇ℎ𝑒𝑎𝑟𝑡
3
𝑉ℎ𝑒𝑎𝑟𝑡 × 𝑃ℎ𝑒𝑎𝑟𝑡
3 ) + (𝐾𝑟𝑒𝑑 × 𝐴𝑀𝑇ℎ𝑒𝑎𝑟𝑡
5 )
− (𝐾𝑜𝑥 × 𝐴𝑀𝑇ℎ𝑒𝑎𝑟𝑡
3 ) 
𝑑𝐴𝑀𝑇ℎ𝑒𝑎𝑟𝑡
5
𝑑𝑡
= 𝑄ℎ𝑒𝑎𝑟𝑡 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
5
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇ℎ𝑒𝑎𝑟𝑡
5
𝑉ℎ𝑒𝑎𝑟𝑡 × 𝑃ℎ𝑒𝑎𝑟𝑡
5 ) − (𝐾𝑟𝑒𝑑 × 𝐴𝑀𝑇ℎ𝑒𝑎𝑟𝑡
5 )
+ (𝐾𝑜𝑥 × 𝐴𝑀𝑇ℎ𝑒𝑎𝑟𝑡
3 ) 
 173 
𝑑𝐴𝑀𝑇ℎ𝑒𝑎𝑟𝑡
𝑚𝑚𝑎
𝑑𝑡
= 𝑄ℎ𝑒𝑎𝑟𝑡 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
𝑚𝑚𝑎
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇ℎ𝑒𝑎𝑟𝑡
𝑚𝑚𝑎
𝑉ℎ𝑒𝑎𝑟𝑡 × 𝑃ℎ𝑒𝑎𝑟𝑡
𝑚𝑚𝑎 ) 
𝑑𝐴𝑀𝑇ℎ𝑒𝑎𝑟𝑡
𝑑𝑚𝑎
𝑑𝑡
= 𝑄ℎ𝑒𝑎𝑟𝑡 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
𝑑𝑚𝑎
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇ℎ𝑒𝑎𝑟𝑡
𝑑𝑚𝑎
𝑉ℎ𝑒𝑎𝑟𝑡 × 𝑃ℎ𝑒𝑎𝑟𝑡
𝑑𝑚𝑎 ) 
Brain:   
𝑑𝐴𝑀𝑇𝑏𝑟𝑎𝑖𝑛
3
𝑑𝑡
= 𝑄𝑏𝑟𝑎𝑖𝑛 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
3
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑏𝑟𝑎𝑖𝑛
3
𝑉𝑏𝑟𝑎𝑖𝑛 × 𝑃𝑏𝑟𝑎𝑖𝑛
3 ) + (𝐾𝑟𝑒𝑑 × 𝐴𝑀𝑇𝑏𝑟𝑎𝑖𝑛
5 )
− (𝐾𝑜𝑥 × 𝐴𝑀𝑇𝑏𝑟𝑎𝑖𝑛
3 ) 
𝑑𝐴𝑀𝑇𝑏𝑟𝑎𝑖𝑛
5
𝑑𝑡
= 𝑄𝑏𝑟𝑎𝑖𝑛 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
5
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑏𝑟𝑎𝑖𝑛
5
𝑉𝑏𝑟𝑎𝑖𝑛 × 𝑃𝑏𝑟𝑎𝑖𝑛
5 ) − (𝐾𝑟𝑒𝑑 × 𝐴𝑀𝑇𝑏𝑟𝑎𝑖𝑛
5 )
+ (𝐾𝑜𝑥 × 𝐴𝑀𝑇𝑏𝑟𝑎𝑖𝑛
3 ) 
𝑑𝐴𝑀𝑇𝑏𝑟𝑎𝑖𝑛
𝑚𝑚𝑎
𝑑𝑡
= 𝑄𝑏𝑟𝑎𝑖𝑛 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
𝑚𝑚𝑎
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑏𝑟𝑎𝑖𝑛
𝑚𝑚𝑎
𝑉𝑏𝑟𝑎𝑖𝑛 × 𝑃𝑏𝑟𝑎𝑖𝑛
𝑚𝑚𝑎 ) 
𝑑𝐴𝑀𝑇𝑏𝑟𝑎𝑖𝑛
𝑑𝑚𝑎
𝑑𝑡
= 𝑄𝑏𝑟𝑎𝑖𝑛 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
𝑑𝑚𝑎
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑏𝑟𝑎𝑖𝑛
𝑑𝑚𝑎
𝑉𝑏𝑟𝑎𝑖𝑛 × 𝑃𝑏𝑟𝑎𝑖𝑛
𝑑𝑚𝑎 ) 
Lung:   
𝑑𝐴𝑀𝑇𝑙𝑢𝑛𝑔
3
𝑑𝑡
= 𝑄𝑙𝑢𝑛𝑔 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
3
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑙𝑢𝑛𝑔
3
𝑉𝑙𝑢𝑛𝑔 × 𝑃𝑙𝑢𝑛𝑔
3 ) + (𝐾𝑟𝑒𝑑 × 𝐴𝑀𝑇𝑙𝑢𝑛𝑔
5 ) − (𝐾𝑜𝑥 × 𝐴𝑀𝑇𝑙𝑢𝑛𝑔
3 ) 
𝑑𝐴𝑀𝑇𝑙𝑢𝑛𝑔
5
𝑑𝑡
= 𝑄𝑙𝑢𝑛𝑔 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
5
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑙𝑢𝑛𝑔
5
𝑉𝑙𝑢𝑛𝑔 × 𝑃𝑙𝑢𝑛𝑔
5 ) − (𝐾𝑟𝑒𝑑 × 𝐴𝑀𝑇𝑙𝑢𝑛𝑔
5 ) + (𝐾𝑜𝑥 × 𝐴𝑀𝑇𝑙𝑢𝑛𝑔
3 ) 
𝑑𝐴𝑀𝑇𝑙𝑢𝑛𝑔
𝑚𝑚𝑎
𝑑𝑡
= 𝑄𝑙𝑢𝑛𝑔 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
𝑚𝑚𝑎
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑙𝑢𝑛𝑔
𝑚𝑚𝑎
𝑉𝑙𝑢𝑛𝑔 × 𝑃𝑙𝑢𝑛𝑔
𝑚𝑚𝑎) 
𝑑𝐴𝑀𝑇𝑙𝑢𝑛𝑔
𝑑𝑚𝑎
𝑑𝑡
= 𝑄𝑙𝑢𝑛𝑔 × (
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
𝑑𝑚𝑎
𝑉𝑏𝑙𝑜𝑜𝑑
−
𝐴𝑀𝑇𝑙𝑢𝑛𝑔
𝑑𝑚𝑎
𝑉𝑙𝑢𝑛𝑔 × 𝑃𝑙𝑢𝑛𝑔
𝑑𝑚𝑎) 
Blood:   
𝑑𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
3
𝑑𝑡
= (∑ 𝑄𝑖
𝑛
𝑖=1
×
𝐴𝑀𝑇𝑖
3
𝑉𝑖 × 𝑃𝑖
3 − ∑ 𝑄𝑖
𝑛
𝑖=1
×
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
3
𝑉𝑏𝑙𝑜𝑜𝑑
) + (𝐾𝑟𝑒𝑑 × 𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
5 )
− (𝐾𝑜𝑥 × 𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
3 ) 
𝑑𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
5
𝑑𝑡
= (∑ 𝑄𝑖
𝑛
𝑖=1
×
𝐴𝑀𝑇𝑖
5
𝑉𝑖 × 𝑃𝑖
5 − ∑ 𝑄𝑖
𝑛
𝑖=1
×
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
5
𝑉𝑏𝑙𝑜𝑜𝑑
) − (𝐾𝑟𝑒𝑑 × 𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
5 )
+ (𝐾𝑜𝑥 × 𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
3 ) 
𝑑𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
𝑚𝑚𝑎
𝑑𝑡
= (∑ 𝑄𝑖
𝑛
𝑖=1
×
𝐴𝑀𝑇𝑖
𝑚𝑚𝑎
𝑉𝑖 × 𝑃𝑖
𝑚𝑚𝑎 − ∑ 𝑄𝑖
𝑛
𝑖=1
×
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
𝑚𝑚𝑎
𝑉𝑏𝑙𝑜𝑜𝑑
) 
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𝑑𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
𝑑𝑚𝑎
𝑑𝑡
= (∑ 𝑄𝑖
𝑛
𝑖=1
×
𝐴𝑀𝑇𝑖
𝑑𝑚𝑎
𝑉𝑖 × 𝑃𝑖
𝑑𝑚𝑎 − ∑ 𝑄𝑖
𝑛
𝑖=1
×
𝐴𝑀𝑇𝑏𝑙𝑜𝑜𝑑
𝑑𝑚𝑎
𝑉𝑏𝑙𝑜𝑜𝑑
) 
 
Urine:   
𝑑𝐴𝑀𝑇𝑢𝑟𝑖𝑛𝑒
3
𝑑𝑡
= (𝑒𝑈 × 𝐴𝑀𝑇𝑘𝑖𝑑
3 );   
𝑑𝐴𝑀𝑇𝑢𝑟𝑖𝑛𝑒
5
𝑑𝑡
= (𝑒𝑈 × 𝐴𝑀𝑇𝑘𝑖𝑑
5 ) 
𝑑𝐴𝑀𝑇𝑢𝑟𝑖𝑛𝑒
𝑚𝑚𝑎
𝑑𝑡
= (𝑒𝑈 × 𝐴𝑀𝑇𝑘𝑖𝑑
𝑚𝑚𝑎);   
𝑑𝐴𝑀𝑇𝑢𝑟𝑖𝑛𝑒
𝑑𝑚𝑎
𝑑𝑡
= (𝑒𝑈 × 𝐴𝑀𝑇𝑘𝑖𝑑
𝑑𝑚𝑎) 
Biliary Excretion:   
𝑑𝐴𝑀𝑇𝑏𝑖𝑙𝑒
3
𝑑𝑡
= (𝑒𝐵 × 𝐴𝑀𝑇𝑙𝑖𝑣
3 )  
𝑑𝐴𝑀𝑇𝑏𝑖𝑙𝑒
5
𝑑𝑡
= (𝑒𝐵 × 𝐴𝑀𝑇𝑙𝑖𝑣
5 ) 
𝑑𝐴𝑀𝑇𝑏𝑖𝑙𝑒
𝑚𝑚𝑎
𝑑𝑡
= (𝑒𝐵 × 𝐴𝑀𝑇𝑙𝑖𝑣
𝑚𝑚𝑎)  
𝑑𝐴𝑀𝑇𝑏𝑖𝑙𝑒
𝑑𝑚𝑎
𝑑𝑡
= (𝑒𝐵 × 𝐴𝑀𝑇𝑙𝑖𝑣
𝑑𝑚𝑎) 
Faecal Excretion:   
𝑑𝐴𝑀𝑇𝑓𝑎𝑒𝑐𝑒𝑠
3
𝑑𝑡
= (𝑒𝐹 × 𝐴𝑀𝑇𝑔𝑖
3 )  
𝑑𝐴𝑀𝑇𝑓𝑎𝑒𝑐𝑒𝑠
5
𝑑𝑡
= (𝑒𝐹 × 𝐴𝑀𝑇𝑔𝑖
5 ) 
𝑑𝐴𝑀𝑇𝑓𝑎𝑒𝑐𝑒𝑠
𝑚𝑚𝑎
𝑑𝑡
= (𝑒𝐹 × 𝐴𝑀𝑇𝑔𝑖
𝑚𝑚𝑎)  
𝑑𝐴𝑀𝑇𝑓𝑎𝑒𝑐𝑒𝑠
𝑑𝑚𝑎
𝑑𝑡
= (𝑒𝐹 × 𝐴𝑀𝑇𝑔𝑖
𝑑𝑚𝑎) 
 
Where: 
AMT
3
, AMT
5
, AMT
mma
 and AMT
dma
 refer to the amount (µmol) of As(III), As(V), MMA and DMA, 
respectively.  
C is the concentration (µmol/L) of As species. 
Q is the blood flow rate into a compartment (L/day). 
V is the volume of compartment (L).  
P is the partitioning coefficient of As species between compartments and the blood (unitless). 
eU is the urinary excretion rate of As species (/day). 
eB is biliary excretion rate of As species (/day). 
eF is faecal excretion rate of As species (/day). 
Abbreviations used: gastrointestinal tract (gi), kidney (kid) and liver (liv).  
i = organ/compartment. 
n = total number of organs/compartments that exchange arsenic with blood. 
Kred and Kox are metabolic constants (/day) for reduction and oxidation, respectively. 
Vmax and Km  are metabolic constants (µmol/day and µmol/L, respectively) for methylation of As(III) 
to MMA and DMA, and MMA to DMA. 
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Table I1: Physiologically based parameters used in the PBPK model for As 
Arsenic 
Parameter 
Symbol 
Parameter 
Value 
Reference Description 
BW 70 kg a Average adult body weight 
Vblood 5.53
$
 L b Volume of blood of adult (70kg) 
 5.11 L c 
Vgi 1.2 L b Volume of GI tract  
Vliv 1.82
$
 L b Volume of liver 
 1.75 L c  
Vkid 0.28
$
 L b Volume of kidney  
 0.29 L c  
Vmuscle 55.5 L b Volume of muscles 
Vskin 2.6 L b Volume of skin  
Vheart 0.35 L b Volume of heart  
Vbrain 1.4 L b Volume of brain  
Vlung 0.56 L b Volume of lung  
QCC 340 
L/day/kgBW 
c, d Cardiac blood flow 
QC 7886 L/day c, d Cardiac blood output = QCC*(BW^0.74) 
 7488
$
 L/day b Total cardiac blood output 
QLC 0.25 d Fraction of QC going to liver 
QKC 0.17
$
 d Fraction of QC going to kidney 
0.19 e Fraction of QC going to kidney 
QS 0.058 a Fraction of QC going to skin 
QM 0.19 a Fraction of QC going to muscles 
QH 0.04 a Fraction of QC going to heart 
QB 0.114 a Fraction of QC going to brain 
Qgi 1440
$
 L/day b Blood flow to GI tract  
 1273 L/day d Blood flow to GI tract (same as kidney) 
Qkid 1440
$
 L/day b Blood flow to kidney 
 1273 L/day d Blood flow to kidney = QKC*QC 
Qliv 446.4
$
 L/day b Blood flow to liver 
 1872 L/day d Blood flow to liver = QLC*QC 
Qmuscle 2592
$
 L/day b Blood flow to muscles 
 1423 L/day a Blood flow to muscles = QM*QC 
Qskin 374.4
$
 L/day b Blood flow to skin 
 434 L/day a Blood flow to skin = QS*QC 
Qheart 288
$
 L/day b Blood flow to heart 
 299 L/day a Blood flow to heart = QH*QC 
Qbrain 907.2
$
 L/day b Blood flow to brain 
 854 L/day a Blood flow to brain = QB*QC 
Qlung 7488 L/day b Blood flow to lung (QC) 
Reduction / Oxidation of inorganic arsenic 
Kred 32.88 /day f As(V) reduction in tissues (first order rate) 
42 /day f As(V) reduction in kidney (first order rate) 
Kox 43.92 /day f As(III) oxidation in tissues (first order rate) 
Metabolism constants for methylation of arsenic in the Liver 
Vmax, As(III)→MMA 748.8 g µmol/day 
763
$
 b 
Vmax, As(III)→DMA 1500 g µmol/day 
2880
$
 b 
Vmax, MMA→DMA 1067 g µmol/day 
950.4
$
 b  
Km, As(III)→MMA 100 g µmol/L 
3
$
 b 
Km, As(III)→DMA 100 g µmol/L 
3
$
 b 
Km, MMA→DMA 100 g µmol/L 
3
$
 b 
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Metabolism constants for methylation of arsenic in the Kidney 
Vmax, As(III)→MMA 499.7 g µmol/day 
305.2
$
 b 
Vmax, As(III)→DMA 667 g µmol/day 
1152
$
 b 
Vmax, MMA→DMA 333 g µmol/day 
380.16
$
 b 
Km, As(III)→MMA 100 g µmol/L 
3
$
 b 
Km, As(III)→DMA 100 g µmol/L 
3
$
 b 
Km, MMA→DMA 100 g µmol/L 
3
$
 b 
Tissue/blood partition coefficients (unitless) 
Pgi-As3 8.3
b
  GI tract/blood partition coefficient for As(III) 
Pgi-As5 2.7
b
  GI tract/blood partition coefficient for As(V) 
Pgi-MMA 2.2
b
  GI tract/blood partition coefficient for MMA 
Pgi-DMA 2.1
b
  GI tract/blood partition coefficient for DMA 
Pkid-As3 11.7
b
, 20
f$
, 4.15
g
  Kidney/blood partition coefficient for As(III) 
Pkid-As5 8.3
b$
, 40
f
, 4.15
g
  Kidney/blood partition coefficient for As(V) 
Pkid-MMA 4.4
b
, 100
f$
, 1.8
g
  Kidney/blood partition coefficient for MMA 
Pkid-DMA 3.8
b
, 5
f#
, 2.08
g
  Kidney/blood partition coefficient for DMA 
Pliv-As3 16.5
b$
, 200
f
, 5.3
g
  Liver/blood partition coefficient for As(III) 
Pliv-As5 15.8
b$
, 1
f
, 5.3
g
  Liver/blood partition coefficient for As(V) 
Pliv-MMA 3.3
b$
, 10
f
, 2.35
g
  Liver/blood partition coefficient for MMA 
Pliv-DMA 3.3
b$
, 1
f
, 2.35
g
  Liver/blood partition coefficient for DMA 
Pmuscle-As3 7.4
b$
, 2.6
g
  Muscle/blood partition coefficient for As(III) 
Pmuscle-As5 7.9
b$
, 2.6
g
  Muscle/blood partition coefficient for As(V) 
Pmuscle-MMA 2.61
b$
, 1.8
g
  Muscle/blood partition coefficient for MMA 
Pmuscle-DMA 2.4
b$
, 2.8
g
  Muscle/blood partition coefficient for MMA 
Pskin-As3 7.4
b$
, 60
f
, 2.5
g
  Skin/blood partition coefficient for As(III) 
Pskin-As5 7.9
b$
, 1
f
, 2.5
g
  Skin/blood partition coefficient for As(V) 
Pskin-MMA 2.61
b$
, 50
f
, 1.25
g
  Skin/blood partition coefficient for MMA 
Pskin-DMA 2.4
b$
, 1
f
, 1.25
g
  Skin/blood partition coefficient for MMA 
Pheart-As3 7.4
b
  Heart/blood partition coefficient for As(III) 
Pheart-As5 7.9
b
  Heart/blood partition coefficient for As(V) 
Pheart-MMA 2.61
b
  Heart/blood partition coefficient for MMA 
Pheart-DMA 2.4
b
  Heart/blood partition coefficient for DMA 
Pbrain-As3 2.4
b
  Brain/blood partition coefficient for As(III) 
Pbrain-As5 2.4
b
  Brain/blood partition coefficient for As(V) 
Pbrain-MMA 2.2
b
  Brain/blood partition coefficient for MMA 
Pbrain-DMA 3.3
b
  Brain/blood partition coefficient for DMA 
Plung-As3 6.7
b$
, 1
f
, 4.15
g
  Lung/blood partition coefficient for As(III) 
Plung-As5 2.1
b$
, 1
f
, 4.15
g
  Lung/blood partition coefficient for As(V) 
Plung-MMA 1.3
b$
, 1
f
, 1.8
g
  Lung/blood partition coefficient for MMA 
Plung-DMA 1.3
b$
, 20
f
, 2.08
g
  Lung/blood partition coefficient for DMA 
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Dimensional parameters (/day) calculated / obtained from the literature  
Rate Calculation / value  
K12As3 Qgi/(Vgi*Pgi-As3) 
K12As5 Qgi/(Vgi*Pgi-As5)  
K12MMA Qgi/(Vgi*Pgi-MMA)  
K12DMA Qgi/(Vgi*Pgi-DMA)  
K21 Qgi/Vblood  
K32As3 Qliv/(Vliv*Pliv-As3)  
K32As5 Qliv/(Vliv*Pliv-As5)  
K32MMA Qliv/(Vliv*Pliv-MMA)  
K32DMA Qliv/(Vliv*Pliv-DMA) 
K23 Qliv/Vblood 
K42As3 Qkid/(Vkid*Pkid-As3)  
K42As5 Qkid/(Vkid*Pkid-As5)  
K42MMA Qkid/(Vkid*Pkid-MMA)  
K42DMA Qkid/(Vkid*Pkid-DMA)  
K24 Qkid/Vblood 
K52As3 Qmuscle/(Vmuscle*Pmuscle-As3)  
K52As5 Qmuscle/(Vmuscle*Pmuscle-As5)  
K52MMA Qmuscle/(Vmuscle*Pmuscle-MMA)  
K52DMA Qmuscle/(Vmuscle*Pmuscle-DMA)  
K25 Qmuscle/Vblood 
K62As3 Qskin/(Vskin*Pskin-As3)  
K62As5 Qskin/(Vskin*Pskin-As5)  
K62MMA Qskin/(Vskin*Pskin-MMA) 
K62DMA Qskin/(Vskin*Pskin-DMA)  
K26 Qskin/Vblood 
K72As3 Qheart/(Vheart*Pheart-As3)  
K72As5 Qheart/(Vheart*Pheart-As5)  
K72MMA Qheart/(Vheart*Pheart-MMA)  
K72DMA Qheart/(Vheart*Pheart-DMA)  
K27 Qheart/Vblood 
K82As3 Qbrain/(Vbrain*Pbrain-As3)  
K82As5 Qbrain/(Vbrain*Pbrain-As5)  
K82MMA Qbrain/(Vbrain*Pbrain-MMA)  
K82DMA Qbrain/(Vbrain*Pbrain-DMA)  
K28 Qbrain/Vblood 
K92As3 Qlung/(Vlung*Plung-As3)  
K92As5 Qlung/(Vlung*Plung-As5)  
K92MMA Qlung/(Vlung*Plung-MMA) 
K92DMA Qlung/(Vlung*Plung-DMA) 
K29 Qlung/Vblood 
eU
+
 100.8
b
 Urinary excretion rate for As(III) and As(V) (/day) 
 432
b
 Urinary excretion rate for MMA (/day) 
 187.2
b
 Urinary excretion rate for DMA (/day) 
 1.2
g
 Urinary elimination constant for As(III) (/day) 
 1.8
g
 Urinary elimination constant for As(V) (/day) 
 100.8
g
 Urinary elimination constant for MMA (/day) 
 57.6
g
 Urinary elimination constant for DMA (/day) 
eB 0.43
g
 Biliary excretion rate for As(V), (assumed for all species) (/day) 
eF 0.03
g
 Faecal excretion rate for As(V), (assumed for all species) (/day) 
Ka 5.76
b
 Oral absorption in the GI tract for As(III) (/day) 
 4.32
b
 Oral absorption in the GI tract for As(V) (/day) 
 10.08
b
 Oral absorption in the GI tract for MMA and DMA (/day) 
aBrown et al. (1997), bEl-Masri & Kenyon (2008), cKirman et al. (2013), dO’Flaherty et al. (2001), eLiao et al. (2008),  
fMann et al. (1996), gYu (1999).  
$Value used in simulations (to fit literature data).  
#Partition coefficient of 1 provided a better fit with literature data. Mann et al. (1996) reported a DMA partitioning coefficient 
of 1 for liver, skin and ‘other’ tissues. 
+We observed that the following eU values fitted well with the literature data: 57.6 day-1 for As(III) and As(V), 100.8 day-1 for 
DMA and 432 day-1 for MMA.  
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Part I2: Cadmium PBTK model equations and parameters 
GI tract: 
𝑑𝐴𝑀𝑇𝑔𝑖 𝑡𝑟𝑎𝑐𝑡
𝑑𝑡
= −(𝐶5 × 𝐴𝑀𝑇𝑔𝑖 𝑡𝑟𝑎𝑐𝑡) − ((1 − 𝐶5) × 𝐴𝑀𝑇𝑔𝑖 𝑡𝑟𝑎𝑐𝑡) 
 
 
Intestine: 
𝑑𝐴𝑀𝑇𝑖𝑛𝑡𝑒𝑠𝑡𝑖𝑛𝑒
𝑑𝑡
= (𝐶5 × 𝐴𝑀𝑇𝑔𝑖 𝑡𝑟𝑎𝑐𝑡) − (𝐶6 × 𝐴𝑀𝑇𝑖𝑛𝑡𝑒𝑠𝑡𝑖𝑛𝑒) 
 
 
Uptake:  
𝑑𝐴𝑀𝑇𝑢𝑝𝑡𝑎𝑘𝑒
𝑑𝑡
= (𝐶6 × 𝐴𝑀𝑇𝑖𝑛𝑡𝑒𝑠𝑡𝑖𝑛𝑒) − (𝐶7 × 𝐴𝑀𝑇𝑢𝑝𝑡𝑎𝑘𝑒) − ((1 − 𝐶7) ×
𝐴𝑀𝑇𝑢𝑝𝑡𝑎𝑘𝑒) 
 
 
Blood1 (Plasma other): 
𝑑𝐴𝑀𝑇𝐵𝑙𝑜𝑜𝑑1
𝑑𝑡
= (𝐶10 × 𝐴𝑀𝑇𝑜𝑡ℎ𝑒𝑟 𝑡𝑖𝑠𝑠𝑢𝑒𝑠) + (𝐶18 × 𝐴𝑀𝑇𝑘𝑖𝑑𝑛𝑒𝑦) +
((1 − 𝐶7) × 𝐴𝑀𝑇𝑢𝑝𝑡𝑎𝑘𝑒) − (𝐶9 × 𝐴𝑀𝑇𝐵𝑙𝑜𝑜𝑑1) − (𝐶11 × 𝐴𝑀𝑇𝐵𝑙𝑜𝑜𝑑1) − (𝐶12 × 𝐴𝑀𝑇𝐵𝑙𝑜𝑜𝑑1) −
(𝐶𝑥 × 𝐴𝑀𝑇𝐵𝑙𝑜𝑜𝑑1) + (𝐶13 × 𝐴𝑀𝑇𝑙𝑖𝑣𝑒𝑟) 
 
 
Blood2 (Red blood cells): 
𝑑𝐴𝑀𝑇𝐵𝑙𝑜𝑜𝑑2
𝑑𝑡
= (𝐶𝑥 × 𝐴𝑀𝑇𝐵𝑙𝑜𝑜𝑑1) − (𝐶16 × 𝐴𝑀𝑇𝐵𝑙𝑜𝑜𝑑2) 
 
 
Blood3 (Plasma metallothionein):
 
𝑑𝐴𝑀𝑇𝐵𝑙𝑜𝑜𝑑3
𝑑𝑡
= (𝐶16 × 𝐴𝑀𝑇𝐵𝑙𝑜𝑜𝑑2) + (𝐶7 × 𝐴𝑀𝑇𝑢𝑝𝑡𝑎𝑘𝑒) + (𝐶14 × 𝐴𝑀𝑇𝑙𝑖𝑣𝑒𝑟) −
(𝐶17 × 𝐴𝑀𝑇𝐵𝑙𝑜𝑜𝑑3) − ((1 − 𝐶17) × 𝐴𝑀𝑇𝐵𝑙𝑜𝑜𝑑3) 
 
 
Liver:  
𝑑𝐴𝑀𝑇𝑙𝑖𝑣𝑒𝑟
𝑑𝑡
= (𝐶12 × 𝐴𝑀𝑇𝐵𝑙𝑜𝑜𝑑1) − (𝐶13 × 𝐴𝑀𝑇𝑙𝑖𝑣𝑒𝑟) − (𝐶14 × 𝐴𝑀𝑇𝑙𝑖𝑣𝑒𝑟) − (𝐶15 ×
𝐴𝑀𝑇𝑙𝑖𝑣𝑒𝑟) 
 
 
Kidney: 
𝑑𝐴𝑀𝑇𝑘𝑖𝑑𝑛𝑒𝑦
𝑑𝑡
= (𝐶17 × 𝐴𝑀𝑇𝐵𝑙𝑜𝑜𝑑3) − (𝐶18 × 𝐴𝑀𝑇𝑘𝑖𝑑𝑛𝑒𝑦) − (𝐶19 × 𝐴𝑀𝑇𝑘𝑖𝑑𝑛𝑒𝑦) 
 
 
Other Tissues:  
𝑑𝐴𝑀𝑇𝑜𝑡ℎ𝑒𝑟 𝑡𝑖𝑠𝑠𝑢𝑒𝑠
𝑑𝑡
= (𝐶9 × 𝐴𝑀𝑇𝐵𝑙𝑜𝑜𝑑1) − (𝐶10 × 𝐴𝑀𝑇𝑜𝑡ℎ𝑒𝑟 𝑡𝑖𝑠𝑠𝑢𝑒𝑠) 
 
 
Urine:   
𝑑𝐴𝑀𝑇𝑢𝑟𝑖𝑛𝑒
𝑑𝑡
= (𝐶19 × 𝐴𝑀𝑇𝑘𝑖𝑑𝑛𝑒𝑦) + ((1 − 𝐶17) × 𝐴𝑀𝑇𝐵𝑙𝑜𝑜𝑑3) 
 
Faeces:  
𝑑𝐴𝑀𝑇𝑓𝑎𝑒𝑐𝑒𝑠
𝑑𝑡
= ((1 − 𝐶5) × 𝐴𝑀𝑇𝑔𝑖 𝑡𝑟𝑎𝑐𝑡) + (𝐶11 × 𝐴𝑀𝑇𝐵𝑙𝑜𝑜𝑑1) + (𝐶15 ×
𝐴𝑀𝑇𝑙𝑖𝑣𝑒𝑟) 
 
Where, 
AMT is the amount (mass) of Cd in compartments (µg). 
Terms beginning with letter ‘C’ refer to transfer coefficients, as described in Table S2.   
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Table I2: Physiologically based parameters used in the Cd PBTK model 
Cadmium 
Parameter 
Symbol 
Parameter 
Value
a
 
Description 
C5 0.048 Fraction absorbed to GI tract and systemic circulation 
C6 0.05/day Rate constant for Cd absorption to system from GI tract 
C7 0.25 Fraction of absorbed Cd in system that is taken up to blood compartment 3 (B3) 
C8 1 g/day Maximum rate that can be up taken to B3 
C9 0.44 Fraction of Cd transferred from blood compartment 1 (B1) to other tissues 
C10 1.4×10-4 /day Rate constant for Cd transfer from other tissues to B1 
C11 0.27 Fraction of Cd transferred from B1 to feces 
C12 0.25 Fraction of Cd transferred from B1 to liver 
C13 3.0×10-5 /day Rate constant for Cd transfer from liver to B1 
C14 1.6×10-4 /day Rate constant for Cd transfer from liver to B3 
C15 5.0×10-5 /day Rate constant for Cd transfer from liver to feces 
C16 0.012/day Rate constant for Cd transfer from blood compartment 2 (B2) to B3 
C17 0.95 Fraction of Cd transferred from B3 to kidney 
C18 1.0×10-5 /day Rate constant for Cd transfer from kidney to B1 
C19 1.4×10-4 /day Rate constant for transfer of Cd from kidney to urine 
C20 0.1 Fraction of Cd in B1 and B3 contributing to Cd in whole blood 
Cx 0.04 Fraction of CD transfer from B1 to B2 
aKjellström & Nordberg (1978) 
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Part I3: Chromium PBPK model equations and parameters 
Gastrointestinal tract:   
𝑑𝐴𝑀𝑇𝑔𝑖
6
𝑑𝑡
= −(𝐾𝐺𝐼6 × 𝐴𝑀𝑇𝑔𝑖
6 ) − (𝐾𝑅𝐸𝐷 × 𝐴𝑀𝑇𝑔𝑖
6 ) − (𝐾𝐹𝑋 × 𝐴𝑀𝑇𝑔𝑖
6 ) 
𝑑𝐴𝑀𝑇𝑔𝑖
3
𝑑𝑡
= −(𝐾𝐺𝐼3 × 𝐴𝑀𝑇𝑔𝑖
3 ) + (𝐾𝑅𝐸𝐷 × 𝐴𝑀𝑇𝑔𝑖
6 ) − (𝐾𝐹𝑋 × 𝐴𝑀𝑇𝑔𝑖
3 ) 
Bone:   
𝑑𝐴𝑀𝑇𝑏𝑜𝑛𝑒
6
𝑑𝑡
= (𝐾𝐼𝑁6 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
6
𝑉𝑠𝑦𝑠𝑃
× 𝑄𝑏𝑜𝑛𝑒) 
𝑑𝐴𝑀𝑇𝑏𝑜𝑛𝑒
3
𝑑𝑡
= (𝐾𝐼𝑁𝑇𝐶𝑅𝐵 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
3
𝑉𝑠𝑦𝑠𝑃
× 𝑄𝑏𝑜𝑛𝑒) − (𝐾𝑂𝑈𝑇𝐶𝐶𝑅𝐵 ×
𝐴𝑀𝑇𝑏𝑜𝑛𝑒
3
𝑉𝑏𝑜𝑛𝑒
× 𝑄𝑏𝑜𝑛𝑒) 
Other Tissues:   
𝑑𝐴𝑀𝑇𝑂𝑇
6
𝑑𝑡
= (𝐾𝐼𝑁6 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
6
𝑉𝑠𝑦𝑠𝑃
× 𝑄𝑂𝑇) − (𝐾𝑅𝐸𝐷 × 𝐴𝑀𝑇𝑂𝑇
6 ) 
𝑑𝐴𝑀𝑇𝑂𝑇
3
𝑑𝑡
= (𝐾𝐼𝑁𝑇𝐶𝑅𝑂𝑇 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
3
𝑉𝑠𝑦𝑠𝑃
× 𝑄𝑂𝑇) − (𝐾𝑂𝑈𝑇𝐶𝐶𝑅𝑂𝑇 ×
𝐴𝑀𝑇𝑂𝑇
3
𝑉𝑂𝑇
× 𝑄𝑂𝑇)
+ (𝐾𝑅𝐸𝐷 × 𝐴𝑀𝑇𝑂𝑇
6 ) 
Kidney:  
𝑑𝐴𝑀𝑇𝑘𝑖𝑑
6
𝑑𝑡
= (𝐾𝐼𝑁6 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
6
𝑉𝑠𝑦𝑠𝑃
× 𝑄𝑘𝑖𝑑) − (𝐾𝑅𝐸𝐷 × 𝐴𝑀𝑇𝑘𝑖𝑑
6 ) 
𝑑𝐴𝑀𝑇𝑘𝑖𝑑
3
𝑑𝑡
= (𝐾𝐼𝑁𝑇𝐶𝑅𝐾 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
3
𝑉𝑠𝑦𝑠𝑃
× 𝑄𝑘𝑖𝑑) + (𝐾𝐼𝑁𝐶𝐶𝑅 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
3
𝑉𝑠𝑦𝑠𝑃
× 𝑄𝑘𝑖𝑑)
+ (𝐾𝑅𝐸𝐷 × 𝐴𝑀𝑇𝑘𝑖𝑑
6 ) − (𝐾𝑈𝑅𝐶 ×
𝐴𝑀𝑇𝑘𝑖𝑑
3
𝑉𝑘𝑖𝑑
) 
Urine:   
𝑑𝐴𝑀𝑇𝑢𝑟𝑖𝑛𝑒
3
𝑑𝑡
= (𝐾𝑈𝑅𝐶 ×
𝐴𝑀𝑇𝑘𝑖𝑑
3
𝑉𝑘𝑖𝑑
) 
Liver:   
𝑑𝐴𝑀𝑇𝑙𝑖𝑣
6
𝑑𝑡
= (𝐾𝐼𝑁6 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
6
𝑉𝑠𝑦𝑠𝑃
× 𝑄𝑙𝑖𝑣) + (𝐾𝐼𝑁6 ×
𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑃
6
𝑉𝑝𝑜𝑟𝑡𝑎𝑙𝑃
× 𝑄𝑝𝑜𝑟𝑡𝑎𝑙𝑃)
− (𝐾𝑅𝐸𝐷 × 𝐴𝑀𝑇𝑙𝑖𝑣
6 ) 
𝑑𝐴𝑀𝑇𝑙𝑖𝑣
3
𝑑𝑡
= (𝐾𝐼𝑁𝑇𝐶𝑅𝐿 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
3
𝑉𝑠𝑦𝑠𝑃
× 𝑄𝑙𝑖𝑣) + (𝐾𝐼𝑁𝑇𝐶𝑅𝐿 ×
𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑃
3
𝑉𝑝𝑜𝑟𝑡𝑎𝑙𝑃
× 𝑄𝑝𝑜𝑟𝑡𝑎𝑙𝑃)
+ (𝐾𝑅𝐸𝐷 × 𝐴𝑀𝑇𝑙𝑖𝑣
6 ) − (𝐾𝑂𝑈𝑇𝐶𝐶𝑅𝐿 ×
𝐴𝑀𝑇𝑙𝑖𝑣
3
𝑉𝑙𝑖𝑣
× (𝑄𝑙𝑖𝑣 + 𝑄𝑝𝑜𝑟𝑡𝑎𝑙𝑃)) 
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Blood (Portal Plasma):   
𝑑𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑃
6
𝑑𝑡
= (𝑄𝑝𝑜𝑟𝑡𝑎𝑙𝑃 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
6
𝑉𝑠𝑦𝑠𝑃
) − (𝑄𝑝𝑜𝑟𝑡𝑎𝑙𝑃 ×
𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑃
6
𝑉𝑝𝑜𝑟𝑡𝑎𝑙𝑃
) + (𝐾𝐺𝐼6 × 𝐴𝑀𝑇𝑔𝑖
6 )
− (𝐾𝑅𝐵𝐶𝐼𝑁6 ×
𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑃
6
𝑉𝑝𝑜𝑟𝑡𝑎𝑙𝑃
) − (𝐾𝐼𝑁6 ×
𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑃
6
𝑉𝑝𝑜𝑟𝑡𝑎𝑙𝑃
× 𝑄𝑝𝑜𝑟𝑡𝑎𝑙𝑃)
− (𝐾𝑅𝐸𝐷 × 𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑃
6 ) 
Cr(III) storage/excretion pool 
𝑑𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑃
3
𝑑𝑡
= (𝑄𝑝𝑜𝑟𝑡𝑎𝑙𝑃 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
3
𝑉𝑠𝑦𝑠𝑃
) − (𝑄𝑝𝑜𝑟𝑡𝑎𝑙𝑃 ×
𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑃
3
𝑉𝑝𝑜𝑟𝑡𝑎𝑙𝑃
) + (𝐾𝐺𝐼3 × 𝐴𝑀𝑇𝑔𝑖
3 )
− (𝐾𝑅𝐵𝐶𝐼𝑁3 ×
𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑃
3
𝑉𝑝𝑜𝑟𝑡𝑎𝑙𝑃
) − (𝐾𝐼𝑁𝑇𝐶𝑅𝐿 ×
𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑃
3
𝑉𝑝𝑜𝑟𝑡𝑎𝑙𝑃
× 𝑄𝑝𝑜𝑟𝑡𝑎𝑙𝑃)
+ (𝐾𝑅𝐸𝐷 × 𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑃
6 ) 
Cr(III) distribution pool 
𝑑𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑃
3
𝑑𝑡
= (𝐾𝑅𝐵𝐶𝑂𝑈𝑇3 ×
𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑃
3
𝑉𝑝𝑜𝑟𝑡𝑎𝑙𝑃
) − (𝑄𝑝𝑜𝑟𝑡𝑎𝑙𝑃 × (
𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑃
3
𝑉𝑝𝑜𝑟𝑡𝑎𝑙𝑃
−
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
3
𝑉𝑠𝑦𝑠𝑃
)) 
Blood (Portal Red Blood Cells):   
𝑑𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑅𝐵𝐶
6
𝑑𝑡
= (𝑄𝑝𝑜𝑟𝑡𝑎𝑙𝑅𝐵𝐶 × (
𝐴𝑀𝑇𝑠𝑦𝑠𝑅𝐵𝐶
6
𝑉𝑠𝑦𝑠𝑅𝐵𝐶
−
𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑅𝐵𝐶
6
𝑉𝑝𝑜𝑟𝑡𝑎𝑙𝑅𝐵𝐶
)) + (𝐾𝑅𝐵𝐶𝐼𝑁6 ×
𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑃
6
𝑉𝑝𝑜𝑟𝑡𝑎𝑙𝑃
)
− (𝐾𝑅𝐸𝐷𝑅𝐶 × 𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑅𝐵𝐶
6 ) 
𝑑𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑅𝐵𝐶
3
𝑑𝑡
= (𝑄𝑝𝑜𝑟𝑡𝑎𝑙𝑅𝐵𝐶 × (
𝐴𝑀𝑇𝑠𝑦𝑠𝑅𝐵𝐶
3
𝑉𝑠𝑦𝑠𝑅𝐵𝐶
−
𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑅𝐵𝐶
3
𝑉𝑝𝑜𝑟𝑡𝑎𝑙𝑅𝐵𝐶
)) + (𝐾𝑅𝐵𝐶𝐼𝑁3 ×
𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑃
3
𝑉𝑝𝑜𝑟𝑡𝑎𝑙𝑃
)
+ (𝐾𝑅𝐸𝐷𝑅𝐶 × 𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑅𝐵𝐶
6 ) − (𝐾𝑅𝐵𝐶𝑂𝑈𝑇3 ×
𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑅𝐵𝐶
3
𝑉𝑝𝑜𝑟𝑡𝑎𝑙𝑅𝐵𝐶
) 
Blood (Systemic Plasma):   
𝑑𝐴𝑀𝑇𝑠𝑦𝑠𝑃
6
𝑑𝑡
= (𝑄𝑝𝑜𝑟𝑡𝑎𝑙𝑃 ×
𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑃
6
𝑉𝑝𝑜𝑟𝑡𝑎𝑙𝑃
) − (𝑄𝑝𝑜𝑟𝑡𝑎𝑙𝑃 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
6
𝑉𝑠𝑦𝑠𝑃
) − (𝐾𝐼𝑁6 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
6
𝑉𝑠𝑦𝑠𝑃
× 𝑄𝑙𝑖𝑣)
− (𝐾𝐼𝑁6 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
6
𝑉𝑠𝑦𝑠𝑃
× 𝑄𝑘𝑖𝑑) − (𝐾𝐼𝑁6 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
6
𝑉𝑠𝑦𝑠𝑃
× 𝑄𝑏𝑜𝑛𝑒)
− (𝐾𝐼𝑁6 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
6
𝑉𝑠𝑦𝑠𝑃
× 𝑄𝑂𝑇) − (𝐾𝑅𝐵𝐶𝐼𝑁6 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
6
𝑉𝑠𝑦𝑠𝑃
) − (𝐾𝑅𝐸𝐷 × 𝐴𝑀𝑇𝑠𝑦𝑠𝑃
6 ) 
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Cr(III) distribution pool 
𝑑𝐴𝑀𝑇𝑠𝑦𝑠𝑃
3
𝑑𝑡
= (𝑄𝑝𝑜𝑟𝑡𝑎𝑙𝑃 ×
𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑃
3
𝑉𝑝𝑜𝑟𝑡𝑎𝑙𝑃
) − (𝑄𝑝𝑜𝑟𝑡𝑎𝑙𝑃 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
3
𝑉𝑠𝑦𝑠𝑃
)
− (𝐾𝐼𝑁𝑇𝐶𝑅𝐿 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
3
𝑉𝑠𝑦𝑠𝑃
× 𝑄𝑙𝑖𝑣) − (𝐾𝐼𝑁𝑇𝐶𝑅𝐾 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
3
𝑉𝑠𝑦𝑠𝑃
× 𝑄𝑘𝑖𝑑)
− (𝐾𝐼𝑁𝑇𝐶𝑅𝐵 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
3
𝑉𝑠𝑦𝑠𝑃
× 𝑄𝑏𝑜𝑛𝑒) − (𝐾𝐼𝑁𝑇𝐶𝑅𝑂𝑇 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
3
𝑉𝑠𝑦𝑠𝑃
× 𝑄𝑂𝑇)
− (𝐾𝑅𝐵𝐶𝐼𝑁3 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
3
𝑉𝑠𝑦𝑠𝑃
) + (𝐾𝑅𝐸𝐷 × 𝐴𝑀𝑇𝑠𝑦𝑠𝑃
6 ) 
Cr(III) storage/excretion pool 
𝑑𝐴𝑀𝑇𝑠𝑦𝑠𝑃
3
𝑑𝑡
= (𝐾𝑂𝑈𝑇𝐶𝐶𝑅𝐿 ×
𝐴𝑀𝑇𝑙𝑖𝑣
3
𝑉𝑙𝑖𝑣
× (𝑄𝑙𝑖𝑣 + 𝑄𝑝𝑜𝑟𝑡𝑎𝑙𝑃)) + (𝐾𝑂𝑈𝑇𝐶𝐶𝑅𝑂𝑇 ×
𝐴𝑀𝑇𝑂𝑇
3
𝑉𝑂𝑇
× 𝑄𝑂𝑇)
+ (𝐾𝑂𝑈𝑇𝐶𝐶𝑅𝐵 ×
𝐴𝑀𝑇𝑏𝑜𝑛𝑒
3
𝑏𝑜𝑛𝑒
× 𝑄𝑏𝑜𝑛𝑒) + (𝐾𝑅𝐵𝐶𝑂𝑈𝑇3 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑅𝐵𝐶
3
𝑉𝑠𝑦𝑠𝑅𝐵𝐶
)
− (𝐾𝐼𝑁𝐶𝐶𝑅 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
3
𝑉𝑠𝑦𝑠𝑃
× 𝑄𝑘𝑖𝑑) + (𝑄𝑝𝑜𝑟𝑡𝑎𝑙𝑃 × (
𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑃
3
𝑉𝑝𝑜𝑟𝑡𝑎𝑙𝑃
−
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
3
𝑉𝑠𝑦𝑠𝑃
)) 
Blood (Systemic Red Blood Cells):   
𝑑𝐴𝑀𝑇𝑠𝑦𝑠𝑅𝐵𝐶
6
𝑑𝑡
= (𝑄𝑝𝑜𝑟𝑡𝑎𝑙𝑅𝐵𝐶 × (
𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑅𝐵𝐶
6
𝑉𝑝𝑜𝑟𝑡𝑎𝑙𝑅𝐵𝐶
−
𝐴𝑀𝑇𝑠𝑦𝑠𝑅𝐵𝐶
6
𝑉𝑠𝑦𝑠𝑅𝐵𝐶
)) + (𝐾𝑅𝐵𝐶𝐼𝑁6 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
6
𝑉𝑠𝑦𝑠𝑃
)
− (𝐾𝑅𝐸𝐷𝑅𝐶 × 𝐴𝑀𝑇𝑠𝑦𝑠𝑅𝐵𝐶
6 ) 
𝑑𝐴𝑀𝑇𝑠𝑦𝑠𝑅𝐵𝐶
3
𝑑𝑡
= (𝑄𝑝𝑜𝑟𝑡𝑎𝑙𝑅𝐵𝐶 × (
𝐴𝑀𝑇𝑝𝑜𝑟𝑡𝑎𝑙𝑅𝐵𝐶
3
𝑉𝑝𝑜𝑟𝑡𝑎𝑙𝑅𝐵𝐶
−
𝐴𝑀𝑇𝑠𝑦𝑠𝑅𝐵𝐶
3
𝑉𝑠𝑦𝑠𝑅𝐵𝐶
)) + (𝐾𝑅𝐵𝐶𝐼𝑁3 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑃
3
𝑉𝑠𝑦𝑠𝑃
)
− (𝐾𝑅𝐵𝐶𝑂𝑈𝑇3 ×
𝐴𝑀𝑇𝑠𝑦𝑠𝑅𝐵𝐶
3
𝑉𝑠𝑦𝑠𝑅𝐵𝐶
) + (𝐾𝑅𝐸𝐷𝑅𝐶 × 𝐴𝑀𝑇𝑠𝑦𝑠𝑅𝐵𝐶
6 ) 
Faeces:  
𝑑𝐴𝑀𝑇𝑓𝑎𝑒𝑐𝑒𝑠
6
𝑑𝑡
= (𝐾𝐹𝑋 × 𝐴𝑀𝑇𝑔𝑖
6 );   
𝑑𝐴𝑀𝑇𝑓𝑎𝑒𝑐𝑒𝑠
3
𝑑𝑡
= (𝐾𝐹𝑋 × 𝐴𝑀𝑇𝑔𝑖
3 ) 
 
Where, 
AMT
3
 and AMT
6
 refer to the mass of Cr(III) and Cr(VI) in compartments, respectively.  
Abbreviations used for compartments: gastrointestinal tract (gi), systemic plasma (sysP), portal 
plasma (portal), other tissues (OT), kidney (kid), liver (liv), systemic red blood cells (sysRBC), 
portal red blood cells (portalRBC). Transfer parameters beginning with letter ‘K’ are described in 
Table S3.  
Q is the blood flow into a compartment (L/day), V is the volume of compartment (L).  
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Table I3: Physiologically based parameters for the Cr PBPK model 
Chromium 
Parameter 
Symbol 
Parameter  
Value 
Reference Description 
BW 70 kg  Average adult body weight 
HCT 0.45
$
 a Blood has approx. 45% hematocrit 
0.43 b 
VLC 0.025 L/kgBW a, b Liver volume fraction in adult 
VKC 0.0042 L/kgBW b Kidney volume fraction in adult 
VBC 0.14 L/kgBW b Bone volume fraction in adult 
VBLC 0.073 L/kgBW b Blood volume fraction in adult 
Vblood 5.53 L c Volume of blood of adult (70kg) male 
5.11
$
 L b Volume of blood = VBLC*BW 
Vrbc 2.3 L b Red Blood Cell volume  = (Vblood*HCT) 
Vplasma 2.8 L b Blood Plasma volume  = (Vblood*(1-HCT)) 
FPT 0.205 b Fraction of blood volume in portal system 
Vliv 1.82 L c Volume of liver of adult (70kg) male 
1.75
$
 L b Volume of liver = VLC*BW 
Vkid 0.28 L c Volume of kidney of adult (70kg) male 
0.29
$
 L b Volume of kidney  = VKC*BW 
Vbone 9.8 L b, d Volume of bone  = VBC*BW 
VOT 53 L b Volume of other tissues  =  
BW-(Vbone + Vliv + Vkid + Vblood) 
VsysRBC 1.83 L b Volume of Red Blood Cell in systemic blood = Vrbc*(1-
FPT) 
VportalRBC 0.47 L b Volume of Red Blood Cell in portal blood = Vrbc*FPT 
VsysP 2.23 L b Volume of Plasma in systemic blood = Vplasma*(1-FPT) 
VportalP 0.57 L b Volume of Plasma in portal blood = Vplasma*FPT 
QCC 340 L/day/kgBW a, b Cardiac blood flow 
QC 7885.9 L/day a, b Cardiac blood output = QCC*(BW^0.74) 
QCG 4337.2 L/day b Cardiac plasma output = QC*(1-HCT) 
QBC 0.03
$
 a Fraction of QC going to bone 
0.05 b 
QKC 0.17
$
 a Fraction of QC going to kidney 
0.19 b 
QLC 0.25 a Fraction of QC going to liver 
QPTC 0.19 b Fraction of QC going to portal plasma 
Qliv 1084.3 L/day a Blood plasma flow to liver = QLC*QCG 
Qkid 737.3 L/day a Blood plasma flow to kidney = QKC*QCG 
824 L/day b 
QportalP 824 L/day b Blood plasma flow in portal system  = QPTC*QCG 
QportalRBC 674.2 L/day b Red Blood Cell flow in portal system  = QportalP *HCT/(1-
HCT) 
Qbone 130.1 L/day a Blood plasma flow to bone = QBC*QCG 
216.9 L/day b 
QOT 1561.4 L/day  b Blood plasma flow to other tissues  =  
QCG-(Qliv+ Qkid+Qbone+QportalP) 
Kinetic Rate Constants 
KGI3 0.25
#
 /day a Absorption of Cr(III) from the GI tract 
KGI6 2.5
#
 /day a Absorption of Cr(VI) from the GI tract 
KFX 14 /day a Loss of Cr from GI tract to faeces 
KIN6 2 b, e Transfer of Cr(VI) from plasma to tissues 
KINTCRB 0.0625 b Cr(III) transfer from distribution pool in plasma to bone 
KOUTCCRB 0.00228 b Cr(III) transfer from bone to plasma  
KREDGI 100 /day a Reduction of Cr(VI) to Cr(III) in GI tract 
KREDRC 7 /day a Reduction of Cr(VI) to Cr(III) in the red blood cells 
KREDBP 0.2 /day a Reduction of Cr(VI) to Cr(III) in blood plasma 
KREDKL 500 /day a Reduction of Cr(VI) to Cr(III) in kidney and liver 
KRED 5 /day a Reduction of Cr(VI) to Cr(III) in all other tissues 
KINTCROT 0.004 b Cr(III) transfer from distribution pool in plasma to other 
tissues 
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KOUTCCROT 0.008 b Cr(III) transfer from other tissues to plasma  
KINTCRK 0.08 b Cr(III) transfer from distribution pool in plasma to kidney  
KINCCR 0.04 b Cr(III) transfer from storage/excretion pool in plasma to 
kidney 
KURC 1.74 L/day b Urinary excretion rate for Cr(III) in storage/excretion pool 
KINTCRL 0.0203 b Cr(III) transfer from distribution pool in plasma to liver 
KOUTCCRL 0.016 b Cr(III) transfer from storage/excretion pool in liver to 
plasma 
KRBCIN6 192 L/day b Cr(VI) transfer from plasma to red blood cells 
KRBCIN3 0.0192 L/day b Cr(III) transfer from plasma to red blood cells 
KRBCOUT3 0.036 L/day b Cr(III) transfer from red blood cells to plasma 
Transfer rates (/day) calculated from physiological parameters and rate constants 
Compartment Calculation 
Bone 
(KIN6*Qbone)/VsysP 
(KINTCRB*Qbone)/VsysP 
(KOUTCCRB*Qbone)/Vbone 
Other Tissues 
(KIN6*QOT)/VsysP 
(KINTCROT*QOT)/VsysP 
(KOUTCCROT*QOT)/VOT 
Kidney  
(KIN6*Qkid)/VsysP 
(KINTCRK*Qkid)/VsysP 
(KINCCR*Qkid)/VsysP 
KURC/Vkid 
Liver 
(KIN6*Qliv)/VsysP 
(KIN6*QportalP)/VportalP 
(KINTCRL*Qliv)/VsysP 
(KINTCRL*QportalP)/VportalP 
(KOUTCCRL*(Qliv+QportalP))/Vliv 
Blood 
QportalP/VsysP 
QportalP/VportalP 
KRBCIN6/ VportalP 
KRBCIN3/ VportalP 
KRBCOUT3/ VportalRBC 
QportalRBC/VsysRBC 
QportalRBC/VportalRBC 
KRBCIN6/ VsysP 
KRBCIN3/ VsysP 
KRBCOUT3/ VsysRBC 
aO’Flaherty et al. (2001), bKirman et al. (2013), cEl-Masri & Kenyon (2008), dO’Flaherty (1993) , eKirman et al. (2012) 
$Value used in simulations. 
#
Because of the inter- and intra-individual variability of gastrointestinal absorption of Cr, we used KGI3 values ranging from 
0.05 to 0.25 day-1 and KGI6 values ranging from 1 to 2.5 day-1 to fit model simulations to the literature data (see discussion in 
report section 6.2.3).  
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Part I4: Lead PBPK model equations and parameters 
GI tract: 
𝑑𝐴𝑀𝑇𝑔𝑖
𝑑𝑡
= −(𝐴𝑔𝑖 × 𝐼𝑅𝑔𝑖) − ((1 − 𝐴𝑔𝑖) × 𝐼𝑅𝑔𝑖) 
Blood-plasma:  
𝑑𝐴𝑀𝑇𝐵𝑝
𝑑𝑡
= (𝑄𝑙𝑖𝑣𝑒𝑟 × (
𝐴𝑀𝑇𝑙𝑖𝑣𝑒𝑟
𝑉𝑙𝑖𝑣𝑒𝑟×𝑃𝑙𝑖𝑣𝑒𝑟
−
𝐴𝑀𝑇𝑝𝑙𝑎𝑠𝑚𝑎
𝑉𝑝𝑙𝑎𝑠𝑚𝑎
)) + (𝑄𝑘𝑖𝑑𝑛𝑒𝑦 × (
𝐴𝑀𝑇𝑘𝑖𝑑𝑛𝑒𝑦
𝑉𝑘𝑖𝑑𝑛𝑒𝑦×𝑃𝑘𝑖𝑑𝑛𝑒𝑦
−
𝐴𝑀𝑇𝑝𝑙𝑎𝑠𝑚𝑎
𝑉𝑝𝑙𝑎𝑠𝑚𝑎
)) + (𝑄𝑏𝑜𝑛𝑒 × (
𝐴𝑀𝑇𝑏𝑜𝑛𝑒
𝑉𝑏𝑜𝑛𝑒×𝑃𝑏𝑜𝑛𝑒
−
𝐴𝑀𝑇𝑝𝑙𝑎𝑠𝑚𝑎
𝑉𝑝𝑙𝑎𝑠𝑚𝑎
)) + (𝑄𝑤𝑝 × (
𝐴𝑀𝑇𝑤𝑝
𝑉𝑤𝑝×𝑃𝑤𝑝
−
𝐴𝑀𝑇𝑝𝑙𝑎𝑠𝑚𝑎
𝑉𝑝𝑙𝑎𝑠𝑚𝑎
)) + (𝑄𝑝𝑝 × (
𝐴𝑀𝑇𝑝𝑝
𝑉𝑝𝑝×𝑃𝑝𝑝
−
𝐴𝑀𝑇𝑝𝑙𝑎𝑠𝑚𝑎
𝑉𝑝𝑙𝑎𝑠𝑚𝑎
)) 
Liver:  
𝑑𝐴𝑀𝑇𝑙𝑖𝑣𝑒𝑟
𝑑𝑡
= (𝐴𝑔𝑖 × 𝐼𝑅𝑔𝑖) + (𝑄𝑙𝑖𝑣𝑒𝑟 × (
𝐴𝑀𝑇𝑝𝑙𝑎𝑠𝑚𝑎
𝑉𝑝𝑙𝑎𝑠𝑚𝑎
−
𝐴𝑀𝑇𝑙𝑖𝑣𝑒𝑟
𝑉𝑙𝑖𝑣𝑒𝑟×𝑃𝑙𝑖𝑣𝑒𝑟
)) − 𝑒𝐵 ×
𝐴𝑀𝑇𝑙𝑖𝑣𝑒𝑟 
Kidney:  
𝑑𝐴𝑀𝑇𝑘𝑖𝑑𝑛𝑒𝑦
𝑑𝑡
= 𝑄𝑘𝑖𝑑𝑛𝑒𝑦 × (
𝐴𝑀𝑇𝑝𝑙𝑎𝑠𝑚𝑎
𝑉𝑝𝑙𝑎𝑠𝑚𝑎
−
𝐴𝑀𝑇𝑘𝑖𝑑𝑛𝑒𝑦
𝑉𝑘𝑖𝑑𝑛𝑒𝑦×𝑃𝑘𝑖𝑑𝑛𝑒𝑦
) − 𝑒𝑈 × 𝐴𝑀𝑇𝑘𝑖𝑑𝑛𝑒𝑦 
Bone:   
𝑑𝐴𝑀𝑇𝑏𝑜𝑛𝑒
𝑑𝑡
= 𝑄𝑏𝑜𝑛𝑒 × (
𝐴𝑀𝑇𝑝𝑙𝑎𝑠𝑚𝑎
𝑉𝑝𝑙𝑎𝑠𝑚𝑎
−
𝐴𝑀𝑇𝑏𝑜𝑛𝑒
𝑉𝑏𝑜𝑛𝑒×𝑃𝑏𝑜𝑛𝑒
) 
Tissues (wp):  
𝑑𝐴𝑀𝑇𝑤𝑝
𝑑𝑡
= 𝑄𝑤𝑝 × (
𝐴𝑀𝑇𝑝𝑙𝑎𝑠𝑚𝑎
𝑉𝑝𝑙𝑎𝑠𝑚𝑎
−
𝐴𝑀𝑇𝑤𝑝
𝑉𝑤𝑝×𝑃𝑤𝑝
) 
Tissues (pp):  
𝑑𝐴𝑀𝑇𝑝𝑝
𝑑𝑡
= 𝑄𝑝𝑝 × (
𝐴𝑀𝑇𝑝𝑙𝑎𝑠𝑚𝑎
𝑉𝑝𝑙𝑎𝑠𝑚𝑎
−
𝐴𝑀𝑇𝑝𝑝
𝑉𝑝𝑝×𝑃𝑝𝑝
) 
Urinary Excretion: 
𝑑𝐴𝑀𝑇𝑢𝑟𝑖𝑛𝑒
𝑑𝑡
= 𝑒𝑈 × 𝐴𝑀𝑇𝑘𝑖𝑑𝑛𝑒𝑦 
Biliary Excretion:  
𝑑𝐴𝑀𝑇𝑏𝑖𝑙𝑒
𝑑𝑡
= 𝑒𝐵 × 𝐴𝑀𝑇𝑙𝑖𝑣𝑒𝑟 
Faecal Excretion:  
𝑑𝐴𝑀𝑇𝑓𝑎𝑒𝑐𝑒𝑠
𝑑𝑡
=  ((1 − 𝐴𝑔𝑖) × 𝐼𝑅𝑔𝑖) 
 
Where, 
AMT is the mass of Pb in compartments, 
Q is the blood flow into a compartment (L/day),  
V is the volume of compartment (L), 
IRgi is the oral intake rate of Pb (mg/day),  
Agi is the Pb absorption coefficient from gastrointestinal tract (unitless), 
eB is the biliary excretion rate of Pb (/day), 
eU is the urinary excretion rate of Pb (/day), 
GI tract refers to the gastrointestinal tract, 
WP is well-perfused tissues, and  
PP is poorly-perfused tissues. 
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Table I4: Physiologically based parameters for the Pb PBPK model 
Lead 
Parameter 
Symbol 
Parameter 
Value 
Reference Description 
BW 70 kg a, c Average adult body weight 
QCC 340 
L/day/kgBW 
a, b Cardiac blood flow 
QC 7885.9 L/day a, b Cardiac blood output = QCC*(BW^0.74) 
HCT 0.45 a, b Blood has approx. 45% hematocrit 
QLC 0.25 a, b Fraction of QC going to liver 
QKC 0.17 a, b Fraction of QC going to kidney 
QBC 0.03 a, b Fraction of QC going to bone 
QWC 0.44 a, b Fraction of QC going to tissues (wp) 
QPC 0.11 a, b Fraction of QC going to tissues (pp) 
QCG 4337.2 L/day a, b Cardiac plasma output = QC*(1-HCT) 
Qliver 1084.3 L/day a, b Blood plasma flow to liver = QLC*QCG 
Qkidney 737.3 L/day a, b Blood plasma flow to kidney = QKC*QCG 
Qbone 130.1 L/day a, b Blood plasma flow to bone = QBC*QCG 
Qwp 86.74 L/day a, b Blood plasma flow to tissues (wp) 
=(QWC*QCG)-Qliver-Qkidney 
Qpp 346.98 L/day a, b Blood plasma flow to tissues (pp) =(QPC*QCG)-Qbone 
VLC 0.025 L/kgBW a, b Constant for liver volume 
VKC 0.0042 
L/kgBW 
a, b Constant for kidney volume 
VBC 0.14 L/kgBW a, b Constant for bone volume 
VBLC 0.073 L/kgBW a, b Constant for blood volume 
Vliver 1.75 L a, b Volume of liver = VLC*BW 
Vkidney 0.29 L a, b Volume of kidney = VKC*BW 
Vbone 9.8 L a, b Volume of bone = VBC*BW 
Vblood 5.11 L a, b Volume of blood = VBLC*BW 
Vplasma 2.81 L a, b Volume of plasma (55% of Vblood) 
Vwp 1.96 L a Volume of well-perfused tissues (wp) = (BW^0.7)*0.1 
Vpp 58.24 L a Volume of poorly-perfused tissues (pp) = BW-Vwp-Vbone 
Pliver 100 a, b Partition coefficient, liver/plasma 
Pkidney 100 a, b Partition coefficient, kidney/plasma 
Pwp 100 a, b Partition coefficient, well-perfused tissues/plasma 
Ppp 20 a, b Partition coefficient, poorly-perfused tissues/plasma 
Pbone 1000 a, b Partition coefficient, bone/plasma 
Transfer rates used in this study 
Rate Units Calculation / value 
K12 day
-1
 Qliver/(Vliver*Pliver) 
K21 day
-1
 Qliver/Vplasma 
K23 day
-1
 Qkidney/Vplasma  
K32 day
-1
 Qkidney/(Vkidney*Pkidney)  
K24 day
-1
 Qbone/Vplasma  
K42 day
-1
 Qbone/(Vbone*Pbone)  
K25 day
-1
 Qwp/Vplasma  
K52 day
-1
 Qwp/(Vwp*Pwp)  
K26 day
-1
 Qpp/Vplasma  
K62 day
-1
 Qpp/(Vpp*Ppp)  
Agi unitless 0.06-0.12
c
 
eU day
-1
 0.47
d
 
eB day
-1
 0.2
d
 
aO’Flaherty (1991), bO’Flaherty (1993), cRabinowitz et al. (1976), dMorisawa et al. (2001)  
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Part I5: Nickel PBTK model equations and parameters 
Gut:  
𝑑𝐴𝑀𝑇𝑔𝑢𝑡
𝑑𝑡
= −𝐾𝑓 − (𝐾1 × 𝐴𝑀𝑇𝑔𝑢𝑡) − (𝜌𝐾1 × 𝐴𝑀𝑇𝑔𝑢𝑡) 
Serum:  
𝑑𝐴𝑀𝑇𝑠𝑒𝑟𝑢𝑚
𝑑𝑡
= 𝐾𝑓 + (𝐾1 × 𝐴𝑀𝑇𝑔𝑢𝑡) + (𝐾21 × 𝐴𝑀𝑇𝑡𝑖𝑠𝑠𝑢𝑒𝑠) − (𝐾12 ×
𝐴𝑀𝑇𝑠𝑒𝑟𝑢𝑚) − (𝑒𝑈 × 𝐴𝑀𝑇𝑠𝑒𝑟𝑢𝑚) 
Urine:  
𝑑𝐴𝑀𝑇𝑢𝑟𝑖𝑛𝑒
𝑑𝑡
= (𝑒𝑈 × 𝐴𝑀𝑇𝑠𝑒𝑟𝑢𝑚) 
Tissues:  
𝑑𝐴𝑀𝑇𝑡𝑖𝑠𝑠𝑢𝑒𝑠
𝑑𝑡
= (𝐾12 × 𝐴𝑀𝑇𝑠𝑒𝑟𝑢𝑚) − (𝐾21 × 𝐴𝑀𝑇𝑡𝑖𝑠𝑠𝑢𝑒𝑠) 
Faeces:  
𝑑𝐴𝑀𝑇𝑓𝑎𝑒𝑐𝑒𝑠
𝑑𝑡
= (𝜌𝐾1 × 𝐴𝑀𝑇𝑔𝑢𝑡) 
 
Where, 
AMT is the mass of Ni in compartments. 
The absorbed fraction of Ni dose in the gut (Agut) was 0.011, as determined by Sunderman et al. 
(1989). The daily rate constant for faecal excretion of unabsorbed Ni in dose was expressed as 
ρK1, and ρ was calculated as (1-Agut)/Agut. 
 
Table I5: Physiologically based parameters for the Ni PBTK model 
Nickel 
Parameter 
Symbol 
Parameter Value Reference Description 
Agut 0.7 ± 0.4  % a Mass fraction of Ni dose absorbed from the gut 
2.95 ± 1.32  % b 
K1 0.33 ± 0.24 /hr a Alimentary absorption of Ni from ingested dose 
Kf 1.05*10
-4
  ±  3.6*10
-5 
mg/hr 
a Alimentary absorption of Ni from dietary (baseline) 
Ni intake (pseudo-zero order) 
eU 0.15 ± 0.11 /hr a Urinary elimination rate of nickel 
K12 0.37 ± 0.34 /hr a Nickel transfer rate from serum to tissues 
K21 0.1/hr a Nickel transfer rate from tissues to serum 
aSunderman et al. (1989), bNielsen et al. (1999) 
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Appendix J: Outputs of Selected Simulations 
Part J1: Selected simulations showing predicted blood Pb concentrations  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. J1-A: Predicted blood Pb concentration for 
participant P04. Daily intake rate (IR, in µg day-1) of Pb 
was calculated using the participant’s produce 
consumption rates. IR was determined for each month, 
ranging from 20 to 154 µg day-1. Measured blood Pb 
concentrations are also indicated.  
Fig. J1-B: Predicted blood Pb concentration for 
participant P09. IR for each month ranged from 17 to 
150 µg day-1. Concentrations of Pb in blood samples 
are indicated.  
Fig. J1-C: Predicted blood Pb concentration for 
participant P10. IR for each month ranged from 30 to 
120 µg day-1. Measured Pb concentrations in blood 
samples are indicated.  
Fig. J1-D: Predicted blood Pb concentration for 
participant P11. IR for each month ranged from 40 to 
186 µg day-1. Measured Pb concentrations in blood 
samples are indicated.  
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Fig. J1-E: Predicted blood Pb concentration for 
participant P15. IR for each month ranged from 22 to 
137 µg day-1. Measured Pb concentrations in blood 
samples are indicated.  
Fig. J1-F: Predicted blood Pb concentration for 
participant P17. IR for each month ranged from 10 to 
120 µg day-1. Measured Pb concentrations in blood 
samples are indicated.  
Fig. J1-G: Predicted blood Pb concentration for 
participant P22. IR for each month ranged from 10 to 
139 µg day-1. Measured Pb concentrations in blood 
samples are indicated.  
Fig. J1-H: Predicted blood Pb concentration for 
participant P23. IR for each month ranged from 10 to 
115 µg day-1. Measured Pb concentrations in blood 
samples are indicated.  
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Fig. J1-I: Predicted blood Pb concentration for 
participant P01, simulated using the average daily 
Pb intake rate (IR) of 50 µg day-1. Continuous 
daily exposure was simulated for a period 1 year.  
Fig. J1-J: Predicted blood Pb concentration for participant P01, 
simulated using the average daily Pb intake rate (IR) of 50 µg 
day-1. Continuous daily exposure was simulated for a period 10 
years. Predicted blood Pb becomes steady at 9.4 µg dL-1 after 
about 1500 days (~ 4 years) of continuous daily exposure.  
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Fig. J1-L: Predicted blood Pb concentration for participant P15, 
simulated using the median daily Pb intake rate (IR) of 45 µg day-1. 
Continuous daily exposure was simulated for a period 10 years. 
Predicted blood Pb becomes steady at 8.6 µg dL-1 after about 1500 
days (~ 4 years) of continuous daily exposure.  
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Fig. J1-K: Predicted blood Pb concentration for 
participant P15, simulated using the median daily Pb 
intake rate (IR) of 45 µg day-1. Continuous daily 
exposure was simulated for a period 1 year.  
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Part J2: Selected simulations of inorganic As in urine  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Fig. J2-A: Predicted and measured iAs in urine for 
participant P12. Simulated doses of iAs varied 
between 0.1 and 1.5 µmol.  
Fig. J2-B: Predicted and measured iAs in urine for 
participant P13. Simulated doses of iAs varied 
between 0.6 and 1.2 µmol.  
Fig. J2-E: Predicted and measured iAs in urine for 
participant P25. Simulated doses of iAs varied 
between 0.01 and 1.6 µmol.  
Fig. J2-F: Predicted and measured iAs in urine for 
participant P26. Simulated doses of iAs varied 
between 0.1 and 1.5 µmol.  
Fig. J2-D: Predicted and measured iAs in urine for 
participant P22. Simulated doses of iAs varied 
between 0.1 and 0.9 µmol.  
Fig. J2-C: Predicted and measured iAs in urine for 
participant P15. Simulated doses of iAs varied 
between 0.2 and 2.5 µmol.  
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Part J3: Summary of output of Cd simulations and measured Cd in urine 
Participant 
ID 
Calculated 
Cd doses 
(µg day
-1
)
a
 
Simulated 
Exposure 
Frequencies 
(years)
b
 
Predicted Cd in 
Urine (µg L
-1
) 
Median of 
measured Cd in 
Urine (µg L
-1
)
c
 
P01 8.3 20 0.12 0.117 
P02 7 20 0.08 0.101 
P03 2.2 1 0.003 0.015 
P04 1.4 2.5 0.003 0.020 
P05 7.8 20 0.1 0.121 
P07 1.8 2 0.004 0.020 
P08 5.5 3 0.015 0.037 
P09 7.1 3.5 0.021 0.053 
P10 9.7 17 0.1 0.123 
P11 10.4 17 0.11 0.132 
P12 9.8 20 0.12 0.154 
P13 6 20 0.07 0.068 
P15 3.8 8 0.022 0.042 
P16 5.8 4 0.02 0.037 
P17 7 4 0.023 0.020 
P18 6.4 2 0.013 0.042 
P19 3.5 20 0.041 0.037 
P20 2.4 1.5 0.004 0.042 
P21 3.8 20 0.044 0.073 
P22 3.9 20 0.045 0.033 
P23 4.5 30 0.07 0.051 
P24 6.5 30 0.1 0.088 
P25 4.8 19 0.054 0.044 
P26 6.4 19 0.1 0.077 
P28 6.1 0.2 0.005 0.018 
P29 9.3 5 0.04 0.055 
P31 4.3 1 0.002 0.018 
P32 8 6 0.036 0.057 
P33 7.3 7 0.04 0.046 
P34 1.4 17 0.015 0.051 
P35 2.2 17 0.023 0.040 
P36 4.5 0.2 0.004 0.033 
P38 1.5 1.5 0.003 0.018 
P39 2.6 6 0.012 0.022 
a
A participant’s daily intake rates (IR) were averaged over 12 months to obtain a representative annual 
IR value used as the dose. Excludes extra data collected over the 2 to 3 consecutive days.  
b
Based on the reported number of years a participant has been using their allotment.  
c
For urinary concentrations ≥LOD.  
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Part J4: Selected simulations of Cr(III) in urine 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Fig. J4-A: Predicted and measured Cr(III) in urine 
for participant P09. Simulated doses varied 
between 42 and 72 µg Cr(III).   
Fig. J4-B: Predicted and measured Cr(III) in urine 
for participant P12. Simulated doses varied 
between 45 and 86 µg Cr(III).   
Fig. J4-C: Predicted and measured Cr(III) in urine 
for participant P21. Simulated doses varied 
between 25 and 92 µg Cr(III).   
Fig. J4-D: Predicted and measured Cr(III) in urine 
for participant P22. Simulated doses varied 
between 25 and 86 µg Cr(III).   
Fig. J4-E: Predicted and measured Cr(III) in urine 
for participant P25. Applied doses varied between 
11 and 83 µg Cr(III).   
Fig. J4-F: Predicted and measured Cr(III) in urine 
for participant P26. Applied doses varied between 
48 and 68 µg Cr(III).   
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Part J5: Selected simulations of Ni in urine 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. J5-A: Predicted and measured Ni in urine for 
participant P01.  Simulated doses varied between 
50 and 90 µg Ni.  
Fig. J5-B: Predicted and measured Ni in urine for 
participant P09.  Simulated doses varied between 
12 and 102 µg Ni.  
Fig. J5-D: Predicted and measured Ni in urine for 
participant P11.  Simulated doses varied between 
80 and 100 µg Ni.  
Fig. J5-C: Predicted and measured Ni in urine for 
participant P10.  Simulated doses varied between 
83 and 100 µg Ni.  
Fig. J5-F: Predicted and measured Ni in urine for 
participant P13.  Simulated doses varied between 
17 and 105 µg Ni.  
Fig. J5-E: Predicted and measured Ni in urine for 
participant P12.  Simulated doses varied between 
32 and 155 µg Ni.  
